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Bioinformatics is a catalyzer of modern life sciences research. Its development and 
impact in life sciences is fundamental to understand the scientific progress in the last 
decades. Bioinformatics fosters the development of computational solutions that 
facilitate a qualitative and quantitative understanding of life, that is, it supports the 
interpretation of data coming from life sciences experiments. It is a multidisciplinary 
area which requires a collaborative effort. 
This book describes several of the most important areas in Bioinformatics, grouped 
into five main sections. In the first section, the importance and relevance of biological 
networks and their relevance is explained and its potential is exploited in different 
research areas. The second one describes the latest developments and applications in 
the active field of next generation sequencing. Since Bioinformatics studies requires 
the use of high performance computing resources, the third section describes its 
exploitation in different scenarios. Detailed reviews of molecular modeling and 
advanced aspects of its application in drug discovery scenarios are described in the 
fourth section. Exposition of the relevance of structural bioinformatics is described in 
the fifth section, and the last part of the book shows different studies where the 
application of intelligent data analysis techniques has been elegantly employed.  
The objective of the book is to give a general view of the different areas of 
Bioinformatics, and each of them both introduces basic concepts and then explains its 
application to problems of great relevance, so both novice and expert readers can 
benefit from the information and research works presented here.  
 
Dr. Horacio Pérez-Sánchez 
Computer Engineering Department, 
School of Computer Science, 
University of Murcia, 
Spain 
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Analysis of Biological Networks 
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1. Introduction 
Biological pathway data is the key resource for biologists worldwide. Interestingly, most of 
these sources that generate, update, and analyze data are open source. One of the 
observations that motivated this research work is that, the repositories of data created by a 
variety of laboratories and research units worldwide represent same pathways with 
significant details. Generally, if the pathway data has resulted from experimentation, then it 
is expected that across different resources, under similar conditions, pathways would be 
exactly identical and biologists may pickup from any source. Interestingly, almost all of the 
biological data sources refer to data integration of some kind. It may involve rigorous 
integration mechanisms within the data source and the purpose of integration may change 
the perspective of looking at the integration.  
These efforts in integration may be either local to the source or lack details associated with 
integration within a pathway, across pathways, or from various data sources etc. Further, 
the key attributes or design criteria may not be well documented and or may not be readily 
available to the biologist. In other words, the integration may be achieved as vertical 
integration (within the data source), or horizontal integration (across data sources). Since 
most of the extensively integrated data sources (plants or humans) like BioCyc-level-I, 
Reactome are human curated, it is hard to identify the integration done by the sources like; 
BioCyc. Also, on a similar note, it may not be apparent to find exactly when the data was 
integrated looking at a pathway.  
Data in general refers to a collection of results, including the results of experience, 
observation, or experiment, or a set of premises and can be utilized at the maximum when 
made available to all in a common format. Different organizations and research laboratories 
around the world store the data in their own formats; this diversity of data sources is caused 
due to many factors including lack of coordination among the organizations and research 
© 2012 Kher et al., licensee InTech. This is a p per distributed under the terms of the C eative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
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laboratories. These intellectual gaps can be bridged by adopting new technology, mergers, 
acquisitions, and geographic coordination of collaborating groups [1]. 
For the open source biological databases, it is common for the biologists and researchers to 
refer to many databases in order to pursue inference or analysis; though it is one of the most 
challenging tasks. Biological pathway data integration is aimed to work with repositories of 
data from a variety of sources. As such, two or more databases may not provide identical 
information for a given pathway, but integrating these two databases may yield a richer 
resource for analysis. Additionally, the conditions under which data is collected, either by 
experimentation or by collecting evidence of the published material, in either case the 
supporting references play a crucial role and is of interest to the biologists in making the 
analysis more meaningful. At present there are over 200 biological pathway databases. 
However, very few of them are independently created. Some of these databases may be 
derived from different data sources. Unfortunately, the documentation often does not reveal 
details of the data collection, sources, and dates. Further, the research groups involved in 
analysis of the data usually selectively use data from a single data source. For example, for 
yeast studies, the Saccharomyces Genome Database (SGD) is the reference for most analyses 
[2].  
In case of biological pathway data, rapid accumulation of genomic and proteomic data have 
made two major bioinformatics problems apparent.  
 The lack of communication between different bioinformatics data resources; whether 
they are databases or individual analysis programs.  
 Biological data are hierarchical and highly related yet are conventionally stored 
separately in individual database and in different formats. 
 Additionally, they are governed more by how data is obtained rather than by what they 
mean.  
Most commercially available bioinformatics systems perform functional analysis using a 
single data source; an approach that emphasizes pathway mapping and relationship 
inference based on the data acquired from multiple data sources. Each pathway modality in 
the data has its own specific representation issues which must be understood before 
attempting to integrate across modalities. 
1.1. Overview 
There has been a dramatic increase in the number of large scale comprehensive biological 
databases that provide useful resources to the community like; Biochemical Pathways 
(KEGG, AraCyc, and MapMan), Protein Interactions (biomolecular interaction network 
database), or systems like; Dragon Plant Biology Explorer and Pathway Miner for 
integrating associations in metabolic networks and ontologies [3-8]. Other databases such as 
Regulon DB, PlantCARE, PLACE, EDP:Eurokaryotic promoter database, Transcription 
Regulatory Regions Database, Athamap, and TRANSFAC store information related to 
transcriptional regulation[9-15].  
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The aim of molecular biology is to understand the regulation of protein synthesis and its 
reactions to external and internal signals. All the cells in an organism carry the same 
genomic data, yet their protein makeup can be drastically different; both temporally and 
spatially, due to regulation. Protein synthesis is regulated by many mechanisms at its 
different stages. These include mechanisms for controlling transcription initiation, RNA 
splicing, mRNA transport, translation initiation, post-translational modifications, and 
degradation of mRNA/protein. One of the main junctions at which regulation occurs is 
mRNA transcription. A major role in this machinery is played by proteins themselves that 
bind to regulatory regions along the DNA, greatly affecting the transcription of the genes 
they regulate [16]. Friedman introduces a new approach for analyzing gene expression 
patterns that uncovers properties of the transcriptional program by examining statistical 
properties of dependence and conditional independence in the data. 
For protein interactions, it is intended to connect related proteins and link biological functions 
in the context of larger cellular processes [17]. The content of these data sources typically 
complements the experimentally determined protein interactions with the ones that are 
predicted from gene proximity, fusion, co-expressed data, as well as those determined by 
using phylogenetic profiling. Each pathway modality in the data has its own specific 
representation issues which must be understood before integration across modalities is 
attempted. At present, the bioinformatics database owner only develops private system to 
provide user with data query and analysis services; such as NCBI develops Entrez database 
query system which is used on GenBank. European Molecular Biology Laboratory (EMBL) 
develops Sequence Retrieval Systems. The EMBL Nucleotide Sequence Database maintained 
at the European Bioinformatics Institute (EBI), incorporates, organizes, and distributes 
nucleotide sequences from public sources [18]. The database is a part of an international 
collaboration with DDBJ (Japan) and GenBank (USA). Data are exchanged between the 
collaborating databases on a daily basis to achieve optimal synchrony. The key point is how to 
share the heterogeneous databases and make a common query platform for users [19].  
Friedman [16] describes early microarray experiments that examined few samples and 
mainly focused on differential display across tissues or conditions of interest. Such 
experiments collect enormous amounts of data, which clearly reflects many aspects of the 
underlying biological processes. An important challenge is to develop methodologies that 
are both statistically sound and computationally tractable for analyzing such data sets and 
inferring biological interactions from them. Most of the analysis tools currently used are 
based on clustering algorithms. The clustering algorithms attempt to locate groups of genes 
that have similar expression patterns over a set of experiments. Such analysis has proven to 
be useful in discovering genes that are co-regulated and/or have similar function. A more 
ambitious goal for analysis is to reveal the structure of the transcriptional regulation 
process. This is clearly a hard problem. Not only the current data is extremely noisy, but, 
mRNA expression data alone only gives a partial picture that does not reflect key events 
such as; translation and protein (in) activation. Finally, the amount of samples, even in the 
largest experiments in the foreseeable future, does not provide enough information to 
construct a fully detailed model with high statistical significance.  
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Some conventional bioinformatics approaches identify hypothetical interactions between 
proteins based on their three dimensional structures or by applying text mining techniques. 
Emerging protein chip technologies are expected to permit the large scale measurement of 
protein expression levels. Corresponding structural data are stored in data source such as 
protein data bank and represent invaluable sources of understanding of protein structures, 
functions and interactions. Successful use of high throughput protein interaction 
determination techniques such as yeast two hybrids, affinity purification followed by mass 
spectrometry and phage display has shifted research focus from a single gene/protein to more 
coherent network perspectives. Large scale protein-protein interaction data and their 
complexes are currently available for a number of organisms and data are stored in several 
interaction data sources such as BIND [6], DIP [20], IntAct [21], GRID [22] and MINT [23] that 
is all equipped with basic bioinformatics tools for protein network analysis and visualization. 
INCLUSive is a web portal and service registry for microarray and regulatory sequence 
analysis [24]. This provides a comprehensive index for all data integration research projects.  
The integration and management technique of heterogeneous sequence data from public 
sequence data source is widely used to manage diverse information and prediction. It is 
important for the biologists to investigate these heterogeneous sources and connect the 
public biological data source and retrieve sequences which are similar to sequences they 
have, and the results of their retrieval are used in homology research, functional analysis, 
and predication. However, there are few software packages available to deal with the 
sequence data in most biological laboratories and they are stored in file formats. File formats 
is another important issue for biological pathway data sources. XMl, SBML (systems biology 
markup language), KBML (KEGG), BSML (Bioinformatic Sequence Markup Language) 
based on XML, and a variety of versions of XML are used for representing the complex and 
hierarchical biological data. Each flat file from public biological database has different 
format. Recent tools which convert formats among standards are implemented in JAVA or 
Perl module. The constraints associated with biological pathway formats are the following;  
 Conversion among different formats needs different parsers to extract the user 
interesting field.  
 Formats can be modified anytime.  
 Understand the range of field, its value is difficult, and data types in the same field in 
each format can be different.  
From the discussions above, one of the major challenges of the modern bioinformatics 
research is therefore to store, process, and integrate biological data to understand the inner 
working of the cell defined by complex interaction networks. Additionally, the integration 
mechanisms may not register the important details like, copies of inputs files and time of 
integration along with the integrated output file.  
In this chapter, issues related to biological pathway data integration system are discussed 
and a user friendly data integration algorithm across data sources for biological pathway, 
particularly, metabolic pathway as a case is presented. i.e. the data integration (BPDI) 
algorithm that integrates pathway information across data sources and also extracts the 
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abstract information embedded within them are addressed. Today, a bioinformatics 
information system typically deals with large data sets reaching a total volume of about one 
terabyte [25]. Such a system serves many purposes; 
 User can select the data sources and  assign confidence to each selected data source 
  It organizes existing data to facilitate complex queries 
 It infers relationships based on the stored data and subsequently predicts missing 
attribute values and incoming information based on multidimensional data.  
 Data marts (extension of data warehouse) support different query requests.  
2. Data management and integration 
The Pathway Resource List contains over 150 biological pathway databases and is growing 
[26]. Usually, first step for the user is to identify a subset of these data sources for integration. 
To consolidate all the knowledge for a particular organism, extract the pathways from each 
database need to be extracted and transformed into a standard data representation before 
integration. Representation of the pathway data in each data source poses another challenge as 
each pathway modality has its own specific representation issues which must be understood 
before attempting integration across modalities. For example, metabolic pathways, signal 
transduction pathways, protein-protein interaction, gene regulation etc.  
Commonly employed styles of data integration may be implemented in different contexts 
and under requirements, in order to reuse the data across applications for research 
collaboration. Some of the data integration and management efforts are presented in [27-32]. 
Several major approaches have been proposed for data integration, which can be roughly 
classified into five groups [33-34] namely; data warehousing, federated databasing, service-
oriented integration, semantic integration and wiki-based integration. Across all of these 
groups, to a significant extent, an increasingly important component of data integration is 
the community effort in developing a variety of biomedical ontologies to deal in a more 
specific manner with the technicality and globality of descriptors and identifiers of 
information that has to be shared and integrated across various resources. Variety of 
approaches for data integration is discussed below. 
Data Warehousing 
The data warehouse approach offers a “one-stop shop” solution to ease access and 
management of a large variety of biological data from different data sources. The user does 
not need to access many web sites for multiple data sources. Despite its advantages, the data 
warehouse approach has a major problem; it requires continuous and often human-guided 
updates to keep the data comprehensive of the evolution of data sources, resulting in high 
costs for maintenance. Many biological data sources change their data structures roughly 
twice a year. 
Data integration with Federated Approach 
Unlike data warehousing (with its focus on data translation), federated databasing focuses 
on query translation. The federated database fetches the data from the disparate data 
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Some conventional bioinformatics approaches identify hypothetical interactions between 
proteins based on their three dimensional structures or by applying text mining techniques. 
Emerging protein chip technologies are expected to permit the large scale measurement of 
protein expression levels. Corresponding structural data are stored in data source such as 
protein data bank and represent invaluable sources of understanding of protein structures, 
functions and interactions. Successful use of high throughput protein interaction 
determination techniques such as yeast two hybrids, affinity purification followed by mass 
spectrometry and phage display has shifted research focus from a single gene/protein to more 
coherent network perspectives. Large scale protein-protein interaction data and their 
complexes are currently available for a number of organisms and data are stored in several 
interaction data sources such as BIND [6], DIP [20], IntAct [21], GRID [22] and MINT [23] that 
is all equipped with basic bioinformatics tools for protein network analysis and visualization. 
INCLUSive is a web portal and service registry for microarray and regulatory sequence 
analysis [24]. This provides a comprehensive index for all data integration research projects.  
The integration and management technique of heterogeneous sequence data from public 
sequence data source is widely used to manage diverse information and prediction. It is 
important for the biologists to investigate these heterogeneous sources and connect the 
public biological data source and retrieve sequences which are similar to sequences they 
have, and the results of their retrieval are used in homology research, functional analysis, 
and predication. However, there are few software packages available to deal with the 
sequence data in most biological laboratories and they are stored in file formats. File formats 
is another important issue for biological pathway data sources. XMl, SBML (systems biology 
markup language), KBML (KEGG), BSML (Bioinformatic Sequence Markup Language) 
based on XML, and a variety of versions of XML are used for representing the complex and 
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format. Recent tools which convert formats among standards are implemented in JAVA or 
Perl module. The constraints associated with biological pathway formats are the following;  
 Conversion among different formats needs different parsers to extract the user 
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particularly, metabolic pathway as a case is presented. i.e. the data integration (BPDI) 
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abstract information embedded within them are addressed. Today, a bioinformatics 
information system typically deals with large data sets reaching a total volume of about one 
terabyte [25]. Such a system serves many purposes; 
 User can select the data sources and  assign confidence to each selected data source 
  It organizes existing data to facilitate complex queries 
 It infers relationships based on the stored data and subsequently predicts missing 
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 Data marts (extension of data warehouse) support different query requests.  
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To consolidate all the knowledge for a particular organism, extract the pathways from each 
database need to be extracted and transformed into a standard data representation before 
integration. Representation of the pathway data in each data source poses another challenge as 
each pathway modality has its own specific representation issues which must be understood 
before attempting integration across modalities. For example, metabolic pathways, signal 
transduction pathways, protein-protein interaction, gene regulation etc.  
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and under requirements, in order to reuse the data across applications for research 
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groups, to a significant extent, an increasingly important component of data integration is 
the community effort in developing a variety of biomedical ontologies to deal in a more 
specific manner with the technicality and globality of descriptors and identifiers of 
information that has to be shared and integrated across various resources. Variety of 
approaches for data integration is discussed below. 
Data Warehousing 
The data warehouse approach offers a “one-stop shop” solution to ease access and 
management of a large variety of biological data from different data sources. The user does 
not need to access many web sites for multiple data sources. Despite its advantages, the data 
warehouse approach has a major problem; it requires continuous and often human-guided 
updates to keep the data comprehensive of the evolution of data sources, resulting in high 
costs for maintenance. Many biological data sources change their data structures roughly 
twice a year. 
Data integration with Federated Approach 
Unlike data warehousing (with its focus on data translation), federated databasing focuses 
on query translation. The federated database fetches the data from the disparate data 
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sources and then displays the fetched data for its user base. Queries in federated databases 
are executed within remote data sources and results displayed in federated databases are 
extracted remotely from the data sources. Due to this capability, federated databasing has 
two major advantages.  
- Federated databases can be regarded as an on-demand approach to provide immediate 
access to up-to-date data deposited in multiple data sources.  
- Compared with data warehousing, federated databasing does not replicate data in data 
sources; therefore, it presents relatively inexpensive costs for storage and curation. 
However, federated databasing still has to update its query translation to keep pace 
with data access methods at diverse remote data sources.  
Service –Oriented Approach 
A decentralized approach is also being developed, in which individual data sources agree to 
open their data via Web Services (WS). The service-oriented approach enables data 
integration from multiple heterogeneous data sources through computer interoperability. 
The service-oriented approach features data integration through computer-to-computer 
communication via Web API and up-to-date data retrieval from diverse data sources. 
Heterogeneous data integration requires that many data sources should become service 
providers by opening their data via WS and by standardizing data identities and 
nomenclature to ease data exchange and analysis. 
Semantic Web 
Most web pages in biological data sources are designed for human reading. RDF provides 
standard formats for data interchange and describes data as a simple statement, containing a 
set of triples: a subject, a predicate, and an object. Any two statements can be linked by an 
identical subject or object. OWL builds on RDF and Uniform Resource Identifier (URI) and 
describes data structure and meaning based on ontology, which enables automated data 
reasoning and inferences by computers. Application of semantic Web technologies is a 
significant advancement for bioinformatics, enabling automated data processing and 
reasoning. The semantic integration uses ontologies for data description and thus represents 
ontology-based integration. [27] reviews the current development of semantic network 
technologies and their applications to the integration of genomic and proteomic data. His 
work elaborates on applying a semantic network approach to modeling complex cell 
signaling pathways and simulating the cause-effect of molecular interactions in human 
macrophages. [31] Illustrates his approach by comparing federated approach versus 
warehousing versus semantic web using multiple sources.  
Wiki-based Integration 
A weakness common to all the above approaches is that the quantity of users’ participations 
in the process is inadequate. With the increasing volume of biological data, data integration 
inevitably will require a large number of users’ participations. A successful example that 
harnesses collective intelligence for data aggregation and knowledge collection is 
Wikipedia: an online encyclopedia that allows any user to create and edit content. It is 
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infeasible to integrate such large amounts of data into a single point (such as a data 
warehouse). Data sources are developed for different purposes and fulfill different 
functions. Therefore, it is promising to establish an efficient way for data exchange among 
these distributed and heterogeneous data sources. However, a dozen of data sources are 
designed merely for data storage, but not for data exchange.  
2.1. Survey of Pathway Databases and Integration Efforts 
Table 1 below shows various data integration efforts and projects for biological pathways 
worldwide.  
Biochemical pathways                    Description  
BRITE Bio molecular Relations in Information Transmission and Expression 
EcoCyc/MetaCyc Encyclopaedia of E. coli genes and metabolism; Metabolic 
encyclopedia 
EMP Metabolic pathways 
KEGG Kyoto encyclopaedia of genes and genomes 
Biochemical 
Pathways 
Enzyme database and link to biochemical pathway map 
Interactive Fly Biochemical pathways in Drosophila 
Metabolic Pathway Metabolic pathways of biochemistry 
Molecular 
interaction 
Kohn molecular interaction maps 
Malaria parasite Malaria Parasite metabolic pathways 
aMAZE Protein function and biochemical pathways project at EBI 
PathDB Metabolic pathway information 
UM-BBD Microbial bio catalytic reactions and biodegradation pathways 
primarily for xenobiotic, chemical compounds 




Description of several metabolic and biochemical pathways 
Signaling pathways 
Apoptosis Pathways of apoptosis at KEGG 
BBID Database of images of biological pathways, macromolecular 
structures, gene families, and cellular relationships 
BioCarta Several signalling pathways 
BIND The bio molecular interaction network database 
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infeasible to integrate such large amounts of data into a single point (such as a data 
warehouse). Data sources are developed for different purposes and fulfill different 
functions. Therefore, it is promising to establish an efficient way for data exchange among 
these distributed and heterogeneous data sources. However, a dozen of data sources are 
designed merely for data storage, but not for data exchange.  
2.1. Survey of Pathway Databases and Integration Efforts 
Table 1 below shows various data integration efforts and projects for biological pathways 
worldwide.  
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KEGG Kyoto encyclopaedia of genes and genomes 
Biochemical 
Pathways 
Enzyme database and link to biochemical pathway map 
Interactive Fly Biochemical pathways in Drosophila 
Metabolic Pathway Metabolic pathways of biochemistry 
Molecular 
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Kohn molecular interaction maps 
Malaria parasite Malaria Parasite metabolic pathways 
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BioCarta Several signalling pathways 
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CSNDB Cell signalling networks database  
GeneNet Information on gene networks, groups of co-ordinately working 
genes 
GeNet Information on functional organization of regulatory gene networks 
SPAD Signalling pathway database 
STKE Pathway information 
TransPath Pathways involved in the regulation of transcription factors 
Protein-protein interactions 
Blue Print Biological interaction database 
CYGD Protein-protein interaction map at Comprehensive Yeast Genome 
Database 
CytoScape Visualization and analysis of biological network 
DIP Database of interacting proteins 
GenMAPP Gene Map Annotator and Pathway Profiler 
GRID The General Repository for Interaction Datasets 
Proteome Bio 
knowledge 





Reactome A knowledgebase of biological processes 
Yeast Interaction 
Pathway 
PathCalling Yeast Interaction Database at Curagen 
Table 1. Various Data integration Efforts 
Other efforts towards designing new applications for data mining and integration at the 
K.U.Leuven Center for Computational Systems Biology include;  
- aBandApart (2007): A software to mine MEDLINE abstracts to annotate human genome 
at the level of cytogenic bands. 
- ReModiscovery (2006): An intuitive algorithm to correlate regulatory programs with 
regulators and corresponding motifs to a set of co-expressed genes  
- LOOP (2007): A toll to analyze ArrayCGH loop designs. ArrayCGH is a microarray 
technology that can be used to detect aberrations in the ploidy of DNA segments in the 
genome of patients with congenital anomalies. 
- SynTReN (2006): A generator of synthetic gene expression data for design and analysis 
of structure learning algorithms.  
- BlockAligner (2005): Provides an API in R to query BioMart databases such as Ensemble. 
- BlockSampler (2005): Finds conserved blocks in the upstream region of sets of 
orthologous genes. 
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- M@cBETH (2005) (a Microarray Classification Benchmarking Tool on a host server): 
Web service offers the microarray community a simple tool for making optimal two 
class predictions. 
- TxTGate (2004): A literature index database designed towards the summarization and 
analysis of groups of genes based on text.  
- Endeavour is a software application for the computational prioritization of test genes 
based on training genes using different information sources such as MEDLINE abstracts 
and LocusLink textual description, gene ontology, annotation, BIND protein 
interactions, and Transcription Factor Binding Sites (TFBS). 
- TOUCAN2 (2004): A workbench for regulatory sequence analysis on metazoan 
genomes: Comparative genomics detection of significant transcription factor binding 
sites and detection of cis-regulatory modules in sets of coexpressed/ coregulated genes. 
- INCLUSive (2003): A suit of algorithms and tools for the analysis of gene expression 
data and the directory of cis-regulatory sequence elements.  
- Adaptive Quality-Based Clustering (AQBC) (2002): AQBC is a heuristic, iterative two-
step algorithm to cluster gene expression data.  
- MotifSampler (2001): Finds over represented motifs in the upstream region of a set of 
co-regulated genes.  
2.2. Types of pathways  
Biological networks are studied and modeled at different description levels establishing 
different pathway types, For example; metabolic pathways describe the conversion of 
metabolites by enzyme-catalyzed chemical reactions given by their stoichiometric equations, 
such as the main pathways of the energy household as Glycolysis or Pentose Phosphate 
pathway. Another pathway type is signal transduction pathways, also known as 
information metabolism, explaining how cells receive, process, and responds to information 
from the environment. A brief description about various types of pathways is given  
below.  
A. Metabolic Pathways describe the network of enzyme-catalyzed reactions that release 
energy by breaking down nutrients (catabolism) and building up the essential compounds 
necessary for growth (anabolism). Experimentally determined metabolic pathways have 
established for a few model organisms, but most metabolic pathways databases contain 
pathway data that has been computationally inferred from the genomes annotations. 
Because most genome annotations are incomplete, metabolic pathway databases contain 
pathway holes which can only be addressed by experiment or computational inference. A 
good test of a reconstructed metabolic network is to ask if it can produce the set of essential 
compounds necessary for growth, given a known minimal nutrient set. To solve this 
problem, metabolism can be represented  as a bipartite directed graph, where one set of 
nodes represents metabolites, the other set represents biochemical reactions with labeled 
edges used to indicate relationships between nodes (reaction X produces metabolite Y, or 
metabolite Y is-consumed-by reaction X. 
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- Adaptive Quality-Based Clustering (AQBC) (2002): AQBC is a heuristic, iterative two-
step algorithm to cluster gene expression data.  
- MotifSampler (2001): Finds over represented motifs in the upstream region of a set of 
co-regulated genes.  
2.2. Types of pathways  
Biological networks are studied and modeled at different description levels establishing 
different pathway types, For example; metabolic pathways describe the conversion of 
metabolites by enzyme-catalyzed chemical reactions given by their stoichiometric equations, 
such as the main pathways of the energy household as Glycolysis or Pentose Phosphate 
pathway. Another pathway type is signal transduction pathways, also known as 
information metabolism, explaining how cells receive, process, and responds to information 
from the environment. A brief description about various types of pathways is given  
below.  
A. Metabolic Pathways describe the network of enzyme-catalyzed reactions that release 
energy by breaking down nutrients (catabolism) and building up the essential compounds 
necessary for growth (anabolism). Experimentally determined metabolic pathways have 
established for a few model organisms, but most metabolic pathways databases contain 
pathway data that has been computationally inferred from the genomes annotations. 
Because most genome annotations are incomplete, metabolic pathway databases contain 
pathway holes which can only be addressed by experiment or computational inference. A 
good test of a reconstructed metabolic network is to ask if it can produce the set of essential 
compounds necessary for growth, given a known minimal nutrient set. To solve this 
problem, metabolism can be represented  as a bipartite directed graph, where one set of 
nodes represents metabolites, the other set represents biochemical reactions with labeled 
edges used to indicate relationships between nodes (reaction X produces metabolite Y, or 
metabolite Y is-consumed-by reaction X. 
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B. Gene Regulatory Networks describe the network of transcription factors that bind 
regulatory regions of specific genes and activate or repress their transcription. Gene regulatory 
networks or transcription networks have been found to contain recurring biochemical wiring 
patterns, termed network motifs, which carry out key functions. How does one find the most 
significant recurring network motif in a given transcriptional network? To answer this 
question, transcription networks can be described as directed graphs, in which nodes are 
genes, and edges represent transcription interactions, where a transcription factor encoded by 
one gene modulates and transcription rate of the second gene. 
C. Signaling Pathways describe biochemical reactions for information transmission and 
processing. Unlike metabolic pathways that catalyze small molecule reactions, signaling 
pathways involve the post translational modification of proteins leading to the downstream 
activation of transcriptional factors. They are often formed by cascades of 
activated/deactivated proteins or protein complexes. Such signal transduction cascades may 
be seen as molecular circuits which mediate the sensing and processing of stimuli. They 
detect, amplify and integrate diverse external signals to generate responses, such as changes 
in enzyme activity, gene expression, or ion channel activity. Integration of signaling 
pathways poses a greater challenge than with metabolic pathways because of diversity of 
representation schemes for signaling. Some Signaling databases like; PATIKA [35] and 
INHO [36] use compound graphs to represent signaling pathways, while other object 
oriented databases use inheritance to establish relationships between post translational 
modifications of proteins. 
D. Protein-Protein Interaction: In proteomic analysis, target genes are used as bait in 
immuno-precipitation to identify potential binding patterns in cell lysate. The higher level 
databases such as; KEGG [3], TRANSPATH [37], ReactomeSTKE [38], and MetaCyc [39] 
networks of interacting proteins with definite cellular processes including metabolism, 
signal transduction and gene regulation. These resources typically represent biological 
information in the form of individual pathway diagrams summarizing experimental results 
collected during years of research on particular cellular functions. Currently, no single 
method is capable of predicting all possible protein interactions and such integrative 
resources as SPRING and predictome combine multiple theoretical approaches to increase 
prediction accuracy and coverage. A problem with these networks is the high number of 
false alarms. 
E. Ontology Vocabulary Mapping: Ontology provides a formal written description of a 
specific set of concepts and their relationships in a particular domain. GO ontology has three 
categories molecular function, biological process and cellular composition. Integration of 
signaling pathways poses a greater challenge than with metabolic pathways because of the 
diversity of representation schemes for signaling.  
2.3. Integration issues 
Biological plant pathway data integration is a multi-step process. It includes integration of 
various types of pathways, interactions, and gene expression. On another level, it includes 
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various species and different databases. A hierarchical pathway data integration scheme is 
presented in Figures 1 and 2 below. 
Each database also defines supporting evidence codes specifically defined to consider 
criteria for selection, however may not be explicitly illustrated and that may not be similar 
across various sources. This heterogeneity in evidence codes and their representation needs 
consideration [40]. Since the evidence code may originate as a result of experimentation or 
as evidence from published text, integration of the plant pathway data across databases 
involves standardizing the evidence code prior to the integration. The first step is to 
integrate the evidence codes for a given pathway across database. Biological databases are 
results of experiments carried out with different conditions and controls, mostly open 
source, and employs a variety of formats [41]. Integrating such databases is a multi-step 
procedure and involves handling the complexities associated with heterogeneous data 
integration. 
 
Figure 1. Hierarchical Pathway data Integration Scheme 
A. Ontology Development 
Since isolation of ontologies complicates data integration, so in order to use ontologies at 
their full potential, concepts, relations, and axioms must be shared when possible. Domain 
ontologies must also be anchored to an upper ontology in order to enable the sharing and 
reuse of knowledge. 
B. Synonym Integration  
While integrating information about a pathway from a database, entities require 
independent approach. One such entity is synonym. Each database lists a set of synonyms 
that need integration to configure a pool of synonyms without causing duplication. In the 
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various species and different databases. A hierarchical pathway data integration scheme is 
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B. Synonym Integration  
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independent approach. One such entity is synonym. Each database lists a set of synonyms 
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data integration platform developed the synonym integration has issues like avoiding 
duplication and accommodating number of synonyms associated with one entity. Some 
pathways may include two compounds with different names but having same empirical 
formula. In such cases integration is challenging as biologists may be further interested in 
reviewing the chemical structure along with the integrated output. However, almost all 
biological pathways are vertically extendable and can associate further details. The point 
here is to include all the salient features (from a biologist’s standpoint) of the pathway. 
There is no thumb rule to define biologist’s interests.  
C. Evidence Codes and issues 
For defining an evidence code with an entity, granularity is another variable. Depending on 
the database, EV may be either for an entity within a pathway such as a gene, a compound, 
reaction or enzyme or for the pathway itself. In other words, many databases use the same 
evidence code for an entire pathway and map that code to each interaction in the pathway. 
Others assign different EV codes to each interaction and sometimes to each compound or 
gene.  
The Gene Ontology (GO) defines a set of thirteen EVs that assign evidence to gene function. 
BioCyc defines a class hierarchy structure of four basic EVs with subclasses. MetNetDB 
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2. Since pathway information cannot be assessed with any reliability, it is hard to assign a 
measure of the orrectness/authenticity to any one database. We propose assignment to 
be user selective to resolve the issue. To combine the information, a heuristic rule set 
computes the composite EVs for the integrated database. The unification can be done 
using any one EV code set as a key. Since each database follows their own standard, it is 
likely that EVs may not find a perfect match among the databases or that there may be 
more than one likely match. To handle these situations, two matching sets, a perfect 
match and a likely match are considered. The EVs to find a match for IEP and ND from 
GO in EV set above with those in BioCyc result in more than one likely match {GO: IEP 
→ BioCyc: EV1, BioCyc: EV2}.  
3. Integrated Evidence Code (EVint) for Perfect Matches: The EV codes encompass the 
quantitative information giving an insight into how the data was obtained. They define 
the conditions/ constraint associated with obtaining the data. 
4. Computing the Reference Index (RIint) 
For biological databases, the pathway information is mostly inferred by the curators 
based on experimental, computational, literature or other evidence. The references 
associated with the database are mostly accounted as a measure of support for the data. 
We introduce a qualitative approach to associate the references supporting the pathway 
or organism (or compounds or reactions). The reference index RIint is computed using a 
heuristic: 
1. For Rank = High, Ignore VF. 
2. For Rank = Low, Use only VF. 
3. For all other combinations of Rank and VF, compute the average. 
Citations may be a robust way of supporting the claim in a database. However, some 
journals are ranked over other journals and citations from those journals will be valued 
more than citations in other sources. To accommodate this, we associate ranks with the 
journals. The Rank specifies the order of importance of journal as designated by the user. 
Additionally, we classify citations based on both the journal Rank and the value factor (VF). 
Finally, based on the Rank and VF, the Reference index (RI) is computed.  
3. Evidence codes integration algorithm 
Given: Set of n databases {D1, D2, D3, D4,……, Dn},  
(For illustration, only three data sources namely, Bio-Cyc, KEGG and MetNetDB 
are considered) 
User input: Confidence weight (CW) 
List: Evidence Codes (EVi) for the object/entity (Ei) among the databases (Di),  
for example; D1/E1 {EV1}, D2/E1 {EV2},…. 
The steps below list the mapping process. 
Step 1. For a given pathway/organism/entity, 
List: EV codes across the databases. (See Tables III(a) and III(b)) 
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Assign: Direct = 1.0; Indirect = 0.8; Computational =0.6; Hypothetical = 0.5. 
Step 2. EV Unification (Rule Set –I) 
BioCyc is a collection of 371 pathway/genome databases. Each pathway/genome database in 
the BioCyc collection describes the genome and metabolic pathways of a single organism. It 
considers a class hierarchy with four main classes. Since BioCyc and MetNetDB virtually use 
the same number of EV codes, the mapping is framed considering four major EV codes. 
KEGG uses only one EV for pathways namely ‘manually entered from published materials’. The 
EV code for KEGG to Direct is mapped using the rules like; 
If Di = BioCyc/AraCyc/MetaCyc, and EV = EV-Exp, then Change EV = Direct 
Unification of the EV codes for the databases is based on the expert knowledge. EV code 
mapping is done with respect to a reference data source and unified according to the set of 
rules above.  
Step 3. Confidence Weight (CWi) Assignment 
Researchers typically have databases that they treat as favored sources for different types of 
information. Since there is no precise rule for deciding which database is more correct and 
up to date, a user defined score, a confidence weight (CW) is applied. The EV mapping process 
is interactive and provides flexibility in choice for databases. Confidence is defined as, 
CWi = {Very Strong, Strong, Moderate, Poor, Very Poor} 
For example: CW KEGG: Strong, CWBioCyc: Normal 
Step 4. EVint (Rule Set-II) 
Using heuristic rules, integrated EVcode is calculated. 
Step 5. Decode EVint value 
The EV value from Step 4 is decoded using: 
EVint = Σ (CWi* EV)/|i| = x  
Step 6. Rank Index 
- Rank the journals in their order of importance. 
- Make an ordered list of journals assigning Rank. 
- Rank the conferences in order of their importance. 
- Make an ordered list of conferences. 
- Assign: 
If the publication in not in the list, Then, Rank = low 
Else, Rank = as defined by the list 
Step 7. Value Factor (VF) 
The VF measures support for the entity using the publication evidence. This is a quantitative 
index with a temporal function. 
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For t = current year, compute VF (t) = |P (t-2)| / |P| where,  
|P (t-2)| = Number of publications in the last (t-2) years for Di, and 
|P| = Total number of publications listed in Di. 
Step 8. Reference Index (RIint) 
- Compute RI for {D1,…Dn} given by, 
RIi{t} = f {Rank, VF} 
- Compute RIint for a pathway as; 
RIint = max {RIi} 
3.1. Integration models 
Data integration aims to work with repositories of data from a variety of sources. As such, 
two databases may not provide identical information, and integrating these two databases 
may yield a richer resource for analysis. The conditions under which data is collected and 
the supporting references play a crucial role in making the analysis more meaningful. So far, 
the integration approaches have focused on different types of pathways. The same pathway 
can have different representations in different databases.  
For example, a known pathway like Glycolysis is represented in different ways in KEGG 
and BioCyc as shown in Figure 3. A universal tool to integrate all types of pathways may 
not be a focus. Additionally, different databases employ various data representations that 
may not provide easy user access or user friendly. Figure 3(a) and 3(b) illustrate 
representational difference between two data sources for the same pathway. Various data 
integration models are defined below. 
 Syntactic Networks: Syntactic networks adhere to the syntax of a set of words as given by 
the representation of the data and do not interpret the meaning associated. Syntactic 
heterogeneity is a result of differences in representation format of data.  
 Semantic Networks (SN): Semantic heterogeneity is a result of differences in 
interpretation of the 'meaning' of data. Semantic models aim to achieve semantic 
interoperability, a dynamic computational capability to integrate and communicate 
both the explicit and implicit meanings of digital content without human intervention.  
 Several features of SN make it particularly useful for integrating biological data include, 
ability to easily define an inheritance hierarchy between concepts in a network format, 
allow economic information storage and deductive reasoning, represent assertions and 
cause effect through abstract relationships, cluster related information for fast retrieval, 
and adapt to new information by dynamic modification of network structures [44]. An 
important feature of SN is the ease and speed to retrieve information concerning a 
particular concept. The use of semantic relationships ensures clustering together related 
concepts in a network. For example, protein synonyms, functional descriptions, coding 
sequences, interactions, experimental data or even relevant research articles can all be 
represented by semantic agents, each of which is directly linked to the corresponding 
protein agent.  
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Biological information can be retrieved effectively through simple relationship traversal 
starting from a query agent in the semantic network. Two approaches primarily in practice 
for SNs are; 
1. memory-mapped data structure and  
2. indexing flat files.  
In the memory-mapped data structure approach, subsets of data from various sources are 
collected, normalized, and integrated in memory for quick access. While this approach 
performs actual data integration and addresses the problem of poor performance in the 
federated approach, it requires additional calls to traditional relational databases to 
integrate descriptive data. While data cleaning is being performed on some of the data 
sources, it is not being done across all sources or in the same place. This makes it difficult to 
quickly add new data sources. In the indexing flat files approach, flat text files are indexed 
and linked thus supporting fast query performance.  
 Causal Models: A causal model is an abstract model that uses cause and effect logic to 
describe the behaviour of a system. Ex: Expression Quantitative Trait Loci: (eQTLs) 
eQTL analysis is to study the relationship between genome and transcriptome. Gene 
expression QTLs that contain the gene encoding the mRNA are distinguished from 
other transacting eQTLs. eQTL mapping tries to find genomic variation to explain 
expression traits. One difference between eQTL mapping and traditional QTL mapping 
is that, traditional mapping study focuses on one or a few traits, while in most of eQTL 
studies, thousands of expression traits get analyzed and thousands of QTLs are 
declared.  
 Context likelihood of relatedness (CLR): It uses transcriptional profiles of an organism 
across a diverse set of conditions to systematically determine transcriptional regulatory 
interactions. CLR is an extension of the relevance network approach. 
(http://gardnerlab.bu.edu/software&tools.html). [34] Presented architecture for context-
based information integration to solve semantic difference problem, defined some novel 
modeling primitives of translation ontology and propose an algorithm for translation. 
 Bayes Networks (BN): Probabilistic graphical models that represent a set of variables and 
their probabilistic independencies. For example, a BN could represent the probabilistic 
relationships between diseases and symptoms. Given symptoms, the network can be 
used to compute the probabilities of the presence of various diseases. Bayes networks 
focus on score-based structure inference. Available heuristic search strategies include 
simulated annealing and greedy hill-climbing, paired with evaluation of a single 
random local move or all local moves at each step. [45] Bases his approach on the well-
studied statistical tool of Bayesian networks [46]. These networks represent the 
dependence structure between multiple interacting quantities (e.g., expression levels of 
different genes). His approach, probabilistic in nature, is capable of handling noise and 
estimating the confidence in the different features of the network. 
 Hidden Markov Models (HMM): HMM is a statistical model that assumes the system 
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hidden parameters from the observable parameters. The extracted model parameters 
can then be used to perform further analysis, for example for pattern recognition 
applications. An HMM can be considered as the simplest dynamic Bayesian network. 
HMMs are being applied to the analysis of biological sequences, in particular DNA 
since 1998 [47]. 
3.2. Need to use open grid service architecture ogsa-dai for data access and 
integration 
Apart from the ubiquitous call for more functionality, bioinformatics projects with 
commercial users/partners are very anxious about the security of their data. The issue is 
further complicated by the lack of coherent security models with the evolving WS-RF and 
WS-I specifications which OGSA-DAI now supports. This issue needs to be resolved if 
bioinformatics projects with commercial users/partners are not to be deterred from adopting 
the product despite its utility. In contrast to the diversity of its data resources, a limited 
range of operations on these resources is typically required. For instance, one operation is to 
create a study data set by aggregating data from iterative searches of remote data collections 
using the same taxonomy object (representing a species or other group) as the search 
parameter [48]. 
3.3. Handling the heterogeneity in data representation among databases 
For biological plant pathways, various databases incorporate information about an 
entity/reaction/pathway to a level of detail and define their own data format. This includes 
information like number of fields, column label/tag, pathway name(s), etc. At the outset, 
common information across the tables may look limited and hard to extract mainly because 
of the tag or synonyms (other names) of pathway. Before proceeding for integration of a 
pathway across data sources following steps need to be carried out. For biological pathway 
integration, following needs to be considered.  
 What is the aim of integration?  
To query autonomous and heterogeneous data sources through a common, uniform 
schema (TARGET SCHEMA). 
 How will the integrated data be used?  
 Resolving various conflicts between source and target schema.  
 Offering a common interface to access integrated information.  
 Preserving the autonomy of participating systems.  
 Easily integrating data sources without major modification.  
 Is it within a single data source or across sources?  
 Does it support web based integration?  
 Does it encompass the dynamic nature of the data?   
 What are the data, source, user models, and assumptions underlying the design of 
integration system? 
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Specific data integration problems in the biological field include: 
 Some biological data sources do not provide an expressive language 
 Derived wrapper (operate in two modes) 
 Traditional wrapper 
 Virtual source that buffers the execution result of a local application 
 Data Model Inconsistencies requires complex data transformation coding 
 Data Schema Inconsistencies  
 Schema matching: error-prone task 
 Mapping info: systematically managed 
 Domain Expert participation  
 Along with the data schema consistencies there may be data level inconsistencies such 
as:  
 Data conflict as each object has its own data type, and may be represented in different 
formats 
 Different Query Capabilities affect the query optimization of data integration system  
 Miscellaneous: Network environment, Security 
File formats: For biological pathways, various data sources incorporate information about an 
entity/reaction/pathway to a level of detail and define their own data format. This includes 
information like number of fields, column label/tag, pathway name(s), etc. At the outset, 
common information across the tables may look limited and hard to extract mainly because of 
the tag or synonyms (other names) of pathway. One of the other important differences in the 
way these data sources are developed lies in the synonym representations. Some of the data 
sources limit the synonyms to 10 others may not result into may be over 40 synonyms. While 
we look at the data integration mechanism, if the names of the compounds do not match, then 
the search should be carried forward with the list of synonyms. In integrating different data 
bases this will take different search time. Also, since the field names (compound names) did 
not match, the search must unify the field names and generate a new list of synonyms.  
Granularity of information: Different pathway databases may model pathway data with 
different levels of details. This primarily depends on the process definition. For example, 
one database might treat processes together as a single process, while another database 
might treat these as separate processes. Also, one database might include specific steps to be 
part of the process, while another database might not consider these steps. Additionally, the 
levels of details associated with a certain data base necessitate pathway data modeling with 
different levels of granularity. Different pathway data formats (e.g., SBML and BIND XML) 
have been used to represent data with different levels of details. A semantic net based 
approach to data integration is proposed in [49].  
Heterogeneous formats: As the eXtensible Markup Language (XML) has become the lingua 
franca for representing different types of biological data, there has been a proliferation of 
semantically-overlapping XML formats that are used to represent diverse types of pathway 
data. Examples include the XML-derivatives KGML, SBML, CellML, PSI MI, BIND XML, 
and Genome Object Net XML. Efforts have been underway to translate between these 
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 Virtual source that buffers the execution result of a local application 
 Data Model Inconsistencies requires complex data transformation coding 
 Data Schema Inconsistencies  
 Schema matching: error-prone task 
 Mapping info: systematically managed 
 Domain Expert participation  
 Along with the data schema consistencies there may be data level inconsistencies such 
as:  
 Data conflict as each object has its own data type, and may be represented in different 
formats 
 Different Query Capabilities affect the query optimization of data integration system  
 Miscellaneous: Network environment, Security 
File formats: For biological pathways, various data sources incorporate information about an 
entity/reaction/pathway to a level of detail and define their own data format. This includes 
information like number of fields, column label/tag, pathway name(s), etc. At the outset, 
common information across the tables may look limited and hard to extract mainly because of 
the tag or synonyms (other names) of pathway. One of the other important differences in the 
way these data sources are developed lies in the synonym representations. Some of the data 
sources limit the synonyms to 10 others may not result into may be over 40 synonyms. While 
we look at the data integration mechanism, if the names of the compounds do not match, then 
the search should be carried forward with the list of synonyms. In integrating different data 
bases this will take different search time. Also, since the field names (compound names) did 
not match, the search must unify the field names and generate a new list of synonyms.  
Granularity of information: Different pathway databases may model pathway data with 
different levels of details. This primarily depends on the process definition. For example, 
one database might treat processes together as a single process, while another database 
might treat these as separate processes. Also, one database might include specific steps to be 
part of the process, while another database might not consider these steps. Additionally, the 
levels of details associated with a certain data base necessitate pathway data modeling with 
different levels of granularity. Different pathway data formats (e.g., SBML and BIND XML) 
have been used to represent data with different levels of details. A semantic net based 
approach to data integration is proposed in [49].  
Heterogeneous formats: As the eXtensible Markup Language (XML) has become the lingua 
franca for representing different types of biological data, there has been a proliferation of 
semantically-overlapping XML formats that are used to represent diverse types of pathway 
data. Examples include the XML-derivatives KGML, SBML, CellML, PSI MI, BIND XML, 
and Genome Object Net XML. Efforts have been underway to translate between these 
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formats (e.g., between PSI MI and BIND XML, and between Genome Object Net and SBML). 
However, the complexity of such a pair-wise translation approach increases dramatically 
with a growing number of different pathway data formats. To address this issue, a standard 
pathway data exchange format is needed. While the Resource Description framework (RDF) 
is an important first step towards the unification of XML formats in describing metadata 
(ontologies), it is not expressive enough to support formal knowledge representation [50]. 
To address this problem, more sophisticated XML-based ontological languages such as the 
Web Ontology Language (OWL) have been developed. An OWL-based pathway exchange 
standard, called BioPAX, has been released to the research community [51]. 
4. Biological Pathway Data Integration  
 An integration model may serve as a tool to the user for a specific type of pathway. An 
algorithm for integration is presented next.  
Metabolic Pathways: Integrating pathways from different data sources for the same species 
extract similar structures in them as the first step; this step integrates vertically given 
pathway within a species across data sources. (Database  is the variable) this includes 
sorting  a graph G (V, E) for common V’s and E’s in Gi (Vi, Ei) and Gj (Vj, Ej). In the discussion 
that follows, integrating pathway as the TCA cycle given by two data sources namely; KEGG 
(Dij1) and BioCyc (Dij2) for E. coli K-12 is considered. For metabolic pathways the details 
associated with each graph include the nodes and edges as given below. For Protein-Protein 
interaction the nomenclature and associated fields for nodes and edges may change. 
However, it is possible to come up with a structure that can describe the Protein-Protein 
interactions or signal transduction pathways.  
 Node: Biological Name, ID, Neighbor, Type, Context, Pathway, Data Source, PubList, 
SynList, empirical formula, Structure 
 Edge: EdgeID, EdgeSource, EdgeDest, Reactiontype (Rev/ Irreversible), Data Source, 
Enzyme, Genes  
Signal Transduction Pathways: The information contained in signal transduction pathways 
is not similar to the metabolic pathways. In signal transduction pathways, the interactions 
can be represented as a class hierarchy. Our aim is also to integrate a sample pathway like 
insulin from sources like KEGG, SPAD to see the performance of our algorithm. 
Interestingly, SPAD assigns evidence code to the edges (interactions) and KEGG assigns 
only one evidence code to the pathway (nodes and edges). The format of the table for 
integration is given above. Before integration information associated with every object 
(node) and edge (interactions) should be considered.  
Before proceeding for integration of a pathway across data sources following steps need to 
be carried out.  
Step 1  
- Check for the pathway name across the input pathways. 
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- If a synonym matches then, go to step 2 else, search for synonyms of pathway name.  
Step 2  
- Choose the integrated output table format as the reference (number of columns, column 
tag)  
- Check for number of columns in the output table. 
- Match each of the column names in the output table with each of the column names in 
the input data files,  
- if column names are same then continue, else see alternate tag for the column, and 
match them.  
- Match order in the output table format with the inputs from different sources.  
- If the order matches, then continue, else reorder the columns as given in output 
table. 
- Check for number of columns in the output table,  
- If the number of columns is not same, then append the table with new columns. 
Step 3  
- Apply EV and Integration algorithms 
The notations used in our algorithm are presented next. 
4.1. Notations 
 S = {s1, s2, s3,…sn} is set of species.      (1) 
 Pij = {pi1, pi2, … pip} is a  set of pathways within si    (2) 
Consider a tuple (Si, (Pij, (Diji))   (3) 
Where, Dijk= {dij1, dij2, dij3, … dijk} is a set of ‘k’ data sources for (Si, Pij)  (4) 
 s1= {(s1, p1j (D1jk)} = {(s1, p1j,d1j1}) (s1, p1j, d1j2}),…( s1,p1j,d1jk)} for  ‘k’ databases,  
For example; s1: E.coli; p1j: TCA Cycle; d1j1= BioCyc, d1j2= KEGG.  
Then, the tuple (v111n, e111m) gives (node, edge) in Biocyc for TCA cycle in E.coli, and the tuple 
(v112p, e112p) gives (node, edge) in KEGG for TCA cycle in E.coli 
• s2 = {(s2, p2j (D2jk)} = {(s2, p2j, d2j1), (s2, p2j, d2j2),……, (s2, p2j, d2jr)} for ‘r’ databases,   
For example, s2: Arabidopsis; p2j: TCA Cycle; d2j1= BioCyc, d2j2= AraCyc 
Then, the tuple (v221p, e221p) gives the (node, edge) in AraCyc for TCA cycle in Arabidopsis, 
and the tuple (v222p, e222p) gives the (node, edge) in KEGG for TCA cycle in Arabidopsis.  
   Each pathway pij for a dijk is given by a graph G (Vijk, Eijk), where, 
 Pijk = G (Vijk, Eijk) represents Pathway ‘j’ from kth datasourcesS for species i’… .(5) 
Where, Vijk = {v ijk1, v ijk2,…v ijkn} = set of nodes in dijk,. (6) 
E ijk = {e ijk1, e ijk2,….e ijkm}=  set of edges in dijk,.  (7) 
• SynList {pathway name} = SynList {Pij} 
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formats (e.g., between PSI MI and BIND XML, and between Genome Object Net and SBML). 
However, the complexity of such a pair-wise translation approach increases dramatically 
with a growing number of different pathway data formats. To address this issue, a standard 
pathway data exchange format is needed. While the Resource Description framework (RDF) 
is an important first step towards the unification of XML formats in describing metadata 
(ontologies), it is not expressive enough to support formal knowledge representation [50]. 
To address this problem, more sophisticated XML-based ontological languages such as the 
Web Ontology Language (OWL) have been developed. An OWL-based pathway exchange 
standard, called BioPAX, has been released to the research community [51]. 
4. Biological Pathway Data Integration  
 An integration model may serve as a tool to the user for a specific type of pathway. An 
algorithm for integration is presented next.  
Metabolic Pathways: Integrating pathways from different data sources for the same species 
extract similar structures in them as the first step; this step integrates vertically given 
pathway within a species across data sources. (Database  is the variable) this includes 
sorting  a graph G (V, E) for common V’s and E’s in Gi (Vi, Ei) and Gj (Vj, Ej). In the discussion 
that follows, integrating pathway as the TCA cycle given by two data sources namely; KEGG 
(Dij1) and BioCyc (Dij2) for E. coli K-12 is considered. For metabolic pathways the details 
associated with each graph include the nodes and edges as given below. For Protein-Protein 
interaction the nomenclature and associated fields for nodes and edges may change. 
However, it is possible to come up with a structure that can describe the Protein-Protein 
interactions or signal transduction pathways.  
 Node: Biological Name, ID, Neighbor, Type, Context, Pathway, Data Source, PubList, 
SynList, empirical formula, Structure 
 Edge: EdgeID, EdgeSource, EdgeDest, Reactiontype (Rev/ Irreversible), Data Source, 
Enzyme, Genes  
Signal Transduction Pathways: The information contained in signal transduction pathways 
is not similar to the metabolic pathways. In signal transduction pathways, the interactions 
can be represented as a class hierarchy. Our aim is also to integrate a sample pathway like 
insulin from sources like KEGG, SPAD to see the performance of our algorithm. 
Interestingly, SPAD assigns evidence code to the edges (interactions) and KEGG assigns 
only one evidence code to the pathway (nodes and edges). The format of the table for 
integration is given above. Before integration information associated with every object 
(node) and edge (interactions) should be considered.  
Before proceeding for integration of a pathway across data sources following steps need to 
be carried out.  
Step 1  
- Check for the pathway name across the input pathways. 
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- If a synonym matches then, go to step 2 else, search for synonyms of pathway name.  
Step 2  
- Choose the integrated output table format as the reference (number of columns, column 
tag)  
- Check for number of columns in the output table. 
- Match each of the column names in the output table with each of the column names in 
the input data files,  
- if column names are same then continue, else see alternate tag for the column, and 
match them.  
- Match order in the output table format with the inputs from different sources.  
- If the order matches, then continue, else reorder the columns as given in output 
table. 
- Check for number of columns in the output table,  
- If the number of columns is not same, then append the table with new columns. 
Step 3  
- Apply EV and Integration algorithms 
The notations used in our algorithm are presented next. 
4.1. Notations 
 S = {s1, s2, s3,…sn} is set of species.      (1) 
 Pij = {pi1, pi2, … pip} is a  set of pathways within si    (2) 
Consider a tuple (Si, (Pij, (Diji))   (3) 
Where, Dijk= {dij1, dij2, dij3, … dijk} is a set of ‘k’ data sources for (Si, Pij)  (4) 
 s1= {(s1, p1j (D1jk)} = {(s1, p1j,d1j1}) (s1, p1j, d1j2}),…( s1,p1j,d1jk)} for  ‘k’ databases,  
For example; s1: E.coli; p1j: TCA Cycle; d1j1= BioCyc, d1j2= KEGG.  
Then, the tuple (v111n, e111m) gives (node, edge) in Biocyc for TCA cycle in E.coli, and the tuple 
(v112p, e112p) gives (node, edge) in KEGG for TCA cycle in E.coli 
• s2 = {(s2, p2j (D2jk)} = {(s2, p2j, d2j1), (s2, p2j, d2j2),……, (s2, p2j, d2jr)} for ‘r’ databases,   
For example, s2: Arabidopsis; p2j: TCA Cycle; d2j1= BioCyc, d2j2= AraCyc 
Then, the tuple (v221p, e221p) gives the (node, edge) in AraCyc for TCA cycle in Arabidopsis, 
and the tuple (v222p, e222p) gives the (node, edge) in KEGG for TCA cycle in Arabidopsis.  
   Each pathway pij for a dijk is given by a graph G (Vijk, Eijk), where, 
 Pijk = G (Vijk, Eijk) represents Pathway ‘j’ from kth datasourcesS for species i’… .(5) 
Where, Vijk = {v ijk1, v ijk2,…v ijkn} = set of nodes in dijk,. (6) 
E ijk = {e ijk1, e ijk2,….e ijkm}=  set of edges in dijk,.  (7) 
• SynList {pathway name} = SynList {Pij} 
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• SynList {entity name} = SynList {v1jkn} 
• EVijk = {EVijk1, …. EVijkh} set of ‘h’ EV Codes  for {si, pij , dijk }, for example; 
 EV1j1= {Set of EVcodes given by Biocyc for E.coli for TCA cycle} 
 EV1j2= {Set of EV codes given by KEGG for E.coli for TCA cycle} 
 EV2j3= {Set of EV codes given by AraCyc for Arabidopsis for TCA cycle} 
 EV2j2= {Set of EV codes given by KEGG for Arabidopsis for TCA cycle} 
• RIijk: Reference index for a database dijk  
• RIijint: Reference index for the integrated pathway 
• CWijk: Confidence weight for a database dijk  
• CWijint: Confidence weight of the integrated  pathway pij within a species 
• Vijint: Integrated node table for a species Si, for a pathway pij  
• Eijint: Integrated edge table for a species Si, for a pathway pij  
• (v1jkn, e ijkm) = (node ‘n’, edge ‘m’) in d1jk  of s1 for p1j; 
• ATT {(v1jkn ,(A)}= {v1jkn, (A1, A2, A3, A4, …As)} = set of attributes of the node v1jkn 
• ATT {(e ijkm, (B)} ={(e ijkm, (B1, B2, B3, … Bt)} = set of attributes of edge e ijkm 
• DATT {v1jkn ,(δA)} = set of derived attributes of the node v1jkn  (EVi, CWi, RIi) 
• DATT {e1jkn ,(δB)}= set of derived attributes of the edge e1jkn  (EVi, CWi, RIi)  
• δVijk  = Set of derived node attributes for Integrated pathway {EVint, CWint, RIint}   
• δEijk= Set of derived edge attributes for Integrated pathway {EVint, CWint, RIint} 
• Vijint = {Σ Vijk } for k= 1 to n 
• E ijint= {Σ E ijk} for k= 1 to n 
• Pijint  = Integrated  pathway from multiple DSs = {Σ Pijk } for k=1 to n  
4.2. Biological Pathway Data Integration Algorithm  
Following selections and inputs are defined by the user. 
 User selected inputs: Species, Pathway, Data sources/database  
 User inputs: Confidence assigned to each database 
 User defined filters (UDF) for entities like substrate nodes, H2O, CO2 etc. for integrated 
pathway [Pijint = G (Vint, Eint)],  
Step 1. 
For each user selected pathway Pij for a species si 
List Dij (d1j1,… dnjk),                                                 ***(KEGG, BioCyc, MetNetDB etc)*** 
Step 2. Define rules to classify the interactions, for example; 
- If the pathway is signal transduction, then use the classifier (Table 1)for interactions 
- If the pathway is metabolic, then reaction is a general representation of the 
interaction 
 Sort (d1j1,… dnjk) according to species (si,dij1), (sj,djj1) etc.  
 Generate a set of (nodes, edges) from all the input data sources {(Vij, Eij)} = {(Vij1, 
Eij1), (Vij2, Eij2)….. (Vijs, Eijs)} 
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 where, Vijk= {vijk1, vijk2, ….vijkt} and Eij1= {e ijk1, e ijk2,….e ijku} 
Step 3.  
For k = 1, …, q (d1j1,… d1jk),  
 For s = 1,.., n, and  q = 1, …m,  
    List ATT {(v1jks, (A)}  
  List ATT {(e ijkq, (B)}   
   Select vijk1 Є Vijk C d1jk  
     For all p =1 to n  
  Check for vijk, 1 Є Vijp (node name match across data sources)  
  If YES, then Apply EV integration algorithm  
   Generate DATT {v1jkn, (δA)}, DATT {e1jkn, (δB)}, 
        Else, For p = 1 to  n, 
   For t = 1, z  
Check if vijk,1 Є SynList {vijp,t } (node name(A) with Synlist(B)) 
   If YES, then Apply EV integration algorithm, 
   Generate DATT {v1jkn, (δA)}, DATT {e1jkn, (δB)}, 
  Else,  
   Check if SynList {vijk,1} has a match with vijp,t 
                If YES, then Apply EV integration Algorithm 
  Else, 
   Check if SynList {vijk,1} has a match with SynList {vijp,t } 
   If vijk,1  =  vijp,l is TRUE,  
   Then,   
   Include vijk, 1 with the matched node name vijk-1, p Є Vijk-1 
   Compute (δVijk, δEijk) 
***This is the node name for the integrated database for the species. Level 1*** 
Generate SynListInt = {SynList (vijk, 1) U Synlist (vijp,l)U…} without duplication 
Associate DOI (date of integration) 




Repeat Step 2-3 for eijk Є Eijk in (dij1,… dijk), for pij 
Include information associated with the edge, as given by ‘edges’ such as reaction, 
enzyme, by products and substrates along with attributes like evidence, reference 
publications, context etc. 
** Outputs Eijint table for si using (d1j1,… d1jk),  with EVijint, CWijint and RIijint . Level 1. ** 
Pijint  = {Σ Pijk } for k=1 to n = [{ Vijint, E ijint} + { Σ δVijkt, Σ δEijk} for k=1 to n ]at t= t1 
       = Σ {ATT [(v1jkn, (A)]}, ATT [(e ijkm, (B)]} + Σ {DATT {v1jkn, (δA), DATT {e1jkn, (δB)}for 
all n, m   {δVijk  δEijk} 
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• SynList {entity name} = SynList {v1jkn} 
• EVijk = {EVijk1, …. EVijkh} set of ‘h’ EV Codes  for {si, pij , dijk }, for example; 
 EV1j1= {Set of EVcodes given by Biocyc for E.coli for TCA cycle} 
 EV1j2= {Set of EV codes given by KEGG for E.coli for TCA cycle} 
 EV2j3= {Set of EV codes given by AraCyc for Arabidopsis for TCA cycle} 
 EV2j2= {Set of EV codes given by KEGG for Arabidopsis for TCA cycle} 
• RIijk: Reference index for a database dijk  
• RIijint: Reference index for the integrated pathway 
• CWijk: Confidence weight for a database dijk  
• CWijint: Confidence weight of the integrated  pathway pij within a species 
• Vijint: Integrated node table for a species Si, for a pathway pij  
• Eijint: Integrated edge table for a species Si, for a pathway pij  
• (v1jkn, e ijkm) = (node ‘n’, edge ‘m’) in d1jk  of s1 for p1j; 
• ATT {(v1jkn ,(A)}= {v1jkn, (A1, A2, A3, A4, …As)} = set of attributes of the node v1jkn 
• ATT {(e ijkm, (B)} ={(e ijkm, (B1, B2, B3, … Bt)} = set of attributes of edge e ijkm 
• DATT {v1jkn ,(δA)} = set of derived attributes of the node v1jkn  (EVi, CWi, RIi) 
• DATT {e1jkn ,(δB)}= set of derived attributes of the edge e1jkn  (EVi, CWi, RIi)  
• δVijk  = Set of derived node attributes for Integrated pathway {EVint, CWint, RIint}   
• δEijk= Set of derived edge attributes for Integrated pathway {EVint, CWint, RIint} 
• Vijint = {Σ Vijk } for k= 1 to n 
• E ijint= {Σ E ijk} for k= 1 to n 
• Pijint  = Integrated  pathway from multiple DSs = {Σ Pijk } for k=1 to n  
4.2. Biological Pathway Data Integration Algorithm  
Following selections and inputs are defined by the user. 
 User selected inputs: Species, Pathway, Data sources/database  
 User inputs: Confidence assigned to each database 
 User defined filters (UDF) for entities like substrate nodes, H2O, CO2 etc. for integrated 
pathway [Pijint = G (Vint, Eint)],  
Step 1. 
For each user selected pathway Pij for a species si 
List Dij (d1j1,… dnjk),                                                 ***(KEGG, BioCyc, MetNetDB etc)*** 
Step 2. Define rules to classify the interactions, for example; 
- If the pathway is signal transduction, then use the classifier (Table 1)for interactions 
- If the pathway is metabolic, then reaction is a general representation of the 
interaction 
 Sort (d1j1,… dnjk) according to species (si,dij1), (sj,djj1) etc.  
 Generate a set of (nodes, edges) from all the input data sources {(Vij, Eij)} = {(Vij1, 
Eij1), (Vij2, Eij2)….. (Vijs, Eijs)} 
 
Hierarchical Biological Pathway Data Integration and Mining 25 
 where, Vijk= {vijk1, vijk2, ….vijkt} and Eij1= {e ijk1, e ijk2,….e ijku} 
Step 3.  
For k = 1, …, q (d1j1,… d1jk),  
 For s = 1,.., n, and  q = 1, …m,  
    List ATT {(v1jks, (A)}  
  List ATT {(e ijkq, (B)}   
   Select vijk1 Є Vijk C d1jk  
     For all p =1 to n  
  Check for vijk, 1 Є Vijp (node name match across data sources)  
  If YES, then Apply EV integration algorithm  
   Generate DATT {v1jkn, (δA)}, DATT {e1jkn, (δB)}, 
        Else, For p = 1 to  n, 
   For t = 1, z  
Check if vijk,1 Є SynList {vijp,t } (node name(A) with Synlist(B)) 
   If YES, then Apply EV integration algorithm, 
   Generate DATT {v1jkn, (δA)}, DATT {e1jkn, (δB)}, 
  Else,  
   Check if SynList {vijk,1} has a match with vijp,t 
                If YES, then Apply EV integration Algorithm 
  Else, 
   Check if SynList {vijk,1} has a match with SynList {vijp,t } 
   If vijk,1  =  vijp,l is TRUE,  
   Then,   
   Include vijk, 1 with the matched node name vijk-1, p Є Vijk-1 
   Compute (δVijk, δEijk) 
***This is the node name for the integrated database for the species. Level 1*** 
Generate SynListInt = {SynList (vijk, 1) U Synlist (vijp,l)U…} without duplication 
Associate DOI (date of integration) 




Repeat Step 2-3 for eijk Є Eijk in (dij1,… dijk), for pij 
Include information associated with the edge, as given by ‘edges’ such as reaction, 
enzyme, by products and substrates along with attributes like evidence, reference 
publications, context etc. 
** Outputs Eijint table for si using (d1j1,… d1jk),  with EVijint, CWijint and RIijint . Level 1. ** 
Pijint  = {Σ Pijk } for k=1 to n = [{ Vijint, E ijint} + { Σ δVijkt, Σ δEijk} for k=1 to n ]at t= t1 
       = Σ {ATT [(v1jkn, (A)]}, ATT [(e ijkm, (B)]} + Σ {DATT {v1jkn, (δA), DATT {e1jkn, (δB)}for 




Generate integrated pathway by consolidating outputs G(Vijint, Eijint) for si 
Step 6. 
For i =1,…n  
Repeat steps 2- 4 to integrate Pij for all species si  
** This generates Table (Vjint, Ejint) = {(Vijint, Eijint) U (Vjjint, Ejjint)U…} for Si, for all i =1, ..n), 
for a pij.  Level 2*** 
Step 7.  
For (j = 1,….p) 
 Integrate for all Pij  
**This generates output table (Vint, Eint) = (Vjint,Ejint) U (Vkint,Ekint) U….for all (j = 1,….p). 
Level 3*** 
Step 8.  
Apply UDF (User defined filter)  
5. Querying Integrated Pathway  
Once the data integration is accomplished, extracting information from the integrated data 
will be of interest to the biologist. There are various mechanisms to extract information from 
the integrated database generated. Some of these are described below.  
Granular computing with semantic network structure captures the abstraction and 
incompleteness associated with biological plant pathway data. It is inspired by the ways in 
which humans granulate information and reason with coarse grained information. The three 
basic concepts underlying the human cognition are granulation, organization, and 
causation. Granulation involves decomposition of whole into parts, organization involves 
integration of parts into whole, and causation involves associations of cause and effects. The 
fundamental issues with granular computing are granulation of the universe, description of 
granules, and relationships between granules. The basic ideas of crisp information 
granulation have appeared in related fields, such as interval analysis, quantization, rough 
set theory, Demster Shafer theory of belief functions, divide and conquer, cluster analysis, 
machine learning, data bases and many others. Granules may be induced as a result of 1) 
equivalence of attribute values, 2) similarity of attribute values, and define the granules 3) 
equality of attribute value. We use granules for defining the user queries associated with the 
integrated pathway. Based on user (biologist) choice, granules can be defined to view the 
integrated pathway. This provides flexibility to the biologist for using the information.  
Previous approaches towards metabolic network reconstruction have used various 
algorithmic methods such as name-matching in IdentiCS [52] and using EC-codes in 
metaSHARK [53] to link metabolic information to genes. The AUtomatic Transfer by 
Orthology of Gene Reaction Associations for Pathway Heuristics (AUTOGRAPH) method 
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[54] uses manually curated metabolic networks, orthologue and their related reactions to 
compare predicted gene-reaction associations.  
Arrendondo [55] Proposes to develop a process for the continuous improvement of the 
inference system used, which is applicable to any such data mining application. It involves 
the comparison of several classifiers like Support Vector Machines (SVMs), Human Expert 
generated Fuzzy, and Genetic Algorithm (GA) generated Fuzzy and Neural Networks using 
various different training data models. In his approach, all classifiers were trained and 
tested with four different data sets: three biological and a synthetically generated mixture 
data set. The obtained results showed a highly accurate prediction capability with the 
mixture data set providing some of the best and most reliable results. 
6. Conclusion 
Biological database integration is a challenging task as the databases are created all over the 
world and updated frequently. For biological data sources that may be derived from an 
earlier existing data source, it is also important to identify the evidence of the data source 
represented by the evidence code, to be included as a candidate for integration. In most data 
integration algorithms the user does not participate thus leading to an integrated data 
source with any effective utility towards analysis.  
Large scale integration of pathway databases promises to help biologists gain insight into 
the deep biological context of a pathway. In this chapter, we presented algorithms that help 
user to select their choice of data sources and apply Evidence code algorithm to compute an 
integrated EV code and RI for the pathway data of interest. The ultimate goal is to generate 
a large-scale composite database containing the entire metabolic network for an organism. 
This qualitative approach includes aspects like user confidence scores for databases for 
mapping EV and generating RI for a given pathway. For the TCA pathway results show that 
generating such a mapping is helpful in visualizing the integrated database that highlights 
the common entities as well as the specifics of each database. As the database confidence 
weight selection is user specific, the integration yields different results for different users for 
the same database which will allow users to explore the effects of different hypotheses on 
the overall network. Once the integrated evidence code is generated, then data integration 
algorithm is applied to get the integrated pathway data. To best attempt integration of such 
data it is imperative to include user participation as user mostly identifies the associations 
and behavior of various compounds, reactions, genes in a given biological pathway leading 
to significant diagnosis. 
Author details 
Shubhalaxmi Kher  
Electrical Engineering, Arkansas State University, USA 
Jianling Peng 




Generate integrated pathway by consolidating outputs G(Vijint, Eijint) for si 
Step 6. 
For i =1,…n  
Repeat steps 2- 4 to integrate Pij for all species si  
** This generates Table (Vjint, Ejint) = {(Vijint, Eijint) U (Vjjint, Ejjint)U…} for Si, for all i =1, ..n), 
for a pij.  Level 2*** 
Step 7.  
For (j = 1,….p) 
 Integrate for all Pij  
**This generates output table (Vint, Eint) = (Vjint,Ejint) U (Vkint,Ekint) U….for all (j = 1,….p). 
Level 3*** 
Step 8.  
Apply UDF (User defined filter)  
5. Querying Integrated Pathway  
Once the data integration is accomplished, extracting information from the integrated data 
will be of interest to the biologist. There are various mechanisms to extract information from 
the integrated database generated. Some of these are described below.  
Granular computing with semantic network structure captures the abstraction and 
incompleteness associated with biological plant pathway data. It is inspired by the ways in 
which humans granulate information and reason with coarse grained information. The three 
basic concepts underlying the human cognition are granulation, organization, and 
causation. Granulation involves decomposition of whole into parts, organization involves 
integration of parts into whole, and causation involves associations of cause and effects. The 
fundamental issues with granular computing are granulation of the universe, description of 
granules, and relationships between granules. The basic ideas of crisp information 
granulation have appeared in related fields, such as interval analysis, quantization, rough 
set theory, Demster Shafer theory of belief functions, divide and conquer, cluster analysis, 
machine learning, data bases and many others. Granules may be induced as a result of 1) 
equivalence of attribute values, 2) similarity of attribute values, and define the granules 3) 
equality of attribute value. We use granules for defining the user queries associated with the 
integrated pathway. Based on user (biologist) choice, granules can be defined to view the 
integrated pathway. This provides flexibility to the biologist for using the information.  
Previous approaches towards metabolic network reconstruction have used various 
algorithmic methods such as name-matching in IdentiCS [52] and using EC-codes in 
metaSHARK [53] to link metabolic information to genes. The AUtomatic Transfer by 
Orthology of Gene Reaction Associations for Pathway Heuristics (AUTOGRAPH) method 
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[54] uses manually curated metabolic networks, orthologue and their related reactions to 
compare predicted gene-reaction associations.  
Arrendondo [55] Proposes to develop a process for the continuous improvement of the 
inference system used, which is applicable to any such data mining application. It involves 
the comparison of several classifiers like Support Vector Machines (SVMs), Human Expert 
generated Fuzzy, and Genetic Algorithm (GA) generated Fuzzy and Neural Networks using 
various different training data models. In his approach, all classifiers were trained and 
tested with four different data sets: three biological and a synthetically generated mixture 
data set. The obtained results showed a highly accurate prediction capability with the 
mixture data set providing some of the best and most reliable results. 
6. Conclusion 
Biological database integration is a challenging task as the databases are created all over the 
world and updated frequently. For biological data sources that may be derived from an 
earlier existing data source, it is also important to identify the evidence of the data source 
represented by the evidence code, to be included as a candidate for integration. In most data 
integration algorithms the user does not participate thus leading to an integrated data 
source with any effective utility towards analysis.  
Large scale integration of pathway databases promises to help biologists gain insight into 
the deep biological context of a pathway. In this chapter, we presented algorithms that help 
user to select their choice of data sources and apply Evidence code algorithm to compute an 
integrated EV code and RI for the pathway data of interest. The ultimate goal is to generate 
a large-scale composite database containing the entire metabolic network for an organism. 
This qualitative approach includes aspects like user confidence scores for databases for 
mapping EV and generating RI for a given pathway. For the TCA pathway results show that 
generating such a mapping is helpful in visualizing the integrated database that highlights 
the common entities as well as the specifics of each database. As the database confidence 
weight selection is user specific, the integration yields different results for different users for 
the same database which will allow users to explore the effects of different hypotheses on 
the overall network. Once the integrated evidence code is generated, then data integration 
algorithm is applied to get the integrated pathway data. To best attempt integration of such 
data it is imperative to include user participation as user mostly identifies the associations 
and behavior of various compounds, reactions, genes in a given biological pathway leading 
to significant diagnosis. 
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A group of animal and human diseases caused by parasitic protozoan trypanosomes is 
called trypanosomiases. The final decade of the 20th century witnessed a frightening revival 
in sleeping sickness (human African trypanosomiasis) in sub-Saharan Africa. Meanwhile, 
Chagas' disease (American trypanosomiasis) remains one of the most widespread infectious 
diseases in South and Central America. Arthropod vectors are responsible for the spread of 
African and American trypanosomiases, and disease restraint through insect control 
programs is an attainable target. However, the existing drugs for both illnesses are far from 
ideal. The trypanosomes are some of the earliest diverging members of the Eukaryotae and 
share several biochemical oddities that have inspired research into discovery of new drug 
targets. Nevertheless, discrepancies in mode of interactions between trypanosome species 
and their hosts have spoiled efforts to design drugs effective against both species. 
Heightened awareness of these neglected diseases might result in progress towards control 
through increased financial support for drug development and vector eradication [1]. 
Trypanosome is a group of unicellular parasitic flagellate protozoa which mostly infects the 
vertebrate genera. A number of trypanosome species cause important veterinary diseases, 
but only two cause significant human diseases. In sub-Saharan Africa, Trypanosoma brucei 
causes sleeping sickness or human African trypanosomiasis whilst in America, Trypanosoma 
cruzi causes Chagas' disease (Figure 1) [2]. Meanwhile, the life cycle of these parasitic 
protozoa engage insect vectors and mammalian hosts (Figure 2) [1]. All trypanosomes 
require more than one obligatory host to complete their life cycle and are transmitted via 
vectors. Most of the species are transmitted by blood-feeding invertebrates, however there 
© 2012 Yahya et al., licensee InTech. This is a paper distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
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A group of animal and human diseases caused by parasitic protozoan trypanosomes is 
called trypanosomiases. The final decade of the 20th century witnessed a frightening revival 
in sleeping sickness (human African trypanosomiasis) in sub-Saharan Africa. Meanwhile, 
Chagas' disease (American trypanosomiasis) remains one of the most widespread infectious 
diseases in South and Central America. Arthropod vectors are responsible for the spread of 
African and American trypanosomiases, and disease restraint through insect control 
programs is an attainable target. However, the existing drugs for both illnesses are far from 
ideal. The trypanosomes are some of the earliest diverging members of the Eukaryotae and 
share several biochemical oddities that have inspired research into discovery of new drug 
targets. Nevertheless, discrepancies in mode of interactions between trypanosome species 
and their hosts have spoiled efforts to design drugs effective against both species. 
Heightened awareness of these neglected diseases might result in progress towards control 
through increased financial support for drug development and vector eradication [1]. 
Trypanosome is a group of unicellular parasitic flagellate protozoa which mostly infects the 
vertebrate genera. A number of trypanosome species cause important veterinary diseases, 
but only two cause significant human diseases. In sub-Saharan Africa, Trypanosoma brucei 
causes sleeping sickness or human African trypanosomiasis whilst in America, Trypanosoma 
cruzi causes Chagas' disease (Figure 1) [2]. Meanwhile, the life cycle of these parasitic 
protozoa engage insect vectors and mammalian hosts (Figure 2) [1]. All trypanosomes 
require more than one obligatory host to complete their life cycle and are transmitted via 
vectors. Most of the species are transmitted by blood-feeding invertebrates, however there 
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Figure 1. Geographic distribution of Trypanosoma brucei and Trypanosoma cruzi, showing endemic 
countries harboring these diseases [2]. 
 
Figure 2. Life cycles of (A) Trypanosoma cruzi and (B) Trypanosoma brucei. Upper cycles represent 
different stages that take place in the insect vectors. Lower cycles represent different stages in man and 
other mammalian hosts [1]. 
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are distinct mechanisms among the varying species. In the invertebrate hosts they are 
generally found in the intestines as opposed to the bloodstream or any other intracellular 
environment in the mammalian host. As trypanosomes develop through their life cycle, they 
undergo a series of morphological changes [3] as is typical of trypanosomatids.   
The life cycle often consists of the trypomastigote form in the vertebrate host and the 
trypomastigote or promastigote form in the gut of the invertebrate host. Intracellular 
lifecycle stages are normally found in the amastigote form. The trypomastigote morphology 
is unique to species in the genus Trypanosoma.  
The genome organization of T. brucei is splitted into nuclear and mitochondrial genomes. 
The nuclear genome of T. brucei is made up of three classes of chromosomes according to 
their size on pulsed-field gel electrophoresis,  large chromosomes (1 to 6 megabase pairs), 
intermediate chromosomes (200 to 500 kilobase pairs) and mini chromosomes (50 to 100 
kilobase pairs) [4]. The large chromosomes contain most genes, while the small 
chromosomes tend to carry genes involved in antigenic variation, including the variant 
surface glycoprotein (VSG) genes. Meanwhile, the mitochondrial genome of the 
Trypanosoma, as well as of other kinetoplastids, known as the kinetoplast, is characterized 
by a highly complex series of catenated circles and minicircles and requires a cohort of 
proteins for organisation during cell division. The genome of T. brucei has been completely 
sequenced and is now available online [5].  
1.2. Nuclear transport 
Nuclear transport of proteins and ribonucleic acids (RNAs) between the nucleus and 
cytoplasm is a key mechanism in eukaryotic cells [6]. The transport between the nucleus and 
cytoplasm involves primarily three classes of macromolecules: substrates, adaptors, and 
receptors. The transport complex is formed when the substrates bind to an import or an 
export receptor. Some transport substrates require one or more adaptors to mediate 
formation of a transport complex. Once assembled, these transport complexes are 
transferred in one direction across the nuclear envelope via aqueous channels that are part 
of the nuclear pore complexes (NPCs). Following dissociation of the transport complex, both 
adaptors and receptors are recycled through the NPC to allow another round of transport to 
occur. Directionality of either import or export therefore depends on the formation of 
receptor-substrate complex on one side of the nuclear envelope and the dissociation of the 
complex on the other. The Ran GTPase is vital in producing this asymmetry. Modulation of 
nuclear transport generally involves specific inhibition of the formation of a transport 
complex, however, more global forms of regulation also occur [7]. The general concept of 
import and export process is shown in Figure 3 [8]. 
1.3. In silico approach 
In silico study is defined as an analysis which is performed using computer or via computer 
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GTP Guanine triphosphate 
GDP Guanine diphosphate 
NTF2 Nuclear transport factor 2 
RCC1 Regulator of chromosome condensation 1 
Figure 3. For import of molecules, cytoplasmic cargo is identified by Importin a, which then binds to 
Importin b (1). This ternary complex translocates through the nuclear membrane and into the nucleus. 
Once there, RanGTP binds to Importin b and causes a dissociation of the complex, which releases cargo 
to the nucleus (2). Import receptors are then recycled back to the nucleus (3) through binding of 
RanGTP and export to the cytosol. RanGTP is then hydrolyzed to the GDP-bound state and causes the 
release of the import receptors (4) and the cycle starts over again. Export of cargo undergoes a similar 
mechanism. Exported molecules will bind to the export receptor with RanGTP and exit the nucleus (5). 
Next RanGTP is hydrolyzed to cause release of cargo into the cytoplasm (6). NTF2 specifically identifies 
RanGDP and returns it to the nucleus (7) for RCC1 to then exchange it to RanGTP (8) [8]. 
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information from biological data at the genomic, metabalomic, proteomic, phylogenetic, 
cellular, or whole organism levels. The bioinformatics instruments and skills become crucial 
for in silico research as genome sequencing projects have resulted in an exponential growth 
in protein and nucleic acid sequence databases. Interaction among genes that gives rise to 
multiprotein functionality generates more data and complexity. In silico approach in 
medicine is not only reducing the need for expensive lab work and clinical trials but also is 
possible to speed the rate of drug discovery. In 2010, for example, researchers found 
potential inhibitors to an enzyme associated with cancer activity in silico using the protein 
docking algorithm EADock [9]. About 50 % of the molecules were later shown to be active 
inhibitors in vitro [9]. A unique advantage of the in silico approach is its worldwide 
accessibility. In some cases, having internet access or even just a computer is sufficient 
enough. Laboratory experiments either in vivo or in vitro both require more materials. In 
protein sequence analysis, in silico approach gives highly reproducible results in many cases 
or even exactly the same results because it only relies on comparison of the query sequence 
to a database of previously annotated sequences. However, in sophisticated analysis such as 
development of the 3-D structure of proteins from their primary sequences, discrepancies in 
results are to be expected due to the manual optimization which must consider several 
crucial steps such as template selection, target-template alignment, model construction and 
model evaluation.   
1.4. Problem statements 
Considering the importance of nuclear shuttling in many cellular processes, proteins 
responsible for the nuclear transport are vital for parasite survival. The presence of nuclear 
transport machinery was highlighted in the eukaryotic parasites such as Plasmodium 
falciparum, Toxoplasma gondii and Cryptosporidium parvum. However, the nuclear transport in 
T. brucei has not been established. Nuclear shuttling is one of the overlooked aspects of drug 
design and delivery. Exploitation of macromolecules movement across the nuclear envelope 
promises to be an exciting area of drug development. Furthermore, the divergence between 
host and parasite systems is always exploited as a strategy in drug development. Therefore, 
the exploitation of peculiarities of T. brucei nuclear transport machinery as compared to its 
host might be a promising strategy for the control of trypanosomiasis, which remains to be 
further investigated. 
1.5. Objectives 
This study is carried out to investigate the nuclear transport constituents of T. brucei by 
determining the functional characteristics of the parasite proteins. This includes functional 
protein domain, post translational modification sites and protein-protein interaction. The 
parasite proteins identified to exhibit the relevant functional protein domains, post 
translational modification sites and protein-protein interaction, are predicted as the true 
components for nuclear transport mechanism. This study also aims to evaluate the unique 
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and human by determining the degree of protein sequence similarity. The information on 
the sequence level divergence between T. brucei proteins and their human counterparts may 
provide an insight into drug target discovery. 
2. Materials and methods 
Our in silico analyses were carried out using the public databases and web based programs 
(Table 1). The programs were employed to identify and annotate the parasite proteins 
involved in the nuclear transport mechanism. The identified parasite proteins were then 
compared with the human counterparts. 
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BLASTp (NCBI) http://blast.ncbi.nlm.nih.gov/ 
Table 1. Databases and web-based programs used in the analysis of nuclear transport of T. brucei. 
We utilized a personal computer equipped with AMD Turion 64x2 dual-core processor, 
memory size of 32 gigabytes and NVIDIA graphics card to perform the analyses. Our in 
silico work is summarized in Figure 4. 
The nuclear transport refers to a process of entry and exit of large molecules from the cell 
nucleus. To identify T. brucei proteins of nuclear transport, the protein sequences of other 
various eukaryotic organisms were retrieved in FASTA format from National Centre for 
Biotechnology Information (NCBI) server and Universal Protein Knowledgebase/SwissProt 
(UniProtKB/ SwissProt) database based on biological processes and protein name search. 
The number of hits obtained for the query was recorded after manual inspection. The 
retrieved protein sequences were clustered into groups with more than 30% similarity using 
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BLASTClust [10] to reduce non-redundant protein sequences. The non-redundant data set 
was subjected to BLASTp [11] analyses against an integrated genomic and functional 
genomic database for eukaryotic pathogens of the family Trypanosomatidae, TriTrypDB. 
The analysis was using cutoff point with E-value of less than 1e-06 and score of more than 
100. Hits that pointed to the same location or overlapped location were removed manually. 
The identified protein sequences then were then retrieved from the TriTrypDB.  
 
Figure 4. In silico analysis workflow. 
A portion of protein that can evolve, function, and exist independently is called protein 
domain. It is a compact three dimensional structure, stable and distribution of polar and 
non-polar side chains contribute to its folding process. To determine the functional protein 
domains, all identified protein sequences of T. brucei from TriTrypDB were subjected to 
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functional annotation which makes use of Conserved Domain Database (CDD) [12], Simple 
Modular Architecture Research Tool (SMART) [13] and InterPro [14] programs. The protein 
sequences were submitted in FASTA format as queries. 
Posttranslational modification (PTM) is the chemical modification of a protein after its 
translation. It is one of the later steps in protein biosynthesis, and thus gene expression, for 
many proteins. In this part of study, in relation to regulatory aspects of nuclear transport 
mechanism, we focused on potential glycosylation and phosphorylation sites. To analyze 
the post translational modification sites, all protein sequences of T. brucei from TriTrypDB 
were subjected to PROSITE [15] programme. The proteins sequences were submitted in 
FASTA format as queries.  
Protein–protein interactions occur when two or more proteins bind together, often to carry 
out their biological function. Proteins might interact for a long time to form part of a protein 
complex, a protein may be carrying another protein, or a protein may interact briefly with 
another protein just to modify it. To analyze the participation of parasite proteins in protein-
protein interactions, all protein sequences of T. brucei from TriTrypDB were subjected to 
mining of STRING 8.2 database [16]. The STRING 8.2 database integrates information from 
numerous sources, including experimental repositories, computational prediction methods 
and public text collections. The proteins sequences were submitted in FASTA format as 
queries. All information on protein-protein interaction were recorded and evaluated 
accordingly.  
The degree of similarity between amino acids occupying a particular position in the protein 
sequence can be interpreted as a rough measure of how conserved a particular region or 
sequence motif is. To compare the parasite proteins with human homologues, all protein 
sequences of T. brucei from TriTrypDB were subjected to BLASTp analysis against Homo 
sapiens proteins. The proteins sequences were submitted in FASTA format as queries. The 
criteria such as cutoff point with E-value of less than 1e-06 and score of more than 100 were 
used. 
3. Results and discussions 
3.1. Parasite proteins involved in the nuclear transport machinery 
Table 2 shows a summary of protein sequences used in this in silico analysis. A total of 904 
and 642 protein sequences were retrieved in FASTA format from NCBI server and 
UniProt/SwissProt database respectively. A total of 18 protein sequences with less than 100 
amino acid residues were excluded from the study as they were considered not completely 
functional [17]. Hence, 1528 protein sequences were used for protein sequence clustering. 
The 30% identity and above at the amino acid level is considered sufficient to imply 
functional relatedness [17]. Therefore, protein clustering with more than 30% similarity on 
the retrieved protein sequences produced a non-redundant data set of 248 protein 
sequences.  
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Protein sequences Total 
Raw protein sequences retrieved from NCBI and UniProtKB 1546 
Raw protein sequences subjected to BLASTClust programme 1548 
Non redundant protein sequences resulting from BLASTClust analysis 248 
Query sequences for BLASTp analysis against TritrypDB database 248 
Table 2. Summary of protein sequences retrieved in in silico analysis. 
The BLASTp analyses against TriTrypDB using cut off point with E-value of less than 1e-06 
and score of more than 100 for the whole 248 query protein sequences resulted in 34 hits of 
parasite proteins. However our approach failed to identify a Ran GTPase-activating protein 
(RanGAP) protein in this parasite. In reference [18] also reported that sequence similarity 
searches have been unable to identify a RanGAP protein in any protozoan. Keyword 
searches among annotated proteins in the T. gondii genome database identified one 
candidate which was shown to have strong similarity to Ran-binding protein 1 (RanBP1) 
based on sequence analysis. Perhaps the RanGAP function in apicomplexans is performed 
by a single protein with multiple cellular responsibilities (i.e., a fusion of Ran binding 
protein 1 and RanGAP). It is also possible that a completely unique parasite protein 
possesses the RanGAP function. 
Table 3 shows the identified and characterized parasite proteins involved in the nuclear 
transport machinery. The functional annotation based on protein domains, showed that, out 
of 34, only 22 parasite protein sequences were predicted with high confidence level to be 
involved in the nuclear transport mechanism with the presence of relevant protein domains. 
This includes guanine triphosphate (GTP)-binding domain, Nucleoporin (NUP) C terminal 
domain, Armadillo repeat, Importin B N-terminal domain, regulator of chromosome 
condensation 1 (RCC1) repeat and Exportin domain (Table 4). All these protein domains 
were experimentally verified to regulate the nuclear transport mechanism in eukaryotes. 
There were seven T. brucei proteins that exhibited functional features of the Importin 
receptor. This finding is consensus with the number of Importin receptors in another 
eukaryotic pathogen, Toxoplasma gondii [8]. In addition, our results of other nuclear transport 
constituents in T. brucei such as RCC1, Ran, nuclear transport factor 2 (NTF2), cell apoptosis 
susceptibility (CAS), Exportin and Ran binding proteins were also in agreement with 
reference [18].  
The nuclear and cytoplasmic compartments are divided by the nuclear envelope in 
eukaryotes. By using this compartmentalization and controlling the movement of molecules 
between the nucleus and the cytosol, cells are able to regulate numerous cellular 
mechanisms such as transcription and translation. Proteins with molecular size lower than 
40 kDa are able to passively diffuse through the nuclear pore complex (NPC), whereas 
larger proteins require active transport through the assistance of Karyopherins, specific 
transport receptors that shuttle between the nucleus and cytosol. Karyopherins which are 
able to distinguish between the diverse proteome to target specific cargo molecules for 
transport, can be subdivided into those that transport molecules into the nucleus (Importins) 
and those that transport molecules out of the nucleus (Exportins). It has been reported that 
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This includes guanine triphosphate (GTP)-binding domain, Nucleoporin (NUP) C terminal 
domain, Armadillo repeat, Importin B N-terminal domain, regulator of chromosome 
condensation 1 (RCC1) repeat and Exportin domain (Table 4). All these protein domains 
were experimentally verified to regulate the nuclear transport mechanism in eukaryotes. 
There were seven T. brucei proteins that exhibited functional features of the Importin 
receptor. This finding is consensus with the number of Importin receptors in another 
eukaryotic pathogen, Toxoplasma gondii [8]. In addition, our results of other nuclear transport 
constituents in T. brucei such as RCC1, Ran, nuclear transport factor 2 (NTF2), cell apoptosis 
susceptibility (CAS), Exportin and Ran binding proteins were also in agreement with 
reference [18].  
The nuclear and cytoplasmic compartments are divided by the nuclear envelope in 
eukaryotes. By using this compartmentalization and controlling the movement of molecules 
between the nucleus and the cytosol, cells are able to regulate numerous cellular 
mechanisms such as transcription and translation. Proteins with molecular size lower than 
40 kDa are able to passively diffuse through the nuclear pore complex (NPC), whereas 
larger proteins require active transport through the assistance of Karyopherins, specific 
transport receptors that shuttle between the nucleus and cytosol. Karyopherins which are 
able to distinguish between the diverse proteome to target specific cargo molecules for 
transport, can be subdivided into those that transport molecules into the nucleus (Importins) 
and those that transport molecules out of the nucleus (Exportins). It has been reported that 
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more than 2000 proteins are shuttled between the nucleus and the cytoplasm in yeast [19]. 
From our result, with the identification of Karyopherin and Nucleoporin proteins in T. 





E-value Score Functional protein domains 
Tb927.3.1120 1.70E-72 718 Ran GTPase, GTP-binding domain 
Tb09.211.4360 5.50E-33 348 Karyopherin Importin Beta, Armadillo repeat 
Tb11.01.5940 9.30E-149 1391 
Exportin-1 C terminal, Importin Beta N terminal 
domain 
Tb11.02.0870 3.20E-16 187 Ran binding domain 
Tb927.2.2240 2.40E-15 190 Exportin-like protein 
Tb927.6.2640 9.10E-83 815 Karyopherin Importin Beta, Armadillo repeat 
Tb927.6.4740 1.10E-75 748 CAS/CSE domain, Importin Beta N terminal domain 
Tb927.7.1190 6.90E-20 172 RCC1 repeat 
Tb11.03.0140 5.80E-09 107 NUP C terminal domain 
Tb927.10.8170 2.10E-28 315 NUP C terminal domain 
Tb927.8.3370 2.50E-48 281 Ran-binding protein Mog1p 
Tb11.01.7010 8.20E-42 464 Armadillo repeat, Karyopherin Importin Beta 
Tb11.02.1720 2.60E-26 276 Armadillo-like helical 
Tb11.01.8030 1.70E-18 218 
HEAT repeat, Armadillo repeat, Importin Beta N 
terminal domain 
Tb11.01.7200  7.10E-07 137 Nsp1-like 
Tb927.7.6320 1.20E-11 136 RCC1 repeat 
Tb927.3.4600 3.70E-08 149 Armadillo-like helical 
Tb09.160.2360 1.40E-36 379 WD40 repeat 
Tb927.6.3870 8.50E-14 164 RNA recognition motif 
Tb927.7.5760 1.30E-08 115 Nuclear transport factor 2 domain 
Tb10.70.4720 4.60E-77 761 
Importin Beta N terminal domain, Karyopherin 
domain 
Tb927.8.4280 2.90E-08 112 Nuclear transport factor 2 domain 
Key: 
GTP Guanine triphosphate 
CAS Cell apoptosis susceptibility 
CSE Chromosome seggregation 
RCC1 Regulator of chromosome condensation 1 
NUP Nucleoporin 
HEAT Huntingtin, elongation factor 3 (EF3), protein phosphatase 2A (PP2A), and the yeast PI3-kinase TOR1 
WD Trp-Asp (W-D) dipeptide 
RNA Ribonucleic acid 
Table 3. Identified and characterized T. brucei proteins of nuclear transport. Protein domain 
identification involved CDD, SMART, InterPro and PROSITE programs. 
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Protein domain Accession Description 
Ran GTPase  SM00176 





This domain binds RanGTP and increases the rate of 
RanGAP1-induced GTP hydrolysis. 
Armadillo IPR000225 
The Armadillo (Arm) repeat is an approximately 40 amino 
acid long tandemly repeated sequence motif first identified in 
the Drosophila melanogaster segment polarity gene armadillo 
involved in signal transduction through wingless. Animal 
Arm-repeat proteins function in various processes, including 
intracellular signalling and cytoskeletal regulation, and 
include such proteins as beta-catenin, the junctional plaque 
protein plakoglobin, the adenomatous polyposis coli (APC), 
tumour suppressor protein, and the nuclear transport factor 
importin-alpha, amongst others 
Importin beta IPR001494 
Members of the Importin-beta (Karyopherin-beta) family can 
bind and transport cargo by themselves, or can form 
heterodimers with importin-alpha. As part of a heterodimer, 
Importin-beta mediates interactions with the pore complex, 
while Importin-alpha acts as an adaptor protein to bind the 
nuclear localisation signal (NLS) on the cargo through the 
classical NLS import of proteins. 
HEAT IPR000357 
Arrays of Huntingtin, elongation factor 3 (EF3), protein 
phosphatase 2A (PP2A), and the yeast PI3-kinase TOR1 
(HEAT) repeats consists of 3 to 36 units forming a rod-like 
helical structure and appear to function as protein-protein 
interaction surfaces. It has been noted that many HEAT 





The sequences featured in this family are similar to a region 
close to the N-terminus of yeast exportin 1 (Xpo1, Crm1). This 
region is found just C-terminal to an importin-beta N-
terminal domain (pfam03810) in many members of this 
family. Exportin 1 is a nuclear export receptor that interacts 
with leucine-rich nuclear export signal (NES) sequences, and 
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Tb11.01.5940 9.30E-149 1391 
Exportin-1 C terminal, Importin Beta N terminal 
domain 
Tb11.02.0870 3.20E-16 187 Ran binding domain 
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Tb11.01.7010 8.20E-42 464 Armadillo repeat, Karyopherin Importin Beta 
Tb11.02.1720 2.60E-26 276 Armadillo-like helical 
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Key: 
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CAS Cell apoptosis susceptibility 
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RCC1 Regulator of chromosome condensation 1 
NUP Nucleoporin 
HEAT Huntingtin, elongation factor 3 (EF3), protein phosphatase 2A (PP2A), and the yeast PI3-kinase TOR1 
WD Trp-Asp (W-D) dipeptide 
RNA Ribonucleic acid 
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identification involved CDD, SMART, InterPro and PROSITE programs. 
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Protein domain Accession Description 
Ran GTPase  SM00176 





This domain binds RanGTP and increases the rate of 
RanGAP1-induced GTP hydrolysis. 
Armadillo IPR000225 
The Armadillo (Arm) repeat is an approximately 40 amino 
acid long tandemly repeated sequence motif first identified in 
the Drosophila melanogaster segment polarity gene armadillo 
involved in signal transduction through wingless. Animal 
Arm-repeat proteins function in various processes, including 
intracellular signalling and cytoskeletal regulation, and 
include such proteins as beta-catenin, the junctional plaque 
protein plakoglobin, the adenomatous polyposis coli (APC), 
tumour suppressor protein, and the nuclear transport factor 
importin-alpha, amongst others 
Importin beta IPR001494 
Members of the Importin-beta (Karyopherin-beta) family can 
bind and transport cargo by themselves, or can form 
heterodimers with importin-alpha. As part of a heterodimer, 
Importin-beta mediates interactions with the pore complex, 
while Importin-alpha acts as an adaptor protein to bind the 
nuclear localisation signal (NLS) on the cargo through the 
classical NLS import of proteins. 
HEAT IPR000357 
Arrays of Huntingtin, elongation factor 3 (EF3), protein 
phosphatase 2A (PP2A), and the yeast PI3-kinase TOR1 
(HEAT) repeats consists of 3 to 36 units forming a rod-like 
helical structure and appear to function as protein-protein 
interaction surfaces. It has been noted that many HEAT 





The sequences featured in this family are similar to a region 
close to the N-terminus of yeast exportin 1 (Xpo1, Crm1). This 
region is found just C-terminal to an importin-beta N-
terminal domain (pfam03810) in many members of this 
family. Exportin 1 is a nuclear export receptor that interacts 
with leucine-rich nuclear export signal (NES) sequences, and 




Protein domain Accession Description 
CAS/CSE IPR005043 
In the nucleus, cell apoptosis susceptibility (CAS) acts as a 
nuclear transport factor in the importin pathway. The 
Importin pathway mediates the nuclear transport of several 
proteins that are necessary for mitosis and further 
progression. CAS is therefore thought to affect the cell cycle 
through its effect on the nuclear transport of these proteins 
WD40 IPR001680 
WD-repeat proteins are a large family found in all eukaryotes 
and are implicated in a variety of functions ranging from 
signal transduction and transcription regulation to cell cycle 
control and apoptosis. Repeated WD40 motifs act as a site for 
protein-protein interaction, and proteins containing WD40 
repeats are known to serve as platforms for the assembly of 
protein complexes or mediators of transient interplay among 
other proteins. 
RCC1 PDOC00544 
The regulator of chromosome condensation (RCC1) is a 
eukaryotic protein which binds to chromatin and interacts 
with ran, a nuclear GTP-binding protein (see <PDOC00859>), 
to promote the loss of bound GDP and the uptake of fresh 





Communication between the nucleus and cytoplams of an 
eukaryotic cell is mediated by the nuclear pore complexes 
(NPCs), which act as selective molecular gateways. Through 
these gateways, ribonucleic acids (RNAs) and proteins are 
exported into the nucleus. Each NPC consists of ~30 distinct 
proteins termed Nucleoporins, each present in at least eight 
copies, reflecting the octagonal symmetry of the complex. 
NSP 1 IPR007758 
The NSP1-like protein appears to be an essential component of 
the nuclear pore complex, for example preribosome nuclear 
export requires the Nup82p-Nup159p-Nsp1p complex. 
NTF 2 IPR002075 
Nuclear transport factor 2 (NTF2) is a homodimer which 
stimulates efficient nuclear import of a cargo protein. NTF2 
binds to both RanGDP and FxFG repeat-containing 
Nucleoporins. 
Table 4. Summary of protein domains 
3.2. Regulatory aspect of the parasite nuclear transport 
Table 5 shows the presence of phosphorylation and glycosylation sites in the parasite 
proteins. The phosphorylation sites were found to be present in all parasite proteins. It was 
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predicted that the parasite proteins could be phosphorylated at Serine, Threonine and 
Tyrosine amino residues. However, the O-glycosylation sites were not present in three 
parasite proteins, namely Tb11.02.0870, Tb927.8.3370 and Tb927.7.5760.  
 
Subject sequences Phosphorylation site Glycosylation site 
Tb927.3.1120 + + 
Tb09.211.4360 + + 
Tb11.01.5940 + + 
Tb11.02.0870 + - 
Tb927.2.2240 + + 
Tb927.6.2640 + + 
Tb927.6.4740 + + 
Tb927.7.1190 + + 
Tb11.03.0140 + + 
Tb927.10.8170 + + 
Tb927.8.3370 + - 
Tb11.01.7010 + + 
Tb11.02.1720 + + 
Tb11.01.8030 + + 
Tb11.01.7200  + + 
Tb927.7.6320 + + 
Tb927.3.4600 + + 
Tb09.160.2360 + + 
Tb927.6.3870 + + 
Tb927.7.5760 + - 
Tb10.70.4720 + + 
Tb09.211.2550 + + 
Tb927.8.4280 + + 
Key: 
(+) indicates presence 
(-) indicates absence 
Table 5. Phosphorylation and O-glycosylation sites in the T. brucei proteins. Identification of these 
functional sites involved ScanProsite programme. 
Most of the parasite proteins were predicted to be involved in O-linked glycosylation. In 
eukaryotes, the O-linked glycosylation takes place in the Golgi apparatus. It also occurs in 
archaea and bacteria. Phosphorylation was reported to be crucial in the regulation of 
protein-protein interactions of the NADPH oxidase in the phagocytic cells [20]. The 
phosporylation-based signaling in T. brucei has been reported by reference [21]. Thus we 
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Protein domain Accession Description 
CAS/CSE IPR005043 
In the nucleus, cell apoptosis susceptibility (CAS) acts as a 
nuclear transport factor in the importin pathway. The 
Importin pathway mediates the nuclear transport of several 
proteins that are necessary for mitosis and further 
progression. CAS is therefore thought to affect the cell cycle 
through its effect on the nuclear transport of these proteins 
WD40 IPR001680 
WD-repeat proteins are a large family found in all eukaryotes 
and are implicated in a variety of functions ranging from 
signal transduction and transcription regulation to cell cycle 
control and apoptosis. Repeated WD40 motifs act as a site for 
protein-protein interaction, and proteins containing WD40 
repeats are known to serve as platforms for the assembly of 
protein complexes or mediators of transient interplay among 
other proteins. 
RCC1 PDOC00544 
The regulator of chromosome condensation (RCC1) is a 
eukaryotic protein which binds to chromatin and interacts 
with ran, a nuclear GTP-binding protein (see <PDOC00859>), 
to promote the loss of bound GDP and the uptake of fresh 





Communication between the nucleus and cytoplams of an 
eukaryotic cell is mediated by the nuclear pore complexes 
(NPCs), which act as selective molecular gateways. Through 
these gateways, ribonucleic acids (RNAs) and proteins are 
exported into the nucleus. Each NPC consists of ~30 distinct 
proteins termed Nucleoporins, each present in at least eight 
copies, reflecting the octagonal symmetry of the complex. 
NSP 1 IPR007758 
The NSP1-like protein appears to be an essential component of 
the nuclear pore complex, for example preribosome nuclear 
export requires the Nup82p-Nup159p-Nsp1p complex. 
NTF 2 IPR002075 
Nuclear transport factor 2 (NTF2) is a homodimer which 
stimulates efficient nuclear import of a cargo protein. NTF2 
binds to both RanGDP and FxFG repeat-containing 
Nucleoporins. 
Table 4. Summary of protein domains 
3.2. Regulatory aspect of the parasite nuclear transport 
Table 5 shows the presence of phosphorylation and glycosylation sites in the parasite 
proteins. The phosphorylation sites were found to be present in all parasite proteins. It was 
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predicted that the parasite proteins could be phosphorylated at Serine, Threonine and 
Tyrosine amino residues. However, the O-glycosylation sites were not present in three 
parasite proteins, namely Tb11.02.0870, Tb927.8.3370 and Tb927.7.5760.  
 
Subject sequences Phosphorylation site Glycosylation site 
Tb927.3.1120 + + 
Tb09.211.4360 + + 
Tb11.01.5940 + + 
Tb11.02.0870 + - 
Tb927.2.2240 + + 
Tb927.6.2640 + + 
Tb927.6.4740 + + 
Tb927.7.1190 + + 
Tb11.03.0140 + + 
Tb927.10.8170 + + 
Tb927.8.3370 + - 
Tb11.01.7010 + + 
Tb11.02.1720 + + 
Tb11.01.8030 + + 
Tb11.01.7200  + + 
Tb927.7.6320 + + 
Tb927.3.4600 + + 
Tb09.160.2360 + + 
Tb927.6.3870 + + 
Tb927.7.5760 + - 
Tb10.70.4720 + + 
Tb09.211.2550 + + 
Tb927.8.4280 + + 
Key: 
(+) indicates presence 
(-) indicates absence 
Table 5. Phosphorylation and O-glycosylation sites in the T. brucei proteins. Identification of these 
functional sites involved ScanProsite programme. 
Most of the parasite proteins were predicted to be involved in O-linked glycosylation. In 
eukaryotes, the O-linked glycosylation takes place in the Golgi apparatus. It also occurs in 
archaea and bacteria. Phosphorylation was reported to be crucial in the regulation of 
protein-protein interactions of the NADPH oxidase in the phagocytic cells [20]. The 
phosporylation-based signaling in T. brucei has been reported by reference [21]. Thus we 
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believe that the phosphorylation could also regulate the nuclear transport components of T. 
brucei to participate in various functional interactions. Meanwhile, it was suggested that O-
linked glycosylation may be analogous to protein phosphorylation. According to [22], 
phosphorylation by proline-directed kinases share the same sites with those potentially O-
glycosylated by O-linked N-acetylglucosamine transferase (OGT). From this it is possible 
that O-glycosylation and phosphorylation may compete for sites of modification. Therefore, 
it is a strong likelihood that the nuclear transport of T. brucei could be regulated by both 
phosphorylation and O-glycosylation. 
Apart from acting simply as an architectural structure which facilitates nuclear transport, 
the NPC may also play a more dynamic role in regulating transport. The specificity of 
import and export may be influenced by recognition of different substrates and alteration of 
the Nucleoporin expression. This would allow different interaction between the NPC and 
Karyopherins and modulate the nuclear import and export. However, the most common 
impact on nucleocytoplasmic movement stems comes from the post translational 
modifications of the cargo proteins themselves [23]. The post translational modification of 
NPC was reported by [24]. Post-translational modification of NUPs by ubiquitylation and 
phosphorylation can affect NUP turnover and pore disassembly, respectively. Our study 
identified four parasite proteins containing the Nucleoporin-related domain. We anticipate 
that the assembly and disassembly of the parasite Nucleoporin proteins might also be 
modulated by phosphorylation. 
The NPC becomes an ideal target for inhibition of nuclear import or export. One of the most 
common features of Nucleoporins is the presence of conserved FG or FXFG repeats that 
bind to the Importin family members [25]. The monoclonoal antibodies such as mAb414 and 
RL2 can interrupt translocation through the NPC by blocking the FG and FXFG epitopes of 
the Nucleoporins. Consequently, several Nucleoporin proteins were identified by their 
reactivity against the anti-FG antibodies. Most of these FG repeat proteins exist as the 
cytoplasmic fibrils or projections on the nuclear side of the NPC. The monoclonal antibodies 
prevent cargo from associating with the edge of an NPC so it cannot cross the membrane 
[26]. Thus, there is a possibility that the pathogenesis of T. brucei could be controlled by 
inhibiting its Nucleoporin proteins. 
3.3. Participation of parasite proteins in functional interaction network 
Figure 5 illustrates the protein interaction data obtained from STRING 8.2 database. The 
mining of protein interaction data which is useful in contextual annotation of protein 
function showed that, out of 22 parasite homologues, only nine parasite proteins were 
interacting with each other. Out of the seven identified T. brucei Importins, only two namely 
Tb927.6.2640 and Tb10.70.4720 were found to be involved in that protein interaction 
network. This database mining approach indicated that T. brucei nuclear transport is typical 
of eukaryotic organisms. Importins initially recruit cargo at low RanGTP concentrations in 
the cytoplasm and release cargo at high RanGTP levels in the nucleus. Importin–RanGTP 
complexes return afterwards to the cytoplasm, where the Ran-bound GTP is finally 
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hydrolysed and Ran dissociates from the receptor. The Importin can then bind and import 
another cargo molecule, while nuclear transport factor 2 (NTF2) recycles RanGDP back to 
nucleus. The cargo binding to exportins is controlled in a reverse manner compared to 
Importins; they recruit cargo at high RanGTP levels in the nucleus and release cargo at low 




Figure 5. Protein functional interaction network in the nuclear transport of T. brucei. This protein 
interaction data was obtained from STRING 8.2 database. The letters (a-i) indicate the parasite proteins 
involved in the nuclear transport. 
Table 5 shows evaluation of the obtained protein interaction data of the parasite nuclear 
transport. There were 13 functional interactions between parasite proteins identified from 
the mining of STRING 8.2 database. The score values of functional interactions range from 
0.45 to 0.976. The Importin alpha (Tb927.6.2640) was found to be the most interactive 
parasite proteins by participating in six functional interactions. Based on the relevant protein 
domains and previous reports, four out of 13 functional interactions were considered with 
high confidence level. It should be emphasized that our approach only considered the protein 
interaction data derived from experiments, gene fusion and text mining. To our knowledge, 
this is the first report of functional protein interactions in the nuclear transport of the 
eukaryotic parasites. Whether other eukaryotic parasites share the common protein interaction 
network for the nuclear transport machinery remains to be elucidated. 
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believe that the phosphorylation could also regulate the nuclear transport components of T. 
brucei to participate in various functional interactions. Meanwhile, it was suggested that O-
linked glycosylation may be analogous to protein phosphorylation. According to [22], 
phosphorylation by proline-directed kinases share the same sites with those potentially O-
glycosylated by O-linked N-acetylglucosamine transferase (OGT). From this it is possible 
that O-glycosylation and phosphorylation may compete for sites of modification. Therefore, 
it is a strong likelihood that the nuclear transport of T. brucei could be regulated by both 
phosphorylation and O-glycosylation. 
Apart from acting simply as an architectural structure which facilitates nuclear transport, 
the NPC may also play a more dynamic role in regulating transport. The specificity of 
import and export may be influenced by recognition of different substrates and alteration of 
the Nucleoporin expression. This would allow different interaction between the NPC and 
Karyopherins and modulate the nuclear import and export. However, the most common 
impact on nucleocytoplasmic movement stems comes from the post translational 
modifications of the cargo proteins themselves [23]. The post translational modification of 
NPC was reported by [24]. Post-translational modification of NUPs by ubiquitylation and 
phosphorylation can affect NUP turnover and pore disassembly, respectively. Our study 
identified four parasite proteins containing the Nucleoporin-related domain. We anticipate 
that the assembly and disassembly of the parasite Nucleoporin proteins might also be 
modulated by phosphorylation. 
The NPC becomes an ideal target for inhibition of nuclear import or export. One of the most 
common features of Nucleoporins is the presence of conserved FG or FXFG repeats that 
bind to the Importin family members [25]. The monoclonoal antibodies such as mAb414 and 
RL2 can interrupt translocation through the NPC by blocking the FG and FXFG epitopes of 
the Nucleoporins. Consequently, several Nucleoporin proteins were identified by their 
reactivity against the anti-FG antibodies. Most of these FG repeat proteins exist as the 
cytoplasmic fibrils or projections on the nuclear side of the NPC. The monoclonal antibodies 
prevent cargo from associating with the edge of an NPC so it cannot cross the membrane 
[26]. Thus, there is a possibility that the pathogenesis of T. brucei could be controlled by 
inhibiting its Nucleoporin proteins. 
3.3. Participation of parasite proteins in functional interaction network 
Figure 5 illustrates the protein interaction data obtained from STRING 8.2 database. The 
mining of protein interaction data which is useful in contextual annotation of protein 
function showed that, out of 22 parasite homologues, only nine parasite proteins were 
interacting with each other. Out of the seven identified T. brucei Importins, only two namely 
Tb927.6.2640 and Tb10.70.4720 were found to be involved in that protein interaction 
network. This database mining approach indicated that T. brucei nuclear transport is typical 
of eukaryotic organisms. Importins initially recruit cargo at low RanGTP concentrations in 
the cytoplasm and release cargo at high RanGTP levels in the nucleus. Importin–RanGTP 
complexes return afterwards to the cytoplasm, where the Ran-bound GTP is finally 
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hydrolysed and Ran dissociates from the receptor. The Importin can then bind and import 
another cargo molecule, while nuclear transport factor 2 (NTF2) recycles RanGDP back to 
nucleus. The cargo binding to exportins is controlled in a reverse manner compared to 
Importins; they recruit cargo at high RanGTP levels in the nucleus and release cargo at low 




Figure 5. Protein functional interaction network in the nuclear transport of T. brucei. This protein 
interaction data was obtained from STRING 8.2 database. The letters (a-i) indicate the parasite proteins 
involved in the nuclear transport. 
Table 5 shows evaluation of the obtained protein interaction data of the parasite nuclear 
transport. There were 13 functional interactions between parasite proteins identified from 
the mining of STRING 8.2 database. The score values of functional interactions range from 
0.45 to 0.976. The Importin alpha (Tb927.6.2640) was found to be the most interactive 
parasite proteins by participating in six functional interactions. Based on the relevant protein 
domains and previous reports, four out of 13 functional interactions were considered with 
high confidence level. It should be emphasized that our approach only considered the protein 
interaction data derived from experiments, gene fusion and text mining. To our knowledge, 
this is the first report of functional protein interactions in the nuclear transport of the 
eukaryotic parasites. Whether other eukaryotic parasites share the common protein interaction 









Tb927.3.1120 Tb11.01.5940 Experiment 0.45 High 
Lounsbury and 
Macara (1997) 
Tb927.3.1120 Tb11.02.0870 Experiment,Text mining 0.512 Moderate None 
Tb927.3.1120 Tb927.8.4280 Experiment 0.534 High 
Fried and Kutay 
(2003) 










0.46 Moderate None 




0.976 Moderate None 
Tb927.6.2640 Tb09.160.2360 Experiment,Text mining 0.647 Moderate None 
Tb927.6.2640 Tb10.70.4720 Experiment,Text mining 0.769 High 
Fried and Kutay 
(2003) 
Tb927.6.2640 Tb927.8.4280 Experiment,Text mining 0.641 Moderate None 
Tb10.70.4720 Tb927.8.4280 Experiment,Text mining 0.535 Moderate None 
Tb927.8.4280 Tb927.8.3370 Experiment 0.502 Moderate None 
Table 6. Evaluation on protein interaction data obtained from STRING 8.2 database. The evaluation 
was based on the identified protein domains. 
To gain an insight into nuclear transport, understanding on interactions between transport 
receptors and proteins of the nuclear pore complex (NPC) is essential. According to [27], the 
fluorescence resonance energy transfer (FRET) can be employed between enhanced cyan 
and yellow fluorescent proteins (ECFP, EYFP) in living cells in order to explain the transport 
of receptor through the NPC. A FRET assay has been used to analyze a panel of yeast strains 
expressing functional receptor--ECFP and nucleoporin-EYFP fusions. Based on this 
approach, points of contact in the NPC for the related Importin Pse1/Kap121 and Exportin 
Msn5 were successfully characterized. That study proved the advantage of FRET in 
mapping dynamic protein interactions in a genetic system. In addition, both Importin and 
Exportin have overlapping pathways through the NPC. However, our database mining 
approach did not reveal any functional interaction between Nucleoporin and Karyopherin 
proteins of T. brucei.   
3.4. Sequence similarity between parasite proteins and their human counterparts 
Table 6 shows the degree of protein sequence similarity between parasite and human 
proteins. The similarity search for the sequence was carried out with the help of BLASTp 
tool. All the parasite proteins of nuclear transport machinery were found to have their 
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counterparts in human. The degree of sequence similarity between parasite proteins and 
human counterparts range from 19% to 72%. The resulting score values range from 49.3 to 
558. Meanwhile, all the identified human proteins contain the same protein domains 
involved in the nuclear transport.  
 
Subject sequence Human counterparts Score E-value 
Sequence 
similarity (%) 
Tb927.3.1120 NP_006316.1 313 1.00E-109 72% 
Tb09.211.4360 NP_694858.1 221 6.00E-62 25% 
Tb11.01.5940 NP_003391.1 558 0 33% 
Tb11.02.0870 AAA85838.1 79.3 5.00E-20 40% 
Tb927.2.2240 AAH20569.1 79.3 2.00E-16 29% 
Tb927.6.2640 NP_036448.1 360 4.00E-119 42% 
Tb927.6.4740 AAC50367.1 368 9.00E-113 29% 
Tb927.7.1190 AAI42947.1 453 2.00E-27 27% 
Tb11.03.0140 AAH45620.2 258 2.00E-09 38% 
Tb927.10.8170 NP_705618.1 134 1.00E-33 28% 
Tb927.8.3370 AAF36156.1 70.9 2.00E-17 27% 
Tb11.01.7010 NP_002262.3 207 2.00E-56 23% 
Tb11.02.1720 NP_006382.1 156 9.00E-28 24% 
Tb11.01.8030 NP_002262.3 101 3.00E-23 21% 
Tb11.01.7200  CAA41411.1 59.7 4.00E-10 19% 
Tb927.7.6320 NP_001041659.1 146 4.00E-17 28% 
Tb927.3.4600 NP_006381.2 65.9 2.00E-12 20% 
Tb09.160.2360 NP_003601.1 142 2.00E-39 30% 
Tb927.6.3870 NP_001073956.2 75.5 8.00E-18 31% 
Tb927.7.5760 NP_037380.1 49.3 6.00E-11 26% 
Tb10.70.4720 NP_002256.2 277 2.00E-81 28% 
Tb927.8.4280 NP_005787.1 73.6 1.00E-19 31% 
Table 7. Comparison of the identified parasite proteins with human counterparts at protein sequence 
level. This comparison involved BLASTp programme.  
A study reported by [28] showed that despite the high degree of similarity in the primary 
structure of human and T. cruzi ubiquitins, the three amino acid difference is sufficient to 
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procedure to partially purify T. cruzi ubiquitin was performed. Following this 
preparation, ELISA and Western blots were carried out to show that chagasic sera 
recognise T. cruzi but not human or Leishmania ubiquitin indicating a species-specific 
response. Thus, it is probable that the T. brucei proteins could also be distinguished from 
human counterparts at primary sequence level by using the immunodetection method. 
4. General discussions 
4.1. Transport of cargoes  
In RanGTPase system, Ran-binding protein 1 (RanBP1) which is cytoplasmic localized 
binds RanGTP and eases the RanGAP-dependent conversion of RanGTP to RanGDP [29]. 
This indicates that RanBP1 catalyses the cytoplasmic disassembly of RanGTP–transport 
receptor complexes. These complexes are kinetically so stable that RanGAP alone fails to 
trigger GTP hydrolysis [30-32]. RanBP2 [33] is a major constituent of the cytoplasmic 
filaments of NPCs and exhibits similar functions as RanBP1. It has four RanBP1 homology 
domains and forms a stable complex with sumoylated RanGAP [34,35], in order to 
dismantle the RanGTP–transport receptor complexes that exit the nucleus. Importin- and 
exportin-mediated transport cycles can accumulate cargoes against gradients of chemical 
activity, which is an energy-dependent process. The RanGTPase system hydrolyses one 
GTP molecule per transport cycle, and a number of evidences suggest that this contains 
the sole input of metabolic energy [36-39]. We have successfully identified all the required 
key components in the T. brucei nuclear transport. Whether their functionalities in vivo are 
consensus with the known ones still remains to be further investigated. 
4.2. Relationship between signaling pathways and nuclear transport 
Many aspects of cell physiology are greatly dependent on the signaling pathways. This 
includes members of the mitogen activated protein (MAP) kinase family as well as 
phosphatidyl inositol 3 (PI3) and adenosine monophosphate (AMP) kinases which are 
crucial in controlling the cell growth, proliferation, apoptosis and the response to stress.  
By activating the signaling pathway through multiple kinase cascades, various stressors 
are able to regulate the nuclear transport. For example, oxidative and heat stress activate 
both MAP kinase kinase (MEK)-extracellular signal regulated kinase 1/2 (ERK1/2) and PI3 
kinase-Akt pathways [40]. Based on these observations and the fact that many of the 
transport components are modified post-translationally, it was sensible to investigate 
whether these modifications are regulated by stress. A study reported by [41] showed that 
oxidant treatment induced phosphorylation and/or GlcNAc modification of soluble 
transport factors and nucleoporins. Interestingly, changes in transport factor 
modifications are not limited to stress conditions, as modifying ERK or PI3 kinase 
activities in unstressed cells also affect the transport factors. This is exemplified by the 
regulation of RanBP3 through ERK1/2-ribosomal S6 kinase (RSK) signaling, a regulatory 
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link which ultimately controls the Ran concentration gradient. Furthermore, 
phosphorylation of Nup50 which is dependent on ERK, reduces its association with 
importin-β1 and transportin in vitro, and ERK2 is responsible to the oxidant-induced 
collapse of the Ran gradient [42]. It remains unknown how much modulating individual 
transport factors contributes to the overall regulation of nuclear trafficking. However, it is 
noteworthy that the kinase inhibitor PD98059, which targets ERK1/2 and ERK5, 
significantly increases classical nuclear import, both under normal and stress conditions. 
Taken together, these results highlight a critical role of ERK activity in nuclear transport, 
with ERK kinases targeting both soluble factors and nucleoporins [41]. Thus, there is an 
urgent need to investigate the possible connection between upstream signaling apparatus 
with nuclear transport components in T. brucei. 
4.3. In silico approach for drug target discovery 
We have provided interpretation of heterologous data sets for nuclear transport system of T. 
brucei from various resources. With the availability of protein databases and computer-aided 
softwares, we are able to explain various functional interactions between identified parasite 
proteins and how these functional interactions give rise to functionality and behavior of the 
parasite nuclear transport. This would partially facilitate the exhausted effort to obtain 
system-level understanding of T. brucei pathogenesis. Our in silico approach has the 
potential to speed up the rate of drug target discovery while reducing the need for 
expensive lab work and clinical trials. The conventional approaches in vivo and in vitro have 
high tendencies to produce inefficient results when investigating complex large scale data 
such as proteins associated with nuclear shuttling of macromolecules across the nuclear 
envelope. Therefore, the systematic in silico approach from this study provides a 
tremendous opportunity of cost effective drug target discovery for the pharmaceutical 
industry.  
4.4. Experimental validation of in silico data 
Experimental techniques such as yeast two-hybrid assay and affinity purification combined 
with mass spectrometry are useful to investigate the possible protein-protein interaction. 
However, they have their limitations in detecting certain types of interactions. They also 
have technical problems to scale-up for high-throughput analysis. In conjunction with this, 
in silico approach may solve those problems in inferring the protein function. The scope of 
experimental data can be expanded to increase the confidence of certain interacting protein 
pairs with the availability of databases containing in silico data such as protein domain and 
3D structure. The databases integrate information from various resources such as 
computational prediction methods and public text collections. Since in silico and 
experimental approaches are complementary to each other, the combination of these 
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4.5. Our further direction 
In silico approach offers various advantages over in vivo and in vitro approaches such as 
non-use of animals, low costs, and reduced execution time. This approach allows 
identification of proteins of interest from a particular biological study. From a protein 
function standpoint, transfer of annotation from known proteins to a novel target is 
currently the only practical way to convert vast quantities of raw sequence data into 
meaningful information. Many bioinformatics tools now provide more sophisticated 
methods to transfer functional annotation, integrating sequence, family profile and 
structural search methodology. Thus, in addition to data mining for protein-protein 
interaction, further in silico approach should also consider structural alignment, molecular 
docking and pathway modeling in order to obtain a comprehensive and more reliable 
insight into protein-protein interaction of T. brucei nuclear transport. 
5. Conclusion 
The availability of protein databases and computer-aided softwares to identify probable 
components of cellular mechanisms has become a new trend in the present scientific era. 
We demonstrate here a computational analysis of nuclear transport in T. brucei as an 
initial step and proof of concept for further investigation. Our approach successfully 
identified 22 T. brucei proteins essential for nuclear transport. All those parasite proteins 
were found to contain relevant functional domains that drive the translocation of 
macromolecules in the parasite. The phosphorylation and O-glycosylation sites were also 
detected in all identified parasite proteins. This has given us an insight into the 
regulatory aspect of parasite nuclear transport. The database mining of protein 
interaction has shown that nine out of 22 parasite proteins possess relevant functional 
interactions for nuclear transport activities. However, more functional interactions from 
nuclear transport constituents of T. brucei are required to elucidate the exact mechanism. 
The homology between the parasite proteins and human counterparts was shown by 
BLASTp analyses. Whether there are structural differences between them remain 
unknown.  
The nuclear transport in T. brucei has been characterized by using the in silico approach. 
The predicted functionalities and regulatory aspects of parasite nuclear transport 
constituents were in agreement with the previous reports. Moreover, the protein 
interaction data derived from the public database has made the participation of parasite 
proteins in the mechanism more convincing. Thus, we have laid a path for understanding 
the nuclear transport machinery in T. brucei. The development of drugs that target as well 
as alter nuclear import and export will undoubtedly become beneficial in controlling 
Trypanosomiasis in future. Drugs that have a direct effect on a single protein must be able 
to localize to the same site as the protein and interact with one or more of its domains. 
Alternatively, a drug that effectively blocks the target protein from reaching its proper 
organelle can also inhibit the protein’s function. 
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1. Introduction 
The human genome is one of the most complex molecular structures ever seen in nature. Its 
extraordinary information content has revealed a surprising mosaicims between coding and 
non-coding sequences [1-4]. This highly regionalized structure introduces complex patterns 
for understanding the gene structure and repetitive DNA sequence composition providing a 
new scenario to study biological process such as Lentivirus cDNA integration into host 
genome. In the field of genome analysis, bioinformatics provides the key connection 
between all different forms of data gathered by new high-throughput techniques such as 
systematic sequencing, expression arrays, and high throughput screenings among others. 
Although the success of bioinformatics in the genome analysis is undeniable, in some cases 
has complicated the relationship of computation with experimental biology. There is a need 
to attend to our pressing needs of bioinformatics applications without forgetting other, 
perhaps less evident but equally important, aspects of computation in biology. 
The study of particular systems is the source of inspiration that guides the formation of 
general ideas from specific cases to general principles. Therefore the systemic approach 
extends towards the study of fundamental biological questions, such as gene assembly, 
protein folding and the nature of functional specificity. Such issues extend beyond the 
current perception of bioinformatics as a support discipline and address aspects of 
biological complexity, including the simulation of molecular interaction networks.  
2. An overview to human genome 
The genome coding regions are defined, in part, by an alternative series of motifs 
responsible for a variety of functions that take place on the DNA and RNA sequences, such 
as, gene regulation, RNA transcription, RNA splicing, and DNA methylation. For example, 
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sequencing of the human genome revealed a controversial number of interrupted genes 
(25,000-32,000) with their regulatory sequences [1, 2] representing about 2% of the genome. 
These genes are immersed in a giant sea of different types of non-coding sequences which 
make up around 98% of the genome. The non-coding regions are characterized by many 
kinds of repetitive DNA sequences, where almost 10.6% of the human genome consists of 
Alu sequences, a type of SINE (short interspersed elements) sequence [3]. [Alu] elements are 
not randomly distributed throughout the genome but rather are biased toward gene-rich 
regions [5]. They can act as insertional mutagens and the vast majority appears to be 
genetically inert (6). LINES, MIR, MER, LTRs, DNA transposons, and introns are other kinds 
of noncoding sequences, which together conform about 86% of the genome. In addition, 
some of these sequences are overlapped one to another, for example, the CpG islands (CGI), 
which complicates analysis of the genomic landscape. In turn, each chromosome is 
characterized by some particular properties of structure and function.  
3. Human lentiviral integration 
The two closely related human lentiviruses HIV-1 and HIV-2 are responsible for the 21th 
century AIDS pandemic [7-9]. Most current therapeutic approaches use combinations of 
antiviral drugs that inhibit activities of viral enzymes such as reverse transcriptase, protease 
and integrase; nevertheless none of those have succeeded in controlling infection [10-12]. 
One option to overcome the problem is to explore new therapies that include the study of 
the integration dynamics of human Lentiviruses because it would permit to understand the 
underpinnings behinds of alterations of cellular homeostasis when a cell is infected [13]. 
Additionally, analysis of integration process is important in HIV-induced disease and in 
Lentivirus-based gene therapy [14]. 
Integration is a crucial step in the life cycle of retrovirus permitting the incorporation of viral 
cDNA into the host genome [15-17]. cDNA integration is mediated by the virally encoded 
integrase enzyme and other viral and cellular proteins in a molecular complex called the pre-
integration complex (PIC) [18]. One cellular factor involved in HIV targeting is the lens 
epithelium-derived growth factor (LEDGF) [19, 20], which binds to both HIV-1 integrase and 
chromatin, tethering the viral integration machinery to chromatin [21]. HIV-1 integration has 
been extensively studied using a wide array of molecular biology, biochemistry and structural 
biology approaches [22]. However, is critical to directly identify the viral distribution inside 
human genome in order to understand at genomic level the relationship between the 
composition and topology of chromatin and the target site selection. 
As shown by previous studies, the preferences in target site selection for integration are not 
entirely random [23-26]; being pronounced favored and disfavored chromosomal regions 
which differ among retroviruses [27]. These preferential regions of host genomes are 
characterized by having a high frequency of integrational events, as known as “hotspot” 
and are distributed along the genome of host cell [28, 29]. In HIV-1, most of proviruses are 
localized into transcriptionally active regions not only in exons and introns, but also in 
sequences around start transcription sites [30, 31].  
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An additional related study performed by Felice et al, 2009 [32] compared and contrasted 
the chromosomal integration patterns between gamma retrovirus (Moloney Leukemia virus, 
MLV) and Lentivirus (human immunodeficiency virus type 1, HIV-1), finding that gamma-
retroviral, but not lentiviral vectors, integrate in genomic regions enriched in cell-type 
specific subsets of transcription factors binding sites (TFBSs), independently from their 
relative position with respect to genes and transcription start sites. Therefore, is proposed 
that TFBSs could be differential genomic determinants of retroviral target site selection in 
the human genome.  
Several in vitro and in vivo studies have shown that HIV-1 integrate predominantly in active 
transcription units and in genome zones with high gene density, high frequency of Alu 
elements, low content of CpG islands and open chromatin regions [33]. Notwithstanding 
this evidence, the identification of particular characteristics of local chromatin that facilitate 
integration in a wider genomic manner still remains to be elucidated.  
The objective of the this chapter is to show the main results that our group of investigation 
have obtained of statistically testing those genomic variables that define a preferred 
genomic environment for human lentiviral integration and localize them in specific 
chromosome loci; moreover in the construction of gene/protein interaction networks among 
those cellular genes located around several Lentivirus integration sites in naturally infected 
humans as a systemic approach to better understand the lentiviral integration process. 
To test our hypothesis we conducted in silico studies of the integration profile in the 
genomic DNA of peripheral blood mononuclear cells (PBMCs) and macrophages for both 
human Lentiviruses (HIV-1 and HIV-2) in a window size analysis of 100K. The statistical 
analyses included several genomic variables such as the chromosomal loci, the numbers of 
CpG Island, protein coding genes, transcripts and also the distribution of SINEs, LINEs, 
LTRs and others; moreover the exploration genomic regions in which epigenetics 
mechanisms would be associated with the integration process. Together, the results allow us 
to propose common genomic environments that favor the target chromatin zones for both 
human Lentiviruses. 
4. Data mining and statistical analyses 
A total of 352 human genome sequences flanking the 5’LTR of human Lentiviruses (176 
sequences of HIV-1 [27] and 176 of HIV-2 [33] were obtained from GenBank (NCBI) under 
accession numbers: CL529260 to CL529766 (HIV-1) and DQ632388 to DQ632563 (HIV-2). 
Using the  BLAST algorithm  (NCBI; http://blast.ncbi.nlm.nih.gov/Blast.cgi), the sequences 
were aligned to the draft human genome (hg18) and those that met the following criteria 
were considered authentic integration sites: (i) contained the terminal 3’ end of the HIV-1 or 
HIV-2 LTR; (ii) had matching genomic DNA within five bp of the end of the viral LTR; (iii) 
had at least 95% homology to human genomic sequence across the entire sequenced region; 
(iv) matched a single human genetic locus with at least 95% homology across the entire 
sequenced region (v) had minimum size of 50 bp. 
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accession numbers: CL529260 to CL529766 (HIV-1) and DQ632388 to DQ632563 (HIV-2). 
Using the  BLAST algorithm  (NCBI; http://blast.ncbi.nlm.nih.gov/Blast.cgi), the sequences 
were aligned to the draft human genome (hg18) and those that met the following criteria 
were considered authentic integration sites: (i) contained the terminal 3’ end of the HIV-1 or 
HIV-2 LTR; (ii) had matching genomic DNA within five bp of the end of the viral LTR; (iii) 
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BLAST of NCBI and the BLAT algorithm of the Genome Browser (University of California, 
Santa Cruz, Human Genome Project) (http://www.genome.ucsc.edu/) were used to obtain 
information about coding protein genes (RefSeq), transcripts, CpG islands and repetitive 
elements. Additional genomic information included molecular process and molecular 
function, was obtained from Gene Ontology (GO) (http://www.geneontology.org/index.shtml), 
GenCard (http://www.genecards.org/cgi-bin/carddisp.pl) and Gene Entrez 
(http://www.ncbi.nlm.nih.gov/ncbi/geneentrez). The chromosomal localization of the HIV-1 and 
HIV-2 proviruses was identified using the G pattern banding of each chromosome, as 
proposed by the Paris Conference (1971) [35], with updating of 850 times resolution. As the 
highest number of HIV-1 and HIV-2 proviruses was recorded on chromosome 17, an 
extensive characterization of its chromatin structure was performed including the genomic 
information available  in several  platforms of the Genome Browser: shows the CpG islands 
and distribution of its methylation; of histone H3 in the Lysine 4 and 27 methylation data 
obtained from ENCODE Histone modification by University of Washington CHIP-seq; 
Nucleosoma occupancy probabilities from A375 by Washington University and DNase1 
hypersensitivity (ENCODE University of Washington) in GM12878 cells. All statistical 
analyses were performed using STATISTICA 7 [35]. The Mann-Whitney test (Wilcoxon 
rank) was used to establish differences between HIV-1 and HIV-2 chromosomal integration. 
Differences in function, molecular process and cell localization were analyzed using the t-
test for independent samples. The Kolgomorov-Smirnov test was used for determining 
normality of data. In order to avoid an erroneous significance level for multiple comparisons 
a Bonferroni correction test was applied. To calculate the significant association among CpG 
numbers, genes numbers and integrations multiple regression analyses were performed. 
CpG numbers and genes per Mpb per chromosomes were determined from the NCBI and 
Ensemble databases (update 2010).  
5. Patterns of provirus distribution 
No significant differences were observed in the integration lymphocytic profiles between 
HIV-1 and HIV-2 (p>0.05, Mann-Whitney test). The integrational events for both human 
Lentiviruses were recorded in all chromosomes except the Y (figure 1). However, significant 
differences between the number of HIV-1 and HIV-2 provirus were observed for 
chromosomes 4, 8, 9, 11 and 16 (p<0.05, X2 test). Most of the total integrations (39/352) 
occurred in chromosome 17 (figure 1). A tendency to a differential distribution of provirus 
towards telomeric and subtelomeric regions of the most of human chromosomes was 
observed. In this sense, other authors showed that centromeric alphoid repeat regions are 
disfavored as integration sites [36]. Although proviruses were observed in all chromosomes, 
we identified some chromatin regions with only HIV-1 integrations in chromosomes 4, 6 
and 9 and only HIV-2 in chromosome 21. 
5.1. Functional characterization of genes flanking integration sites 
The ontology of genes hosting HIV integrations events were analyzed using G.O (Gene 
Ontology from NCBI). 83% (146/176) of HIV-1 and 77% (135/176) of HIV-2 integrations 
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occurred close to chromatin regions containing protein coding genes (p>0.05, t-student test). 
In a 100Kb extension of chromatin that harbored both HIV-1 and HIV-2 proviruses no 
differences were observed for the gene functional categories (p>0.05, Bonferoni´s correction). 
According to molecular function, 46% of HIV-1 integrations and 57% of HIV-2 were 
associated with molecular binding, while 19% and 18% respectively occurred in regions that 
code for genes associated with enzymatic function (figure 2a). Otherwise an exploring about 
the biological process revealed a preferential integration in a collection of genes involved in 
metabolism and gene expression for HIV-1 (36%) and HIV-2 (37%) (p>0.05, Bonferoni´s 
correction) (figure 2b).  
 
Figure 1. Chromosomal loci where 352 HIV-1 and HIV-2 cDNA have integrated into the human 
genome. Localization  of chromosomal sequences matching both lentivirus are indicated in the 
graphics. Upper for each chromosome. Blue lines identify HIV-2 integrations and red lines identify 
HIV-1 integrations. 
5.2. Distribution of the repetitive elements flanking integration sites 
A low number of repetitive elements including SINEs, LINEs and LTRs were identified 
associated with provirus in an extension of 100Kb of flanking host chromatin. In general, 
there were no differences in the distribution of repetitive elements categories (SINEs, LINEs 
and LTRs) between HIV-1 and HIV-2 integrations (p>0.05, X2 test). Our results showed that 
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both lentiviruses had a preferential integration close to Alu elements which correspond to 
SINEs. Within LINEs, differences among L1, L2 and L3 were recorded. The other class of 
repetitive elements like LTR, simple repeats and low complexity represented a minor 
proportion of the integration associated chromatin (figure 3). 
 
Figure 2. Functional characterization of the coding protein genes located in genome regions around 100 
kb of human lentivirus. (a) Molecular function by GO of genes associated with HIV-1 and HIV-2 
integration. (b) Biological process by GO of genes associated with HIV-1 and HIV-2 integration. Blue 
blocks correspond to HIV-1. Red blocks to HIV-2 
5.3. Definition of the common genomic environment of integrations 
As the integration do not follow a random model [23-25], some characteristics of the 
chromatin associated with regions with high level of provirus integration, support the 
hypothesis that a preferential integration is conditioned by structural and functional states 
of local chromatin; these states are defined by several genomic variables which were studied 
in this work, and together would define genomic environments.  
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The results of multiple-regression analysis conducted on the HIV-1 and HIV-2 data sets 
showed that there were differential distributions of CpG island, genes, and Alu elements 
that together conditioned a specific genomic environment per chromosome (R2=0.91, 
p<0.05). Gene density was the independent variable contributed most in the prediction of 
the dependent variable (integrations) due to the highest regression coefficients (B= 0.83; 
p<0.05). The highest relative likelihood of hosting a lentiviral integration event in the human 
genome was registered in chromosome 17 (figure 4a). To test that integration events are 
favored by gene-rich regions in all chromosomes, a comparison between those variables was 
done indicating that a high gene density in chromatin regions determine a favorable 
environment for integration, even when the chromosome 17 is excluded  (Figure 4b). 
Because chromosome 17 registered the highest percentage of Lentiviral integration events, a 
detailed analysis of chromatin structure correlating several variables that give data about 
the cellular chromatin status was performed. In general the distal chromatin regions of p 
and q arms showed similarities in the distribution of methylation in CpG islands, 
methylation in several lysine residues of histone H3 (K4, K27 and K36) and variable levels of 
open chromatin and nucleosome occupancy (figure  5a and b). 
 
Figure 3. Frequencies of several repetitive elements associated with regions of 100 kb around the HIV-1 
and HIV-2 proviruses. SINEs, short interspersed nuclear element; LINEs, long interspersed nuclear 
element. 
Experimental studies have demonstrated that regulatory regions in general and promoters 
in particular, tend to be DNase sensitive and are target for integration of the majority of 
retroviruses [37, 38]. In 2006, the complete nucleotide sequence of chromosome 17 was 
published [39]. This chromosome is rich in protein coding genes, having the second highest 
gene density in the genome, (16.2 genes per Mb), with a relative excess of short interspersed 
elements (SINEs, 22.3%) and a deficit of long interspersed elements (LINEs, 14.4%). 
Likewise, this chromosome has high average CpG content (45.5%) and high euchromatin 
 
Bioinformatics 60 
both lentiviruses had a preferential integration close to Alu elements which correspond to 
SINEs. Within LINEs, differences among L1, L2 and L3 were recorded. The other class of 
repetitive elements like LTR, simple repeats and low complexity represented a minor 
proportion of the integration associated chromatin (figure 3). 
 
Figure 2. Functional characterization of the coding protein genes located in genome regions around 100 
kb of human lentivirus. (a) Molecular function by GO of genes associated with HIV-1 and HIV-2 
integration. (b) Biological process by GO of genes associated with HIV-1 and HIV-2 integration. Blue 
blocks correspond to HIV-1. Red blocks to HIV-2 
5.3. Definition of the common genomic environment of integrations 
As the integration do not follow a random model [23-25], some characteristics of the 
chromatin associated with regions with high level of provirus integration, support the 
hypothesis that a preferential integration is conditioned by structural and functional states 
of local chromatin; these states are defined by several genomic variables which were studied 
in this work, and together would define genomic environments.  
 
Systemic Approach to the Genome Integration Process of Human Lentivirus 61 
The results of multiple-regression analysis conducted on the HIV-1 and HIV-2 data sets 
showed that there were differential distributions of CpG island, genes, and Alu elements 
that together conditioned a specific genomic environment per chromosome (R2=0.91, 
p<0.05). Gene density was the independent variable contributed most in the prediction of 
the dependent variable (integrations) due to the highest regression coefficients (B= 0.83; 
p<0.05). The highest relative likelihood of hosting a lentiviral integration event in the human 
genome was registered in chromosome 17 (figure 4a). To test that integration events are 
favored by gene-rich regions in all chromosomes, a comparison between those variables was 
done indicating that a high gene density in chromatin regions determine a favorable 
environment for integration, even when the chromosome 17 is excluded  (Figure 4b). 
Because chromosome 17 registered the highest percentage of Lentiviral integration events, a 
detailed analysis of chromatin structure correlating several variables that give data about 
the cellular chromatin status was performed. In general the distal chromatin regions of p 
and q arms showed similarities in the distribution of methylation in CpG islands, 
methylation in several lysine residues of histone H3 (K4, K27 and K36) and variable levels of 
open chromatin and nucleosome occupancy (figure  5a and b). 
 
Figure 3. Frequencies of several repetitive elements associated with regions of 100 kb around the HIV-1 
and HIV-2 proviruses. SINEs, short interspersed nuclear element; LINEs, long interspersed nuclear 
element. 
Experimental studies have demonstrated that regulatory regions in general and promoters 
in particular, tend to be DNase sensitive and are target for integration of the majority of 
retroviruses [37, 38]. In 2006, the complete nucleotide sequence of chromosome 17 was 
published [39]. This chromosome is rich in protein coding genes, having the second highest 
gene density in the genome, (16.2 genes per Mb), with a relative excess of short interspersed 
elements (SINEs, 22.3%) and a deficit of long interspersed elements (LINEs, 14.4%). 
Likewise, this chromosome has high average CpG content (45.5%) and high euchromatin 
 
Bioinformatics 62 
density [39] (figure 6). Our statistical analysis determined that chromosome 17 had the 
highest number of integrations, mainly concentrate towards the telomeres of both arms.  
 
Figure 4. Multiple-regression analysis among gene density, CpG island number, and frequency of HIV-
1 and HIV-2 proviruses including every human chromosome. A high statistical correlation is observed 
mainly for chromosome 17. (a) Analysis including all human chromosomes. (b) The same analysis but 
excluding chromosome 17. 
The most relevant relationship was related to the conformational state of chromatin 
including the nucleosomes occupancy, methylation of CpG Islands, DNase hypersensitive 
regions and transcriptionally active genes that are found in open-decondensed chromatin 
regions. These regions provide the environment for DNA regulatory processes such as DNA 
replication, repairs and transcription. Albanese et al. (2008) [40], found histone and IN 
acetylation may favor integration by tethering the virus to acetylated/decondensed regions 
of the chromatin. We concluded that the structural characteristics and the epigenetic 
modifications observed in those regions with high frequency of cDNA viral integrations 
would synergistically configure a local “genomic environment” that facilitates the target site 
selection during the retroviral integration. 
5.4. Construction of HIV-1 gene/protein networks  
Host-virus interactions is a complex level of systems information that permits a thorough 
understanding of how the virus exploits the host cell and uses the cellular machinery to 
integrate into host genome. Recently, the HIV-1 Human Protein Interaction Database 
(HHPID) registered 3959 interactions among 1452 human proteins and nineteen HIV 
proteins (fifteen of them structural and four intermediate proteins) [41].  
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Figure 5. Flash image of the Genome Browser showing the distribution of several characteristics of the 
chromatin along 9.5 Mb of the p and q arm representing 25% of chromosome 17. (a) p arm, (b) q arm. 
The figure shows the GC percentage for each: 5pb (black), refseq Genes (black), CpG islands (several 
tones of gray), levels of open chromatin (ENCODE, Duke) in GM12878 cells with DNasel and FAIRE 
(Formaldehyde Assisted Isolation of Regulatory Elements) (black), DNase1 hypersensitivity (ENCODE, 
University of Washington) in GM12878 cells (gray), pk (sites identified as signal peaks within FDR 0.5% 
hypersensitive zones), Hspots (zones identified using the HotSpot algorithm), and predicted 
nucleosome occupancy in A375 cells (black peaks). 
Previous studies have identified most of human cell pathways been disturbed by at least 
one interaction with an HIV-1 protein during the virus life cycle [42-44]. Those interactions 
are of two types: either direct, via host cell protein-viral proteins or indirect, such as 
regulatory interactions that alter expression of human genes [45, 46]; the signaling network 
cc-cytokine is both disrupted and exploited by HIV at various stages of infection. 22 
candidates human class E proteins were connected into coherent network by 43 different 
protein-protein interactions, in which AIP1 play a key role in linking complexes that act 
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early (TSG101/ESCRT-I) and late (CHMP4/ESCRT-III) in the HIV infection pathways [47, 
49]. Monocyte/macrophage infection is characterized by a viral dynamic substantially 
different from that of T lymphocytes. In fact, in vivo HIV infection of activated CD4-T 
lymphocytes accounts for the majority of the daily production of virus particles. However, a 
large number of lymphocytes are in a resting state, thus unable to sustain a complete and 
productive virus life cycle, and contribute only minimally to the daily virus production [50-
52]. Because of the limited HIV-induced cytopathic effect and of their ability to accumulate 
high levels of HIV particles in intracellular compartments, HIV-infected macrophages serve 
as a potentially important reservoir, and as “Trojan horses” exploited by the virus to favor 
its dissemination in different tissues. [53, 54]. 
Cytoscape v.2.63 [55] was also used to construct a gene expression network from two kinds 
of files: The first one from gene expression profiles as a text file (.pvals) that were imported 
of expression data microarray experiments (GEO profiles, NCBI). The second, as data 
annotation in text files (.sif) that corresponds to each one gene-gene interactions (online 
databases). In the first one, gene expression values were collected from the microarray data 
series GSE19236 composed by two Agilent platforms (GPL6480 and GPL6848) with 48 
samples of monocytes to macrophages, macrophages and dendritic cells. These are available 
from the National Center for Biotechnology Information (NCBI) Gene Expression Omnibus 
(GEO) repository (accession number GEO: GSE19236) and for our analysis, we selected all 
macrophages expression samples (GSM476720, GSM476721, GSM476722, GSM476723, 
GSM476724, GSM476725). To identify which genes were significant among samples in 
microarrays; considering a p-value< 0.001 as significant, an ANOVA test was calculated. 
Additionally, a Hierarchical clustering analysis of the samples using Euclidean Distance 
Method and mean linking were performed. MultiExperiment Viewer v4.1 [56] was applied 
to make the corresponding statistical analyses. Using data from BOND (Biomolecular 
Network Data Bank, http://bond.unleashedinformatics.com/Action), BioGird (Biological 
General Repository for Interaction Datasets, http://thebiogrid.org/), KEEG (Kyoto 
Encyclopedia of Genes and Genomes, http://www.genome.jp/kegg/), available online, a new 
file with the interaction data of 28 genes located close to integration sites was constructed.  
Cytoscape v2.6 was used for visualizing and analyzing the genetic interaction networks 
among 28 human macrophages genes and their interactions. BiNGO v2.6 plugin (Biological 
Networks Gene Ontology tool) was used to determine which Gene Ontology (GO) terms are 
significantly overrepresented in a set of genes. A hypergeometric test was applied to 
determine which categories were significantly represented (p-value< 0.01); significant value 
was adjusted for multiple hypotheses testing using the Bonferroni Family-wise error rate 
correction [57]. The network topology parameters were calculated using Network Analyzer 
plug-in, which includes network diameter, the number of connected pairs of nodes and 
average number of neighbors; it also analyses node degrees, shortest paths, clustering 
coefficients, and topological coefficients (Max Planck Institute Informatik).  
To identify active sub-networks as highly connected regions of the main network we used j 
ActiveModules plug-in that grouped genes according with significant p-values of gene 
expression over particular subsets of samples. The result shows active modules, listed 
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according to the number of nodes, and an associated Z-score. An active module with Z-
scores greater than 3.0 indicated significant response upon the conditions of the experiment. 
We kept the standard default values, as being the most effective for initial analyses (58). 
 
Figure 6. (A). Interaction values of 28 genes of human macrophages interrupted by HIV-1 cDNA 
integration. (B). Gene expression network in non HIV-1 infected macrophage. Visualization of gene 
network composed by 28 genes located close to regions with high frequency of HIV-1 provirus in 
human macrophages. These genes interact with 1202 genes through 2770 interactions. The network was 
constructed using Cytoscape. Each node corresponds to a gene and edges represent interactions among 
genes. The color gradient represents the expression values 
Eleven thousand and seven hundred and thirteen (11,713) significant genes of 41,000 probes 
were clustered in two significant different groups of cells; one of them included only 
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dendritic cells, meanwhile the second grouped monocyte to macrophages and macrophages 
which are sharing similar gene expression patterns. A total of 2,770 interactions among 28 
genes which were located closed to HIV-1 proviruses in human macrophages were 
recorded. AKT3 was gene with highest number of interactions (456), followed by FLT1 (381), 
STAT5A (356) and AXIN1 (328) (figure 6a). In contrast ZNF36, DYRK1A and RBMS3 genes 
had the lowest number of gene interactions. The normal macrophage gene network showed 
tree components: the main cluster composed by 26 macrophages genes and its interactions 
and two minor clusters in which ZNF36 gene was the central node with five interactions; 
and STX1A as central node with twelve interactions (Figure 6a).  
To further identify active sub-networks inside the main gene network, we performed an 
expression clustering analysis using p-values calculated by comparison of gene level 
expression among five macrophage samples. We found 5 subnetworks, in which the most 
significant active module was integrated by 222 genes with a score of 3.15 (p<0.01). Within 
them 12 genes related with provirus integration sites were found: AXIN1, NFAT5, STAT5A, 
FLT1, AKT3, HTT, RIPK2, DGCR8, WWOX, NRG1, DYRK1A and SLC2A14 (figure 6b). 
The GO functional significant categories in this active module showed enrichment for 
positive regulation of biological process and cell proliferation. Most of the genes identified 
in this sub-network were associated with cellular pathways that play significant role by 
modulating cell signaling networks including Wnt signaling, MAPK signaling and ErbB 
signaling.  
5.5. Effects on normal macrophage gene networks by HIV-1 integration 
In order to better understand the alteration of macrophages homeostasis by the HIV-1 
integration, our analyses were focused to simulate what are the effects of viral cDNA 
integration in the alteration of several gene expression networks in human macrophage. In 
general the topology of non-infected macrophage network gene was dramatically changed 
by the HIV-1 integration events that lead to turned off the expression of five genes by the 
integration of proviral cDNA (Figure 7).  
The evaluation of the several topological parameters such as clustering coefficient, shortest 
paths, network heterogeneity, the centralization, average number of neighbors and 
characteristic path length, showed a changed in the values of HIV-1 macrophage infected 
gene network, compared with normal macrophage network. The non- altered network was 
more condensed, had more number of interactions, was wide open rich in shortest paths 
and also was composed by one major component and two minor clusters being more 
heterogeneous and multi-functional (table 1). 
Statistical differences between the topology states of two networks were registered for 
topological coefficients, closeness centrality and neighborhood connectivity distribution 
(Kolgomorov-Smirnov test p<0.05), but not in average clustering coefficient distribution. 
These results indicate that normal network was significantly more central and densely 
connected in comparison with that of HIV-1 macrophage infected network.  
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Figure 7. Effects in the topology gene expression network in macrophage by HIV-1 integration. (A) 
Normal macrophage genes expression network. (B) HIV-1 integration network when five macrophage 
genes were turned off. 
 
Parameter Normal macrophage HIV-1 infected macrophage 
Clustering coefficient 0.30 0.04 
Connected components 3 3 
Shortest paths 94% 90% 
Network heterogeneity 5.63 3.75 
Centralization 0.34 0.21 
Avg. number of neighbors 4.2 2.70 
Characteristic path length 3.30 4.13 
Table 1. Comparison of network parameter values in normal and HIV-1 infected macrophages. 
Using Random network plugin by Cytoscape we found the Clustering Coefficient of the 
non-infected Network and simulated infected Network in comparison with those generated 
at random showed not statistical differences (Kruskal-Wallis test, P= 0.317). The data 
confirmed that the topology of both reported networks have a strong support that the 
simulation of our gene network is valid.  
We test our hypothesis that integration HIV-1 generate disturbs in the gene expression 
having a global effect in cellular networks and essential biological pathways. The enriched 
GO terms were categorized for normal and infected macrophages networks to identify the 
functional cellular change by HIV-1 integration. From all the GO categories covered by the 
28 macrophages genes and its interactions, we have listed the ten most significant categories 
of the enriched GO terms in table 2. 
The Gene Ontology (GO) enrichment analysis that normal network was composed by 423 
significant functional categories of a total of 1190. These individual significant categories 
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could be further classified into two major groups; cell function regulation and signaling of 
biological process. In contrast HIV-1 infected macrophage gene network was enriched with 
10 significant functional categories of a total of 40. The significantly overrepresented 
categories indicated that this emergent new gene network was composed by genes involved 
in metabolic process and DNA repair process.  
In this study we simulated at systemic level, the alterations of cellular pathways when HIV 
provirus integrates into genes by turning them off and produce dysregulation of several 
local signaling pathways. One of the target gene associated with HIV-1 integration was 
AKT3, also called PKB, which is a serine/threonine protein kinase family member. It is 
involved in a wide range of biological processes including cell proliferation, differentiation, 
apoptosis, stimulating cell growth, and regulating other biological responses (59, 60). Also, it 
have been identified playing important roles of regulation in the G2/M transition of the  
cell cycle.  
 
Normal Network p-value b HIV-1 infected Network p-value b 
Signal transduction [GO-ID: 
7165] 
3,90E-123 Biopolymer biosynthetic process 
[GO-ID: 43284] 
6,27E-05 
Cell communication [GO-ID: 
7154] 
4,63E-120 Metabolic process [GO-ID: 8152] 8,00E-05 
Positive regulation of cellular 
process [GO-ID: 51242] 
1,39E-95 Macromolecule biosynthetic process 
[GO-ID: 9059] 
1,40E-03 
Positive regulation of 
biological process [GO-ID: 
48518] 
1,93E-92 Biosynthetic process [GO-ID: 9058] 2,43E-03 
Biological regulation [GO-ID: 
65007] 
1,45E-88 alcohol metabolic process [GO-ID: 
6066] 
3,19E-03 
Intracellular signaling cascade 
[GO-ID: 7242] 
1,40E-86 Maintenance of fidelity during 
DNA-dependent DNA replication 
[GO-ID: 45005] 
6,24E-03 
Regulation of cellular process 
[GO-ID: 51244] 
2,29E-85 Mismatch repair [GO-ID: 6298] 6,24E-03 
Regulation of biological 
process [GO-ID: 50791] 
2,65E-84 Furaldehyde metabolic process [GO-
ID: 33859] 
6,68E-03 
Phosphate metabolic process 
[GO-ID: 6796] 
3,01E-80 Age-dependent response to reactive 
oxygen species during chronological 
cell aging [GO-ID: 1320] 
6,68E-03 
phosphorus metabolic process 
[GO-ID: 6793] 
3,01E-80 oxidation reduction [GO-ID: 55114] 6,90E-03 
a. The description of the gene ontology biological processes and the corresponding gene ontology identifiers are given. 
b. p-Value calculated as an  exponential function. 
Table 2. The top 10 of significant biological process of normal and HIV-1 infected macrophages 
networks a.  
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AKT3 via JNK interacts with NFTA and Jun that are targets for the HIV-1 macrophage 
integration network and are included in the mitogen-activated protein kinase (MAPK) 
cascade which perform essential functions such as proliferation, survival and inflammation, 
apoptosis in all cell types. This pathway is associated with others that include the 
phosphatidylinositol signaling system, Wnt signaling pathway, ERK5 pathway, P53 
signaling pathway. (61-63). According with these previous data, we propose that, when 
AKT3 is turned off by HIV-1 integration, the cross talk with others is disrupted leading to a 
signaling dysfunction of metabolic associated pathways. When AKT3 was inactive the direct 
interaction with MKK7 produce a disruption of JNK and after with JUN that would result in 
a non activation by phosphorilation of apoptotic and cell cycle process. On the other hand 
inactivation of the MAPK pathway in both macrophages and dendritic cells leads to 
inhibition of proinflammatory cytokine secretion, downregulation of co-stimulatory 
molecules such as CD80 and CD86, and ineffective T cell priming. The net result is an 
impaired innate and adaptive immune response (64, 65). 
Recently it have been reported that HIV-1 infection triggers the activation of the PI3K/Akt 
cell survival pathway in primary human macrophages as reflected by decreased PTEN 
protein expression and increased Akt kinase activity and renders these cells resistant to 
cytotoxic insults (54, 61, 64, 65). As result of HIV-1 integration close to AKT3, PTEN, AKT1 
and 2, FOXO 1 and MDM2 that are included into the macrophage gene network, would 
expected a disruption of the apoptotic process. 
6. Conclusions 
We can conclude that a general effect of HIV-1 integrations in macrophages DNA is to 
disrupt several signaling pathways that control the normal cell homeostasis. Comparison 
between normal and infected macrophages of top 10 GO function categories showed the 
dramatic change of one non-infected macrophage whose main cellular functions are devoted 
to maintain a cell signaling crucial functions, to one infected in which the most important 
function are macromolecular biosynthetic process, maintenance of fidelity during DNA-
dependent DNA replication, mismatch repair, age-dependent response to reactive oxygen 
species during chronological cell aging and oxidation reduction. As HIV infected 
macrophage is an abnormal reservoir in which the metabolic cascades are altered, it is 
possible to propose that the metabolism of macrophage adapt to perform survival functions 
where the apoptotic process is interrupted and a SOS metabolism make that the macrophage 
change of its life style       
In silico studies are based upon statistical calculations which permit the drawing of 
generalizations about a biological process; however since some variables could affecting the in 
toto process, in order to get a real history of Lentivirus integration it would be important to 
consider that there is another factors, including physiological process and cellular 
compartments that would be influencing the in vivo integration site selection. Some of these are 
cell-cycle phase, the transcriptional state of the cell, the topology of chromosomal DNA, cell 
type infected, and presence of co-helper molecules during the PIC complex conformation 
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By providing these new testable hypotheses we hope that our results will accelerate 
experimental efforts to define a reliable disturbing in the gene complex relationship by 
lentivirus integration in PBMC and macrophages which are critical immune cells 
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1. Introduction 
The discovery of genome-wide genetic variation was central to the field of genomics [1,2]. 
Now, recent advances in second-generation sequencing technologies and better methods of 
targeted enrichment mean the detection of genome-wide patterns of genetic variation will 
soon be a routine operation [3,4]. Yet these advances in DNA sequencing have revealed a 
new bottleneck: the functional classification and interpretation of newly discovered genetic 
variation. 
The scale of this problem is enormous. The high throughput and low cost of second-
generation sequencing platforms now allow geneticists to routinely perform single 
experiments that identify tens of thousands to millions of variant sites in a single individual, 
but the methods that exist to annotate these variant sites using information from publicly 
available databases are too slow to be useful for the large sequencing datasets being 
generated. Because sequence annotation of variant sites is required before functional 
characterization can proceed, the lack of a high-throughput pipeline to annotate variant sites 
efficiently can be a major bottleneck in genetics research and clinical applications of 
genomics technologies. 
To address this problem, we developed the Sequence Annotator (SeqAnt, 
http://seqant.genetics.emory.edu/), an open source web service and software package that 
rapidly annotates DNA sequence variants and identifies recessive or compound 
heterozygous loci in human, mouse, fly, and worm genome sequencing experiments [5]. 
Variants are characterized with respect to their functional type, frequency, and evolutionary 
conservation. Annotated variants can be viewed on a web browser, downloaded in a tab-
delimited text file, or directly uploaded in a Browser Extensible Document (BED) format to 
the UCSC Genome Browser. To demonstrate the speed of SeqAnt, we annotated a series of 
© 2012 Zwick et al., licensee InTech. This is a paper distributed under the terms of the Creative Commons
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publicly available datasets that ranged in size from 37 to 3,439,107 variant sites; the total 
time to annotate these data completely ranged from 0.17 seconds to 28 minutes 49.8 seconds. 
1.1. Sequence annotation tools 
Genome databases accessible via web browsers are very useful in the search for annotation 
information for DNA sequences. The UCSC Genome Browser web application has been a 
huge development of great value in analyzing and characterizing sequence information [6]. 
The application includes a variety of genomic tracks, assemblies, and browsers with genetic 
information from a host of species. The UCSC Genome Browser, with its various 
functionalities and annotation options, offers a one-stop shop for researchers, who can work 
directly on the web application by uploading their data, or they can download source codes 
of interest from the UCSC Genome Browser and run those locally. Despite its power, 
however, the main limitation we see in using the UCSC browser for sequence annotation lies 
in the limited amount of data that can be accessed at a given time, along with the need for 
human intervention. For example, it is time-consuming for geneticists who want annotation 
across multiple variant sites at once over different functional classes to use the browser 
comfortably. Ensembl is yet another superb broad-based web application with an expansive 
database, offering researchers choices on extracting specific regions of interest and 
annotating particular regions in the genome [7]. This application has various functionalities 
and tools that can accept uploaded data, convert formats of documents, and search for 
sequences of interest; still, like the UCSC browser, it is not the best choice for performing 
high-throughput sequencing annotation. 
SNPnexus is a genetic variation tool developed to help determine functionally relevant 
SNPs for a given genomic region [8]. It has a user-friendly web interface that accepts inputs 
in the form of genomic positions, dbSNP id, or chromosomal region. The application 
database includes two different human genome assemblies: the hg19 and hg18 builds. 
SNPnexus generates calls on genomic mapping of variant sites, protein function 
consequences of such variants in the genome, the regulatory elements conserved within the 
region, and the conservation score of the variant site. The application also provides the 
genotype and allele frequencies estimation for known SNPs using data from the HapMap 
Project. This annotation tool, like so many others, is very useful for human variant 
annotation; however, it does not characterize variants in other species. 
Since the development of SeqAnt in 2010, other software tools have come along to perform 
sequence annotation. Segtor is a tool designed to annotate large sets of genomic coordinates, 
intervals, single nucleotide variants (SNVs), indels, and translocations [9]. A more recent 
and very closely related annotation tool is AnnTools [10]. This is an open source web 
application that accepts user Inputs and queries their database for a full spectrum of variant 
site annotation, including single nucleotide variants, insertions and deletions, structural 
variants, and copy number variants. The application has a minimal memory footprint and 
likewise annotates variants quite rapidly. Nevertheless, AnnTools is restricted to human 
genome variant annotations and in this sense differs from SeqAnt, which annotates other 
species besides humans. There are also a number of other variant site annotation tools 
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available either as downloadable command line applications or user interface web 
applications; these include snpEff (http://snpeff.sourceforge.net), MU2A[11], and Snat [12]. 
1.2. The distinction of SeqAnt 
The uniqueness of SeqAnt versus all the other annotation tools we mentioned lies in three 
factors, which had been the key considerations for developing this technology to begin with. 
First, SeqAnt delivers annotations for multiple different species, ranging from primates to 
mammals, and now zebrafish and nematodes. Second, the web application has its own 
database updated from the UCSC website, which is a collection of binary files that drive the 
record speed with which large genomic data are annotated. Third, in addition to speed, the 
memory footprint is quite minimal, as data stored in binary files enable individuals from the 
public to download both the source file and database and locally run the application 
without elaborate computing apparatus. Some of the other tools mentioned have one or two 
of these unique features, but none have the robustness that comes from combining all three 
approaches to efficiently annotate variants and make meaningful functional calls across 
species, like SeqAnt does. Overall, we believe these represent important changes to SeqAnt 
that will be of broad utility to researchers using next-generation sequencing platforms in a 
wide variety of systems. SeqAnt will continue to be a fully open source web service and 
software package, and we believe it will prove especially useful for those investigators who 
lack dedicated bioinformatics personnel or infrastructure in their laboratories. 
2. Upgraded features of SeqAnt 2.0 
Since the initial publication of SeqAnt, we made a number of improvements that have been 
incorporated into SeqAnt 2.0 [5]. These modifications fall into four main categories. The first 
focused on updating the SeqAnt website (http://seqant.genetics.emory.edu). The second 
includes major changes made to the content and structure of the underlying binary 
databases that hold the annotation information. The third involves a significant redesign of 
the directory structure holding the output files. Finally, the last modification included 
substantial revisions to the number and content of output files themselves. Each of these 
updates will be described in greater detail in the sections that follow.  
2.1. SeqAnt 2.0 - website updates 
We undertook a major redesign of the SeqAnt web interface to make it more user-friendly. 
On the home page, we eliminated redundant tabs and buttons, simplified the overall design, 
and upgraded the graphic interface’s color scheme (Figure 1). This page includes basic 
information about the original publication of SeqAnt [5], a link to contact the Zwick 
laboratory, and the web URL for the the SourceForge website (http://seqant.sourceforge.net), 
where the source code and associated binary libraries can be freely downloaded. From this 
page, the user is able to quickly access the three main types of input data accepted by 
SeqAnt. These include SEQUENCE FILE, LIST OF VARIANTS, and SINGLE VARIANT. 
In addition, the user can choose to view a TUTORIAL or select a set of SAMPLE FILES to 
gain experience performing analyses with the SeqAnt.  
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publicly available datasets that ranged in size from 37 to 3,439,107 variant sites; the total 
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Figure 1. Screenshot of new SeqAnt 2.0 home page 
Selecting the SEQUENCE FILE option returns the web interface shown in Figure 2. A 
typical use of this feature is when the user wants variation annotation information in a 
genomic region from a particular chromosome. Three different input files are accepted. The 
first is a reference sequence file in FASTA format of the entire genomic region being 
annotated. The second is a sequence file containing multiple FASTA sequences from a 
sequencing experiment, with each FASTA sequence representing a chromosomal region. 
The third is a genomic position file in the BED format which represents the coordinates for 
each of the chromosomal regions in the sequence file. The sequences in both the reference 
file and the sequence file should be in the positive orientation to ensure accurate annotation. 
The user is provided the option to choose a reference genome and assembly that will be 
used for annotating variant sites. 
Selecting the LIST OF VARIANTS option returns the web interface shown in Figure 3. Only 
one input file is required to use this feature, the variations list file, which contains a listing of 
variant sites and the chromosomal regions of these sites, the minor allele and the reference 
allele. The variant list file is basically a pileup file, with a '.snp' or a '.txt' extension. If the 
PEMapper option were selected in this interface, the variation list file would be modified to 
include the sample ID for each individual within the experimental study where the 
sequence data was generated, if multiple individual samples were being analyzed. This 
particular (List of Variants) feature is very useful for researchers who want to perform 
genetic variation analysis (such as whole exome annotation) over a wide expanse of the 
genome. 
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Figure 2. Screenshot of the SEQUENCE FILE page 
Selecting the SINGLE VARIANT option returns the web interface shown in Figure 4. The 
user is provided the option to choose a reference genome and assembly that will be used for 
annotating a single variant site.The user then only needs to provide a chromosome and base 
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Figure 4. Screenshot of the SINGLE VARIANT page 
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2.2. SeqAnt 2.0 - Binary database upgrades 
One of the unique features of SeqAnt is the ease and speed with which variant information 
is accessed from a set of customized binary databases. The SeqAnt binary databases are 
created from flat text table files obtained from the UCSC Genome Browser website [6]. Five 
main types of data constitute the SeqAnt binary databases. These include: 
1. Reference Genome Sequence 
2. RefGene Annotation  
3. dbSNP Variation Data 
4. PhastCons Evolutionary Conservation Scores 
5. PhyloP Evolutionary Conservation Score 
Standard queries, implemented through the web interfaces described above, are able to 
extract the annotation information from the binary databases. The actual structure of the 
binary databases is not directly visible to a SeqAnt user, but is worth examining in greater 
detail. The Reference Genome Sequence provides the basic backbone for other annotation 
information. Reference sequences for a given species are organized by different builds (i.e. 
human genome 18, human genome 19). Within each build, data are organized by 
chromosome, which reflects the structure of the flat files obtained from UCSC. The RefGene 
Annotation is the collection of information pertaining to known genes for a given species 
and build. This information is also organized by chromosome. The collection of variant sites 
in a given species is contained within the dbSNP Variation Data that is also organized by 
chromosome. Finally, the SeqAnt 2.0 binary databases include two different measures of 
evolutionary conservation for all sites in a given reference genome sequence. The PhastCons 
score is best used to detect functional elements in noncoding sequences, whereas the phyloP 
score provides a measure of the evolutionary conservation of single sites and is most useful 
for evaluating sites located in coding regions of genes. 
Binary files are significantly smaller than their corresponding flat files, so querying binary 
files uses less memory than the same analysis performed with a flat file. Considering the 
vast amount of data that has to be accessed during sequence annotation of large genomic 
regions, the significant difference in the size of the binary files versus flat files helps to 
account for the speed with which information is processed using binary files. SeqAnt 2.0 
updated a number of these specific binary files; a detailed description of the changes follows 
in the next sections. 
2.2.1. Upgrade of dbSNP to SNP132 Track for hg19 Assembly (Homo sapiens) 
The original goal of the dbSNP database (http://www.ncbi.nlm.nih.gov/projects/SNP/) was 
to develop a comprehensive catalog of common (>5% frequency) human genetic variation 
[13,14]. These variants were subsequently validated by genotyping in multiple human 
populations, and their patterns of statistical correlation among variants, known as linkage 
disequilibrium, were revealed in the HapMap project [15,16]. SeqAnt 1.0 included data from 
the SNP131 track from the dbSNP [17]. SeqAnt 2.0 was updated to the SNP132 build, which 
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was characterized and uploaded to the UCSC Genome Browser in the summer of 2011. 
SNP132 has an expanded collection of variant sites that can help researchers determine 
whether an identical variant has been seen before in a different individual. 
 
Figure 5. Contents of SeqAnt Output Directory. Directories are in bold; individual files shown in a 
standard font face. 
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2.2.2. Addition of PhyloP46way Conservation Score Database for hg19 Assembly (Homo 
sapiens) 
The phyloP Evolutionary Conservation Score data type is a new addition to SeqAnt 2.0. 
Binary databases, including phylopP scores from a 46-way alignment of vertebrate species 
to the human genome, were included to complement the PhastCons Evolutionary 
Conservation Scores previously included in the application. The phyloP scores predict the 
probability of a given variant site having undergone evolution over time. The absolute 
phyloP values represent negative log p-values for the null hypothesis that there was no 
evolution across the regions annotated [18]. Regions that are more conserved tend to have 
more positive values, whereas sites believed to be fast evolving have negative values. The 
medium range of these scores for the 46-way alignment from the UCSC Genome Browser is 
between approximately -3 and +3. It should be noted that, unlike PhastCons, which takes 
into account flanking bases on a sequence in arriving at its final score for a given variant 
site, phyloP scores are computed by basically comparing the particular base in the sequence 
with aligned bases from other species [18]. Variations in highly conserved regions often 
suggest a significant change that could have functional implications. The PhyloP46way 
dataset we have on the upgraded SeqAnt web application is the most recent phyloP track in 
the UCSC, released in December 2009. 
2.2.3. Addition of Full Genome Data Set by Chromosome of Zebrafish (danRer6 Assembly) 
We selected zebrafish (Danio rerio) as the next species to be incorporated into the SeqAnt 
database because of its emergence as a model organism for a wide range of scientific studies, 
from behavioral genetics to drug modeling studies and integrative physiology [19,20]. 
SeqAnt 2.0 has now been updated to include binary files for the genome sequence of 
zebrafish. We derived binary databases for the first four data types from flat table files on 
the UCSC Genome Browser website. Flat table files for the phyloP evolutionary 
conservation score were not available and were therefore not included. The reference 
genome binaries use the danRer6 assembly, which annotated the datasets by chromosome 
and was released in December of 2008. The RefGene annotation and dbSNP variation data 
are relative to the danRer6 assembly. PhastCons evolutionary conservation scores were 
derived from multiple alignment between seven species and zebrafish. Including the 
zebrafish in SeqAnt 2.0 should prove valuable for researchers who work with this species. 
2.3. SeqAnt 2.0: output directory structure and files 
Significant changes to the number and types of output files are reflected in a new output 
directory structure in SeqAnt 2.0. The output from SeqAnt is contained within a Results 
directory that includes three subdirectories (Figure 5). This Results directory has the name of 
the original SeqAnt input file and a subscript '_Annotation_Files'. Within this directory, there 
are three distinct directories (All_Variations, BED_Annotation, Unique_Variations) holding the 
output of SeqAnt, which will be described in detail below. This directory also contains three 
other files of interest to a user. The first is a *.summary.txt file that provides a summary of all 
the variants annotated by SeqAnt. The second is a Compound.Replacement file that identifies 
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variants, genes, and sample identifiers for those loci with two or more replacement variants. 
The collected list of variants includes those that could be compound recessive in a given 
individual, although since the phase of the variants is not determined, this would have to be 
validated by other means. This file may be useful when looking for genes that harbor variants 
that may fit a recessive loss-of-function model. The last is a *.log file generated by SeqAnt that 
records the major events that occur when SeqAnt processes a dataset. 
2.3.1. All_variations directory 
This directory contains the complete variant annotation files obtained from annotating input 
files with SeqAnt 2.0 (Figure 5). Two main types of genetic variation are annotated by 
SeqAnt: single nucleotide variants (SNPs) and insertions/deletions (INDELs). For SNPs, a 
given variant site when annotated belongs in one of five functional classifications. These 
include exonic.replacement, exonic.silent, untranslated region (UTR), intronic, or intergenic. 
For INDELs, a given variant when annotated belongs in one of four functional 
classifications. These include exonic, UTR, intronic, or intergenic. Overall, there are a total of 
nine files that contain the variants and their associated annotation information. These 
annotation files include all possible splice variants impacted by a given variant site. Thus, a 
given variant site may be listed multiple times in one of the nine output files. 
2.3.2. BED_annotation directory 
This directory contains files in BED format (http://genome.ucsc.edu/FAQ/FAQformat) that 
can be visualized on the UCSC Genome Browser or other viewer able to process files in this 
format. There are ten files total in this directory. Nine of the files include the variants and 
annotation information as described above; the tenth file (*.ucsc.bed) contains all the 
annotation information from each of the nine files in a single BED file for the entire genomic 
region to be visualized. These files can be uploaded to the UCSC browser as custom tracks 
to be visualized. They can also be visualized in other software packages that process BED 
files, such as the Integrative Genomics Viewer (Version 2.1) [21]. 
2.3.3. Unique_variations directory 
In contrast to the annotation in the All_Variations directory, the Unique_Variations 
directory contains nine files that contain a single variant annotation for each SNP or INDEL. 
Thus, each variant is listed just once, regardless of the number of different splice variants it 
is predicted to impact. These files allow the user to quickly determine the total number of 
variants for any specific functional class. 
2.4. SeqAnt 2.0 - Output files 
2.4.1. Redesign of Result Columns for Annotation Files 
We introduced a number of changes to the annotation fields contained within the SeqAnt 
output files. First, we rearranged the order of columns in the output files to aid users in 
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evaluating their results. Second, we introduced additional feature columns to the output 
files. These included row 10, which depicts the transcript change that occurs for a coding 
sequence variant, row 14, which shows the concomitant amino-acid change for a coding 
sequence variant, and rows 21 and 22, which report the phyloP conservation score values for 
each variant position annotated. A summary of the annotation information provided by 
SeqAnt 2.0 is shown below in Table 1. A representation of an example output file is shown 
in Figure 6 below. 
 
Field ID Annotation Field Description 
1 Variation_Type Type of variant 
2 Functional Class Annotated functional category for variant site 
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Figure 6. Snapshot of Exonic Replacement Annotation Output File. The top half shows the data for 
fields 1 - 13. The bottom half of the figure shows the data from fields 14 - 23. The last four columns 
report the number of homozygous and heterozygous SNPs and associated sample IDs. 
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3. An application of SeqAnt 2.0: Targeted next-generation sequencing of 
NLGN3 and NLGN4X in humans 
The targeted sequencing of specific genes or genomic regions is a common experimental 
design that can benefit from the use of SeqAnt. Here we describe such a study. We 
sequenced the NLGN3 and NLGN4X loci in a sample of 144 males with a diagnosis of 
autism. All the patient samples were obtained from the multiplex Autism Genetic Resource 
Exchange (AGRE) [22]. Raw base-calling data generated with an Illumina Genome Analyzer 
(IGA) were used as input for mapping and alignment. The total amount of sequence 
generated was 7.04 GB. Paired-end reads were mapped and variants were called using 
PEMapper (Cutler DJ et al, personal communication). In total, 99.7% of target bases had at 
least 8X coverage, with a median depth of coverage of 452. We identified a total of 208 sites 
of variation, with 176 single nucleotide polymorphisms and 32 insertions or deletions. 
Overall levels of variation were estimated at 5.8 x 10-4 (Θw per site [23]), which matched our 
expectation for loci from the human X chromosome. We also observed an excess of rare 
variants, as evidenced by a negative value for the Tajima’s D test statistic (-0.27,[24]). 
Single nucleotide variants (SNVs) and small insertions and deletions (INDELs) were 
annotated using SeqAnt [5]. For the SNPs, a total of 68, or 39%, had not been reported before 
(31 in NLGN3 and 37 in NLGN4X, Table 2). For the INDELs, a total of 24, or 75%, had not 
been reported before (5 in NLGN3 and 19 in NLGN4X, Table 3). As summarized in Figure 7, 
almost all common variation (>5% frequency in our sample) is contained in dbSNP, whereas 
most rare variants (<5%) have not been cataloged there. 
 






Novel SNPs at Evolutionary 
Conserved Sites 
Replacement 1 1 0 0 
Silent 3 3 0 0 
UTR 18 10 8 2 
Intron 134 78 56 9 
Intergenic 20 16 4 0 
Total 176 108 68 11 
Table 2. Functional annotation of SNPs at the NLGN3 and NLGN4X loci identified by next-generation 
sequencing of 144 males with autism. 
Using SeqAnt to rapidly annotate our sequence data allows us to quickly draw four main 
conclusions. First, most common variation is already contained in dbSNP, while much of the 
rare variation remains undiscovered. Second, we did not see any novel replacement variants 
at either NLGN3 or NLGN4X, suggesting that mutations at these loci are rare causes of 
autism. Third, we identified novel UTR variants at highly evolutionarily conserved sites, 
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which could contribute to autism susceptibility. We focused on this set of variants for direct 
functional testing. Finally, we identified novel intronic variants at evolutionarily conserved 
sites that appear to be located in transcription factor binding sites. These variants are being 
followed up to determine whether they have a regulatory role that impacts the expression of 
NLGN3 or NLGN4X. In summary, SeqAnt 2.0 allowed us to rapidly annotate all the sites of 
variation in our sample and rapidly focus attention on those variants most likely to be 
autism susceptibility alleles. 
 





Novel Indels at Evolutionary 
Conserved Sites 
Coding 0 0 0 0 
UTR 1 0 1 1 
Intron 25 7 18 0 
Intergenic 6 1 5 0 
Total 32 8 24 1 
Table 3. Functional annotation of INDELs at the NLGN3 and NLGN4X loci identified by next-
generation sequencing of 144 males with autism. 
 
Figure 7. Summary of SNV and indel variation discovered at the NLGN3 and NLGN4X loci in males 
with ASD. The frequency of SNVs and INDELs (minor alleles) in cases is plotted against their level of 
evolutionary conservation. Most common variation has already been discovered and exists in public 
databases (blue; circles and diamonds); most of the rare variation at both loci was discovered in our 
study and not contained in public databases (red; circles and diamonds). 
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4. An application of SeqAnt 2.0: Sequencing the AFF2 locus and X 
chromosome exome in patients with autism 
With improvements in methods of targeted enrichment and next-generation sequencing, the 
targeted sequencing of all genes on a specific chromosome has become feasible. Specific 
genes/genomic regions is a common experimental design that benefits from the use of 
SeqAnt [25]. Here we performed an experiment that combined targeted sequencing with 
chromosomal exome sequencing. We selected 127 males from the Autism Genetic Resource 
Exchange (AGRE) multiplex collection and 75 males from the Simons Foundation Autism 
Research Initiative (SFARI) Simplex Collection, New York, NY, USA (SSC) for target DNA 
amplification and DNA sequencing. From the AGRE collection, we chose multiplex families 
with two or more male affected sib-pairs who shared >99% of 76 genotyped SNPs in the 
AFF2 genomic region [22]. One male was randomly chosen if both affected siblings were 
equally affected; otherwise, the male with autism was chosen over those boys with a 
diagnosis of not quite autism (NQA) or broad spectrum. From the SSC collection, we chose 
only those boys who were described as autistic and not reported to have any other 
syndromes. From the SSC collection, we chose 75 male children from different families with 
a diagnosis of ASD [26].  
For the AGRE samples, we prepared target DNA for sequencing the AGRE samples by 
performing long PCR (LPCR) amplification of the AFF2 genomic region, followed by 
sequencing on an Illumina Genome Analyzer. For the SSC samples, we prepared target 
DNA for Illumina sequencing by using RainDance Technology’s (RDT) microdroplet-based 
technology to enrich for the human X chromosome exome, as described previously [25]. 
Following enrichment we performed 70-bp single-end multiplex sequencing on an Illumina 
Genome Analyzer (IGA). Nearly 20 GB of sequence was generated for AGRE samples, while 
~55 GB of sequence was generated for the SSC samples. The AFF2 reference sequence used 
for the AGRE samples consists of 10 discontiguous fragments covering 84.8 kb, and the SSC 
reference sequence consisted of the entire human X chromosome, which spanned 5748 
discontiguous fragments covering 4.7 Mb. Raw base-calling data generated with the IGA 
were mapped and variants called using PEMapper (Cutler DJ et al, personal 
communication). For AGRE samples, 99% of the bases had more than 8X coverage. Median 
depth of coverage was in the range of 388-1548. For the SSC samples, between 83% and 97% 
of the targeted reference bases had more than 8X coverage. Median depth of coverage was 
in the range of 20-607. We identified a total of 286 sites of variation, with 269 single 
nucleotide polymorphisms (SNPs) and 17 insertions or deletions (INDELs). Overall levels of 
variation were similar between the two datasets (Θw per site [23]; AGRE - 6.0 x 10-4, SSC - 6.7 
x 10-4), with an excess of rare variants as evidenced by a negative value for the Tajima’s D 
test statistics for both sets of samples ([24]; AGRE: -1.46, SSC: -1.41). 
We used SeqAnt to annotate the variants found at the AFF2 locus in the total sample of 202 
males with a diagnosis of autism (Mondal et al, in revision). We sought to test the 
hypothesis that rare variants at the AFF2 locus can act as autism susceptibility alleles. 
Annotating our variants using the other web-based tools, like the UCSC Genome Browser or 
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the Ensembl Genome Browser, would have been time-consuming and laborious. SeqAnt 
helped us rapidly annotate these SNPs and INDELs into different functional classes, as well 
as reported whether a variant had already been cataloged in the dbSNP database (Tables 4, 
5). SeqAnt also reported the PhastCons and phyloP conservation scores, which are 
important in helping to determine whether a variant might cause a deleterious change in the 
protein structure/function, since variants in the well-conserved sites are likely to cause such 
changes. By using this feature of SeqAnt, we could easily identify our list of candidate 
variants that were rare, as well as likely to cause a damaging change. 
 





Novel SNPs at 
Conserved Sites 
Replacement 5 0 5 5 
Silent 8 4 4 4 
UTR 33 20 13 1 
Intron 223 129 94 6 
Total 269 153 116 16 
Table 4. Functional annotation of single nucleotide polymorphisms at the AFF2 locus identified by 
next-generation sequencing of 202 males with autism 
 





Novel Indels at 
Conserved Sites 
Exonic 0 0 0 0 
UTR 2 0 2 1 
Intron 15 7 8 1 
Total 17 7 10 2 
Table 5. Functional annotation of indels at the AFF2 locus identified by next-generation sequencing of 
202 males with autism 
As expected, almost all common variation (>5% frequency in our population) is contained in 
dbSNP, whereas most rare variants (<5%) are not cataloged in dbSNP (Figure 8). We found 
that, in our cases, there were five (2.5% of total cases sequenced) singleton nonsynonymous 
variants. This level of variation in our cases was significantly higher than that seen in a set of 
5400 controls. Furthermore, we used SeqAnt to rapidly annotate 1006 X chromosome genes 
that had been sequenced in the 75 SSC samples, and ultimately showed that the excess 
mutations at AFF2 were unusual compared to other X chromosome loci. Thus, the ability to 
rapidly annotate our sequence variants discovered from sequencing the entire X 
chromosome exome had a major impact on our ability to assess the role of AFF2 as an 
autism susceptibility locus. Finally, SeqAnt helped us identify three rare noncoding UTR 
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sequence variants, one of which was at an evolutionarily conserved site. Subsequent 
functional testing suggested that the variant at the conserved site acts to influence the level 
of AFF2 expression. Thus, for this experiment, SeqAnt allowed us to rapidly focus on those 
sites of greatest interest for both statistical analyses and direct functional testing. 
 
Figure 8. Summary of SNV and indel variation discovered at the AFF2 locus in males with ASD. The 
frequency of SNVs and indels (minor alleles) in cases is plotted against their level of evolutionary 
conservation. Most common variation has already been discovered and exists in public databases (blue; 
circles and diamonds). Most of the rare variation at AFF2 was discovered in our study and not 
contained in public databases (red; circles and diamonds). 
5. An application of SeqAnt 2.0: Discovering new mutations from 
forward genetic screens in the mouse 
Forward genetic screens in Mus musculus have been very informative, revealing 
unsuspected mechanisms governing basic biological processes [27-32]. In this approach, a 
potent chemical mutagens, such as N-ethyl-N-nitrosourea (ENU), is used to randomly 
induce mutations in mice. The mice are then bred and phenotypically screened to identify 
lines that disrupt a specific biological process of interest. Although identifying a mutation 
using the rich resources of mouse genetics is straightforward, it is unfortunately neither fast 
nor cheap.  
To solve this problem, we developed a methodology that combines multiplex chromosome-
specific exome capture, next-generation sequencing, rapid mapping, sequence annotation, 
and variation filtering to detect newly induced causal variants in a dramatically accelerated 
way [33]. Rapid sequence annotation and variation filtering are critical to this approach. We 
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used SeqAnt as a part of this methodology for rapid annotation of variations obtained from 
mutant, parental, and background strains in a single experiment. By using SeqAnt, we first 
annotated all the variants into different functional classes. Next, by comparing variants 
identified in mutant offspring to those found in dbSNP, the unmutagenized background 
strains, and parental lines, we could immediately distinguish the induced putative causative 






















AB5 Replacement 96 80 13 3 1 
AB5 Silent 157 143 12 2 - 
AB5 UTR 331 191 135 5 - 
AB5 Intronic 106 87 17 2 - 
AB5 Intergenic 54 50 4 0 - 
M2 Replacement 43 8 31 4 2 
M2 Silent 19 11 7 1 - 
M2 UTR 73 16 55 2 - 
M2 Intronic 46 18 20 8 - 
M2 Intergenic 40 4 36 0 - 
X5 Replacement 128 59 63 6 2 
X5 Silent 192 128 63 1 - 
X5 UTR 387 231 152 4 - 
X5 Intronic 205 116 86 3 - 
X5 Intergenic 89 34 55 0 - 
Y1 Replacement 17 1 14 2 1 
Y1 Silent 5 0 4 1 - 
Y1 UTR 14 2 11 1 - 
Y1 Intronic 34 0 31 3 - 
Y1 Intergenic 7 0 7 0 - 
Table 6. Results of filtering homozygous variants sites for each mouse mutant line sequenced. 
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We demonstrated the use of this approach to find the causative mutations induced in four 
novel ENU lines identified from a recent ENU screen. In all four cases, after applying our 
method and combining with standard mapping data used to initially localize the variant 
to a chromosome, we found two or fewer putative mutations (and sometimes only a 
single one). Confirming that the variant was in fact causative was then easily achieved via 
standard segregation approaches. SeqAnt gave us the ability to rapidly annotate and 
screen variants of lesser interest (silent, UTR, intronic, intergenic), so we could instead 
focus our attention on those variants (replacement) that were most likely to account for 
the mutant phenotype. 
6. An application of SeqAnt 2.0: Exome sequencing to discover mutations 
affecting neutrophil function in very-early-onset pediatric Crohn’s 
disease 
Children with very-early-onset (VEO) pediatric Crohn’s disease (CD) are found to have high 
levels of neutrophil dysfunction. Neutrophils are an abundant type of white blood cell that 
play an essential role in innate immunity. We therefore hypothesized that children with 
very-early-onset Crohn’s disease would exhibit an increased frequency of genetic mutations 
affecting neutrophil function. For an initial study we selected 45 VEO CD patients (median 
(range) age: 8.5 (5-10) years) with CBir1 sero-reactivity and moderate-to-severe clinical 
disease activity at diagnosis. We used the Roche NimbleGen SeqCap EZ Human Exome 
Library v2.0 on genomic DNA extracted from whole blood to capture the whole exome for 
each patient. Barcodes were used to prepare the libraries for whole-exome capture, which 
allowed us to sequence two whole exomes per lane of next-generation sequencing. We 
performed multiplexed 100 base-pair paired-end sequencing on an Illumina HiSeq 2000 
instrument. We used PEMapper (Cutler and Zwick, in revision) to map raw sequence reads 
and identify variants sites relative to the ~30.8 Mb human exome reference sequence 
(NCBI37/hg19). 
We then used SeqAnt to annotate all variant sites for functional significance, frequency, 
presence in databases like dbSNP, and measures of evolutionary conservation. Our 
central hypothesis was that early-onset (pediatric) forms of IBD would be substantially 
influenced by deleterious mutations found in the neutrophil pathway. If true, a 
straightforward evolutionary model of mutation-selection balance predicts that these 
variants ought to be rare in the general population, found at highly evolutionarily 
conserved sites, and have large effects on gene function. Thus, variants found in coding 
regions (replacement, nonsense, exonic insertions/deletions) that putatively alter protein 
structure and function will be the strongest candidates as contributors to IBD in pediatric 
patients. A number of lines of evidence specifically implicate loci involved in neutrophil 
functional pathways. We therefore proposed a strategy of first discovering variation in 
genes known to function in the neutrophil pathway, followed by direct functional testing 
of alleles from specific patients.  
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SNP 89182666 0.02 0.0022 
NOX5 chr15 (q23) 0 - - oxidative burst - - 
PRAM1 chr19 (p13.2) 1 Indel 8564497-500 adhesion 0.02 - 
RAC1 chr7 (p22.1) 0 - - oxidative burst - - 
RAC2 chr22 (q12.3) 0 - - oxidative burst - - 
SELPLG chr12 (q24.11) 1 SNP 109017468 adhesion 0.11 - 

















STAT5A chr17 (q21.2) 1 SNP 40461109 GM-CSF signaling 0.02 - 
STAT5B chr17 (q21.2) 0 - - GM-CSF signaling - - 
VAV1 chr19 (p13.3) 0 - - oxidative burst - - 
VAV2 chr9 (q34.2) 0 - - oxidative burst - - 
VAV3 chr1 (p13.3) 0 - - oxidative burst - - 
 
Table 7. Genetic variants found in genes that regulate neutrophil function. 
We used SeqAnt to annotate all the sequence variations from the 45 exomes and identified a 
total of 60,682 variant sites of interest in coding regions (54,313 replacement SNPs, 2953 
indels covering 6369 bases). For our exploratory genome-wide analysis of SNPs, we 
restricted our analysis to those variants with phyloP scores greater than 2.0, which 
corresponds to the top 1% of conserved sites in the human genome. Remaining were 12,575, 
of which 51% (6490) were not cataloged in dbSNP 132 and might constitute novel mutations 
contributing to early-onset IBD. We then restricted our analysis to 33 neutrophil genes. 
Table 6 contains a list of these 33 neutrophil genes with the number of rare putative 
functional variants (replacement SNPs or exonic indels). These variants are to be followed 
up using direct functional assays to assess function. Again, SeqAnt enabled us to rapidly 
annotate all variants, ignore those variants of lesser interest, and focus our attention on 
those most likely to contribute to the VEO CD in our sequenced patients. 
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7. Future directions 
We have shown many useful features of SeqAnt and how it can be applied in a variety of 
experiments, yet we continue to develop SeqANt and plan to expand its functionalities 
going forward. Our goal is to create a one-stop online tool that readily accepts raw 
sequencing data and generates output through the annotation and functional 
characterization stages. Moreover, because our software and libraries are open source, they 
can be downloaded and optimized locally as part of a next-generation sequencing pipeline. 
SeqAnt is a truly dynamic application that is updated regularly to keep up with the constant 
flow of new sequencing data, genome assemblies, and improved annotation information 
available from public databases like those found at the UCSC Genome Browser. 
Genomic sequence annotation requires an up-to-date and comprehensive database of DNA 
sequence information for a given organism. Our first aim is to continue adding to our 
database organisms whose genomic information could be annotated. We plan on including 
several other mammals, vertebrates, invertebrates, and ultimately bacteria strains in the near 
future. This will give researchers a web application they can use to speed their genetic 
studies of such organisms. We are also in the process of updating the dbSNP information 
contained in the SeqAnt database. 
Another area of future focus is to broaden the types of input and output files that SeqAnt 
could work with, while embracing standards in broad use in the bioinformatics community. 
We intend to include the capability to directly annotate .vcf files as a standard input file 
format. Presently, all our output files are either text files or BED files. We also plan to 
provide the option of having the annotation output in .vcf format. Furthermore, we intend 
to modify SeqAnt to make the .map and .ped files (PLINK formats) from the snp variant file, 
which will be beneficial for substructure analysis and several other analyses that can be 
done using PLINK. 
The inclusion of additional custom tracks from the UCSC browser to annotate for conserved 
and putatively functional sites will also be a future area of SeqAnt development. Our hope 
is that this will improve the effectiveness of downstream functional analysis. We also plan to 
have the application hosted in a cloud computing environment, side by side with other 
bioinformatics tools. This is relevant not only because of the wider accessibility it 
guarantees, but there is often the added ease of using other tools in the same environment to 
generate and modify input and output files from SeqAnt for further analysis. 
SeqAnt was set up to be a dynamic application, and our improvements to this software make 
it possible to apply SeqAnt to different genomic variant analysis situations. Inevitable 
advances in sequencing technologies will spur continued demand for tools that can make 
sense out of the enormous raw sequence data generated, and we will work continually to 
make SeqAnt adaptable to these improvements and even more accessible to the wider public. 
8. Conclusion 
Great advances in targeted enrichment methods and DNA sequencing are beginning to 
allow individual investigators to sequence significant portions of many genomes; the 
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8. Conclusion 
Great advances in targeted enrichment methods and DNA sequencing are beginning to 
allow individual investigators to sequence significant portions of many genomes; the 
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bottleneck this has revealed lies with the annotation and interpretation of the resulting 
genomic variation data. SeqAnt is a software tool that directly addresses this bottleneck in a 
wide variety of potential applications. SeqAnt is an open source application that contains a 
number of unique features. The first is its ability to annotate data from many organisms, not 
just humans. Second, it is able to perform this analysis with a minimal memory footprint. 
Third, it completes this analysis in record time, thereby removing a significant bottleneck 
facing a researcher using the latest next-generation sequencing platforms. 
The modifications we made to the application ensure we have the latest data tracks for the 
species we currently have in the SeqAnt binary databases. Furthermore, we have expanded 
the number of species that can now be annotated. Finally, with the addition of the 
PhyloP46Way conservation track, researchers can more confidently assess the evolution and 
significance of a particular variant site when the phyloP scores are viewed side by side with 
the PhastCons score values. 
We have applied SeqAnt to various studies in our lab, from the work analysis of data on 
targeted sequencing of particular genes to the analysis of whole-exome data. We also used 
SeqAnt in the variant annotation of mouse genome and the adaptation of HapMap data for 
analyzing human exomes. The results from these various applications establish SeqAnt as a 
user-friendly tool that could help researchers in their work over a wide range of endeavors. 
SeqAnt will continue to be an open source web application, which we will constantly update 
to meet the demands of changing and improving genomic and sequencing technologies. The 
future of genomics and variation studies lies in our ability to properly use the massive 
amounts of information we have obtained from DNA sequencing. Sequence annotation tools 
like SeqAnt that can efficiently turn such data into useable information will play a key role 
in this future. 
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1. Introduction
Current generation of high-throughput DNA sequencing machines [1, 35, 66] can
generate large amounts of DNA sequence data. For example, the machine HiSeq
2000 from the company Illumina, a current workhorse of genome centers, is capable
of generating 600 Giga base-pairs of sequence in one single run [35]. The
Human Microbiome project (https://commonfund.nih.gov/hmp) and the 1000 Genomes
project (http://www.1000genomes.org) are two examples of projects that are generating
terabyte-scale amounts of DNA sequence.
Such vast amounts of data can only be handled by powerful computational infrastructures
(also known as cyberinfrastructures), sophisticated algorithms, efficient programs, and
well-designed boinformatics workflows. As a response to this challenge, a large ecosystem
composed by different technologies and service providers has emerged in recent years with
the paradigm of cloud computing [2, 58, 63, 71]. In this paradigm users have transparent
access to a wide variety of distributed infrastructures and systems. In this environment,
computing and data storage necessities are accomplished in different and unanticipated ways
to give the user the illusion that the amount of resources is unrestricted.
In this scenario, cloud computing is an interesting option to control and distribute processing
of large volumes of data produced in genome sequencing projects and stored in public
databases that are widespread in distinct places. However, considering the constant growing
of computational and storage power needed by different bioinformatics applications that are
continously beeing developed in different distributed environments, working with one single
cloud service provider can be restrictive for bioinformatics applications. Working with more
than one cloud can make a workflow more robust in the face of failures and unanticipated
needs. Cloud federation [11, 14, 15] is one such solution. Cloud federation offers other
advantages over single-cloud solutions. Bioinformatics centers can profit from participation
in a cloud federation, by having access to other center programs, data, execution and
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storage capabilities, in a collaborative environment. The federation can abstract cloud-specific
mechanisms, thus potetially making the use of such a resource more user-friendly and easier
to install and customize. This is particularly valuable for small and medium centers that can
enlarge their hardware resources and software tools using machines and programs of other
centers integrating a federated system.
In this work, we propose a hybrid federated cloud computing platform that aims at
integrating and controlling different bioinformatics tools in a distributed, transparent, flexible
and fault tolerant manner, also providing highly distributed processing and large storage
capability. The objective is to make possible the use of tools and services provided by multiple
institutions, public or private, that can be easily aggregated to the cloud. We also discuss a use
case of this platform, a bioinformatics workflow for identifying differentially expressed genes
in cancer tissues.
2. Federated cloud computing
There are many distinct definitions of cloud computing. According to [29], cloud computing
could be defined as “a computational paradigm highly distributed, directed by a scale economy, in
which the computational power, storing, abstract platforms and services, virtualized, managed and
dinamically scalable are provided on demand by external users through the Internet".
[71], using all the characteristics collected from the literature, proposed a definition of clouds
as “a big pool of virtualized resources, easily usable. The resources can be reconfigured dinamically
according to a variable load, allowing optimized using. This pool is typically explored by a pay-per-use
model in which guarantees are offered by the infrastructure provider, following a service contract".
These authors attempted to define cloud computing using only common characteristics in
cloud providers, but they did not find features that were mentioned by all providers. The
most common were scalability, pay-per-use model and virtualization.
From these definitions we can state that the goal of cloud computing is to offer to users the
idea that they have unrestricted resources, but they have to pay only for those effectively
used (model pay-per-use). Another significant advantage of clouds is the management of
the computational infrastructure, relieving users from concerns such as power failures and
backups. The property of allocating computational resources depending on user needs is
called elasticity.
Cloud services can be deployed by providers in different ways [48]:
• Private cloud: operated for the use of a single organization. It can be managed by the
organization itself or by external ones.
• Community Cloud: shared by several organizations and used as a tool for a specific group
of users with common interests.
• Public Cloud: available to the general public or a large corporate group that is part of the
organization that sells this service.
• Hybrid cloud: composed of two or more clouds (private, community or public) that remain
separate entities, but that are bound together by standardized or proprietary technologies
that enable portability of data and applications.
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In clouds, one of the key technologies adopted to execute bioinformatics programs is the
Apache Hadoop framework [6], in which the MapReduce [25] model and its distributed file
system (HDFS) [13] are used as infrastructure to distribute large scale processing and data
storage. In the MapReduce model parallelization does not require communication among
simultaneously processed tasks, since they are independent from one another.
Bittman [11] claimed that the evolution of cloud computing market could be divided in
three phases. In phase 1 (Monolithic), cloud computing services were based on proprietary
architectures, or cloud services were delivered by megaproviders. In phase 2 (Vertical Supply
Chain), some cloud providers leveraged services from other providers, i.e. independent
software vendors (ISVs) developed applications as a service using an existing cloud
infrastructure. Clouds were still proprietary, but ecosystems construction started. In phase
3 (Horizontal Federation), smaller providers would horizontally federate to gain economy
of scale and efficient use of their assets. Projects would leverage horizontal federation to
enlarge their capacibilities, more choices at each cloud computing layer would be provided,
and discussion about standards would begin.
In general, cloud computing intends to increase efficiency in service delivery, dealing with
services including infrastructure, platforms and software, and treating with distinct users like
a single user, other clouds, academic institutions and large companies. Besides public clouds
maintained by large organizations, hundreds of smaller heterogeneous and independent
clouds, private or hybrid, are being developed. In this scenario, cloud federation becomes
an interesting way to optimize the use of the resources offered by various organizations.
In particular, in this chapter, we are interested in horizontal cloud federation, also called
federated cloud computing, inter-cloud [14] or cross-cloud [15].
Federated cloud computing can be defined as a set of cloud computing providers, public
and private, connected through the Internet [14, 15]. Among its objectives we distinguish
the seemingly availability of unrestricted resources, independence of a single infrastructure
provider, and optimization when using a set of distinct resource providers.
Thus, federation allows each cloud computing provider to increase its processing and storage
capabilities by requesting more resources to other clouds in the federation when needed. This
means that a local cloud provider is able to satisfy user requests beyond its capabilities, since
idle resources from other providers can be used. Furthermore, if a provider fails, resources
can be requested to another one, providing more fault tolerance.
Although the advantages of federated cloud computing are obvious, its implementation is
not trivial, since the participating clouds present heterogeneous and frequently changing
resources. Therefore, traditional models of federation are not useful [15]. Typically, federated
models are based on a priori agreements among their members, noting that these agreements
can be inappropriate according to the particular characteristics of a cloud provider. Thus, to
make possible the creation of a federated cloud environment, it is necessary to achieve the
following requirements [14, 15]:
• Automatism: a cloud member of the federation, using discovery mechanisms, should be
able to identify the other clouds in the federation together with their resources, responding
to changes in a transparent and automatic way;
109Tow rds a Hybrid Federated Cloud Platform to Effi  ciently Execute Bioinformatics Work ows
2 Will-be-set-by-IN-TECH:Bioinformatics, ISBN: 980-953-307-202-4
storage capabilities, in a collaborative environment. The federation can abstract cloud-specific
mechanisms, thus potetially making the use of such a resource more user-friendly and easier
to install and customize. This is particularly valuable for small and medium centers that can
enlarge their hardware resources and software tools using machines and programs of other
centers integrating a federated system.
In this work, we propose a hybrid federated cloud computing platform that aims at
integrating and controlling different bioinformatics tools in a distributed, transparent, flexible
and fault tolerant manner, also providing highly distributed processing and large storage
capability. The objective is to make possible the use of tools and services provided by multiple
institutions, public or private, that can be easily aggregated to the cloud. We also discuss a use
case of this platform, a bioinformatics workflow for identifying differentially expressed genes
in cancer tissues.
2. Federated cloud computing
There are many distinct definitions of cloud computing. According to [29], cloud computing
could be defined as “a computational paradigm highly distributed, directed by a scale economy, in
which the computational power, storing, abstract platforms and services, virtualized, managed and
dinamically scalable are provided on demand by external users through the Internet".
[71], using all the characteristics collected from the literature, proposed a definition of clouds
as “a big pool of virtualized resources, easily usable. The resources can be reconfigured dinamically
according to a variable load, allowing optimized using. This pool is typically explored by a pay-per-use
model in which guarantees are offered by the infrastructure provider, following a service contract".
These authors attempted to define cloud computing using only common characteristics in
cloud providers, but they did not find features that were mentioned by all providers. The
most common were scalability, pay-per-use model and virtualization.
From these definitions we can state that the goal of cloud computing is to offer to users the
idea that they have unrestricted resources, but they have to pay only for those effectively
used (model pay-per-use). Another significant advantage of clouds is the management of
the computational infrastructure, relieving users from concerns such as power failures and
backups. The property of allocating computational resources depending on user needs is
called elasticity.
Cloud services can be deployed by providers in different ways [48]:
• Private cloud: operated for the use of a single organization. It can be managed by the
organization itself or by external ones.
• Community Cloud: shared by several organizations and used as a tool for a specific group
of users with common interests.
• Public Cloud: available to the general public or a large corporate group that is part of the
organization that sells this service.
• Hybrid cloud: composed of two or more clouds (private, community or public) that remain
separate entities, but that are bound together by standardized or proprietary technologies
that enable portability of data and applications.
108 Bioinformatics Towards a Hybrid Federated Cloud Platform to Efficiently Execute Bioinformatics Workflows 3
In clouds, one of the key technologies adopted to execute bioinformatics programs is the
Apache Hadoop framework [6], in which the MapReduce [25] model and its distributed file
system (HDFS) [13] are used as infrastructure to distribute large scale processing and data
storage. In the MapReduce model parallelization does not require communication among
simultaneously processed tasks, since they are independent from one another.
Bittman [11] claimed that the evolution of cloud computing market could be divided in
three phases. In phase 1 (Monolithic), cloud computing services were based on proprietary
architectures, or cloud services were delivered by megaproviders. In phase 2 (Vertical Supply
Chain), some cloud providers leveraged services from other providers, i.e. independent
software vendors (ISVs) developed applications as a service using an existing cloud
infrastructure. Clouds were still proprietary, but ecosystems construction started. In phase
3 (Horizontal Federation), smaller providers would horizontally federate to gain economy
of scale and efficient use of their assets. Projects would leverage horizontal federation to
enlarge their capacibilities, more choices at each cloud computing layer would be provided,
and discussion about standards would begin.
In general, cloud computing intends to increase efficiency in service delivery, dealing with
services including infrastructure, platforms and software, and treating with distinct users like
a single user, other clouds, academic institutions and large companies. Besides public clouds
maintained by large organizations, hundreds of smaller heterogeneous and independent
clouds, private or hybrid, are being developed. In this scenario, cloud federation becomes
an interesting way to optimize the use of the resources offered by various organizations.
In particular, in this chapter, we are interested in horizontal cloud federation, also called
federated cloud computing, inter-cloud [14] or cross-cloud [15].
Federated cloud computing can be defined as a set of cloud computing providers, public
and private, connected through the Internet [14, 15]. Among its objectives we distinguish
the seemingly availability of unrestricted resources, independence of a single infrastructure
provider, and optimization when using a set of distinct resource providers.
Thus, federation allows each cloud computing provider to increase its processing and storage
capabilities by requesting more resources to other clouds in the federation when needed. This
means that a local cloud provider is able to satisfy user requests beyond its capabilities, since
idle resources from other providers can be used. Furthermore, if a provider fails, resources
can be requested to another one, providing more fault tolerance.
Although the advantages of federated cloud computing are obvious, its implementation is
not trivial, since the participating clouds present heterogeneous and frequently changing
resources. Therefore, traditional models of federation are not useful [15]. Typically, federated
models are based on a priori agreements among their members, noting that these agreements
can be inappropriate according to the particular characteristics of a cloud provider. Thus, to
make possible the creation of a federated cloud environment, it is necessary to achieve the
following requirements [14, 15]:
• Automatism: a cloud member of the federation, using discovery mechanisms, should be
able to identify the other clouds in the federation together with their resources, responding
to changes in a transparent and automatic way;
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• Application behavior prediction: the system implementing the federation has to be able
to predict demands and behaviors of the offered applications, so that its load balancing
mechanism can have its efficiency improved;
• Mapping services to resources: the services offered by the federation must be mapped to
available resources in a flexible manner so that it can achieve the highest levels of efficiency
and cost/benefit. In other words, the schedule must choose the best hardware-software
combination to ensure the quality of service at lowest cost, taking into account the
uncertainty of the availability of resources;
• Interoperable security model: federation must allow the integration of different security
technologies so that a cloud member does not need to change its security policies when
entering the federation;
• Scalability in monitoring components: considering the possible large number of
participants, the federation must be able to handle multiple task queues and the largest
number of requests, so that management can guarantee that the various cloud providers
of the federation will mantain scalability and performance.
It is noteworthy that issues to choose an appropriate cloud provider and lack of common
cloud standards hinder the interoperability across these federated cloud providers. Thus,
nowadays the user is faced with the challenging problem of selecting the appropriate cloud
that fits his or her needs. To address this problem, the BioNimbus platform offers to users a
federated platform that can execute bioinformatics applications in a transparent and flexible
manner. This is possible because BioNimbus offers standardized interfaces and intermediate
services to manage the integration of different cloud providers. Moreover, as will be seen next,
BioNimbus was designed to incorporate the requirements defined by [15].
3. BioNimbus: a federated cloud platform
As mentioned before, cloud computing is a promising paradigm for bioinformatics due to its
ability to provide a flexible computing infrastructure on demand, its seemingly unrestricted
resources, and the possibility to distribute execution in a large number of machines leading
to a significant reduction in processing time due to the high degree of achieved parallelism.
Some bioinformatics tools have been implemented in cloud environments belonging to
several infrastructures of physically separated institutions, which makes it difficult for them
to be integrated.
BioNimbus [12, 62] is a federated cloud platform designed to integrate and control different
bioinformatics tools in a distributed, flexible and fault tolerant manner, providing rapid
processing and large storage capabilities, transparently to users. BioNimbus joins physically
separate platforms, each modelled as a cloud, which means that independent, heterogenous,
private/public clouds providing bionformatics applications can be used as if they were a
single system. In BioNimbus, resources of each cloud can be maximally explored, but if
more are required, other clouds can be requested to participate, in a transparent manner.
BioNimbusis thus able to satisfy further service allocation requests sent by its users. The
objective is to offer an environment with apparently unrestricted computational resources
given that computing and storage space demands are always provided on demand to the
users.
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3.1. BioNimbus architecture
All the components of BioNimbus architecture together with their funcionalities are defined
such that it allows simplicity, speed and eficiency when a new cloud provider enters in
the federation. Another key characteristic is the communication among the BioNimbus
components that is realized through a Peer-to-Peer (P2P) [67] network, guaranteeing the
following properties:
• Fault tolerance, since there is not a single fail point. Thus, even if some nodes fail, the
others can work;
• Efficiency, since there is not a single bottleneck. Then, messages are end-to-end and not
routed by a single node;
• Flexibility, since clouds can operate independently or in a coordinated manner;
• Scalability, since the use of a P2P network allows integration of thousands of
interconnected machines.
BioNimbus (Figure 1) architecture enables the integration of different cloud computing
platforms, meaning that independent, heterogeneous, private or public providers may offer
their bioinformatics services in an integrated manner, while maintaining their particular
characteristics and internal policies. BioNimbus is composed of three layers: application layer,
core layer and cloud provider layer.
Figure 1. The architecture of BioNimbus hybrid federated cloud.
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mechanism can have its efficiency improved;
• Mapping services to resources: the services offered by the federation must be mapped to
available resources in a flexible manner so that it can achieve the highest levels of efficiency
and cost/benefit. In other words, the schedule must choose the best hardware-software
combination to ensure the quality of service at lowest cost, taking into account the
uncertainty of the availability of resources;
• Interoperable security model: federation must allow the integration of different security
technologies so that a cloud member does not need to change its security policies when
entering the federation;
• Scalability in monitoring components: considering the possible large number of
participants, the federation must be able to handle multiple task queues and the largest
number of requests, so that management can guarantee that the various cloud providers
of the federation will mantain scalability and performance.
It is noteworthy that issues to choose an appropriate cloud provider and lack of common
cloud standards hinder the interoperability across these federated cloud providers. Thus,
nowadays the user is faced with the challenging problem of selecting the appropriate cloud
that fits his or her needs. To address this problem, the BioNimbus platform offers to users a
federated platform that can execute bioinformatics applications in a transparent and flexible
manner. This is possible because BioNimbus offers standardized interfaces and intermediate
services to manage the integration of different cloud providers. Moreover, as will be seen next,
BioNimbus was designed to incorporate the requirements defined by [15].
3. BioNimbus: a federated cloud platform
As mentioned before, cloud computing is a promising paradigm for bioinformatics due to its
ability to provide a flexible computing infrastructure on demand, its seemingly unrestricted
resources, and the possibility to distribute execution in a large number of machines leading
to a significant reduction in processing time due to the high degree of achieved parallelism.
Some bioinformatics tools have been implemented in cloud environments belonging to
several infrastructures of physically separated institutions, which makes it difficult for them
to be integrated.
BioNimbus [12, 62] is a federated cloud platform designed to integrate and control different
bioinformatics tools in a distributed, flexible and fault tolerant manner, providing rapid
processing and large storage capabilities, transparently to users. BioNimbus joins physically
separate platforms, each modelled as a cloud, which means that independent, heterogenous,
private/public clouds providing bionformatics applications can be used as if they were a
single system. In BioNimbus, resources of each cloud can be maximally explored, but if
more are required, other clouds can be requested to participate, in a transparent manner.
BioNimbusis thus able to satisfy further service allocation requests sent by its users. The
objective is to offer an environment with apparently unrestricted computational resources
given that computing and storage space demands are always provided on demand to the
users.
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3.1. BioNimbus architecture
All the components of BioNimbus architecture together with their funcionalities are defined
such that it allows simplicity, speed and eficiency when a new cloud provider enters in
the federation. Another key characteristic is the communication among the BioNimbus
components that is realized through a Peer-to-Peer (P2P) [67] network, guaranteeing the
following properties:
• Fault tolerance, since there is not a single fail point. Thus, even if some nodes fail, the
others can work;
• Efficiency, since there is not a single bottleneck. Then, messages are end-to-end and not
routed by a single node;
• Flexibility, since clouds can operate independently or in a coordinated manner;
• Scalability, since the use of a P2P network allows integration of thousands of
interconnected machines.
BioNimbus (Figure 1) architecture enables the integration of different cloud computing
platforms, meaning that independent, heterogeneous, private or public providers may offer
their bioinformatics services in an integrated manner, while maintaining their particular
characteristics and internal policies. BioNimbus is composed of three layers: application layer,
core layer and cloud provider layer.
Figure 1. The architecture of BioNimbus hybrid federated cloud.
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3.1.1. Application layer
This layer provides the service of interaction with users, which can be implemented by web
pages, command lines, graphical interfaces (GUI) or workflow management systems (WfMS).
Users can execute workflows or a single application, choosing among available services. Job
controller service has the function of collecting user requests and sending the input data to the
core layer. Moreover, this layer is responsible for showing to each user the current status of
his running applications. Users can list the files stored in the federation, upload or download
files, create and execute workflows in the BioNimbus cloud environment.
3.1.2. Cloud provider layer
This layer encompasses the cloud providers belonging to BioNimbus. The previous described
core layer ensures a unified view of the cloud, which allows users to see all the resources
available on each cloud as if they were one unified system.
A plug-in service is used to integrate a cloud provider (public or private) in the federation.
Each plug-in service is an interface that aims at communicating the BioNimbus core with
each cloud provider. Cloud providers can communicate among themselves also using the
core layer. Each plug-in needs to map the requests sent by the core components to the
corresponding actions that have to be realized in each cloud provider. This implies that each
cloud requires a special plug-in service. Furthermore, to integrate distinct providers (public
or private), each plug-in needs to treat three different kinds of requests: information about the
provider infrastructure, task management and file transfer.
3.2. Core layer
This layer is responsible for managing the federated environment. Among their functions are:
identification of new providers with their corresponding hardware and software resources;
task scheduling and controlling; definition, establishment and monitoring of SLA (Service
Level Agreement); storage and managing of input and output files; maintainance of the
online environment; and the election of new coordinators for each requested service. To each
function implemented in this layer, a controller service was included in the architecture, as
described next.
3.2.1. Discovery service
This service identifies the cloud providers integrating the federation, and consolidates
information about storage and processing capabilities, network latency, availability of
resources, available bioinformatics tools, details of parameters and input and output files.
To realize this, the discovery service waits for information published by providers about
their infrastructure and available tools. To consolidate these data, the discovery service
maintains a data structure that is updated whenever new data is received. Furthermore, the
discovery service has a policy of controlling each provider, removing from the federation
those providers not regularly sending updated information, which guarantees the correct
and update task execution on the federated cloud. Regarding to the entrance of a cloud
provider in BioNimbus, a priori, at any time a peer participating in the P2P network can
start the process of publishing its resources (storage and processing capabilities) and available
bioinformatics applications. However, for security and controlling purposes, permission to
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join the federation as a provider must be verified with the support of the security service
whenever any information about a new provider arrives to the discovery service.
As can be seen from the above description, an efficient resource discovery mechanism plays a
central role in our federated cloud, since the information gathered by this service is essential to
other services to properly perform their functions. According to [49], in large-scale distributed
services, a resource discovery infrastructure has to meet the following key requirements: it
must be scalable so it can handle thousands of machines without being unavailable or losing
performance; it must be able to handle both static and dynamic resources; and it must be
flexible enough so its queries could be extended in order to handle different types of resources.
Possible implementations of a resource discovery service could be developed using central
or hierarchical approaches, but these are known to have serious limitations of scalability,
fault-tolerance and network congestion [56].
In BioNimbus, we plan to use a publish/subscribe mechanism, in which providers publish
information about their resources to a decentralised resource discovery system. This
system will use a Distributed Hash Table (DHT) data structure [7] in order to achieve low
management costs and network overhead, efficient resource searching and fault-tolerance.
For resource information handling, we plan to use serializable and extendable formats such
as the JSON format [23]. In this way it will be possible for the federated cloud to deal with
different types of information, thus causing the least impact possible.
3.2.2. Job controller
The job controller links the core and the application layers of BioNimbus. It first calls the
security service to verify if a user has permission (authentication) to execute jobs in BioNimbus
and what are the credentials of this user. Moreover, the job controller’s main function is
to manage distinct and simultaneously running workflows, noting that the workflows may
belong to the same or to different users. Thus, for each accepted workflow, the job controller
generates an associated ID and controls each workflow execution using this ID.
3.2.3. SLA controller
According to [74], SLA is a formal contract between service providers and consumers to
guarantee that consumers’ service quality expectations can be achieved. In BioNimbus,
the SLA controller is responsible for implementing the SLA lifecycle, which has six steps:
discovers service providers, defines SLA, establishes agreement, monitors SLA violation,
terminates SLA and enforces penalties for violation. A SLA template represents, among
others, the QoS parameters that a user has negotiated with BioNimbus. The user can
populate, through an user interface, a suitable template with required values or even define
a new SLA from scratch in order to describe functional (e.g. CPU cores, memory size,
CPU speed, OS type and storage size) and non-functional (e.g. response time, budget, data
transfer time, availability and completion time) service requirements. In bioinformatics,
functional requirements are number of cores, amounts of memory and storage, CPU speed,
bioinformatics programs and databases and respective versions. Non-functional requirements
are latency (transfer rate) and uptime (reliability, in the sense that it measures how frequently
a cloud provider is running tasks or if it is not entering and leaving the federation).
The SLA controller has the responsibility to investigate whether the SLA template submitted
by the user can be supported by the federated cloud platform. For this, the SLA controller
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pages, command lines, graphical interfaces (GUI) or workflow management systems (WfMS).
Users can execute workflows or a single application, choosing among available services. Job
controller service has the function of collecting user requests and sending the input data to the
core layer. Moreover, this layer is responsible for showing to each user the current status of
his running applications. Users can list the files stored in the federation, upload or download
files, create and execute workflows in the BioNimbus cloud environment.
3.1.2. Cloud provider layer
This layer encompasses the cloud providers belonging to BioNimbus. The previous described
core layer ensures a unified view of the cloud, which allows users to see all the resources
available on each cloud as if they were one unified system.
A plug-in service is used to integrate a cloud provider (public or private) in the federation.
Each plug-in service is an interface that aims at communicating the BioNimbus core with
each cloud provider. Cloud providers can communicate among themselves also using the
core layer. Each plug-in needs to map the requests sent by the core components to the
corresponding actions that have to be realized in each cloud provider. This implies that each
cloud requires a special plug-in service. Furthermore, to integrate distinct providers (public
or private), each plug-in needs to treat three different kinds of requests: information about the
provider infrastructure, task management and file transfer.
3.2. Core layer
This layer is responsible for managing the federated environment. Among their functions are:
identification of new providers with their corresponding hardware and software resources;
task scheduling and controlling; definition, establishment and monitoring of SLA (Service
Level Agreement); storage and managing of input and output files; maintainance of the
online environment; and the election of new coordinators for each requested service. To each
function implemented in this layer, a controller service was included in the architecture, as
described next.
3.2.1. Discovery service
This service identifies the cloud providers integrating the federation, and consolidates
information about storage and processing capabilities, network latency, availability of
resources, available bioinformatics tools, details of parameters and input and output files.
To realize this, the discovery service waits for information published by providers about
their infrastructure and available tools. To consolidate these data, the discovery service
maintains a data structure that is updated whenever new data is received. Furthermore, the
discovery service has a policy of controlling each provider, removing from the federation
those providers not regularly sending updated information, which guarantees the correct
and update task execution on the federated cloud. Regarding to the entrance of a cloud
provider in BioNimbus, a priori, at any time a peer participating in the P2P network can
start the process of publishing its resources (storage and processing capabilities) and available
bioinformatics applications. However, for security and controlling purposes, permission to
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join the federation as a provider must be verified with the support of the security service
whenever any information about a new provider arrives to the discovery service.
As can be seen from the above description, an efficient resource discovery mechanism plays a
central role in our federated cloud, since the information gathered by this service is essential to
other services to properly perform their functions. According to [49], in large-scale distributed
services, a resource discovery infrastructure has to meet the following key requirements: it
must be scalable so it can handle thousands of machines without being unavailable or losing
performance; it must be able to handle both static and dynamic resources; and it must be
flexible enough so its queries could be extended in order to handle different types of resources.
Possible implementations of a resource discovery service could be developed using central
or hierarchical approaches, but these are known to have serious limitations of scalability,
fault-tolerance and network congestion [56].
In BioNimbus, we plan to use a publish/subscribe mechanism, in which providers publish
information about their resources to a decentralised resource discovery system. This
system will use a Distributed Hash Table (DHT) data structure [7] in order to achieve low
management costs and network overhead, efficient resource searching and fault-tolerance.
For resource information handling, we plan to use serializable and extendable formats such
as the JSON format [23]. In this way it will be possible for the federated cloud to deal with
different types of information, thus causing the least impact possible.
3.2.2. Job controller
The job controller links the core and the application layers of BioNimbus. It first calls the
security service to verify if a user has permission (authentication) to execute jobs in BioNimbus
and what are the credentials of this user. Moreover, the job controller’s main function is
to manage distinct and simultaneously running workflows, noting that the workflows may
belong to the same or to different users. Thus, for each accepted workflow, the job controller
generates an associated ID and controls each workflow execution using this ID.
3.2.3. SLA controller
According to [74], SLA is a formal contract between service providers and consumers to
guarantee that consumers’ service quality expectations can be achieved. In BioNimbus,
the SLA controller is responsible for implementing the SLA lifecycle, which has six steps:
discovers service providers, defines SLA, establishes agreement, monitors SLA violation,
terminates SLA and enforces penalties for violation. A SLA template represents, among
others, the QoS parameters that a user has negotiated with BioNimbus. The user can
populate, through an user interface, a suitable template with required values or even define
a new SLA from scratch in order to describe functional (e.g. CPU cores, memory size,
CPU speed, OS type and storage size) and non-functional (e.g. response time, budget, data
transfer time, availability and completion time) service requirements. In bioinformatics,
functional requirements are number of cores, amounts of memory and storage, CPU speed,
bioinformatics programs and databases and respective versions. Non-functional requirements
are latency (transfer rate) and uptime (reliability, in the sense that it measures how frequently
a cloud provider is running tasks or if it is not entering and leaving the federation).
The SLA controller has the responsibility to investigate whether the SLA template submitted
by the user can be supported by the federated cloud platform. For this, the SLA controller
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retrieves the SLA level published through the provider plug-in (e.g. gold, silver or bronze
SLA level).
So, if the service agreement required by the SLA template can not be satisfied, a negotiation
phase starts. The SLA negotiation phase is done as follows: the user submits a service
request with the new SLA template to the job controller. Next, after parsing the SLA
definition, the SLA controller asks the monitoring service if it could execute the service with
the specified requirements. In order to respond to this request, the monitoring service requests
the scheduling service to find the best suitable provider by matching the gathered resource
properties to the service requirements by applying predefined scheduling algorithms. If none
of the providers can be matched, the monitoring service enables the discovery service, which
must seek new cloud providers to be integrated into the federated environment, aiming at
satisfying the SLA template requested by the user. However, if this is not possible, the
mentioned steps must be repeated for renegotiation, with a new SLA template, until reaching
an agreement.
After establishing an agreement, the SLA controller generates an ID for the agreement, and
sends the ID to the job controller, which records this ID agreement. Then, the job controller
forwards both the request and the agreement ID to the monitoring service, which sends
the tasks for the scheduling service. The monitoring service is responsible for checking if a
violation of the agreement occurred and in this case it immediately has to inform the SLA
controller, which terminates the SLA and enforce penalties for violation.
3.2.4. Monitoring service
This service verifies if a requested service is available in a cloud provider, searching for
another cloud in the federation if it is not; receives the tasks to be executed from the job
controller, and sends them to the scheduling service that will distribute them, guaranteeing
that all the tasks of a process are correctly executed; and informs the job controller when a
task successfully finishes its execution. To ensure the monitoring of all the requested tasks,
this service periodically sends messages to the clouds that are executing tasks, and informs
the user the current status of each submitted task.
To perform the activities described above, the monitoring service must be able to gather
information about resource allocation and task execution, which depends on the application
being executed [28]. Therefore, we have to establish some criteria about the frequency
that data are obtained and their corresponding format, so that the decision-making process
performed by this service can be made with reliability with respect to data timeliness and
flexibility towards distinct applications. In BioNimbus, the monitoring service was planned
to send messages at regular intervals to all the federation members or whenever needed.
The latter case happens when a decision has to be taken for a specific federation member or
when data update is necessary. All information exchange is done with timestamps so only the
updated data are sent in order to save network bandwidth. We also plan to use an extensible
and flexible format, such as JSON [23], like in the discovery service.
In federated clouds the monitoring service must have other characteristics, such as: scalability,
to handle a large number of resources and tasks to be monitored; elasticity, to handle addition
and removal of resources in a transparent manner; and federation, to handle entering and
leaving providers [20]. In order to meet these requirements, we propose to use a decentralized
information indexing infrastructure, which would be the same DHT available to the discovery
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service. Furthermore, as previously described, the monitoring service has to verify agreement
violations.
3.2.5. Storage service
This service decides how to distribute and replicate data among the cloud providers
integrating the federation [8, 39, 73], particularly model the storage strategy of the files
consumed and produced by the jobs executed in BioNimbus. To realize this, the storage
service can communicate with the discovery service to access information about the
federation, since the discovery service knows the actual storage conditions of each provider
integrating the federation. Thus a storage policy is defined, so that this choice can be made
based on receiving information about the file (FileInfo) and returns at least one cloud provider
(PluginInfo) to store this file.
Some characteristics of biological data for bioinformatics applications are: large volume;
it is not necessary to guarantee the ACID transaction properties since there are no users
simultaneously updating data during execution; according to a particular bioinformatics
application, fragmentation and replication can use different models; and data provenance
is essential.
Considering these characteristics, the BioNimbus storage service proposal is based on the
HBase NoSQL (Not only SQL) database. Among distinct noSQL databases, like HBase [38],
Dynamo [26], Bigtable [17], Cassandra [41], PNUTS [22], monogDB [19] and cloudDB [5],
we adopted HBase since its basic data storage is Apache’s Hadoop Distributed File System
(HDFS) [13] and it is a column-oriented database [24, 50, 51], which allows joining data
(biological data file) and sets of information (e.g. data provenance).
Replication will be done copying data to at most three clouds in order to ensure recovery
in case of failure. Total or partial fragmentation depends on the biological data and the
application. On the top of HBase, we propose to create an Analyzer module, which will decide
where the replication has to be done. The objective of the Analyzer module is to reduce data
transfers among the cloud providers, based on three criteria: disk space, geographic position
and data transfer speed. The most important analysis is the available space, which should
be sufficient to store input and output. The geographic position criterion has the objective of
reducing data transfer on the network, being the closer clouds used first if possible. Finally,
the Analyzer module uses data transfer speed, which must be computed using the time to
transfer packages.
3.2.6. Security service
This service guarantees integrity among the distinct tasks executed in the federated clouds. A
federated cloud needs to include the security policies of each cloud provider while avoiding
strong inter-dependency among the clouds. A security context can be partitioned into three
main topics: authentication, authorization and confidentiality. We address those requirements
using standard algorithms and protocols as described next.
• Authentication: The descentralized federated cloud infrastructure should not make a
centralized authentication, which is a not a good choice because it limits the scalability and
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retrieves the SLA level published through the provider plug-in (e.g. gold, silver or bronze
SLA level).
So, if the service agreement required by the SLA template can not be satisfied, a negotiation
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request with the new SLA template to the job controller. Next, after parsing the SLA
definition, the SLA controller asks the monitoring service if it could execute the service with
the specified requirements. In order to respond to this request, the monitoring service requests
the scheduling service to find the best suitable provider by matching the gathered resource
properties to the service requirements by applying predefined scheduling algorithms. If none
of the providers can be matched, the monitoring service enables the discovery service, which
must seek new cloud providers to be integrated into the federated environment, aiming at
satisfying the SLA template requested by the user. However, if this is not possible, the
mentioned steps must be repeated for renegotiation, with a new SLA template, until reaching
an agreement.
After establishing an agreement, the SLA controller generates an ID for the agreement, and
sends the ID to the job controller, which records this ID agreement. Then, the job controller
forwards both the request and the agreement ID to the monitoring service, which sends
the tasks for the scheduling service. The monitoring service is responsible for checking if a
violation of the agreement occurred and in this case it immediately has to inform the SLA
controller, which terminates the SLA and enforce penalties for violation.
3.2.4. Monitoring service
This service verifies if a requested service is available in a cloud provider, searching for
another cloud in the federation if it is not; receives the tasks to be executed from the job
controller, and sends them to the scheduling service that will distribute them, guaranteeing
that all the tasks of a process are correctly executed; and informs the job controller when a
task successfully finishes its execution. To ensure the monitoring of all the requested tasks,
this service periodically sends messages to the clouds that are executing tasks, and informs
the user the current status of each submitted task.
To perform the activities described above, the monitoring service must be able to gather
information about resource allocation and task execution, which depends on the application
being executed [28]. Therefore, we have to establish some criteria about the frequency
that data are obtained and their corresponding format, so that the decision-making process
performed by this service can be made with reliability with respect to data timeliness and
flexibility towards distinct applications. In BioNimbus, the monitoring service was planned
to send messages at regular intervals to all the federation members or whenever needed.
The latter case happens when a decision has to be taken for a specific federation member or
when data update is necessary. All information exchange is done with timestamps so only the
updated data are sent in order to save network bandwidth. We also plan to use an extensible
and flexible format, such as JSON [23], like in the discovery service.
In federated clouds the monitoring service must have other characteristics, such as: scalability,
to handle a large number of resources and tasks to be monitored; elasticity, to handle addition
and removal of resources in a transparent manner; and federation, to handle entering and
leaving providers [20]. In order to meet these requirements, we propose to use a decentralized
information indexing infrastructure, which would be the same DHT available to the discovery
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service. Furthermore, as previously described, the monitoring service has to verify agreement
violations.
3.2.5. Storage service
This service decides how to distribute and replicate data among the cloud providers
integrating the federation [8, 39, 73], particularly model the storage strategy of the files
consumed and produced by the jobs executed in BioNimbus. To realize this, the storage
service can communicate with the discovery service to access information about the
federation, since the discovery service knows the actual storage conditions of each provider
integrating the federation. Thus a storage policy is defined, so that this choice can be made
based on receiving information about the file (FileInfo) and returns at least one cloud provider
(PluginInfo) to store this file.
Some characteristics of biological data for bioinformatics applications are: large volume;
it is not necessary to guarantee the ACID transaction properties since there are no users
simultaneously updating data during execution; according to a particular bioinformatics
application, fragmentation and replication can use different models; and data provenance
is essential.
Considering these characteristics, the BioNimbus storage service proposal is based on the
HBase NoSQL (Not only SQL) database. Among distinct noSQL databases, like HBase [38],
Dynamo [26], Bigtable [17], Cassandra [41], PNUTS [22], monogDB [19] and cloudDB [5],
we adopted HBase since its basic data storage is Apache’s Hadoop Distributed File System
(HDFS) [13] and it is a column-oriented database [24, 50, 51], which allows joining data
(biological data file) and sets of information (e.g. data provenance).
Replication will be done copying data to at most three clouds in order to ensure recovery
in case of failure. Total or partial fragmentation depends on the biological data and the
application. On the top of HBase, we propose to create an Analyzer module, which will decide
where the replication has to be done. The objective of the Analyzer module is to reduce data
transfers among the cloud providers, based on three criteria: disk space, geographic position
and data transfer speed. The most important analysis is the available space, which should
be sufficient to store input and output. The geographic position criterion has the objective of
reducing data transfer on the network, being the closer clouds used first if possible. Finally,
the Analyzer module uses data transfer speed, which must be computed using the time to
transfer packages.
3.2.6. Security service
This service guarantees integrity among the distinct tasks executed in the federated clouds. A
federated cloud needs to include the security policies of each cloud provider while avoiding
strong inter-dependency among the clouds. A security context can be partitioned into three
main topics: authentication, authorization and confidentiality. We address those requirements
using standard algorithms and protocols as described next.
• Authentication: The descentralized federated cloud infrastructure should not make a
centralized authentication, which is a not a good choice because it limits the scalability and
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creates a strong interdependency among the clouds. We intend to use a Single Sign-On
(SSO) protocol [52] so that no central authority is in charge of its users’ authentication,
which prevents a single point of failure and allows scalability according to the number
of users. We chose the OpenID standard [57] as our SSO mechanism, since it has been
used by corporate and academic sites around the world. OpenID allows each ”site” (e.g.
a cloud) to provide an authentication facility to its users so that they do not need to
authenticate with each other cloud integrating the federation. Instead, each cloud provider
acts as an identity provider for user credentials, so that each user should authenticate with
its affiliated provider. Once this user is authenticated, each time his/her credentials are
required, OAuth [10] allows a user’s site to forward authorization without exposing the
user account or login information.
• Authorization: The authorization of a federated cloud resource is provided by the Access
Control Lists (ACLs) [69] provided by each cloud provider. An ACL determines who
can access a given resource, e.g. disk storage, CPU cycles and bioinformatics services.
Therefore, each cloud is able to determine access patterns so that it can control its resource’s
uses.
• Confidentiality: Communication between each two cloud providers is established using
TLS/SSL [68] connection. The use of secure connections between two clouds in the
federation is not enforced by our model, but it can be provided as well. As far as we know,
few cloud systems provide secure intra-cloud communication. Each cloud should provide
a certificate that will be used by hosts in two clouds to establish a secure connection. As
we improve BioNimbus, we plan to include audit trails so that each required resource can
be available when needed.
3.2.7. Fault tolerance service and high availability
This service guarantees that all the core services are always available. In a cloud environment,
machine failures occur, and it is well known among the cloud community that those failures
are the norm rather than the exception. Thus, any federated cloud should be designed for
fault recovering and system availability. Therefore, a fault tolerance service is an essential
part of our federated cloud, and has the objective of providing high availability and resiliency
against periodic or transient failures.
There are extensive studies in the literature on failure detection systems [16, 31, 45, 70]. On the
other hand, few systems are designed to scale with a large number of nodes as those found
on clouds. Thus, an important requirement of our fault detection service is to be scalable with
a large number of machines. We adopted a modified gossip based failure detector proposed
by Renesse et al [70], which works as described. Each host runs the gossip failure detector
service, which maintains a list of known hosts in the cloud. Every Tseconds, a host increases
a heartbeat, and at random chooses a set of nodes for sending a list of known nodes. When
received, each list is merged with the host current list, assuming the largest heartbeat for each
node in the list. If a node does not update its heartbeat for a Telapsed time, then it will be
marked as failed. Note that a node may be marked as failed due to slow network links or
even in presence of a fractioned network. But our failure detection service is conservative so
that it only purges a host from the list after a T >= 2 ∗ Telapsed.
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Besides using this gossip based failure detector, we use a coordination service based on atomic
broadcast protocol [59]. The open source system Apache Zookeeper [34] runs on each cloud
and allows our system to detect node failures and realize an election of leaders among the
cloud machines, in order to guarantee the services availability, including discovery and fault
tolerance services. Zookeeper is used to elect some of the nodes that are known as gossip
servers. Those servers are dinamically chosen so that they can exchange the list of nodes
among the cloud providers. This helps to reduce the bandwidth between two clouds to a few
servers.
3.2.8. Scheduling service
This service dynamically distributes tasks among the cloud providers belonging to the
federation, maintaining a register for the allocated tasks, controlling load of each cloud
provider, and redistributing the tasks when resources are overloaded. The scheduling service
is responsible for receiving the tasks created from the user requests, and maintaining a record
about the status of each executed task. Before being executed in a cloud provider, a task is
sent to the scheduling service, which uses one or more scheduling policies to choose the cloud
provider that will execute this task, according to the negotiated SLA. Each policy receives a
list of tasks to be scheduled and an agreement ID, and returns a mapping of the tasks and
the cloud providers where these tasks will be executed. To do this, the scheduling policy
communicates with the discovery service. The scheduling policy should consider the SLA
QoS parameters and the margin values accepted by the cloud providers (e.g. gold, silver and
bronze SLA level). These parameters are important for a matching of a cloud provider that
is done by the scheduling policy, and therefore the user needs to give reasonable values for
them. Some typical SLA parameters used in context of a cloud provider are CPU cores, CPU
speed, memory size, in/ou bandwidth, OS type, storage size, response time, budget, data
transfer time, completion time and availability. In BioNimbus, the scheduling service can be
easily modified to use different scheduling policies.
We implemented a new DynamicAHP algorithm in BioNimbus [12]. The key idea of
DynamicAHP is to map available resources of the cloud providers to the requested tasks,
then associating a cloud to execute each task. This algorithm is based on a decision making
strategy proposed by [61]. DynamicAHP worked well on a first BioNimbus prototype, since
it was capable to dinamically scale using only the knowledge about the length of each task
input file, while performing load balancing among the cloud providers. Since BioNimbus
stores information about the cloud providers such as network latency and wait time in the
execution queues, DynamicAHP reduced costs and execution time of the tasks. The promising
results obtained from developing DynamicAHP in BioNimbus showed that good scheduling
algorithms can really lower the time to execute bioinformatics applications in federated
clouds.
It is interesting to investigate new scheduling metrics, mainly related to costs. For example, a
public cloud can be associated to a lower priority due to its associated costs, when compared
to other public clouds integrating the federation. Another idea is to assign weights to the
metrics that could set a priority order among them. To develop and analyze a model capable of
storing information about the executed tasks, such that the scheduling service could combine
this information to estimate the execution time of a particular task is another challenging
project.
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acts as an identity provider for user credentials, so that each user should authenticate with
its affiliated provider. Once this user is authenticated, each time his/her credentials are
required, OAuth [10] allows a user’s site to forward authorization without exposing the
user account or login information.
• Authorization: The authorization of a federated cloud resource is provided by the Access
Control Lists (ACLs) [69] provided by each cloud provider. An ACL determines who
can access a given resource, e.g. disk storage, CPU cycles and bioinformatics services.
Therefore, each cloud is able to determine access patterns so that it can control its resource’s
uses.
• Confidentiality: Communication between each two cloud providers is established using
TLS/SSL [68] connection. The use of secure connections between two clouds in the
federation is not enforced by our model, but it can be provided as well. As far as we know,
few cloud systems provide secure intra-cloud communication. Each cloud should provide
a certificate that will be used by hosts in two clouds to establish a secure connection. As
we improve BioNimbus, we plan to include audit trails so that each required resource can
be available when needed.
3.2.7. Fault tolerance service and high availability
This service guarantees that all the core services are always available. In a cloud environment,
machine failures occur, and it is well known among the cloud community that those failures
are the norm rather than the exception. Thus, any federated cloud should be designed for
fault recovering and system availability. Therefore, a fault tolerance service is an essential
part of our federated cloud, and has the objective of providing high availability and resiliency
against periodic or transient failures.
There are extensive studies in the literature on failure detection systems [16, 31, 45, 70]. On the
other hand, few systems are designed to scale with a large number of nodes as those found
on clouds. Thus, an important requirement of our fault detection service is to be scalable with
a large number of machines. We adopted a modified gossip based failure detector proposed
by Renesse et al [70], which works as described. Each host runs the gossip failure detector
service, which maintains a list of known hosts in the cloud. Every Tseconds, a host increases
a heartbeat, and at random chooses a set of nodes for sending a list of known nodes. When
received, each list is merged with the host current list, assuming the largest heartbeat for each
node in the list. If a node does not update its heartbeat for a Telapsed time, then it will be
marked as failed. Note that a node may be marked as failed due to slow network links or
even in presence of a fractioned network. But our failure detection service is conservative so
that it only purges a host from the list after a T >= 2 ∗ Telapsed.
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Besides using this gossip based failure detector, we use a coordination service based on atomic
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and allows our system to detect node failures and realize an election of leaders among the
cloud machines, in order to guarantee the services availability, including discovery and fault
tolerance services. Zookeeper is used to elect some of the nodes that are known as gossip
servers. Those servers are dinamically chosen so that they can exchange the list of nodes
among the cloud providers. This helps to reduce the bandwidth between two clouds to a few
servers.
3.2.8. Scheduling service
This service dynamically distributes tasks among the cloud providers belonging to the
federation, maintaining a register for the allocated tasks, controlling load of each cloud
provider, and redistributing the tasks when resources are overloaded. The scheduling service
is responsible for receiving the tasks created from the user requests, and maintaining a record
about the status of each executed task. Before being executed in a cloud provider, a task is
sent to the scheduling service, which uses one or more scheduling policies to choose the cloud
provider that will execute this task, according to the negotiated SLA. Each policy receives a
list of tasks to be scheduled and an agreement ID, and returns a mapping of the tasks and
the cloud providers where these tasks will be executed. To do this, the scheduling policy
communicates with the discovery service. The scheduling policy should consider the SLA
QoS parameters and the margin values accepted by the cloud providers (e.g. gold, silver and
bronze SLA level). These parameters are important for a matching of a cloud provider that
is done by the scheduling policy, and therefore the user needs to give reasonable values for
them. Some typical SLA parameters used in context of a cloud provider are CPU cores, CPU
speed, memory size, in/ou bandwidth, OS type, storage size, response time, budget, data
transfer time, completion time and availability. In BioNimbus, the scheduling service can be
easily modified to use different scheduling policies.
We implemented a new DynamicAHP algorithm in BioNimbus [12]. The key idea of
DynamicAHP is to map available resources of the cloud providers to the requested tasks,
then associating a cloud to execute each task. This algorithm is based on a decision making
strategy proposed by [61]. DynamicAHP worked well on a first BioNimbus prototype, since
it was capable to dinamically scale using only the knowledge about the length of each task
input file, while performing load balancing among the cloud providers. Since BioNimbus
stores information about the cloud providers such as network latency and wait time in the
execution queues, DynamicAHP reduced costs and execution time of the tasks. The promising
results obtained from developing DynamicAHP in BioNimbus showed that good scheduling
algorithms can really lower the time to execute bioinformatics applications in federated
clouds.
It is interesting to investigate new scheduling metrics, mainly related to costs. For example, a
public cloud can be associated to a lower priority due to its associated costs, when compared
to other public clouds integrating the federation. Another idea is to assign weights to the
metrics that could set a priority order among them. To develop and analyze a model capable of
storing information about the executed tasks, such that the scheduling service could combine
this information to estimate the execution time of a particular task is another challenging
project.
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3.3. Performing tasks in BioNimbus
Figure 2 shows how BioNimbus works. Initially (step 1), the user interacts with BioNimbus
through an interface, which could be a command line or a web interface, for example. The
user informs details of the application (or workflow) to be executed, and these information
are sent to the job controller in form of jobs to be executed. Then, the job controller verifies the
availability of the informed applications and input files, sending a response message to the
user accordingly. Afterwards, these jobs’ features are analyzed by the security service (step
2), which verifies the user permission to access the resources of the federation, and sends a
response to the job controller (step 3).
If the requested jobs can be executed, a message is sent to the SLA Controller (step 4) that
investigates whether the SLA template submitted by the user can be identified by BioNimbus.
If the user request can be executed, the SLA controller sends a message to the monitoring
service (step 5), which stores the jobs in a pending task list. This service is responsible for
informing to the scheduling service that there are pending jobs waiting to be scheduled.
Next (step 6), the scheduling service starts when the monitoring service informs that there are
pending jobs. The scheduling policy adopted in BioNimbus can be easily changed, according
to the characteristics of a particular application. The scheduling service gets information about
the resources using the discovery service (steps 9 and 10), which periodically updates the
status of the federation infrastructure, and stores these information in a management data
structure. This information is used to generate the list of ordered resources, and to assign the
more demanding jobs to the best resources, according to the scheduling policy.
With the resource and job ordered lists, the scheduling service communicates with the storage
service to ensure that all the input files are available to the providers chosen to execute the
jobs (steps 7 and 8).
Next, the scheduler distributes instances of jobs (tasks) to be executed by the plug-ins and
their corresponding clouds (steps 11 and 12).
The scheduling service decision is then passed to the monitoring service (step 13) so that it can
monitor each job status until it is finished. When the jobs are all completed, the monitoring
service informs the SLA Controller (step 14), which sends a message to the job controller (step
15). Finally, the job controller communicates with the user interface (step 16) informing that
the jobs were completed, which closes one execution cycle in BioNimbus.
The BioNimbus architecture follows [3], who claims that high-throughput sequencing
technologies have decentralized sequence acquisition, which increases demands for new and
efficient bioinformatics tools that have to be easy to use, portable across multiple platforms,
and scalable for high-throughput applications.
4. A case study
A federation with two cloud providers, one nonpublic (University of Brasilia) and one public
(EC2 Amazon), were created in order to study BioNimbus when applied to a simple workflow
with real data.
A prototype of BioNimbus containing all the main controller services was implemented:
monitoring and scheduling service, discovery service and a simple storage service, using an open
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Figure 2. Example of a job execution in the BioNimbus hybrid federated cloud.
source implementation of the Zab protocol [59], which allows a distributed consensus among
a group of processes. We also implemented Hadoop infrastructure plug-ins. Each plug-in
provides information about the current status of its respective infrastructure, like number
of cores, processing and storage resources and bioinformatics tools that can be executed in
BioNimbus, as well as information of input and output files. The interaction of the user and
the platform was implemented by a command line that sends requests. Services and plug-ins
communicate through a P2P network based on the Chord protocol [67] .
In order to study the runtime performance of a workflow involving real biological data, we
created a three-phase workflow in BioNimbus. The objective was to compare the time of a
workflow running in a federated cloud to a single cloud.
4.1. Cloud providers
At the University of Brasilia, a Hadoop cluster was implemented with 3 machines, each one
with two Intel Core 2 Duo 2.66Ghz (so a total of 6 cores), 4 GB RAM and 565 GB of storage.
The Hadoop cluster executed Bowtie [44] with the Hadoop MapReduce (Hadoop streaming),
with storage implemented with the Hadoop Distributed FileSystem (HDFS).
In addition, at Amazon EC2, a Hadoop cluster Cluster Hadoop was implemented with 4
virtualized machines, each one with two Intel Xeon 2.2 7Ghz (so a total of 8 cores), 8 GB
RAM, and 1.6 TB of storage. The cluster also executed Bowtie.
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Figure 2. Example of a job execution in the BioNimbus hybrid federated cloud.
source implementation of the Zab protocol [59], which allows a distributed consensus among
a group of processes. We also implemented Hadoop infrastructure plug-ins. Each plug-in
provides information about the current status of its respective infrastructure, like number
of cores, processing and storage resources and bioinformatics tools that can be executed in
BioNimbus, as well as information of input and output files. The interaction of the user and
the platform was implemented by a command line that sends requests. Services and plug-ins
communicate through a P2P network based on the Chord protocol [67] .
In order to study the runtime performance of a workflow involving real biological data, we
created a three-phase workflow in BioNimbus. The objective was to compare the time of a
workflow running in a federated cloud to a single cloud.
4.1. Cloud providers
At the University of Brasilia, a Hadoop cluster was implemented with 3 machines, each one
with two Intel Core 2 Duo 2.66Ghz (so a total of 6 cores), 4 GB RAM and 565 GB of storage.
The Hadoop cluster executed Bowtie [44] with the Hadoop MapReduce (Hadoop streaming),
with storage implemented with the Hadoop Distributed FileSystem (HDFS).
In addition, at Amazon EC2, a Hadoop cluster Cluster Hadoop was implemented with 4
virtualized machines, each one with two Intel Xeon 2.2 7Ghz (so a total of 8 cores), 8 GB
RAM, and 1.6 TB of storage. The cluster also executed Bowtie.
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Two Perl scripts implementing the workflow (SAM2BED and genome2interval) and the
coverageBed program (integrating the BEDTolls suite [54]) were installed in each cloud
provider.
4.2. Workflow, tools and data
Workflow
Now we describe the workflow used as our case study. The objective of the workflow was to
identify differentially expressed genes in human kidney and liver cancerous cells [47, 60], with
fragments of genes sequenced with Illumina technology [35]. The workflow consists of four
phases (Figure 3): (i) mapping the input sequences onto the 24 human chromosome sequences;
(ii) converting format from SAM (Bowtie) to BED (a specific format of the CoverageBED
program); (iii) generating fixed intervals for all chromossomes based on their length, since
this is the input for the CoverageBED program; and (iv) executing the CoverageBED program,
which generates histograms showing the number of mappings for each interval.
The mapping phase has the objective of identifying the region of a reference genome where
each input sequence was located. A set of sequences mapping in the same region allows the
inferences that these sequences have the same structural organization of the reference genome.
The CoverageBED program [54] allowed the study of the expression level of the cancerous
genes using histograms of the mapped input sequences onto the human reference genome, so
that differentially expressed genes between kidney and liver cancer genes could be identified.
Figure 3. The workflow investigated the expression level of liver and kidney genes (generated by
Illumina) mapping them to 24 human chromosome sequences.
Tools
Four tools were implemented in each cloud provider: Bowtie [44], SAM2BED (a Perl script),
genome2interval (another Perl script) and coverageBed [54].
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Data
The 24 human chromosome sequences were downloaded from HG19:
ftp://ftp.ncbi.nih.gov/genomes/H_sapiens/Assembled_chromosomes/seq/
The reference site is:
http://www.ncbi.nlm.nih.gov/genome/assembly/293148/
Finally, the names of the files followed the format:
hs_ref_GRCh37.p5_chr*.fa.gz.
4.3. Implementation details
A message module allowed the communication among the services, having been created
using the Nettycommunication library [36], which is responsible for the TCP connection event
manager. Messages were serialized using both JSON format [23] and Jackson library [21], and
file transfer was accomplished through the HTTP protocol GET and PUT methods. Message
and file communications were realized using an unique TCP port, which avoided the necessity
to create complex firewall rules. Besides, the message module is capable of multiplexing both
message and file traffic. A simplified version of the Chord [67] protocol was implemented for
the P2P network and plug-ins. We developed plug-in prototypes for Apache Hadoop and
SunGridEngine. Java was the language used to implement the BioNimbus prototype.
Next, we briefly describe somefeatures of the services implemented on our BioNimbus
prototype (Figure 4):
• Discovery service: this implementation used two execution threads. The first one is
responsible for updating and cleaning the data structure storing information about the
cloud providers. The second thread waits for P2P network messages that have to be
treated by the discovery service. A data structure map was used for storing information
about each federated cloud provider using a unique identifier. Besides, each cloud has a
timestamp for its last mapping. To update the infrastructure, the first thread is executed in
intervals of 30 seconds in order to send messages to all the BioNimbus members. The
response of each plug-in is treated by the second thread, which updates the mapping
with the received new information and corresponding timestamp for each execution. The
first thread removes from the map those pieces of information that did not have their
date modified in the last 90 seconds, which indicates that those cloud providers left the
federation. The second thread also treats the requisition about the federation clouds, using
the map maintained by the discovery service.
• Monitoring and scheduling service: to realize the work of receiving, monitoring and
scheduling user jobs, three main data structures of type map were used. The first one,
called PendingJobs, maps each job identifier to its information and also represents those
jobs waiting to be scheduled. The second one, named RunningJobs, maps each executing
task identifier to its information and the job to which it belongs. The third data structure,
called CancelingJobs, maps the task identifier to its corresponding job and to the user
requiring its cancelation.
In the monitoring service, there is a thread responsible for waiting the user requests and
responses received from other services of the infrastructure. When a request initiates a
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Finally, the names of the files followed the format:
hs_ref_GRCh37.p5_chr*.fa.gz.
4.3. Implementation details
A message module allowed the communication among the services, having been created
using the Nettycommunication library [36], which is responsible for the TCP connection event
manager. Messages were serialized using both JSON format [23] and Jackson library [21], and
file transfer was accomplished through the HTTP protocol GET and PUT methods. Message
and file communications were realized using an unique TCP port, which avoided the necessity
to create complex firewall rules. Besides, the message module is capable of multiplexing both
message and file traffic. A simplified version of the Chord [67] protocol was implemented for
the P2P network and plug-ins. We developed plug-in prototypes for Apache Hadoop and
SunGridEngine. Java was the language used to implement the BioNimbus prototype.
Next, we briefly describe somefeatures of the services implemented on our BioNimbus
prototype (Figure 4):
• Discovery service: this implementation used two execution threads. The first one is
responsible for updating and cleaning the data structure storing information about the
cloud providers. The second thread waits for P2P network messages that have to be
treated by the discovery service. A data structure map was used for storing information
about each federated cloud provider using a unique identifier. Besides, each cloud has a
timestamp for its last mapping. To update the infrastructure, the first thread is executed in
intervals of 30 seconds in order to send messages to all the BioNimbus members. The
response of each plug-in is treated by the second thread, which updates the mapping
with the received new information and corresponding timestamp for each execution. The
first thread removes from the map those pieces of information that did not have their
date modified in the last 90 seconds, which indicates that those cloud providers left the
federation. The second thread also treats the requisition about the federation clouds, using
the map maintained by the discovery service.
• Monitoring and scheduling service: to realize the work of receiving, monitoring and
scheduling user jobs, three main data structures of type map were used. The first one,
called PendingJobs, maps each job identifier to its information and also represents those
jobs waiting to be scheduled. The second one, named RunningJobs, maps each executing
task identifier to its information and the job to which it belongs. The third data structure,
called CancelingJobs, maps the task identifier to its corresponding job and to the user
requiring its cancelation.
In the monitoring service, there is a thread responsible for waiting the user requests and
responses received from other services of the infrastructure. When a request initiates a
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Figure 4. The services implemented for our case study, noting that we used two cloud providers in the
BioNimbus prototype.
job (JobStartReq) is received, this thread generates an unique identifier for this job
and saves this informaticon in the PendingJobs map. Next, it calls the scheduling
policy, which returns a mapping among the jobs and the plug-ins that can execute them.
Thus, when the jobs are all scheduled, this thread sends requests in order to create tasks
(TaskStartReq) that have to be executed in the cloud providers, and waits for their
corresponding outputs (TaskStartReply). When an output is received, the service
removes the job from the PendingJobs map and creates an input in the RunningJobs
map, with information about the job and its corresponding tasks, removing a job when all
its tasks finish. As previouly mentioned, a new DynamicAHP algorithm was implemented
in BioNimbus [12], which is based on on a decision making strategy proposed by [61].
Another thread in the monitoring service, executed at intervals of 15 seconds, is
responsible for following the jobs. First, it sends status requests (TaskStatusReq) to
each job registered in RunningJobs. The response (TaskStatusReply), treated by the
previous described thread, can again initiate the scheduling service according to some
parameters. Cancelling messages (TaskCancelReq and TaskCancelReply) will be
sent, and the job will be reinserted in the PendingJobs map and removed from the
RunningJobs. This thread also verifies whether there are pending jobs in PendingJobs,
initiating another scheduling process in this case, and sending query messages to the
discovery service (CloudReq) and to the storage service (ListReq), whose responses
(CloudReply and ListReply) will be received by the first thread and used by the
scheduling policy when needed.
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• Storage service: two threads were used for its implementation. The first one waits for the
requests sent by other services. To treat the request of saving files (StoreReq), the storage
service executes the storage policy adopted in BioNimbus. For this case study, we used
a method based on a round-robin of the plug-ins that informed having enough space to
store the file. When a cloud is chosen, a response (StoreReply) is sent to the service
making the request, which will send the file to the cloud indicated by the storage service.
When this transfer finishes, the plug-in receiving the file storage sends a special message
(StoreAck), which contains information that will keep correct the federation file table.
In the case study, a simple backend was implemented to maintain the federation file table.
Every time a new confirmation is received by the storage service, it adds an input in the
map file with the file identifier containing information such as name, size and storage
cloud. This mapping is stored in JSON format [23] in a file in the federation file system
of the cloud where the service will be executed. When initiating its execution, the storage
service verifies if the map file left and load in memory the federation file table last status.
The other two types treated by the first thread are file list (ListReq) and localization
(GetReq). For the first case, the thread builds a response (ListReply) with the mapping
loaded in memory. For localization, it builds a response (GetReply) searching for the
cloud information in the map using the request identifier.
Finally, another thread is executed at intervals of 30 seconds requesting to the discovery
service the current configuration of the federation (CloudReq message). The received
information is used by the storage policy.
4.4. Results
We executed the workflow at the University of Brasilia and the Amazon EC2, and on both
cloud providers (Table 1).
Cloud Providers hour:minute:second
University of Brasilia (UnB) 1:11:47
Amazon EC2 1:18:44
Both clouds (UnB and EC2) 1:09:07
Table 1. Workflow execution time on each cloud and on the BioNimbus federated cloud.
We measured how the file transfer time affected the job execution total time. Table 2 and
Figure 5 shows the total and file transfer times of the 18 longest jobs of the workflow, as well
as the percentage of the file transfer time related to the total time. These percentages show
that file transfer represents at least 50% of the total time of this job execution. This means that
in federated clouds executing data-driven bioinformatics applications, storage services have
to be especially designed to minimize as much as possible huge file transfers.
We also investigated how the time execution of a job was affected when sent to execution in
a cloud provider, taking a long time, being cancelled and returning to the list of pending jobs
to be executed again. There were seven jobs cancelled, the first seven jobs in Table 2 with
the longest times to be executed. When making an experiment without cancelling jobs, we
obtained greater times, when compared to the experiment with cancelling since they were
sent to clouds almost idle.
We mention now some points that can affect BioNimbus performance: (i) the scheduler does
not consider jobs being transferred and identifies CPUs involved in these transfers as idle; (ii)
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(TaskStartReq) that have to be executed in the cloud providers, and waits for their
corresponding outputs (TaskStartReply). When an output is received, the service
removes the job from the PendingJobs map and creates an input in the RunningJobs
map, with information about the job and its corresponding tasks, removing a job when all
its tasks finish. As previouly mentioned, a new DynamicAHP algorithm was implemented
in BioNimbus [12], which is based on on a decision making strategy proposed by [61].
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each job registered in RunningJobs. The response (TaskStatusReply), treated by the
previous described thread, can again initiate the scheduling service according to some
parameters. Cancelling messages (TaskCancelReq and TaskCancelReply) will be
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service the current configuration of the federation (CloudReq message). The received
information is used by the storage policy.
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We executed the workflow at the University of Brasilia and the Amazon EC2, and on both
cloud providers (Table 1).
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University of Brasilia (UnB) 1:11:47
Amazon EC2 1:18:44
Both clouds (UnB and EC2) 1:09:07
Table 1. Workflow execution time on each cloud and on the BioNimbus federated cloud.
We measured how the file transfer time affected the job execution total time. Table 2 and
Figure 5 shows the total and file transfer times of the 18 longest jobs of the workflow, as well
as the percentage of the file transfer time related to the total time. These percentages show
that file transfer represents at least 50% of the total time of this job execution. This means that
in federated clouds executing data-driven bioinformatics applications, storage services have
to be especially designed to minimize as much as possible huge file transfers.
We also investigated how the time execution of a job was affected when sent to execution in
a cloud provider, taking a long time, being cancelled and returning to the list of pending jobs
to be executed again. There were seven jobs cancelled, the first seven jobs in Table 2 with
the longest times to be executed. When making an experiment without cancelling jobs, we
obtained greater times, when compared to the experiment with cancelling since they were
sent to clouds almost idle.
We mention now some points that can affect BioNimbus performance: (i) the scheduler does
not consider jobs being transferred and identifies CPUs involved in these transfers as idle; (ii)
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Table 2. Total and file transfer times of the longest jobs executed in BioNimbus.
Figure 5. Comparing the total and file transfer times of the longest jobs executed in BioNimbus. The file
transfer time is colored red, while its percentage related to the total time is shown in blue.
the input files are all simultaneously downloaded, i.e. there are no priorities for downloads;
(iii) jobs are now canceled based only on the wait time in the pending jobs list, i.e. the file
transfering time is not considered; and (iv) jobs with small input files that were sent to a
cloud provider after jobs with large input files got executed earlier, while the later were still
downloading their input data.
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Table 3 and Figure 6 show the number of jobs executed in a single cloud provider and on
both. Note that, including the transfer time, jobs with smaller inputs execute faster on two
cloud providers, since the possibility to cancel delayed jobsthat are running and scheduling
them again lowered the total execution time. Besides, when files are small, the time to transfer
files is rapid, while when they are large the transfer time strongly affects the total execution
time (as shown in Table 2). Thus, for large files, the storage policy has to be very carefully
designed using replication and fragmentation in order to significantly decrease file transfer
time.
Cloud Providers until 200 seconds between 200 seconds above 1000 seconds
and 1000 seconds
University of Brasilia 34 30 32
EC2 Amazon 37 27 32
UnB and EC2 64 8 24
Table 3. Number of executed jobs, where time includes the file transfer time.
Figure 6. Comparing the number of executed jobs in BioNimbus, where time (in seconds) includes the
file transfer time.
5. Related work
In this section, we discuss cloud projects designed to accelerate execution and increase
the amount of storage available to bioinformatics applications. When compared to
BioNimbus, these projects are dedicated to particular applications or are executed in a
single cloud environment. BioNimbus intends to integrate public and private centers
offering bioinformatics applications in one single platform using the hybrid federation cloud
paradigm.
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Cloudburst [64] parallel algorithm is optimized for mapping DNA fragments, also known as
short read sequences (SRSs), to a reference genome. The execution time varies almost linearly
with the increase in the number of processors. The mapping of millions of SRSs to the human
genome, executed in 24 cores, is thirty times faster when compared to other non-distributed
applications [44, 65]. CloudBurst uses the MapReduce model.
Crossbow [43] is a pipeline developed in the infrastructure provided by the Apache Hadoop
streaming mode. It combines the Bowtie [43] SRS mapping tool, performed during the map
phase, with the SOAPsnp [46] tool to identify SNPs, processed during the reduce phase.
During the execution of the workflow, the SRSs are sent as input to the nodes of the Hadoop
cluster, which executes the map phase. In this phase, the SRSs are mapped to a reference
genome using Bowtie. Afterwards, the mappings are joined with parts of the reference
genome, and each group is sent to a node that executes the reduce phase. The SOAPsnp
tool is used to detect SNPs in the already analyzed parts of the genome. The execution time
for about 2.6 billion SRSs and the entire human genome used as a reference took a little more
than 3 hours in a 320 core cluster of the Amazon EC2 [2] infrastructure. The experiments cost
less than US$ 100.
Myrna [42] identifies differentially expressed genes in large sets of sequenced data. The
workflow combines a mapping phase with a statistical analysis phase, performed with R [55],
which is able to analyze more than one billion SRSs in a little more than 90 minutes, using 320
cores and costing around US$ 75.
The RSD (Reciprocal Smallest Distance) comparative genomics algorithm, composed of
different bioinformatics tools, was adapted to be executed in the Amazon EC2 infrastructure,
having obtained expressive results [72].
[3] created the Cloud Virtual Resource (CloVR), a desktop application for automated sequence
analysis using cloud computing resources. CloVR is implemented as a single portable virtual
machine (VM) that provides several automated analysis pipelines for microbial genomics,
whole genome and metagenome sequence analysis. The CloVR VM runs on a personal
computer, uses local computer resources and addresses problems arising in constructing
bioinformatics workflows.
[4] noted that genomic applications are limited by the “bioinformatics bottleneck”, due to
computational costs and infrastructure needed to analyze the enormous amounts of SRSs.
They presented benchmark costs and runtimes for microbial genomics applications, microbial
sequence assembly and annotation, metagenomics and large-scale BLAST. They also analyzed
workflows (also called pipelines) implemented in the CloVR virtual machine running in
Amazon EC2, having achieved cost-efficient bioinformatics processing using clouds, and
thereby claiming that this is an interesting alternative to local computing centers.
[53] adapted a particular peptide search engine called X!Tandem to Hadoop MapReduce.
Their MR-Tandem application runs on any Hadoop cluster, but it was especially designed
to run on Amazon Web Services. They modified the X!Tandem C++ program and created a
Python script for driving Hadoop clusters, which includes the Amazon Web Services (AWS)
Elastic Map Reduce (EMR) used by the modified X!Tandem as a Hadoop streaming mapper
and reducer.
[75] worked on pathway-based or gene set analysis of expression data, having developed a
gene set analysis algorithm for biomarker identification in a cloud. Their YunBe tool is ready
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to use on the Amazon Web Services. YunBe performed well when compared to desktop and
cluster executions. YunBe is open-source and freely accessible within the Amazon Elastic
MapReduce service.
[27] ported two bioinformatics applications, a pairwise Alu sequence alignment application
and an Expressed Sequence Tag (EST) sequence assembly program, to the cloud technologies
Apache Hadoop and Microsoft DryadLINQ. They studied the performance of both
applications in these two cloud technologies, comparing them with traditional MPI
implementation. They also analyzed how non-homogeneous data affected the scheduling
mechanisms of the cloud technologies, and compared performance of the cloud technologies
under virtual and nonvirtual hardware platforms.
[32] used cloud computing for scientific workflows, and discussed a case study of a widely
used astronomy application.
The Bio-Cloud Computing platform [9] was designed to support large-scale bioinformatics
processing. It has five main bio-cloud computing centers, with a total peak performance up
to 157 Teraflops, 33.3 TB memory and 12.6 PB storage.
Recently, many bioinformatics applications have been ported to clouds [33, 37, 40], noting that
they offer user-friendly web interfaces and efficiency in the execution of tools that extensively
use memory and storage resources.
6. Conclusion and future work
In this work, we proposed a hybrid federated cloud computing platform called BioNimbus,
which aims at integrating and controlling different bioinformatics tools in a distributed,
transparent, flexible and fault tolerant manner, also providing highly distributed processing
and large storage capability. The objective was to make possible the use of tools and services
provided by multiple institutions, public or private, that could be easily aggregated to the
federated cloud. We also discussed a case study in a prototype of BioNimbys including two
cloud providers, in order to verify its performance in practice. We created a bioinformatics
workflow for identifying liver and kidney cancerous differentially expressed genes, and
measured its total time execution on each single cloud provider and on all of them.
The next step is to study different scheduling strategies for the scheduling service, in order to
improve its efficiency when choosing a cloud provider to execute jobs. Our results showed
that the execution time is strongly affected by the file transfer time, implying that we have
to carefully design the storage service; we plan to use data replication and fragmentation to
address this problem. A fault tolerance service to check the cloud providers and other services
status will be developed and evaluated. We also plan to use an adaptive fault monitoring
algorithm, as proposed by [18, 30] and [70], which are more adaptable to be used in a
large-scale distributed environment. It is also important to include a security service and an
SLA service in the federated platform. Finally, we will investigate the use of a Workflow
Management System (WfMS) in BioNimbus.
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1. Introduction 
Hardware acceleration is the general concept of applying a specialized hardware for a given 
problem instead of an ordinary CPU in order to get lower processing time. General purpose 
CPUs can be considered as a totally general platform suitable for executing virtually any 
software or algorithm. Application specific accelerators have a custom architecture that fits 
the needs of a certain family of algorithms. As a consequence, they are able to outperform 
CPUs by orders of magnitude in a special application area but they are unfit for other, more 
general tasks. In contrast to normal CPUs, which are essentially serial machines executing 
instructions sequentially, hardware accelerators use parallel architectures which allow them 
to exploit the parallelism available in the given application by performing independent 
operations simultaneously.  
The most important examples of hardware accelerators are graphics processing units 
(GPUs) and field-programmable gate array devices (FPGAs). GPUs are special many-core 
processors optimized for 3D rendering and image processing purposes. GPU devices are 
nowadays part of any desktop PC configurations and they can be programmed with general 
purpose programming languages. These facts make them an easily accessible and cost-
effective accelerator platform and explain why they are used more and more frequently 
even in applications that are not graphics-related (general purpose GPU programming). 
FPGAs are programmable logic devices consisting of hundreds of thousands of general logic 
elements whose interconnection can be configured by the user. Thus FPGAs have a highly 
flexible architecture that allows to implement a totally custom digital hardware without the 
enormous cost of designing and manufacturing an application-specific integrated circuit 
(ASIC). When using an FPGA as a hardware accelerator a custom logic device is realized in 
the FPGA whose only purpose is to execute the algorithm to be accelerated as effectively as 
possible; thus the algorithm is usually implemented as pure hardware instead of software. 
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Hardware accelerators such as GPUs or FPGAs are utilized in many scientific applications, 
when the time-consuming operations make it impractical or even impossible to use ordinary 
CPUs. Bioinformatics is not an exception; it includes many problems and algorithms which 
are computationally expensive due to the large amount of data to be processed or the 
complex operations involved. Typical examples are different sequence alignment 
algorithms, protein structure prediction algorithms and molecular dynamics simulations 
which were implemented on various accelerator platforms several times.  
Molecular docking is another key field of bioinformatics whose purpose is to determine the 
binding geometry of molecules and is used by the pharmaceutical industry for identifying 
drug candidate compounds. Docking algorithms are usually computationally demanding 
since they consist of generating and evaluating a large amount of different molecule 
conformations and placements. However, these different placements can often be processed 
simultaneously and evaluating a single placement usually offers further parallelization 
possibilities. These facts make molecular docking an ideal target for hardware acceleration. 
In accordance with this, several GPU- and FPGA-based docking implementations were 
reported applying different approaches for hardware acceleration. In this chapter our 
purpose is to give a general overview of the most interesting implementations and to 
compare them with respect to the applied parallelization, applicability and achieved 
speedup. The remainder of this chapter is organized as follows. Section 2 surveys the 
concept and methods of molecular docking. Section 3 gives a general overview of FPGA and 
GPU devices. Section 4 and 5 introduce the existing FPGA- and GPU-based docking 
implementations, respectively. Finally, Section 6 surveys the current state and perspectives 
of hardware accelerated molecular docking.  
2. Overview of molecular docking 
Molecular docking is a computer simulation technique for determining the possible binding 
position and binding energy of molecules whose initial 3D spatial structure is known. Many 
docking methods and software exist, which may be different in several respects such as the 
size and number of molecules involved, the applied docking algorithm, the applied 
chemical model or the modeling of molecular flexibility. 
Molecular docking usually refers to docking a molecule to another one, that is, to determine 
the binding pose of the former relative to the latter. In case of protein-protein docking both 
of the molecules are large macromolecules. The more typical case is the protein-ligand 
docking when one of them is a small ligand molecule whose binding pose needs to be 
determined within the active site of a receptor. Since the computational complexity (the 
number of atoms, the size of the search space, etc.) differ by orders of magnitude, protein-
protein and protein-ligand docking usually require different approaches. Although the 
number of molecules involved in the docking problem is generally two, some protein-ligand 
docking software allow to dock more than one ligand to a macromolecule simultaneously. 
For some software a good starting position has to be provided manually which is then 
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refined by the algorithm; other ones are totally automated and try to find the docked 
position without any a priori knowledge. 
Another important aspect is how the docking algorithm takes into account molecular 
flexibility. Rigid-body docking methods keep the structure of the molecules rigid, flexible 
algorithms consider one or both of the molecules flexible allowing their conformation to 
change. The two approaches correspond to the lock-key and the induced fit model, 
respectively. Rigid docking methods are usually much faster but may easily fail to find the 
proper binding position in case of molecules that actually undergo a conformational change 
upon binding. The most obvious way to model flexibility is to consider some bonds 
rotatable by allowing their torsional angle to change during docking. This method is 
effective in case of small ligands, but greatly increases the number of degrees of freedom 
and the computational complexity of the docking problem when applied for a large protein. 
As a consequence, protein flexibility is often taken into account only partially (allowing a 
few bonds of some side chains to rotate) or is modeled differently. One example is the soft 
receptor technique which allows small atomic collisions between neighboring protein and 
ligand atoms by reducing the repulsion energy term. The method is based on the 
assumption that the highly flexible protein could avoid the collision in practice by a low 
energy conformational change. Modeling flexibility in this way is computationally economic 
but may easily lead to invalid docked positions. Another straightforward technique is to 
keep the protein structure rigid and repeat the docking process with different pre-generated 
(or experimentally determined) protein conformations. Ultimately, this enables taking into 
account both protein and ligand flexibility even in case of rigid-body docking methods. The 
approach is also useful for considering the flexibility of rings within the ligand, which 
cannot be modeled with rotatable bonds; instead, a set of pre-generated, valid substructure 
conformations can be used during docking.  
Although there are numerous different molecular docking algorithms, essentially each of 
them consists of two important components: a scoring function and a search method. The 
scoring function represents a chemical model and usually estimates the free energy of a 
geometrical arrangement of the molecules, thus it scores the given placement. The search 
method tries to find the ideal arrangement by sampling the search space according to a 
strategy. Docking can be viewed as an optimization problem where the global optimum of 
the scoring function is to be identified and the degrees of freedom are the variables 
describing the position, orientation and conformation of the molecules. Some docking 
methods apply one of the standard force fields as scoring function such as AMBER or 
CHARMM [1-4]. Other ones use empirical scoring functions that consist of a sum of terms 
representing different interaction types between the molecules; the term types are weighted 
with values determined empirically from a set of protein-ligand complexes [5, 6]. 
Knowledge-based functions are also typical which are derived from the statistical analysis 
of a large database containing molecular structures [7, 8]. The search methods applied by the 
different docking methods are also very diverse. One example is incremental reconstruction 
applied by the docking tools DOCK [4] and FlexX [9], which split the ligand to be docked 
and place the fragments one-by-one at the binding site. AutoDock [6] and GOLD [10] use 
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genetic algorithms as global optimization methods. AutoDock Vina [11] applies a quasi-
Newton BFSG algorithm along with Monte Carlo simulation. Other standard algorithms 
such as simulated annealing, tabu search or particle swarm optimization techniques are also 
common. A good overview of the general terms and concepts of molecular docking can be 
found in references [12-14].  
The most important application area of molecular docking is computer-aided, structure-
based drug design. Docking can be used for identifying drug candidates (potential 
inhibitors) for a given target receptor molecule. During virtual screening the members of a 
large ligand database are docked one by one to the target; promising compounds are 
subjected to further experiments. Virtual screening is extremely time-consuming; 
accelerating it can make the drug design process more effective. Trivially, this can be done 
by executing the docking runs of different molecules in parallel utilizing a lot of CPU cores. 
The other method is to accelerate the applied docking algorithm itself, potentially by an 
FPGA- or GPU-based hardware accelerator.  
3. Accelerator platforms 
3.1. FPGA devices 
A field-programmable gate array is a programmable logic device - an integrated circuit with a 
flexible hardware architecture that can be configured to implement a specific functionality. 
FPGAs represent a trade-off between highly flexible, general purpose microprocessors and 
high-performance application-specific integrated circuits (ASICs). FPGA devices execute the 
required computation with a specific hardware architecture just like ASICs. Although they are 
not as efficient in terms of performance and power consumption, implementing a custom 
hardware in a 100-1000$ FPGA does not require to manufacture a new chip which is affordable 
only in case of large-scale production. In addition, FPGAs can be reconfigured many times. 
Thus they can be considered general-purpose similarly to CPUs but due to the applied custom 
architecture they can be orders of magnitude faster in case of a specific application. 
The two major FPGA vendors, Xilinx and Altera offer a wide range of FPGAs and FPGA 
families with different capabilities, the performance and complexity of the devices is also 
continuously growing; however, the basic architecture remains the same. FPGA devices 
consist of a large number of similar basic logic blocks or cells arranged usually in rows and 
columns on the chip and a configurable interconnect structure. Figure 1. shows a simplified 
diagram of the basic logic block (slice) of a Xilinx Virtex-4 FPGA. The slice consists of two 4-
input LUTs (look-up tables), two D flip-flops, carry logic supporting chaining of 
neighboring slices for high-performance arithmetic operations and routing resource 
configurable by multiplexers. A 4-input look-up table is a simple 24=16 bit memory element 
that can realize any four-variable logic functions when initialized with the truth table of the 
corresponding function. D flip-flops are 1-bit registers that capture and store the value of the 
D input at every active CLK clock edge. Thus LUTs are the basic resources of the FPGA for 
implementing combinational logic and D flip-flops for sequential logic, respectively. In 
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addition to the general logic resources FPGAs usually include special purpose cells such as 
dedicated memory blocks or DSP (digital signal processing) blocks consisting of adders and 
multipliers for arithmetic-intensive applications. FPGA-based accelerator cards are usually 
equipped with high-capacity external memory modules and high-speed interfaces like PCIe 
in addition to the FPGA. 
 
Figure 1. Virtex-4 slice  
FPGA devices have an inherently parallel architecture which makes them suitable for high-
performance computing applications. Different parts of an algorithm are executed by 
different hardware elements or modules; the execution can be simultaneous if the 
operations are independent. In data-parallel applications, where the same steps need to be 
performed on different data elements, the data can be distributed among many identical 
processing elements in the FPGA. In this case the achievable parallelism is limited only by 
the capacity of the device and the speed of the interface providing the input data. Another 
typical design concept is to apply a pipeline consisting of serially connected stages, which 
execute different steps of the same algorithm on different independent data elements.  
Implementing an algorithm in an FPGA instead of a CPU may lead to a much shorter 
execution time; however, it usually requires more programming time and effort. The FPGA 
configuration can be defined with hardware description languages (HDL) such as VHDL 
and Verilog. HDLs allow the designer to describe the operation and interconnection of 
general digital circuits at a relatively high level (called register-transfer level). The HDL 
description is then mapped to the FPGA architecture by automatic tools. Further 
information regarding FPGA architectures, programming languages and design 
methodologies can be found in references [15-16].  
3.2. GPU devices 
Graphics processing units are massively parallel processors consisting of hundreds of 
processing cores, thus capable of executing hundreds of threads in parallel. Their 
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information regarding FPGA architectures, programming languages and design 
methodologies can be found in references [15-16].  
3.2. GPU devices 
Graphics processing units are massively parallel processors consisting of hundreds of 
processing cores, thus capable of executing hundreds of threads in parallel. Their 
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architecture is optimized for data-parallel applications, which consist of instructions that 
have to be carried out on many different data elements. GPU operation is akin to the SIMD 
(single instruction multiple data) behavior – the parallel threads execute the same code but 
process independent input data. There are two main GPU manufacturers, AMD and 
NVIDIA, and although there are differences between the GPU architectures, the basic 
concepts are very similar. The same is true for the two widely used programming 
languages, CUDA and OpenCL. The former is developed by NVIDIA and is applicable to 
NVDIA devices only. OpenCL in turn is a standard parallel programming language 
supporting not only both GPU architectures but also multicore CPUs and heterogeneous 
platforms in general. The remainder of this section gives an overview of NVIDIA GPUs and 
CUDA since this is used by the majority of the GPU-based molecular docking 
implementations introduced in Section 5. However, the basic methodology and design 
patterns are very similar in case of OpenCL, only the terminology differs. 
CUDA (Compute Unified Device Architecture) is the computing architecture of NVIDIA 
GPUs, which defines a parallel programming model based on high-level programming 
languages. CUDA C gives minimal extensions to the standard C language and provides an 
API, which enable the user to write a CUDA program consisting of serial code and special 
parallel functions called kernels. The former runs on the host CPU, the latter are executed K-
times parallel by K different CUDA threads on the GPU. Threads of a kernel are grouped 
into thread blocks; the blocks in turn form a grid. Threads within the same block can 
communicate and synchronize with each other. This is not possible between different blocks 
of threads, since these are scheduled and executed in a random, non-deterministic order 
based on run-time decisions. This leads to automatic scalability; among ideal circumstances 
a GPU with twice as many processing cores can execute the same kernel twice faster. 
The simplified hardware architecture can be seen on Figure 2. An NVIDIA GPU consists of 
multiprocessors. Each multiprocessor includes several processing cores, a large amount of 
registers, shared memory and a scheduler. In addition, each multiprocessor can access the 
external memory and has caches for texture and constant data access. When a kernel is 
launched, a certain number of thread blocks is assigned to every multiprocessor and 
becomes active. A multiprocessor executes its active blocks logically in parallel, and it 
manages, schedules and executes the threads of its active blocks in groups of 32 threads 
called warps. Warps are executed physically in parallel, that is, a multiprocessor is able to 
execute the same operation of every 32 thread within a warp simultaneously in one or a few 
clock cycle. However, if threads of a warp take different execution paths after a conditional 
branch statement, the different instructions get serialized, that is, they are executed 
sequentially (warp divergence). 
Keeping the number of active blocks and warps high is important since this helps keeping 
every multiprocessor of the GPU busy as well as since the scheduler can hide the instruction 
and memory access latencies by switching between active warps. The maximal number of 
blocks that can be active on a multiprocessor is limited by the register and shared memory 
usage of the block since these resources are split among the active blocks. On the other 
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hand, internal register and shared memory access is very fast. Threads can access their own 
registers in parallel; shared memory is divided into banks, and can be accessed also in 
parallel, as long as parallel threads access different memory banks. This suggests that data 
should be stored in registers and shared memory whenever possible. External memory 
access is much slower, but if threads of a warp read from or write to a contiguous memory 
space, the memory operations can be coalesced and executed as a single access, which can 
greatly increase the effective memory bandwidth. Constant data access is faster than 
ordinary memory read operations since it is cached. All of the aspects mentioned above 
have to be taken into account when choosing data storage areas, grid and block sizes. 
Further information about GPU architectures and programming can be found in references 
[17-19]. 
 
Figure 2. NVIDIA GPU architecture 
4. Molecular docking on FPGA platforms 
We believe that there are only three FPGA-based docking implementations which have been 
published until now. This chapter introduces all of them: a docking engine using 3D 
correlation, its successor, the FPGA-based implementation of the PIPER [20] docking 
program, and the FPGA-based acceleration of AutoDock.  
4.1. Docking with 3D correlation 
This implementation is described in references [21, 22]. The applied algorithm uses 3D 
correlation which is a common rigid-body docking technique. The molecules to be docked 
are represented with 3D grids whose voxels consist of pre-calculated values expressing 
some property of the molecule at the corresponding spatial location related to the binding 
affinity. In order to evaluate an arrangement the two grids are shifted relative to each other, 
then the voxels are multiplied pairwise and the values are summed to get the final score. By 
calculating the whole correlation array every possible translational position is evaluated. 
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This process has to be repeated for each orientation to be investigated, which requires the 
rotation of one of the grids periodically. In case of correlation-based docking methods the 
applied search method is essentially exhaustive search. Obviously the molecules are treated 
rigid during docking, since their structure is hard-coded in the grids.  
The CPU-based docking programs using correlation usually replace it with Fourier 
transformation (FFT) and multiplication, which can be much faster on serial machines. The 
described FPGA-based implementation, however, performs direct correlation which can be 
effectively implemented with a highly parallel systolic chain in the FPGA. Another 
advantage of this method is that, by avoiding FFT, the operation for determining the voxel-
voxel interaction is not restricted to multiplication; even non-linear functions can be used. In 
order to exploit this the implementation has a flexible structure; the design can be easily 
configured to adapt different scoring schemes. The initial implementation [21] used a very 
simple voxel type consisting of only two bits that distinguish molecule interiors from 
exteriors and mark the surface of the molecules. The final version allows using voxels with 
tuple data type that represent different effects including directional interactions like 
hydrogen bonding. 
 
Figure 3. Systolic 3D array architecture [22, 23]  
The core element of the implementation is a systolic 3D correlation array consisting of cells. 
Each cell stores one voxel of the grid corresponding to the smaller (ligand) molecule. The 
receptor grid is stored in external memory. Instead of rotating the ligand at the beginning of 
each new correlation cycle, rotated orientation is obtained by reading the receptor voxels in 
rotated order. Thus rotation is performed on the fly by the address logic and uses only little 
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of the FPGA resources. The receptor voxels read from the memory are also rotated in case of 
directional data types; then they are passed to the systolic array. Figure 3/a shows a 1D 
correlation array consisting of pipelined cells. Each cell executes a pairwise operation (in this 
case, a multiplication) defined by the scoring method on its ligand voxel (Li) and the 
receptor voxel (Ri) available at its input, then adds it to the sum received from the previous 
cell and stores the result in a register. 1D correlation arrays are connected by FIFO delay 
lines to form a 2D correlation plane; planes in turn are connected by delay planes to obtain 
the 3D correlation array (Figure 3/b and 3/c). Due to the pipeline-based structure, the 
systolic array produces the result of one position evaluation (correlation) in each clock cycle, 
and the achieved parallelism is proportional to the number of ligand grid voxels. Due to the 
large amount of output data the resulting grids are not sent to the host machine directly. 
Instead, a data reduction filter module detects the best score (local maximum) within each 
subblock of the correlation array; only these promising docked positions are returned for 
further analysis. Certain parts of the FPGA design are configurable according to the applied 
voxel word with and type, score data type, and the applied pairwise scoring operation in 
order to support various force laws and scoring schemes. 
Performance tests were carried out with a Xilinx Virtex-II Pro XC2VP70-5 FPGA. Results 
were compared to a software running on a 3 GHz Xeon CPU. The software applied direct 
correlation since FFT proved to be slower for the applied small problem sizes. FPGA 
speedup varied between ×100-1000 according to the scoring method used.  
4.2. PIPER on FPGA 
The docking engine described in reference [23] is a modified, extended version of the 
docking core introduced in Section 4.1 and implements the PIPER software [20]. PIPER is 
based on 3D correlation and calculates it with the standard FFT method. The scoring 
function of PIPER consists of the weighted sum of different terms represented with separate 
grids; as a consequence, several independent forward FFTs have to be performed during 
evaluation. In addition to the van der Waals repulsion and attraction terms and the 
electrostatic interaction, desolvation effect is taken into account as well. The latter is 
described by a pairwise potential which is transformed to correlation grids with eigenvalue-
eigenvector decomposition. Grids corresponding to low eigenvalues are often discarded 
which reduces computational complexity but retains the accuracy of the algorithm [20]. 
The original implementation described in Section 4.1 was modified in a variety of ways to 
support multiple energy grids as well as to allow docking of larger molecules which would 
not fit in the systolic 3D array, thus permitting even protein-protein docking. The basic cell 
element of the systolic array is extended to process the independent grids in parallel; as a 
consequence, each correlation is performed simultaneously. At the end of every 1D 
correlation array a new weighted scorer module sums the partial correlation results with 
respect to the weights defined in PIPER. New FIFOs are used to propagate the output of a 
scorer module to the input of the next one. Calculating the weighted sum at the end of every 
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1D array requires a balanced amount of multipliers and FIFOs (block RAMs) of the FPGA 
keeping the resource utilization optimal. To support large molecules both the receptor and 
the ligand are stored in external memories. The ligand grid is partitioned into subgrids 
small enough to fit the size of the correlation array. Correlation is performed piece-wise; 
each subgrid is first loaded to the FPGA, then the receptor voxels are streamed through the 
array. 
The docking engine was implemented on an Altera Stratix-II EP2S180 and was validated 
against the original PIPER software. FPGA performance, however, was determined with 
post place-and-route simulations supposing an Altera Stratix-III EPSL340. Performance was 
compared to the original PIPER code, its multithreaded version, as well as a GPU-based 
implementation of PIPER (introduced in Section 5.1). The host CPU was a quad-core Intel 
Xeon 2 GHz CPU, the GPU code run on an NVIDIA Tesla C1060 device. The measured 
FPGA speedup depended greatly on the ligand grid size. In case of a 43 ligand grid speedup 
of the correlation task only and that of the whole application was almost ×1000 and ×37, 
respectively, compared to the single-core PIPER. However, it dropped exponentially with 
respect to the ligand size, decreasing below the ×16 speedup of the GPU at grid edge size 16 
and below the ×3 speedup of the quad-core version at grid edge size 32. The reason for this 
is that the FFT method applied by the CPU and the GPU became greatly superior to direct 
convolution at this problem sizes.  
4.3. AutoDock on FPGA 
References [24, 25] introduce our own FPGA-based docking implementation, the 
acceleration of the AutoDock [6] docking software. AutoDock is applicable basically for 
protein-ligand docking and models molecular flexibility with rotatable bonds. AutoDock 
uses a semi-empirical scoring function that consists of weighted terms representing van der 
Waals and electrostatic interactions, hydrogen bonding and desolvation. The scoring 
function gives the energy contribution of one non-bonded atom pair; this value has to be 
summed over all movable atom pairs of the system to determine the score. To reduce 
computational complexity AutoDock represents the rigid part of the receptor molecule with 
pre-calculated potential grids. Thus the energy contribution of a given ligand atom and the 
whole receptor can be determined with trilinear interpolation and iterating over the receptor 
atoms is not necessary. AutoDock uses a standard genetic algorithm (GA) as search method. 
Genetic algorithms generate sets of potential solutions (generations of entities) iteratively. 
Solutions are represented with values of the degrees of freedom (called genes) and are 
created by combining the genes (crossover) of selected previous entities (selection) and 
altering them randomly (mutation). In addition to the genetic algorithm AutoDock subjects 
some selected entities of each generation to an iterative local search method (LS) similar to 
hill climbing, which greatly increases the effectiveness of the algorithm. 
AutoDock was implemented on the SGI RASC RC100 module on a Xilinx Virtex-4 LX200 
FPGA. The design consists of four main blocks organized as a three stage pipeline (Figure 4). 
The first pipeline stage executes the genetic algorithm, that is, it generates the genes of a 
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new entity periodically. The second stage calculates the positions of the atoms of the ligand 
based on the input gene values. This step consists mainly of performing atomic rotations 
according to the positions of rotatable bonds and to the orientation of the ligand. The third 
stage includes two modules. One of them determines the receptor-ligand interaction energy 
based on the potential grids stored in external memory, that is, it performs a trilinear 
interpolation for each ligand atom; the other one calculates the energy contribution of each 
movable ligand atom pair by evaluating the scoring function directly. Each of the four 
modules consists of massively parallel, fine-grained internal pipelines; as a consequence, all 
of them are able to produce a new result of the realized operation in each clock cycle. The 
first module generates a new gene value, the second one performs the rotation of an atom, 
the other ones calculate the interaction energy of a ligand atom and the receptor molecule or 
that of an internal ligand atom pair in every clock cycle.  
 
Figure 4. FPGA core implementing AutoDock [24]  
In order to increase the performance of the docking engine the implemented algorithm 
slightly differs from the original AutoDock code and uses fixed-point arithmetic that fits 
better the FPGA architecture. According to test runs these differences does not degrade the 
accuracy of docking. Performance tests showed that the FPGA-based implementation yields 
an average speedup of ×23 over AutoDock running on a 3.2 GHz Intel Xeon CPU; the actual 
speedup varied between ×10-40 according to the structure and size of the molecules.  
5. GPU-based implementations 
Compared to the relatively small number of FPGA-accelerated docking engines, quite a lot 
of GPU-based solutions have been reported, which clearly indicates the advantages of 
GPUs over FPGAs in terms of accessibility and programming effort. It is neither reasonable 
nor possible to introduce every one of them. Instead, we aim at describing a wide variety of 
different approaches, and we tried to select the most promising implementations. Two of 
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the docking codes introduced in the following subsections were implemented also on 
FPGA.  
5.1. PIPER on GPU 
The authors of the FPGA-based PIPER (Section 4.2) published also a GPU-based version 
[26]. In case of the FPGA the FFT applied in PIPER was replaced with direct correlation, 
which can be executed by a very effective standard structure in the FPGA. On GPU, both 
FFT and direct correlation were implemented and they proved to be advantageous at 
different ligand grid sizes. Other steps such as summing the grids and filtering the results 
by identifying local maxima also run on the GPU; although they comprise only a few 
percent of total PIPER runtime, executing them on the CPU would have limited the 
achievable speedup. The only exception is re-calculation of the ligand grid according to the 
current orientation and charges, which run on the host CPU. 
3D correlation includes a lot of parallelism which can be exploited on a GPU as easily as on 
FPGA. Each voxel of the result grid can be calculated by a different thread simultaneously; 
in addition, correlation of grids representing different terms can be performed in parallel. In 
this implementation two different approaches are applied whose performance turned out to 
be similar: assigning each 2D plain to a different tread block, and assigning the same part of 
each 2D plain to a thread block. Receptor grid is stored in the external memory of the GPU 
due to its size and since it has to be available for each thread block (multiprocessor). Ligand 
grid is stored in shared or constant memory if possible; if the grid is small enough grids 
corresponding to multiple ligand orientations are stored and processed in parallel, which 
leads to further performance improvement. 
Forward and inverse FFT is executed with the standard NVIDIA CUFFT library consisting 
of optimized FFT-related CUDA functions. Receptor grids are calculated by the CPU, 
moved to the GPU memory and transformed by the GPU only once at initialization. Ligand 
grids are re-calculated, copied and transformed for each ligand orientation. Voxels of the 
transformed receptor and ligand grids are multiplied pairwise by the GPU. The CUDA 
implementation is trivial, since each voxel pair can be processed independently by a 
different thread. Finally the product grid is inverse transformed. 
The final step of each orientation evaluation is to sum the result grids according to the 
PIPER coefficients and find the voxels with the best scores corresponding to the best 
translational poses. PIPER uses several different sets of weights; these are assigned to 
different thread blocks in the GPU. Each block performs averaging according to the given 
set of weights. Individual threads process different parts of the grid. During averaging each 
thread identifies the best score of the grid part assigned to it and stores it in shared memory. 
Finally a single thread iterates over the scores to find the best one. Clearly the last filtering 
step could be implemented on the GPU the less effectively; if the number of coefficient sets 
is less than that of the multiprocessors, certain processors are not utilized, and serial steps 
such as finding the very last best score leads to idle threads. The majority of the algorithm, 
however, suits well the GPU architecture. 
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Performance tests were carried out on the platforms already mentioned in Section 4.2; the 
CUDA code run on a Tesla C1060 GPU and was compared to the FPGA-based version and to 
PIPER running on a single core and on all the four cores of a 2 GHz Intel Xeon CPU. Speedup 
of the correlation task was about ×300 compared to the single core version at a minimal 
ligand grid size of 4, but decreased exponentially with respect to ligand size similarly to the 
FPGA-based implementation. FPGA speedup was about ×1000 in case of a 43 ligand grid, so 
in case of direct correlation the FPGA outperformed the GPU. The FFT-based GPU code 
achieved a speedup of about ×30 regardless the ligand size and proved to be faster than GPU-
based direct correlation above ligand grid size 83. Worst-case speedup of the whole GPU 
application was ×17.7 and ×6.1 versus single core and quad-core PIPER, respectively, and was 
faster than the FPGA accelerated version if ligand grid size was above 83.  
5.2. A general FFT-based approach 
In reference [27] another CUDA implementation is presented that applies FFT for 
performing the correlation-based rigid docking algorithm. The approach is very similar to 
the one described in Section 5.1. The scoring function is very simple; it consists of two terms 
which represent the shape of the molecules and the electrostatic field. These terms are 
calculated over the 3D grid for the receptor and for each orientation of the ligand. Again, 
FFT is executed with the CUDA library. 
The test environment consisted of a dual-core AthlonX2 3600+ CPU and an NVIDIA 
GeForce9800GT GPU. The GPU speedup proved to be about ×3-4, depending on the grid 
size and the angle step size between different ligand orientations. That is, for the same 
search space size a finer discretization of the grids (meaning higher number of grid voxels) 
and a finer discretization of the ligand orientation (leading to more different orientations to 
be evaluated) resulted higher speedup. The reason is that in this case the FFT-grid 
multiplication-IFFT steps became more dominant compared to the whole GPU algorithm, 
and these can be executed the most effectively on the GPU. 
The achieved GPU performance seems to be lower with respect to the GPU-based PIPER 
(Section 5.1). Although the applied algorithms and implementation methods are similar, the 
achieved speedups are hard to compare due to the different hardware platforms. The 
GeForce 9800 GT includes about half the number of multiprocessors than Tesla C1060. CPU 
frequencies are the same but the architectures are very different; the applied AMD CPU is 
older than the Intel used in case of PIPER. The other possible explanation of the different 
performance improvements is that in case of PIPER several grids has to be processed during 
docking, which leads to more parallelism and requires more FFT computation; thus the 
advantages of the GPU can be exploited more effectively.  
5.3. AutoDock on GPU 
AutoDock is one of the best-known docking software; it was the most cited docking 
program in the ISI Web of Science database in 2005 [28]. This explains why it is a popular 
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subject for GPU-based acceleration. There is even a related SourceForge project called 
gpuautodock. The following subsections focus on three different AutoDock 
implementations; each of them maps different parts of the original algorithm to the GPU 
architecture.  
5.3.1. Acceleration based on profiling 
This AutoDock implementation is described in a case study [29]. The authors followed a 
traditional way – they profiled the original code in order to identify the most time-
consuming functions and ported only these to GPU. Two functions were selected – eintcal() 
and trilininterp() – which together accounted for about 63% of the total runtime. The former 
calculates the internal energy of the ligand molecule, that is, it evaluates the scoring function 
for each ligand atom pair whose distance can change due to rotatable bonds. The latter is 
called for each ligand atom during the calculation of receptor-ligand intermolecular energy 
to perform interpolation based on the pre-calculated potential grids. 
Each time these functions are called the corresponding CUDA kernel is executed instead of 
the original function. In both cases the number of threads within the kernel equals to the 
number of ligand atoms. This molecule usually consists of a few tens of atoms, which is a 
very low number compared to the GPU capabilities leading to a poor GPU utilization ratio. 
In addition, before each kernel call some data is transferred from the main memory to the 
GPU according to the current ligand position; these frequent memory transfer operations 
further decrease the performance.  
According to test runs, which were executed on an NVIDIA GeForce GTX 280 GPU, the 
GPU accelerated application could not achieve speedup but was slower than the CPU for 
typical ligand sizes. Performance improvement was obtained only if the number of atoms 
(threads) was in the range of 104, which is not a realistic use case. The reasons are mentioned 
above. Accelerating only a few computationally expensive functions without restructuring 
the original code is straightforward and does not require much programming effort; 
however, it does not allow to exploit all the parallelism available in the algorithm, and also 
limits the maximal achievable speedup according to Amdahl’s law.  
5.3.2. Acceleration excluding local search  
AutoDock includes further parallelism that is not exploited by the implementation 
described in Section 5.3.1. It uses a genetic algorithm as search method, which can be 
parallelized easily; each entity of the next generation can be created and evaluated 
simultaneously by different processing cores. The default population size is 150, which 
makes this approach promising with respect to GPU-based acceleration. However, 
AutoDock also applies an iterative local search method in addition to the GA, which is 
executed only on a few percent of the population (6%, that is, averagely 9 entities by 
default). Executing local search of different entities in parallel is possible, but would lead to 
low GPU utilization. In addition, performing the local search algorithm on an entity may 
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consist of hundreds of iterations (energy evaluations); that is, executing the whole LS on 
CPU would greatly reduce the achievable speedup.  
To overcome this problem, the authors of reference [30] chose to exclude the local search 
from the algorithm, but implement virtually every other part of AutoDock (the genetic 
algorithm, the ligand position calculation and the scoring function evaluation) on the GPU. 
Although the genetic algorithm (generating the degrees of freedom according to the GA 
rules) is usually not time-critical, leaving it on the host CPU would require periodic CPU-
GPU memory transfer operations, which is avoided if it is executed by the GPU.  
The main idea behind the implementation is to assign a different thread block to each entity 
of the new generation, whose threads cooperatively execute the different steps on the given 
entity. Another scheme was also tried where different entities were assigned to different 
threads, but this leads to low GPU utilization in case of typical population sizes – using 
default size, the number of parallel threads would be only 150 instead of 150 multiplied by 
the thread block size. The coordinates of ligand atoms are stored in the fast shared memory, 
which is crucial since every step of the scoring function evaluation modifies or reads this 
data and each thread of the block has to access it. During evaluation, each thread block first 
determines the atom positions (using two kernels for calculating the ligand conformation 
and orientation). Independent rotations of different atoms can be executed by different 
threads of the block. Then each thread performs trilinear interpolation for a different ligand 
atom (determining the atom-receptor intermolecular energy), and each thread evaluates the 
scoring function directly for a different ligand-ligand atom pair. Trilinear interpolation 
offers a further optimization, since NVIDIA GPUs support the fast access of 3D data by 
hardware. 
Parallelization of the GA operators (selection, crossover and mutation) is also 
straightforward. Selection requires to calculate the relative score (fitness) of the entities 
compared to the average score, which can be performed for each entity simultaneously. 
Genes of the new entities can be generated by crossover and mutation in parallel by threads 
of the block assigned to the entity. 
The test platform included an AMD Athlon 2.4 GHz and an NVIDIA Tesla C1060. 
Validation of the CUDA code was performed by using the same random seeds and 
comparing the output to that of original AutoDock. The results differed slightly only due to 
the single precision arithmetic applied in the GPU. The speedup of the different kernels 
depended highly on the population size. At default size speedup of the scoring function 
evaluation proved to be ×50, the selection and crossover ×1.25 and ×2.75. In case of mutation 
no speedup was obtained. The overall speedup of the algorithm was ×10 for a population 
size 50, it increased to ×20 for the default size and become saturated at 10000 yielding a 
speedup of ×47 over the CPU. On one hand, the GA operators could be implemented on the 
GPU much less effectively than the fitness evaluation. The probable reason is that they are 
much more control-intensive than the different steps of the scoring function evaluation 
consisting of a lot of arithmetic operations. On the other hand, executing GA on the CPU 
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consist of hundreds of iterations (energy evaluations); that is, executing the whole LS on 
CPU would greatly reduce the achievable speedup.  
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default size, the number of parallel threads would be only 150 instead of 150 multiplied by 
the thread block size. The coordinates of ligand atoms are stored in the fast shared memory, 
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and orientation). Independent rotations of different atoms can be executed by different 
threads of the block. Then each thread performs trilinear interpolation for a different ligand 
atom (determining the atom-receptor intermolecular energy), and each thread evaluates the 
scoring function directly for a different ligand-ligand atom pair. Trilinear interpolation 
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compared to the average score, which can be performed for each entity simultaneously. 
Genes of the new entities can be generated by crossover and mutation in parallel by threads 
of the block assigned to the entity. 
The test platform included an AMD Athlon 2.4 GHz and an NVIDIA Tesla C1060. 
Validation of the CUDA code was performed by using the same random seeds and 
comparing the output to that of original AutoDock. The results differed slightly only due to 
the single precision arithmetic applied in the GPU. The speedup of the different kernels 
depended highly on the population size. At default size speedup of the scoring function 
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consisting of a lot of arithmetic operations. On the other hand, executing GA on the CPU 
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would certainly decrease the speedup due to the additional transfer operations between the 
CPU and GPU memory.  
5.3.3. Acceleration including local search  
Implementing AutoDock on CUDA without local search as in Section 5.3.2 clearly offers a 
straightforward parallelization scheme that avoids GPU underutilization. However, the 
local search process usually increases docking accuracy of AutoDock significantly [31]. In 
order to include the LS in the implemented algorithm and simultaneously achieve a high 
speedup we ported AutoDock to CUDA exploiting a further high-level parallelization 
possibility [25]. Due to the heuristic nature of the search algorithm, often several (10-100) 
different docking runs are performed with AutoDock for the same receptor-ligand complex. 
This increases the reliability of the results as well as helps identifying multiple valid docked 
poses. Since these docking runs are totally independent from each other, they can be 
executed in parallel. 
Our implementation includes two CUDA kernels. In each generational cycle, first Kernel A 
is launched that creates and evaluates a whole population; then Kernel B is launched for 
performing LS on the selected entities. The two kernels call the same CUDA functions for 
scoring function evaluation; they differ only in how the degrees of freedom are generated 
(using either GA or LS rules). Basically, our implementation is quite similar to the one 
introduced in Section 5.3.2. Each thread block of the kernels is assigned to a different entity. 
Threads within a thread block generate different gene values, calculate independent 
rotations, and process different ligand atoms or atom pairs during scoring function 
evaluation. However, in case of kernel A a thread block is launched for each new entity of 
every independent docking run; in case of kernel B a block is launched for each entity of 
every run which is selected for local search.  
The advantage of this method is that local search is included which allows preserving 
docking accuracy, and even significant performance improvement can be achieved if the 
number of independent runs is high enough. The performance improvement, however, 
depends strongly on this number and in case of too few parallel runs the GPU is 
underutilized during LS, which leads to a low speedup.  
Test runs were carried out on an NVIDIA GeForce GTX 260 GPU; performance was 
compared with that of AutoDock running on a 3.2 GHz Intel Xeon CPU. In case of only one 
docking run the GPU achieved a low, ×2-5 speedup depending on the ligand structure and 
size. In case of 10 and 100 independent runs the average speedup proved to be ×30 and ×65, 
respectively, for a large set of ligands.  
Our FPGA-based AutoDock implementation described in Section 4.3 achieved an average 
speedup of ×23. This value does not depend on the number of docking runs since the FPGA 
executes only one at a time. Due to the applied three stage pipeline (Figure 4) only three 
entities are processed simultaneously in the FPGA. On the contrary, the GPU applies a brute 
force approach by processing each entity of every run in parallel. The low level (per 
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rotation, per atom, etc.) parallelization possibilities are exploited by fine-grained pipelines in 
the FPGA very effectively; this allows the FPGA-based implementation to achieve a 
significant speedup regardless the number of runs. As a consequence, the FPGA is faster 
than the GPU for a low number of runs. Further advantage of the FPGA architecture is that 
implementing local search is not problematic. However, if the number of runs is high 
enough, the GPU outperforms the FPGA; that is, similarly to the FPGA and GPU-based 
PIPER (Section 4.2 and 5.1) the two platforms are advantageous at different parameter 
ranges.  
5.4. MolDock on GPU 
Reference [32] describes the GPU-based acceleration of the MolDock [33] docking software. 
MolDock is very similar to AutoDock: it models molecular flexibility with rotatable bonds, 
its scoring function consists of the summation of pairwise energy terms, it uses pre-
calculated potential grids for representing the receptor during docking and it applies a 
genetic (evolutionary) algorithm as search method. Differences are the actual form of the 
energy terms (which is virtually irrelevant from the point of view of parallelization) and the 
lack of local search. 
Due to the similar algorithms the basic implementation schemes are practically the same as 
the ones described in Section 5.3.2 and 5.3.3; the gene values and atoms of every entity are 
distributed among the threads and are processed in parallel. Although no local search 
process is used, independent docking runs are performed in parallel to increase GPU 
utilization ratio (like in Section 5.3.3). Due to these similarities the implementation is not 
described here in more details. However, we would like to emphasize an apparent 
difference regarding how different jobs are aligned to the threads of the kernel. 
 
Figure 5. Job alignment comparison 
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rotation, per atom, etc.) parallelization possibilities are exploited by fine-grained pipelines in 
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In the GPU-based AutoDock implementations each thread block processes a different entity. 
In case of receptor-ligand energy calculation, for example, threads within the block perform 
trilinear interpolation for different atoms of the same ligand orientation (Figure 5/a). On the 
contrary, in this implementation threads within the same block perform interpolation for the 
same ligand atom of different entities (orientations) (Figure 5/b). Parallelization of other 
steps (genetic operators, internal energy calculation, etc.) also follows this scheme. This 
makes orientation calculation more effective; its disadvantage is that data corresponding to 
a given entity has to be stored in external GPU memory. 
Performance tests were carried out using a 2.66 GHz Intel Core 2 Quad CPU and an 
NVIDIA GeForce 8800 GT. Average GPU speedup was ×5, ×27 and ×33 for 1, 10 and 20 
parallel docking runs, respectively. The speedup, that is, GPU utilization showed a similar 
saturating tendency as in case of our GPU-based AutoDock implementation (Section 5.3.3).  
5.5. PLANTS on GPU 
PLANTS [34] stands for Protein-Ligand ANT System; it is a docking software using ant 
colony optimization (ACO) as search method. ACO is an optimization technique that 
mimics the behavior of ants when they collectively found the shortest path between the food 
source and the nest. At initialization, the degrees of freedom of the problem are discretized, 
and the same probability (pheromone level) is assigned to each discrete value of every 
degree of freedom. Then in each iteration a set of ants (potential solutions of the problem) 
choose a value for each degree of freedom according to the probability distribution. At the 
end of the iteration most of the probabilities are decreased (pheromone evaporation), but the 
ones corresponding to the best solution (shortest route) of the current iteration are 
increased, making it more likely that these values will be chosen by the ants in the next 
iteration. In PLANTS each solution is subjected to a local search algorithm at the end of each 
ACO iteration; then in a refinement step the LS is repeated for the best solution, which 
potentially further increases its fitness. PLANTS models flexibility with rotatable bonds and 
uses two different empirical scoring functions. One of them includes terms for protein-
ligand steric interactions, torsions and clashes of the ligand (representing ligand internal 
energy), in addition, steric interactions and side-chain clashes of the protein (representing 
protein internal energy). The other scoring function is similar but models hydrogen bonds as 
well. The protein is represented with 3D grids during docking making the protein-ligand 
energy calculation more effective. From the point of view of parallelization ACO is similar 
to genetic algorithms: the ants can be generated, evaluated and subjected to local search in 
parallel like the entities of the GA. 
The GPU accelerated PLANTS is described in reference [35]. The authors followed the 
traditional way of GPU programming using OpenGL and the NVIDIA Cg shading 
language. This method is less flexible than using CUDA; input data has to be encoded as 
textures, and functionality is implemented as shader programs processing these textures. 
The receptor grids, for example, are stored in a four channel (red, green, blue and alpha) 3D 
texture; the channels correspond to the four atom types which the scoring function of 
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PLANTS distinguishes. The optimization algorithms run on the CPU. The degrees of 
freedom are generated for each ant, then they are mapped to textures and moved to the 
GPU memory. Different shader programs calculate the coordinates of atoms, the protein-
ligand interaction energy (by exploiting the interpolation capabilities of the GPU), the ligand 
clash and torsional energy terms. Finally a shader sums the partial energy terms. These 
steps are executed for each ant of the current ACO or LS iteration in parallel. 
In order to exploit the capabilities of the GPU effectively the optimization algorithm was 
modified. The default value of ant colony size is 20 in PLANTS; to increase the number of 
solutions than can be evaluated in parallel multiple colonies are used, which sometimes 
exchange information by modifying the pheromone values of every colony according to the 
currently best solution. The refinement step was removed since it involves only one 
solution; in addition, the termination criterion of the LS was modified to prevent the parallel 
LS iterations from stopping after different number of steps. Although these modifications 
were necessary to achieve a high GPU utilization ratio, the altered algorithm turned out to 
be less effective than the original one; it requires a higher number of evaluations for finding 
the same solutions.  
Test runs were performed on a 3.0 GHz dual core Pentium 4 CPU and an NVIDIA GeForce 
8800 GTX GPU. For protein-ligand complexes the speedup of GPU accelerated steps was ×2-
6 in case of 100 parallel solutions (5 colonies) and ×7-16 in case of 4000 parallel solutions (200 
colonies), depending on the ligand structure. For protein-protein complexes with higher 
arithmetic intensity the speedup was ×10-20 and ×40-50 for 100 and 4000 parallel ants, 
respectively. The speedup of the whole GPU-based application with typically 400-500 
parallel solutions proved to be about ×4 over the original PLANTS. This is an average value 
for a large set of protein-ligand complexes; in case of large and highly flexible ligands 
speedups over ×7 were observed.  
5.6. Other approaches 
As we mentioned, it is not possible to introduce every GPU-based docking solution 
reported; instead we try to give a general overview of the diverse methods applied in this 
field. In this subsection some further GPU-based implementations are mentioned, which in 
a way are different from the solutions described above. Instead of introducing these in 
details, we focus on the differences.  
5.6.1. Hex on GPU 
Reference [36] describes the GPU-based acceleration of the Hex [37] program. Hex uses the 
FFT-correlation technique for docking. Instead of the ordinary Cartesian grids and 
translational correlation, however, Hex applies the spherical polar Fourier method based on 
rotational correlations, which allows to traverse not just the translational but also the 
orientational search space with FFT. The docking can be executed both with multiple 3D 
and with multiple 1D FFTs. Using 1D FFTs turned out to be much more advantageous on 
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In the GPU-based AutoDock implementations each thread block processes a different entity. 
In case of receptor-ligand energy calculation, for example, threads within the block perform 
trilinear interpolation for different atoms of the same ligand orientation (Figure 5/a). On the 
contrary, in this implementation threads within the same block perform interpolation for the 
same ligand atom of different entities (orientations) (Figure 5/b). Parallelization of other 
steps (genetic operators, internal energy calculation, etc.) also follows this scheme. This 
makes orientation calculation more effective; its disadvantage is that data corresponding to 
a given entity has to be stored in external GPU memory. 
Performance tests were carried out using a 2.66 GHz Intel Core 2 Quad CPU and an 
NVIDIA GeForce 8800 GT. Average GPU speedup was ×5, ×27 and ×33 for 1, 10 and 20 
parallel docking runs, respectively. The speedup, that is, GPU utilization showed a similar 
saturating tendency as in case of our GPU-based AutoDock implementation (Section 5.3.3).  
5.5. PLANTS on GPU 
PLANTS [34] stands for Protein-Ligand ANT System; it is a docking software using ant 
colony optimization (ACO) as search method. ACO is an optimization technique that 
mimics the behavior of ants when they collectively found the shortest path between the food 
source and the nest. At initialization, the degrees of freedom of the problem are discretized, 
and the same probability (pheromone level) is assigned to each discrete value of every 
degree of freedom. Then in each iteration a set of ants (potential solutions of the problem) 
choose a value for each degree of freedom according to the probability distribution. At the 
end of the iteration most of the probabilities are decreased (pheromone evaporation), but the 
ones corresponding to the best solution (shortest route) of the current iteration are 
increased, making it more likely that these values will be chosen by the ants in the next 
iteration. In PLANTS each solution is subjected to a local search algorithm at the end of each 
ACO iteration; then in a refinement step the LS is repeated for the best solution, which 
potentially further increases its fitness. PLANTS models flexibility with rotatable bonds and 
uses two different empirical scoring functions. One of them includes terms for protein-
ligand steric interactions, torsions and clashes of the ligand (representing ligand internal 
energy), in addition, steric interactions and side-chain clashes of the protein (representing 
protein internal energy). The other scoring function is similar but models hydrogen bonds as 
well. The protein is represented with 3D grids during docking making the protein-ligand 
energy calculation more effective. From the point of view of parallelization ACO is similar 
to genetic algorithms: the ants can be generated, evaluated and subjected to local search in 
parallel like the entities of the GA. 
The GPU accelerated PLANTS is described in reference [35]. The authors followed the 
traditional way of GPU programming using OpenGL and the NVIDIA Cg shading 
language. This method is less flexible than using CUDA; input data has to be encoded as 
textures, and functionality is implemented as shader programs processing these textures. 
The receptor grids, for example, are stored in a four channel (red, green, blue and alpha) 3D 
texture; the channels correspond to the four atom types which the scoring function of 
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PLANTS distinguishes. The optimization algorithms run on the CPU. The degrees of 
freedom are generated for each ant, then they are mapped to textures and moved to the 
GPU memory. Different shader programs calculate the coordinates of atoms, the protein-
ligand interaction energy (by exploiting the interpolation capabilities of the GPU), the ligand 
clash and torsional energy terms. Finally a shader sums the partial energy terms. These 
steps are executed for each ant of the current ACO or LS iteration in parallel. 
In order to exploit the capabilities of the GPU effectively the optimization algorithm was 
modified. The default value of ant colony size is 20 in PLANTS; to increase the number of 
solutions than can be evaluated in parallel multiple colonies are used, which sometimes 
exchange information by modifying the pheromone values of every colony according to the 
currently best solution. The refinement step was removed since it involves only one 
solution; in addition, the termination criterion of the LS was modified to prevent the parallel 
LS iterations from stopping after different number of steps. Although these modifications 
were necessary to achieve a high GPU utilization ratio, the altered algorithm turned out to 
be less effective than the original one; it requires a higher number of evaluations for finding 
the same solutions.  
Test runs were performed on a 3.0 GHz dual core Pentium 4 CPU and an NVIDIA GeForce 
8800 GTX GPU. For protein-ligand complexes the speedup of GPU accelerated steps was ×2-
6 in case of 100 parallel solutions (5 colonies) and ×7-16 in case of 4000 parallel solutions (200 
colonies), depending on the ligand structure. For protein-protein complexes with higher 
arithmetic intensity the speedup was ×10-20 and ×40-50 for 100 and 4000 parallel ants, 
respectively. The speedup of the whole GPU-based application with typically 400-500 
parallel solutions proved to be about ×4 over the original PLANTS. This is an average value 
for a large set of protein-ligand complexes; in case of large and highly flexible ligands 
speedups over ×7 were observed.  
5.6. Other approaches 
As we mentioned, it is not possible to introduce every GPU-based docking solution 
reported; instead we try to give a general overview of the diverse methods applied in this 
field. In this subsection some further GPU-based implementations are mentioned, which in 
a way are different from the solutions described above. Instead of introducing these in 
details, we focus on the differences.  
5.6.1. Hex on GPU 
Reference [36] describes the GPU-based acceleration of the Hex [37] program. Hex uses the 
FFT-correlation technique for docking. Instead of the ordinary Cartesian grids and 
translational correlation, however, Hex applies the spherical polar Fourier method based on 
rotational correlations, which allows to traverse not just the translational but also the 
orientational search space with FFT. The docking can be executed both with multiple 3D 
and with multiple 1D FFTs. Using 1D FFTs turned out to be much more advantageous on 
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the GPU, since it has a better memory read pattern than 3D FFT. The measured speedup on 
an NVIDIA GeForce GTX 285 was about ×45 compared to running Hex with 1D FFTs on a 
single CPU core.  
5.6.2. Calculating pairwise potentials  
Reference [38] focuses on the acceleration of calculating the pairwise potentials between the 
protein-ligand atoms. In many docking applications this is performed with pre-calculated 
grids which reduces the O(Nprot*Nlig) complexity to O(Nlig) during docking (where N 
denotes the number of atoms of the molecule). This implementation, however, calculates the 
double sum directly; one protein atom is assigned to each CUDA thread, which iterates over 
the ligand atoms and calculates the corresponding potential values. Although the 
effectiveness of the approach is uncertain due to the increased complexity, it is interesting 
since it fits the GPU architecture perfectly. The number of protein atoms is usually high 
enough to keep the multiprocessors of the GPU busy; it is not necessary to evaluate multiple 
ligand positions simultaneously. In addition, the amount of input data is smaller (the 
number of protein atoms is usually lower than that of the grid points), making this approach 
less memory-intensive. Depending on the molecule sizes, speedups between ×10-260 were 
observed on an NVIDIA Tesla C1060 GPU, compared to the same algorithm running on an 
Intel Xeon E5530 CPU.  
5.6.3. Using multiple GPUs 
Similarly to the previous section, reference [39] deals with accelerating only the pairwise 
potential calculation on GPU. The scoring function consists of two usual terms representing 
the van der Waals and electrostatic interaction. However, in this implementation two 
separate GPU devices are used; one of them calculates the van der Waals, the other one the 
electrostatic term. In a real docking application this approach would be probably impractical 
due to the required CPU-GPU memory transfer operations. Still, the applicability of 
multiple GPUs to the docking problem is intriguing; the most trivial way of utilizing them is 
to perform independent runs on the different devices. In case of this implementation overall 
speedup factors between ×118-193 were achieved; the test platform consisted of a 2.4 GHz 
Intel Core 2 Quad CPU and an NVIDIA GeForce 8800 GTX GPU.  
6. Conclusion 
Three FPGA-based and several GPU-based molecular docking implementations were 
surveyed in the previous sections. Although molecular docking algorithms are quite diverse 
in general, the methods introduced in this chapter actually fall into two categories. Both 
categories represent a docking approach which is easily parallelizable and thus suits well 
the architecture of accelerator platforms.  
The first group includes the correlation-based methods (Section 4.1, 4.2, 5.1, 5.2 and 5.6.1). 
As it was shown, correlation is a massively parallel operation and can be implemented 
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effectively in FPGA; on GPU in turn it can be performed with optimized FFT kernels. This 
makes correlation-based docking algorithms ideal for hardware acceleration; the limitation 
is that they support only rigid-body docking. 
The second group includes docking algorithms based on a global optimization algorithm 
which is inherently parallel (Section 4.3, 5.3-5.5). Both the evolutionary algorithms used by 
AutoDock and MolDock, and the ant colony optimization method of PLANTS operate on 
sets of potential solutions, which allows members of the set to be processed in parallel. The 
usual pairwise scoring functions applied by these programs offer further parallelization at 
the level of atoms or atom pairs. In addition, these methods support modeling of molecular 
flexibility, too.  
Many of the introduced, accelerator-based docking implementations achieved significant 
speedup over single or even multi-core CPUs. The actual speedup value is always a matter 
of reference platform, of course; still, the results prove that molecular docking can 
effectively accelerated by hardware and often a performance improvement of 1-2 orders of 
magnitude can be obtained. However, this improvement is usually not constant; in many 
cases it was shown that it strongly depends on input parameters (number of atoms, size of 
search space, search exhaustiveness, etc.), making accelerators usually more suitable for 
larger problem sizes. 
It should also be noted that performance improvement may come at a price: in some cases 
(4.3, 5.3.2, 5.5) the original algorithm had to be altered to make it more suitable for 
parallelization. Typically these changes were related to the local search in these cases, which 
is essentially a sequential algorithm. Such modifications are often necessary, however, they 
change the behavior and accuracy of the algorithm, which is sometimes unacceptable. 
Another typical necessity is that in addition to the computationally intensive but 
parallelizable steps that suit well the accelerator architecture, other parts must also be 
mapped to the accelerator in order to avoid that the host-accelerator bandwidth becomes a 
bottleneck. This, however may greatly increase the required programming effort.  
Another interesting point is the applicability and performance of FPGAs vs. GPUs. In case of 
the PIPER implementations (Section 4.2, 5.1) the FPGA outperformed the GPU when both 
executed correlation directly; but due to the effective FFT-based approach the GPU 
implementation seemed to be more suitable since its performance scaled well with the 
problem size. In case of AutoDock (Section 4.3, 5.3.3) the GPU outperformed the FPGA in 
practical cases, although the latter exploited the low-level parallelism of the docking 
algorithm more effectively and thus was faster than the GPU if the number of parallel runs 
was low. All these results confirm that GPU devices represent a real competitor of FPGAs 
even when considering only performance. In addition, as it was mentioned in Section 3, 
FPGA programming usually requires hardware skills while GPUs can be programmed in C-
like languages (although there are high-level C-based HDLs they are usually not as effective 
as VHDL or Verilog). GPU cards are cheaper by far than high-performance FPGA 
accelerators, and often they are already available in the desktop PC. All these facts suggest 
that GPUs are a better choice as accelerator platform than FPGAs in case of floating point-
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the GPU, since it has a better memory read pattern than 3D FFT. The measured speedup on 
an NVIDIA GeForce GTX 285 was about ×45 compared to running Hex with 1D FFTs on a 
single CPU core.  
5.6.2. Calculating pairwise potentials  
Reference [38] focuses on the acceleration of calculating the pairwise potentials between the 
protein-ligand atoms. In many docking applications this is performed with pre-calculated 
grids which reduces the O(Nprot*Nlig) complexity to O(Nlig) during docking (where N 
denotes the number of atoms of the molecule). This implementation, however, calculates the 
double sum directly; one protein atom is assigned to each CUDA thread, which iterates over 
the ligand atoms and calculates the corresponding potential values. Although the 
effectiveness of the approach is uncertain due to the increased complexity, it is interesting 
since it fits the GPU architecture perfectly. The number of protein atoms is usually high 
enough to keep the multiprocessors of the GPU busy; it is not necessary to evaluate multiple 
ligand positions simultaneously. In addition, the amount of input data is smaller (the 
number of protein atoms is usually lower than that of the grid points), making this approach 
less memory-intensive. Depending on the molecule sizes, speedups between ×10-260 were 
observed on an NVIDIA Tesla C1060 GPU, compared to the same algorithm running on an 
Intel Xeon E5530 CPU.  
5.6.3. Using multiple GPUs 
Similarly to the previous section, reference [39] deals with accelerating only the pairwise 
potential calculation on GPU. The scoring function consists of two usual terms representing 
the van der Waals and electrostatic interaction. However, in this implementation two 
separate GPU devices are used; one of them calculates the van der Waals, the other one the 
electrostatic term. In a real docking application this approach would be probably impractical 
due to the required CPU-GPU memory transfer operations. Still, the applicability of 
multiple GPUs to the docking problem is intriguing; the most trivial way of utilizing them is 
to perform independent runs on the different devices. In case of this implementation overall 
speedup factors between ×118-193 were achieved; the test platform consisted of a 2.4 GHz 
Intel Core 2 Quad CPU and an NVIDIA GeForce 8800 GTX GPU.  
6. Conclusion 
Three FPGA-based and several GPU-based molecular docking implementations were 
surveyed in the previous sections. Although molecular docking algorithms are quite diverse 
in general, the methods introduced in this chapter actually fall into two categories. Both 
categories represent a docking approach which is easily parallelizable and thus suits well 
the architecture of accelerator platforms.  
The first group includes the correlation-based methods (Section 4.1, 4.2, 5.1, 5.2 and 5.6.1). 
As it was shown, correlation is a massively parallel operation and can be implemented 
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effectively in FPGA; on GPU in turn it can be performed with optimized FFT kernels. This 
makes correlation-based docking algorithms ideal for hardware acceleration; the limitation 
is that they support only rigid-body docking. 
The second group includes docking algorithms based on a global optimization algorithm 
which is inherently parallel (Section 4.3, 5.3-5.5). Both the evolutionary algorithms used by 
AutoDock and MolDock, and the ant colony optimization method of PLANTS operate on 
sets of potential solutions, which allows members of the set to be processed in parallel. The 
usual pairwise scoring functions applied by these programs offer further parallelization at 
the level of atoms or atom pairs. In addition, these methods support modeling of molecular 
flexibility, too.  
Many of the introduced, accelerator-based docking implementations achieved significant 
speedup over single or even multi-core CPUs. The actual speedup value is always a matter 
of reference platform, of course; still, the results prove that molecular docking can 
effectively accelerated by hardware and often a performance improvement of 1-2 orders of 
magnitude can be obtained. However, this improvement is usually not constant; in many 
cases it was shown that it strongly depends on input parameters (number of atoms, size of 
search space, search exhaustiveness, etc.), making accelerators usually more suitable for 
larger problem sizes. 
It should also be noted that performance improvement may come at a price: in some cases 
(4.3, 5.3.2, 5.5) the original algorithm had to be altered to make it more suitable for 
parallelization. Typically these changes were related to the local search in these cases, which 
is essentially a sequential algorithm. Such modifications are often necessary, however, they 
change the behavior and accuracy of the algorithm, which is sometimes unacceptable. 
Another typical necessity is that in addition to the computationally intensive but 
parallelizable steps that suit well the accelerator architecture, other parts must also be 
mapped to the accelerator in order to avoid that the host-accelerator bandwidth becomes a 
bottleneck. This, however may greatly increase the required programming effort.  
Another interesting point is the applicability and performance of FPGAs vs. GPUs. In case of 
the PIPER implementations (Section 4.2, 5.1) the FPGA outperformed the GPU when both 
executed correlation directly; but due to the effective FFT-based approach the GPU 
implementation seemed to be more suitable since its performance scaled well with the 
problem size. In case of AutoDock (Section 4.3, 5.3.3) the GPU outperformed the FPGA in 
practical cases, although the latter exploited the low-level parallelism of the docking 
algorithm more effectively and thus was faster than the GPU if the number of parallel runs 
was low. All these results confirm that GPU devices represent a real competitor of FPGAs 
even when considering only performance. In addition, as it was mentioned in Section 3, 
FPGA programming usually requires hardware skills while GPUs can be programmed in C-
like languages (although there are high-level C-based HDLs they are usually not as effective 
as VHDL or Verilog). GPU cards are cheaper by far than high-performance FPGA 
accelerators, and often they are already available in the desktop PC. All these facts suggest 
that GPUs are a better choice as accelerator platform than FPGAs in case of floating point-
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intensive applications like the majority of the docking algorithms, although clearly there are 
problem domains where FPGAs remain superior.  
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1. Introduction 
Nowadays, information about targeted diseases needed for structure-based drug design can 
be accessed easily. There are more than 80,000 coordinate entries of macromolecules 
revealed by X-ray, NMR, and Electron Microscopy techniques available in the Brookhaven 
Protein Data Bank. Many new target proteins whose 3D structures have not been solved 
experimentally can also be easily predicted by homology modelling with adequate 
reliability. Similarly, thousands of compounds including their drug-like properties are 
provided in free chemical databases such as the NCI Diversity set, ZINC, and the Drug 
Bank. Therefore, it is crucial to applied suitable tools to take advantages of these promising 
resources for rational drug design. Molecular dynamics (MD) simulation has proven itself as 
a complement to lab experiments to fill in the gaps in our knowledge between 3D structures 
of biological targets and their potential inhibitors (Rognan et al., 1998 & Jacob et al., 2011). 
MD can be simply understood as a simulation of physical movements of particles like atoms 
in atomistic simulation or a group of atoms in coarse-grained simulation. These particles are 
allowed to move and interact with each others. Their motions are described by Newton's 
equations, in which forces between the particles and potential energy are obtained from 
empirical data or quantum mechanical calculations. There are quite several MD simulation 
packages that are free for academics such as NAMD (Phillips et al., 2005), AMBER (Case et 
al., 2005), GROSMOS (Christen et al., 2005) and CHARMM (Brooks et al., 1983). The method 
was introduced by Alder and Wainwright in the late 1950's (Alder and Wainwright, 1957) 
for the study of the behaviour of simple liquids and the first protein simulation, bovine 
pancreatic trypsin inhibitor was done successfully twenty years later (McCammon et al., 
1977). After that, MD simulation has been used wildly for investigating, interpreting and 
discovering the dynamics of biological macromolecules, not only fast internal motions but 
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also slow conformational changes and even whole folding processes of some small proteins. 
MD simulation has become important complement to experimental procedures in structure-
function determination of targeted diseases and rational design of their inhibitors. In the 
lead discovery stage, thousands of compounds from free chemical databases are docked 
against the rigid structures of receptors. Such screening processes are fast but are associated 
with a high number of false positives and false negatives. Flexible docking has improved the 
outcome of this process, but to a very limited degree. A recent method that significantly 
increases the accuracy of the lead identification process is called ensemble-based docking. This 
method combines the docking algorithm (Morris et al., 1998) with the dynamic structure of 
proteins taken from MD simulations as well as statistical analysis of binding energy (Amaro et 
al., 2008). Another important aspect of rational drug design is to understand all drug-protein 
interactions at an atomistic level and how these interactions are ruptured by certain mutations, 
leading to drug resistance. Thorough understanding of drug resistant mechanisms is crucial 
for the design of new agents effective against current drug-resistant strains. MD simulation is 
also an important tool in identifying drug binding pathway. However, this could be one of the 
most challenging tasks in computer-aided drug design due to the limitation of MD simulation 
time scale. One of the solutions is to combine electrostatic surface potential analysis with 
steered MD (SMD) simulation (Isralewitz et al., 2001). Forces can be applied to drug molecules 
in order to pull it along possible pathways predicted from electrostatic surface potential. The 
findings of drug binding pathway are highly important for investigation on non-active site 
mutations which possibly prevent drugs from entering binding site by rupture the structure of 
binding pathway as well as for the rational design of new drugs with good binding kinetics. 
In this chapter we highlight the successes in using MD simulations to speed up the rational 
design of antiviral drugs. Due to their ability to mutate quickly, the viruses can easily 
survive people’s immune systems and resist current drugs. Currently, there are two 
pathogenic viruses, the 2003 avian flu (H5N1) virus( Ford Stephen et al., 2006) and the 2009 
swine flu (H1N1pdm) virus (Butler et al., 2009), which share the same subtype 1 (N1) of 
neuraminidase. Neuraminidase, a glycoprotein component on a flu virus’ surface that 
cleaves the alpha-ketosidic linkage of sialic acid (SA) located on human cells to release new 
virions that then infect nearby healthy cells, is the most important target for antiviral drug 
design. Oseltamivir functions as a neuraminidase inhibitor that binds competitively to the 
Sialic Acid (SA) binding site (Laver et al., 2006). Unfortunately, oseltamivir resistance has 
been a big concern to public health since 2005 and thus continues effort to gain insight of 
drug resistant mechanism and designing new effective medicine become highly significant. 
2. Ensemble-based docking 
2.1. Receptor 
2.1.1. MD simulation of ionized oseltamivir-neuraminidase complex 
The molecular model of H1N1pdm used in MD simulation was built from the crystal 
structure of avian H5N1 and the amino acid sequence of swine flu H1N1pdm from 
Incorporating Molecular Dynamics Simulations  
into Rational Drug Design: A Case Study on Influenza a Neuraminidases 161 
GenBank Locus ID CY041156. All simulations were performed using NAMD 2.720 and the 
CHARMM31 force field with the CMAP correction. The ionized systems were minimized 
for 10,000 integration steps and equilibrated for 20 ns with a 1 fs time step. Following this, a 
20 ns unconstrained equilibration production run was performed for subsequent trajectory 
analysis, with frames stored after each picosecond (every 1000 time steps). Constant 
temperature (T = 300 K) was enforced using Langevin dynamics with a damping coefficient 
of 1 ps−1. Constant pressure (p = 1 atm) was enforced using the Nosé-Hoover Langevin 
piston method. Van der Waals interaction cut-off distances were set at 12 Å (smooth 
switching function beginning at 10 Å) and long-range electrostatic forces were computed 
using the particle-mesh Ewald (PME) summation method. The trajectories from our 20ns 
production run of EQ simulation of H1N1pdm neuraminidase with oseltamivir bound, were 
clustered as shown in Figure 1, and then used for ensemble based docking. 
 
Figure 1. Schematic representations of drug-bound simulation systems. Shown here as a representative 
example of simulated systems is H1N1pdm bound to oselvamivir. In A), the simulation system is 
shown in the full explicit solvation box with oseltamivir and the active-site calcium ion labelled. In B), 
oseltamivir is shown buried in the SA binding pocket of H1N1pdm rendered in surface view 
2.1.2. RMSD clustering to extract receptor ensembles from an all-atom MD simulation 
The holo system with oseltamivir removed was used for RMSD clustering and the docking 
experiments. Clustering analyses were performed on 20 ns MD trajectories using the g_cluster 
tool in the Gromacs package. In brief, snapshots at every 10 ps over the 20 ns simulation were 
recorded. 2000 resulting structures were superimposed, using all Cα atoms to remove possible 
rotational and translational movements of the whole system. We have visually verified that 
the binding-site residues of avian H5N1 neuraminidase, which cover the active site and are 
responsible for interaction with putative inhibitors, can also be used for the swine flu 
H1N1pdm neuraminidase. The four most populated clusters are shown in Figure 2. The 
RMSD clustering analysis was performed on this subset (117-119, 133-138, 146-152, 156, 179, 
180, 196-200, 223-228, 243-247, 277, 278, 293, 295, 344-347, 368, 401, 402, and 426-441) using all-
atoms (including side chains and hydrogen atoms) with the cut-off of 1.5 Å. A total of 13 
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representative clusters were obtained, which account for 96.2% of the configuration space from 
the 20 ns MD trajectories. These 13 clusters were used in the docking experiments. 
 
Figure 2. 13 representative ensembles resulting from clustering analysis, accounting for 96.2% of the 
configuration space, are ordered by the corresponding simulation time. The four largest cluster 
ensembles account for over 66% of the configuration space from the 20 ns MD simulation. The most 
dominant cluster is colored in orange, the second one in silver, the third one in blue and the fourth one 
in cyan. 
2.2. Ligands 
The high percentage sequence identity (91.47 %) of swine H1N1pdm compared to avian 
H5N1 neuraminidase, and similarities in 3D structures (active-site 150-loop and SA binding 
site residues) explain why oseltamivir, which has been developed for the H5N1 virus, is also 
effective against the swine flu virus H1N1pdm. These facts also suggest that top-binding 
ligands of avian H5N1 are likely to have high affinity to the swine flu H1N1pdm 
neuraminidase. Therefore, the 27 top hits for H5N1 neuraminidase (Cheng et al., 2008) and 
six known drugs for avian H5N1 namely: SA, N-acetyl neuraminic acid, aka, NANA or 
Neu5Ac), DANA (2,3-didehydro-2-deoxy-N-acetyl neuraminic acid), oseltamivir, zanamivir, 
peramivir (clinical trial phase 3 drug candidate) and SK (shikimic acid) were selected for our 
study. Ligand structures were obtained from the NCI and optimized by the MOPAC 
(Stewart, 2007). Our selection of ligands for docking is based on the high sequence identity 
and observation that mutations mainly appear on the H1N1 neuraminidase surface not its 
active site (Le et al., 2009). However, further screening for all the entries of the NCI is 
suggested to avoid false positives and false negatives.  
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2.3. Molecular docking 
In the docking experiments, the 13 most representative configurations were used as 
receptors. AutoDockTools 1.5.2 was used to add polar hydrogens, assign Gasteiger 
charges11 and create grid binding boxes. The volume of each grid box was 72 x 72 x 72, with 
the default 0.375 Å spacing. The binding box was positioned to encompass all three possible 
binding sites, namely the SA, 150 and 430 cavities (Cheng et al., 2008). AutoGrid version 
4.2.1 was used to calculate the binding affinities using the following atom types: A (aromatic 
carbon), C, N, NA (hydrogen bond accepting N), OA (hydrogen bond accepting O), P, S, SA 
(hydrogen bond accepting S), Cl, HD (polar hydrogen) and e (electrostatics). 
AutoDockTools version 1.5.2 was also used to merge nonpolar hydrogens, add Gasteiger 
charges and visually set up rotatable bonds for each ligand via AutoTors. For screening 
larger ligand libraries, Autodock Vina (Trott et al., 2010), which run more efficiently than this 
version, is highly suggested. The Lamarckian genetic algorithm was used to do the docking 
experiments using AutoDock 4.2.1.16 Docking parameters were chosen to reproduce 
structures of 13 corresponding oseltamivir–neuraminidase complexes in the MD simulation. 
Other parameters are as follows: trials of 100 dockings, population size of 200, random starting 
position and conformation, translation step range of 2.0 Å, rotation step range of 50 degrees, 
maximum number of generations of 27000, elitism of 1, mutation rate of 2%, crossover rate of 
80%, local search rate of 6%, 8 million energy evaluations, unbound model was “same as 
bound”, and docked conformations were clustered with the tolerance of 2.0 Å RMSD. Docking 
results were sorted by the lowest binding energy of the most populated cluster in cases of 
convergence. In the case of no dominant cluster, docking results were visually analyzed using 
VMD (Humphrey et al., 1996) to choose the best binding pose. Hydrogen bond analysis 
utilized a distance and angle cut-off of 3.5 Å and 45 degrees, respectively.  
















Where i is the index number of each ensemble; ni the size of each ensemble; and hi = 1 if 
hydrogen bond exists, and 0 otherwise. After the dockings, statistical calculations were 
performed to obtain the final binding energies for compound ranking, using the arithmetic 
mean (AM) and harmonic mean (HM) binding energies as defined in the previous study. 
















Where Ei is the binding energy of each ensemble with the standard deviation 
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Figure 2. 13 representative ensembles resulting from clustering analysis, accounting for 96.2% of the 
configuration space, are ordered by the corresponding simulation time. The four largest cluster 
ensembles account for over 66% of the configuration space from the 20 ns MD simulation. The most 
dominant cluster is colored in orange, the second one in silver, the third one in blue and the fourth one 
in cyan. 
2.2. Ligands 
The high percentage sequence identity (91.47 %) of swine H1N1pdm compared to avian 
H5N1 neuraminidase, and similarities in 3D structures (active-site 150-loop and SA binding 
site residues) explain why oseltamivir, which has been developed for the H5N1 virus, is also 
effective against the swine flu virus H1N1pdm. These facts also suggest that top-binding 
ligands of avian H5N1 are likely to have high affinity to the swine flu H1N1pdm 
neuraminidase. Therefore, the 27 top hits for H5N1 neuraminidase (Cheng et al., 2008) and 
six known drugs for avian H5N1 namely: SA, N-acetyl neuraminic acid, aka, NANA or 
Neu5Ac), DANA (2,3-didehydro-2-deoxy-N-acetyl neuraminic acid), oseltamivir, zanamivir, 
peramivir (clinical trial phase 3 drug candidate) and SK (shikimic acid) were selected for our 
study. Ligand structures were obtained from the NCI and optimized by the MOPAC 
(Stewart, 2007). Our selection of ligands for docking is based on the high sequence identity 
and observation that mutations mainly appear on the H1N1 neuraminidase surface not its 
active site (Le et al., 2009). However, further screening for all the entries of the NCI is 
suggested to avoid false positives and false negatives.  
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2.3. Molecular docking 
In the docking experiments, the 13 most representative configurations were used as 
receptors. AutoDockTools 1.5.2 was used to add polar hydrogens, assign Gasteiger 
charges11 and create grid binding boxes. The volume of each grid box was 72 x 72 x 72, with 
the default 0.375 Å spacing. The binding box was positioned to encompass all three possible 
binding sites, namely the SA, 150 and 430 cavities (Cheng et al., 2008). AutoGrid version 
4.2.1 was used to calculate the binding affinities using the following atom types: A (aromatic 
carbon), C, N, NA (hydrogen bond accepting N), OA (hydrogen bond accepting O), P, S, SA 
(hydrogen bond accepting S), Cl, HD (polar hydrogen) and e (electrostatics). 
AutoDockTools version 1.5.2 was also used to merge nonpolar hydrogens, add Gasteiger 
charges and visually set up rotatable bonds for each ligand via AutoTors. For screening 
larger ligand libraries, Autodock Vina (Trott et al., 2010), which run more efficiently than this 
version, is highly suggested. The Lamarckian genetic algorithm was used to do the docking 
experiments using AutoDock 4.2.1.16 Docking parameters were chosen to reproduce 
structures of 13 corresponding oseltamivir–neuraminidase complexes in the MD simulation. 
Other parameters are as follows: trials of 100 dockings, population size of 200, random starting 
position and conformation, translation step range of 2.0 Å, rotation step range of 50 degrees, 
maximum number of generations of 27000, elitism of 1, mutation rate of 2%, crossover rate of 
80%, local search rate of 6%, 8 million energy evaluations, unbound model was “same as 
bound”, and docked conformations were clustered with the tolerance of 2.0 Å RMSD. Docking 
results were sorted by the lowest binding energy of the most populated cluster in cases of 
convergence. In the case of no dominant cluster, docking results were visually analyzed using 
VMD (Humphrey et al., 1996) to choose the best binding pose. Hydrogen bond analysis 
utilized a distance and angle cut-off of 3.5 Å and 45 degrees, respectively.  
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Where R is the Boltzmann constant and T is the temperature (298.15K). The harmonic means 





















2.4. Results  
The obtained docking scores reveal that 6 compounds, specifically NSC211332, NSC141562, 
NSC109836, NSC350191, NSC1644640, and NSC5069, have higher binding affinity to the 
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2 141562 -10.14 0.037 -9.87 0.63 
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7 Oseltamivir -8.69 0.429 -8.57 0.35 
 
Table 1. Docking results ranked by harmonic mean of binding energy. The first column is the final rank 
and also the compound ID. The predicted Ki calculated according to the harmonic mean binding free 
energies are also shown, as well as the arithmetic mean binding free energies and their corresponding 
standard deviations. 
The results also confirm the observed effectiveness of oseltamivir against both the swine 
H1N1pdm and H5N1 flu. Detailed analysis on the hydrogen bond networks between top 
binding candidates with the swine H1N1pdm neuraminidase protein reveals that the 
mutations H274Y and N294S do not have any direct interactions with these compounds, and 
thus suggest the possibility of using the present top hit compounds for further 
computational and experimental studies to design new antiviral drugs against swine 
H1N1pdm flu virus and its variants (Hung et al., 2009). Furthermore, a more complete 
virtual screening using the full NCI diversity set (NCIDS) or larger sets from the ZINC 
database should be done to identify drug candidates that may have been missed in this 
study. The NCIDS has over 2000 compounds thus the full screening should be done with 
parallel automatic pipeline. 
3. Investigation of drug resistant mechanism by MD simulation 
Genetics study of influenza H5N1 virus isolated from patients who died despite being given 
oseltamivir showed that mutations H274Y or N294S confer high-level resistance to 
oseltamivir (De Jong et al., 2005 & Le et al., 2005)). There is even emerging evidence that 
these drug-resistant mutants pose the same risk with H1N1pdm, as shown by reported 
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cases of the H274Y mutation of H1N1pdm (Guo et al, 2009). The rapid emergence of 
oseltamivir resistance in avian flu has already motivated numerous studies, both 
experimental and theoretical, to uncover the mechanisms of how point mutations in 
neuraminidase alter drug binding. Despite initial inroads, the current understanding of 
drug resistance remains incomplete and some conclusions are conflicting. For example, in 
one study, it was reported that the H274Y mutation disrupts the E276-R224 salt bridges, but 
in a separate study the same salt bridges were observed to be stable. We characterize the 
drug-protein interactions of oseltamivir bound forms of wild type avian H5N1 and swine 
H1N1pdm neuraminidases and how their mutations, H274Y and N294S, rupture these 
interactions to confer drug resistance through molecular modelling and atomistic MD 
simulation. 
3.1. Computational details 
The coordinates for the H5N1 neuraminidase bound with oseltamivir was taken from a 
monomer of the Protein Data Bank (PDB) structure 2HU4 (tetramer), while those of mutants 
H274Y and N294S were taken from structures 3CL0 (monomer) and 3CL2 (monomer) 
respectively. Even though the biological form of neuraminidase is tetrameric, its monomer 
contains a functionally complete active site and yields reasonable results in a prior study 
using MD simulations. The position for oseltamivir bound to H1N1pdm was adopted from 
its corresponding location in H5N1, as the two proteins’ binding pockets differ only by 
residue 347 (which is Y in H5N1 and N in H1N1pdm), located on a loop at the periphery of 
the active site. Oseltamivir-mutant complexes of H1N1pdm were built by mutating H274Y 
and N294S of the H1N1pdm wild type model. In total, 6 systems were modelled and 
simulated for oseltamivir bound H5N1, and H1N1pdm wild type and H274Y and N294S 
mutants. Crystallographically resolved water molecules and a structurally relevant calcium 
ion near the native binding site for SA were retained and modelled in all simulated systems. 
The protein complexes were then solvated in a TIP3P water box and ionized by NaCl 
(0.152M) to mimic physiological conditions.  
All simulations were performed using NAMD 2.7 and the CHARMM31 force field with 
CMAP correction. The ionized systems were minimized for 10,000 integration steps and 
equilibrated for 20 ns with 1 fs time steps. Following this, a 20 ns unconstrained 
equilibration production run was performed for subsequent trajectory analysis, with frames 
stored after each picosecond (every 1000 time steps). Constant temperature (T = 300 K) was 
enforced using Langevin dynamics with a damping coefficient of 1 ps−1. Constant pressure 
(p = 1 atm) was enforced using the Nosé-Hoover Langevin piston method. Van der Waals 
interaction cut-off distances were set at 12 Å (smooth switching function beginning at 10 Å) 
and long-range electrostatic forces were computed using the particle-mesh Ewald (PME) 
summation method.  
Analysis included the calculation of an averaged electrostatic potential field over all frames 
of the trajectory using RMSD-aligned structures. Maps of the electrostatic potential field 
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cases of the H274Y mutation of H1N1pdm (Guo et al, 2009). The rapid emergence of 
oseltamivir resistance in avian flu has already motivated numerous studies, both 
experimental and theoretical, to uncover the mechanisms of how point mutations in 
neuraminidase alter drug binding. Despite initial inroads, the current understanding of 
drug resistance remains incomplete and some conclusions are conflicting. For example, in 
one study, it was reported that the H274Y mutation disrupts the E276-R224 salt bridges, but 
in a separate study the same salt bridges were observed to be stable. We characterize the 
drug-protein interactions of oseltamivir bound forms of wild type avian H5N1 and swine 
H1N1pdm neuraminidases and how their mutations, H274Y and N294S, rupture these 
interactions to confer drug resistance through molecular modelling and atomistic MD 
simulation. 
3.1. Computational details 
The coordinates for the H5N1 neuraminidase bound with oseltamivir was taken from a 
monomer of the Protein Data Bank (PDB) structure 2HU4 (tetramer), while those of mutants 
H274Y and N294S were taken from structures 3CL0 (monomer) and 3CL2 (monomer) 
respectively. Even though the biological form of neuraminidase is tetrameric, its monomer 
contains a functionally complete active site and yields reasonable results in a prior study 
using MD simulations. The position for oseltamivir bound to H1N1pdm was adopted from 
its corresponding location in H5N1, as the two proteins’ binding pockets differ only by 
residue 347 (which is Y in H5N1 and N in H1N1pdm), located on a loop at the periphery of 
the active site. Oseltamivir-mutant complexes of H1N1pdm were built by mutating H274Y 
and N294S of the H1N1pdm wild type model. In total, 6 systems were modelled and 
simulated for oseltamivir bound H5N1, and H1N1pdm wild type and H274Y and N294S 
mutants. Crystallographically resolved water molecules and a structurally relevant calcium 
ion near the native binding site for SA were retained and modelled in all simulated systems. 
The protein complexes were then solvated in a TIP3P water box and ionized by NaCl 
(0.152M) to mimic physiological conditions.  
All simulations were performed using NAMD 2.7 and the CHARMM31 force field with 
CMAP correction. The ionized systems were minimized for 10,000 integration steps and 
equilibrated for 20 ns with 1 fs time steps. Following this, a 20 ns unconstrained 
equilibration production run was performed for subsequent trajectory analysis, with frames 
stored after each picosecond (every 1000 time steps). Constant temperature (T = 300 K) was 
enforced using Langevin dynamics with a damping coefficient of 1 ps−1. Constant pressure 
(p = 1 atm) was enforced using the Nosé-Hoover Langevin piston method. Van der Waals 
interaction cut-off distances were set at 12 Å (smooth switching function beginning at 10 Å) 
and long-range electrostatic forces were computed using the particle-mesh Ewald (PME) 
summation method.  
Analysis included the calculation of an averaged electrostatic potential field over all frames 
of the trajectory using RMSD-aligned structures. Maps of the electrostatic potential field 
were calculated on a three-dimensional lattice. The long-range contributions to the 
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electrostatics were approximated using the multilevel summation method (MSM), which 
uses nested interpolation of the smoothed pairwise interaction potential, with 
computational work that scales linearly with the size of the system. The calculation was 
performed using the molecular visualization program VMD that provides a graphics 
processing units (GPU) accelerated version of MSM to produce the electrostatic potential 
map. The GPU acceleration of MSM ( Hardy et al., 2009) provided a significant speedup 
over conventional electrostatic summation methods such as the Adaptive Poisson Boltzman 
Solver (APBS), achieving a benchmark processing time of 0.2s per frame versus 180 seconds 
per frame (on a conventional CPU) using APBS69 for a 35,000 atom system, offering a 
speedup factor of about 900. The use of GPU acceleration enabled averaging the electrostatic 
potential field over all frames of the simulation trajectories. Hydrogen bond analysis utilized 
a distance and angle cut-offs of 3.5 Å and 60 degrees, respectively.  
3.2. Results and discussion 
Hydrogen bonds which form the primary interactions between oseltamivir and H5N1/ 
H1N1pdm neuraminidases were shown in figure 4 and figure 5 accordingly. While the SA 
binding sites of H5N1 and H1N1pdm appear to differ mainly in the sequence of loop 
residue 347, it is not well understood whether antiviral drugs bind to each protein in the 
same manner, or if the drug resistant H274Y and N294S mutations disrupt critical hydrogen 
bonds. To address this question, the hydrogen bonds which form between oseltamivir and 
the residues lining the SA binding pockets of H5N1 and H1N1pdm were calculated for all 
simulation trajectories. R292 and R371 were observed to hydrogen bond with oseltamivir’s 
carboxyl moiety, and E119 and D151 with oseltamivir’s amino group (NH3+). The H274Y 
mutation, however, appeared to disrupt the hydrogen bonding of oseltamivir’s acetyl group 
with R152, an interaction which was seen in the wild type and N294S systems for both 
simEQ1 and simEQ2. Prior analyses of crystallographic data alone suggested that Y347 
forms a stable hydrogen bond with oseltamivir’s carboxyl group and is the source of 
oseltamivir-resistance in the N294S mutant.  
Our MD simulations however, reflect statistics collected from long timescale simulations 
which produce a dynamic picture of molecular interactions in greater detail and resolution 
than can be seen from a static crystal structure. In our simulations oseltamivir’s carboxyl 
group primarily forms hydrogen bonds with R292 and R371, having little involvement with 
Y347. In fact, residue Y347 undergoes rotation to interact strongly with residue W295. 
Therefore, the speculation from previous studies, that the N294S mutation in the case of 
H5N1 actually destabilizes the hydrogen bonding between oseltamivir and Y347 to induce 
drug resistance, is not supported in our simulations.  
The notable difference between H5N1 and H1N1pdm neuraminidases is the replacement of 
Y347 by N347 at the drug binding pocket. No conserved drug-protein hydrogen bond was 
observed for N347 in any of the three H1N1pdm simulations. Given the transient nature of 
even the N294S mutant induced hydrogen bond involving residue 347 in the case of H5N1, 
and the lack of interaction with residue 347 in any of the other simulations, it is highly 
unlikely that the single residue change (Y347 to N347), between the H5N1 and H1N1pdm 
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strains significantly alters the drug-protein stability in regard to the hydrogen bond network 
involved. H274Y mutation induced disruption of the stable hydrophobic packing of 







Figure 3. Network and occupancy of hydrogen bonds stabilizing oseltamivir in the SA binding pocket 
of wild type and drug-resistant mutant avian H5N1 neuraminidases, in simEQ1, simEQ3, and 
simEQ5.(A) shows histograms of the percent of hydrogen-bond occupancies for interactions between 
oseltamivir and residues E119, D151, R152, R292, Y347, and R371 across each simulation run. (B) 
through (D) are schematic views depicting the orientation of protein sidechains which form protein-
drug hydrogen bonds.  
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strains significantly alters the drug-protein stability in regard to the hydrogen bond network 
involved. H274Y mutation induced disruption of the stable hydrophobic packing of 
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of wild type and drug-resistant mutant avian H5N1 neuraminidases, in simEQ1, simEQ3, and 
simEQ5.(A) shows histograms of the percent of hydrogen-bond occupancies for interactions between 
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Figure 4. Network and occupancy of hydrogen bonds stabilizing oseltamivir in the SA binding pocket 
of wild type and drug-resistant mutant avian H1N1pdm neuraminidases, in simEQ2, simEQ4, and 
simEQ6. (A) are histograms of the percent of hydrogen-bond occupancies for interactions between 
oseltamivir and residues E119, D151, R152, R292, N347, and R371 across each simulation run. (B) 
through (D) are schematic views depicting the orientation of protein sidechains which form protein-
drug hydrogen bonds.  
Beyond disrupting the drug-protein hydrogen-bonding network, another mechanism 
through which protein mutations may induce drug resistance is by disruption of the 
hydrophobic packing of the drug into the protein binding pocket. Through inspection of the 
static crystal structures of the H274Y and N294S mutants of H5N1, it has been speculated 
that the mutations disrupt favourable hydrophobic packing interactions necessary for strong 
binding of oseltamivir. In our wild type simulations for both the H5H1 and H1N1pdm 
systems, the packing of oseltamivir’s pentyl moiety tended to favour close association with 
residues I222, R224, A246, and E276. To test the effect of mutations H274Y and N294S on 
hydrophobic interactions of oseltamivir’s pentyl group with the proteins, we calculated the 
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solvent accessible surface area (SASA) of oseltamivir’s pentyl group for all simulation 
trajectories. While there was no significant change to the pentyl group SASA (henceforth 
referred to as PG-SASA) in the wild type and N294S mutant for either H5N1 or H1N1pdm 
neuraminidases, an outward rotation of the pentyl group was observed in the H274Y 
mutant simulations, visible in oseltamivir’s binding pose and evident in a notably higher 
calculated PG-SASA. The PG-SASAs for all simulated systems are plotted in Figure 5, with 
inset images of oseltamivir’s binding pose in simEQ2 (Figure 5A) and simEQ4 (Figure 5B) 
illustrating the rotation of the pentyl group towards the open mouth of the binding pocket.  
 
Figure 5. The solvent accessible surface area of oseltamivir's pentyl group (PG-SASA) in H5N1 and 
H1N1pdm wild type and mutant simulations. The PG-SASA in the N294S mutant simulation (simEQ5 
and simEQ6) did not vary significantly from wild type simulations (simEQ1 and simEQ2). However, 
there was a huge loss of hydrophobic interaction between drug and protein in the case of the H274Y 
mutant simulations (simEQ3 and simEQ4), resulting in an increase in measured PG-SASA. 
Previously published MD simulations performed over relatively short time scales (3 to 6 ns) 
have suggested two possible mechanisms: 1) that the H247Y mutation reduces the size of the 
hydrophobic pocket within the SA binding pocket near Oseltamivir’s pentyl moiety 
(Malaisree et al., 2008), and 2) that the H274Y mutation breaks a critical salt bridge between 
E276 and R224 to disrupt drug binding( Wang et al., 2009). Our longer (40ns) simulations 
were able to corroborate the former suggested mechanism (as shown by the increase in PG-
SASA in the case of the H274Y mutant simulations) but not the latter. In fact, in all six of our 
simulations, E276 maintains stable charge-charge interactions (salt bridging) with R224 despite 
displacement of the drug from the protein I222-R224-A246-E276 pocket in the case of H274Y 
mutants. This drug displacement increases water penetration into the I222-R224-A246-E276 
pocket (Figure 5B). Evidence from our simulations therefore supports predictions from earlier 
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simulations, E276 maintains stable charge-charge interactions (salt bridging) with R224 despite 
displacement of the drug from the protein I222-R224-A246-E276 pocket in the case of H274Y 
mutants. This drug displacement increases water penetration into the I222-R224-A246-E276 
pocket (Figure 5B). Evidence from our simulations therefore supports predictions from earlier 
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studies of a possible mechanism for the H274Y mutation-induced drug resistance through 
water infiltration and destabilization of favourable drug packing. However, because no change 
in PG-SASA was observed during our simulations in the case of N294S for either protein, 
N294S induced drug resistance is probably due to a different mechanism.  
 
Figure 6. Electrostatic surface potential of avian H5N1 and swine H1N1pdm neuraminidases in 
oseltamivir-bound simulations, revealing a positively charged pathway into the binding pocket. (A) 
through (C) show oseltamivir bound to H5N1 wild type, H274Y, and N294S drug-resistant mutant 
structures, respectively. (D) through (F) show oseltamivir bound to wild type, H274Y, and N294S drug-
resistant mutant structures, respectively. The outer columns show a close-up view of the binding 
pocket, highlighted as a subset of the enter protein shown in the central column. The positions of the 
mutant residues are shown in green for residue 274 and 294 in the mutant systems 
While alterations in hydrophobic sidegroup packing may explain in part the mechanism 
behind H274Y mutation-induced drug resistance, they fail to shed light on the role that the 
N294S mutation plays for oseltamivir binding inhibition. Initial investigations of the 
electrostatic surface potentials of drug-bound N1 neuraminidases have proposed that drug 
binding affinity is closely related to favourable charge-charge interactions with the 
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electrostatic potential of the binding pocket wall, which exhibits a weak negative charge. In 
order to understand whether charge-charge interactions may play a role in mutation 
induced drug resistance, the electrostatic potentials were calculated and mapped onto the 
surfaces of the proteins. Even though prior studies have investigated the possible role of the 
electrostatic surface potential for drug binding in neuraminidases, the extensive electrostatic 
calculations required for fully understanding role of this phenomenon over a long 
simulation trajectory has not yet been done. The electrostatic surface potentials of the 
equilibrated systems were calculated and averaged across every trajectory frame in six 
equilibrium simulations. Extensive electrostatic calculations for the six systems show that 
the mouth of the binding pocket is positively charged, except for a narrow pathway of 
negative surface charge that seems to direct a possible binding pathway through which the 
drug may access the binding pocket. In Figure 6, the electrostatic surface potentials 
calculated from all six simulations is shown for the SA binding pocket with oseltamivir 
bound. 
Mutation H274Y in the H1N1pdm virus shares the same sources of oseltamivir resistance as 
H5N1, including loss of hydrogen bonds with R152 and reduction of hydrophobic 
interaction of oseltamivir’s pentyl group. This leads to our suggestion to replace the pentyl 
group by a more hydrophilic one by adding a few hydroxyl groups on this bulky 
hydrophobic group. Our results do not support previous suggestions that the N294S 
mutation of H5N1 destabilizes the hydrogen bonding between oseltamivir and Y347, or that 
it disrupts the hydrophobic pocket, leading to drug resistance. Sources of drug resistance in 
mutant N294S remain unclear. Quantitative analysis of drug binding to the pocket is 
surrounded by a highly positive potential ring (colored blue). Simulations revealed the 
presence of a negatively charged pathway at the mouth of the binding pocket which may 
play a role for drug binding and mutation induced resistance, as the position of residue 294 
maps directly onto the pathway while position of residue 274 is positioned on or adjacent( 
Le et al., 2009). WT and the mutants will be importantly complementary to obtained results in 
this chapter. Since the two mutations are nonactive-site, endpoint interactions alone cannot 
account for all drug resistance. Kinetics of drug binding is therefore also important for drug 
resistant mechanism. Especially, based on the decrease in association rate constants (Kon) of 
oseltamivir with H5N1 neuraminidase mutants (2.52 μM−1s−1 in the WT, 0.24 2.52 μM−1s−1 in 
H274Y and 1.1 2.52 μM−1s−1 in N294S mutants), we speculate that mutations also prevent 
drugs from entering the SA binding site. It is hoped that our observation of a possible binding 
pathway for oseltamivir will encourage further investigations that test the hypothesis posed 
here, by identifying whether the actual drug binding pathway follows this route. 
4. Identification of drug binding pathway 
4.1. Characteristics of the electrostatic surface potential of N1 neuraminidases 
shed light for further study on drug binding and drug resistance 
Up to this point, all proposed mechanisms for oseltamivir resistance have focused on the 
effects of the mutations on the SA binding site but little has been known about the effects of 
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those mutations on the kinetics of drug binding. Since both H274Y and N294S are nonactive 
site mutations, prior studies which focused on endpoint interactions between drug and 
proteins have been unable to provide a full understanding of how these mutations directly 
impact drug binding. In fact, given that the drug binding kinetics of H5N1 mutants are 
significantly diminished, it is possible that these mutations alter the binding process, and not 
necessarily just the specific endpoint interactions. It is well known that electrostatic surface 
potential of a protein can be an important driving force directing the diffusion of ligands into a 
protein’s active site. The resulting electrostatic maps shown in Figure 7A for H5N1 and Figure 
7B for H1N1pdm reveal a highly negatively charged column of residues that forms a pathway 
10 Å in length between the SA binding site and the edge of the binding cavity mouth. 
Electrostatic calculations also reveal that oseltamivir has a highly positive electrostatic surface 
potential, illustrated in Figure 7C. The question arises whether the negatively charged surface 
column plays a role in the binding and unbinding of oseltamivir, given a possible mutual 
attraction between oseltamivir and this column. To answer this question, we employed SMD 
simulations (described in the Methods section) to pull oseltamivir out of the SA binding site 
and probe possible unbinding pathways. Such simulations have  
  
Figure 7. Electrostatic surface potential of the SA binding pocket of H1N1pdm and oseltamivir. Shown 
in A) and B) are closeup views of the SA binding pocket with drug bound H1N1pdm and avian H5N1 
neuraminidase, respectively. The region of the binding pocket where the drug bound possesses a highly 
negative potential (colored red), whereas the opening of the pocket is surrounded by a highly positive 
potential ring (colored blue). In C), a detailed surface electrostatic potential for oseltamivir. Shown are 
the “front” side facing the annulus of the binding pocket, and “back” side facing the interior of the 
binding pocket is shown.  
4.2. Computational details 
Six systems were modelled and simulated for oseltamivir bound H5N1, and H1N1pdm wild 
type and H274Y and N294S mutants. In simSMD1, steered molecular dynamics (SMD) 
simulations were used to remove oseltamivir from its stable binding site in H5N1 
neuraminidase. In simFEQ1-10, equilibration simulations used a starting point generated 
from simSMD1 in which Oseltamivir has undergone an axial rotation such that it is partially 
displaced from its binding site. In total, 680 ns of simulations were carried out on system 
sizes of approximately 35,000 atoms. 
The “Ensemble” column lists the variables held constant during the simulations; N, p, T, 
and V correspond to the number of atoms, pressure, temperature, and volume respectively. 
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Under “Type”, EQ denotes equilibration, and SCV denotes constant velocity SMD 
simulation with the speed of 0.5 Å/ns. SimSMD1 is a steered MD simulation with the 
starting structure from equilibrated simEQ1 (“preflip” drug position). In simFEQ1 to 
simFEQ10, the starting structure reflected a “flipped” position of oseltamivir from simSMD1 
after 7.5ns of simulation, whereas several of its main stabilizing hydrogen bonds to the 
protein had already been ruptured. Crystallographically resolved water molecules and a 
structurally relevant calcium ion near the native binding site for SA were retained and 
modelled in all simulated systems. The protein complexes were then solvated in a TIP3P 
water box 23 and ionized by NaCl (0.152M) to mimic physiological conditions. 
All simulations were performed using NAMD 2.7 and the CHARMM31 force field 
(Mackerrel et al., 1998). The ionized systems were minimized for 10,000 integration steps 
and equilibrated for 20 ns with 1 fs time steps. Following this, a 20 ns unconstrained 
equilibration production run was performed for subsequent trajectory analysis, with frames 
stored after each picosecond (every 1000 time steps). Constant temperature (T = 300 K) was 
enforced using Langevin dynamics with a damping coefficient of 1 ps−1. Constant pressure 
(p = 1 atm) was enforced using the Nose´-Hoover Langevin piston method with a decay 
period of 100 fs and a damping time constant of 50 fs. Van der Waals interaction cut-off 
distances were set at 12Å, (smooth switching function beginning at 10 Å) and long-range 
electrostatic forces were computed using the particle-mesh Ewald (PME) summation 
method with a grid size of less than 1Å, along with the pencil decomposition protocol where 
applicable. SMD simulations fixed the center of mass of neuraminidase -carbons and 
applied a force to the center of mass of oseltamivir, along a vector connecting the two 
centers of masses. In simSMD1, a constant velocity protocol was employed, with stretching 
velocity of 0.5Å/ns. For the SMD spring constant we chose kSMD = 3kBT/Å2 which 
corresponds to an RMSD value of (pkBT/kSMD)1/2 < 0.6 Å. 
4.3. Results 
To simulate the binding of the drug would be the most natural approach, but the 
computations would be rather expensive. It is possible to the put drug in front of the 
receptor active site and the attraction forces between the drug and the receptor will drive it 
to the binding site. This process usually requires microsecond simulations and there is a 
high chance that the drug will fluctuate around the water box. Unbinding simulations 
however are feasible and may also reveal features that are characteristic for binding. In 
simSMD1, a pulling force was applied to rupture all the stabilizing hydrogen bonds 
between H5N1 and oseltamivir, in order to draw the drug away from the SA binding site. 
The results of simSMD1 show that the behaviour of oseltamivir under effect of a pulling 
force can be divided into three distinct stages: 1) from 0 to 8 ns, a buildup of forces during 
which hydrogen bonds between oseltamivir with E119, D151 and R152 are destabilized; 2) at 
8 ns where the remaining stable hydrogen bonds with R292 and R371 rupture; 3) after 8 ns 
during which the drug is pulled out of the binding pocket. Figure 8 shows the force 
dependent rupture of hydrogen bonds in simSMD1 by plotting both hydrogen bond 
stability and (in inset) the force vs. time curve. To our surprise, it was observed that  
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those mutations on the kinetics of drug binding. Since both H274Y and N294S are nonactive 
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type and H274Y and N294S mutants. In simSMD1, steered molecular dynamics (SMD) 
simulations were used to remove oseltamivir from its stable binding site in H5N1 
neuraminidase. In simFEQ1-10, equilibration simulations used a starting point generated 
from simSMD1 in which Oseltamivir has undergone an axial rotation such that it is partially 
displaced from its binding site. In total, 680 ns of simulations were carried out on system 
sizes of approximately 35,000 atoms. 
The “Ensemble” column lists the variables held constant during the simulations; N, p, T, 
and V correspond to the number of atoms, pressure, temperature, and volume respectively. 
Incorporating Molecular Dynamics Simulations  
into Rational Drug Design: A Case Study on Influenza a Neuraminidases 175 
Under “Type”, EQ denotes equilibration, and SCV denotes constant velocity SMD 
simulation with the speed of 0.5 Å/ns. SimSMD1 is a steered MD simulation with the 
starting structure from equilibrated simEQ1 (“preflip” drug position). In simFEQ1 to 
simFEQ10, the starting structure reflected a “flipped” position of oseltamivir from simSMD1 
after 7.5ns of simulation, whereas several of its main stabilizing hydrogen bonds to the 
protein had already been ruptured. Crystallographically resolved water molecules and a 
structurally relevant calcium ion near the native binding site for SA were retained and 
modelled in all simulated systems. The protein complexes were then solvated in a TIP3P 
water box 23 and ionized by NaCl (0.152M) to mimic physiological conditions. 
All simulations were performed using NAMD 2.7 and the CHARMM31 force field 
(Mackerrel et al., 1998). The ionized systems were minimized for 10,000 integration steps 
and equilibrated for 20 ns with 1 fs time steps. Following this, a 20 ns unconstrained 
equilibration production run was performed for subsequent trajectory analysis, with frames 
stored after each picosecond (every 1000 time steps). Constant temperature (T = 300 K) was 
enforced using Langevin dynamics with a damping coefficient of 1 ps−1. Constant pressure 
(p = 1 atm) was enforced using the Nose´-Hoover Langevin piston method with a decay 
period of 100 fs and a damping time constant of 50 fs. Van der Waals interaction cut-off 
distances were set at 12Å, (smooth switching function beginning at 10 Å) and long-range 
electrostatic forces were computed using the particle-mesh Ewald (PME) summation 
method with a grid size of less than 1Å, along with the pencil decomposition protocol where 
applicable. SMD simulations fixed the center of mass of neuraminidase -carbons and 
applied a force to the center of mass of oseltamivir, along a vector connecting the two 
centers of masses. In simSMD1, a constant velocity protocol was employed, with stretching 
velocity of 0.5Å/ns. For the SMD spring constant we chose kSMD = 3kBT/Å2 which 
corresponds to an RMSD value of (pkBT/kSMD)1/2 < 0.6 Å. 
4.3. Results 
To simulate the binding of the drug would be the most natural approach, but the 
computations would be rather expensive. It is possible to the put drug in front of the 
receptor active site and the attraction forces between the drug and the receptor will drive it 
to the binding site. This process usually requires microsecond simulations and there is a 
high chance that the drug will fluctuate around the water box. Unbinding simulations 
however are feasible and may also reveal features that are characteristic for binding. In 
simSMD1, a pulling force was applied to rupture all the stabilizing hydrogen bonds 
between H5N1 and oseltamivir, in order to draw the drug away from the SA binding site. 
The results of simSMD1 show that the behaviour of oseltamivir under effect of a pulling 
force can be divided into three distinct stages: 1) from 0 to 8 ns, a buildup of forces during 
which hydrogen bonds between oseltamivir with E119, D151 and R152 are destabilized; 2) at 
8 ns where the remaining stable hydrogen bonds with R292 and R371 rupture; 3) after 8 ns 
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Figure 8. Distances between hydrogen bond acceptor-donor pairs between oseltamivir and active site 
amino acids vs. simulation time in simSMD1. Most hydrogen bonds were quickly broken by the pulling 
force except for those with R292 and R371, which fully ruptured only after 8 ns, corresponding to the 
peak of the curve of the applied force vs. simulation time (shown in inset). Position of oseltamivir and 
all its possible hydrogen bonding pairs with residues located along this pathway, it was seen that 
nonspecific electrostatic attractions formed the predominant interactions between drug and protein.  
Oseltamivir followed a lateral escape path through strong interaction with the negatively 
charged column of residues indentified via electrostatic mapping above, despite application 
of force to pull the drug straight out of the binding pocket. This divergent path taken by the 
drug is shown in Figure 9A-D. A second notable observation in simSMD1 was that just 
before rupture of hydrogen bonds between oselvamivir’s carboxyl functional group and 
residues R292 and R371 of the binding pocket, the drug underwent a rather significant 
rotation due to the destabilization of hydrogen bonds with E119, D151 and R152. It is likely 
that this rotation or “flip” is crucial for placing oseltamivir in a position which permits it to 
leave the SA binding site. Despite application of force to pull oseltamivir straight out of its 
binding pocket, the drug followed a somewhat lateral path through the electrostatically 
charged funnel. The “preflip” or stably bound state for oseltamivir in H5N1 is shown in 
Figure 10A1, 10A2, 10A3, and the flipped transition state shown in Figure 10B1 and 10B2, 
10B3. 
It was observed in simSMD1 that following the transition to the flipped state, very little 
force was then required to subsequently draw oseltamivir out of its binding pocket in 
neuramidase. This result suggests that one may be able to probe the unbinding pathway via 
diffusion, if the starting state consists of oseltamivir already in its flipped orientation. We 
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therefore performed additional equilibrium simulations (simFEQ1-10) with oseltamivir 
already in this flipped state. From these simulations, we were able to observe two distinct 
outcomes: 1) oseltamivir is able to escape the binding pocket by interacting favourably with 
the charged binding funnel and 2) the drug returns, not unexpectedly, to its stably bound 
“preflip” state. Each simulation for FEQ1-10 was run long enough to observe either 
outcome, with the exception of FEQ5. SimFEQ5 was a special case in which the drug, after 
following the binding funnel to escape the protein, actually rebound to the SA active site 
through the same binding funnel after we extended the simulation to follow its movement. 
A summary of observed outcomes from these simulations is shown in Table 2. In simFEQ1-
5, oseltamivir successfully escaped the SA binding site, whereas in simFEQ6-10, oseltamivir 
returned to its stably bound “preflip” state. Oseltamivir was observed to diffuse out of the 
SA active site after strong interaction with the electrostatically charged binding funnel 
(described above) in five out of ten equilibrium simulations we performed (simFEQ1-5). 
 
Figure 9. Forced unbinding of oseltamivir from H5N1 neuraminidase. Shown here are the relative 
positions of oseltamivir on the electrostatic surface of avian H5N1 neuraminidase during simSMD1.At 0 
ns (A), oseltamivir was stably bound within the active site, as seen in simEQ1. Application of force 
ruptured the stabilizing hydrogen bonds between H5N1 and oseltamivir (see Figure 9), drawing the 
drug away from its stable binding site within 10 ns, as shown in B. Over the next 2.5 ns of pulling, 
oseltamivir followed the charged binding funnel (shown in C) until it was completely free of the protein 
binding pocket after 15 ns, as shown in D). 
In four of the cases (simFEQ1-3, 5) oseltamivir was observed to diffuse along the full length 
of the binding funnel before disassociating with neuraminidase. In simFEQ5 we observed 
not only a diffusion of oseltamivir through the charged binding funnel, but also the re-entry. 
Snapshots from each of these events in FEQ5 are shown in Figure 10. Analysis of 
interactions of the newly rebound oseltamivir with active site residues from 50 to 100 ns 
revealed that the drug was stabilized by hydrogen bonds with Y406, R292, D151, E119, and 
R118, even though the pentyl group had not yet moved to its requisite hydrophobic pocket 
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Figure 10. Oseltamivir in “flipped” position (position of oseltamivir at 7.5ns in simSMD1) in 
comparison with its stable equilibrium position,  
 
 
Name Result Time (ns) 
simFEQ1 Drug escape via binding funnel 15 
simFEQ2 Drug escape via binding funnel 10 
simFEQ3 Drug escape via binding funnel 15 
simFEQ4 Drug interaction with binding funnel but escape via 430-cavity 50 
simFEQ5 Drug escape and rebind into SA pocket via binding funnel 100 
simFEQ6 Drug returned to “preflip” position 10 
simFEQ7 Drug returned to “preflip” position 15 
simFEQ8 Drug returned to “preflip” position 50 
simFEQ9 Drug returned to “preflip” position 50 
simFEQ10 Drug returned to “preflip” position 50 
Table 2. Summary of FEQ1-10 simulations starting from “flipped” position of oseltamivir taken from 
simSMD1 at 7.5 ns. 
This image cannot currently be displayed.
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Figure 11. Escape and rebinding of oseltamivir through the electrostatic binding funnel in H5N1 
neuraminidase during simFEQ5. Shown here are snapshots of simFEQ5, in which oseltamivir first 
diffused out of the SA active site through interaction with the electrostatic binding funnel within the 
first 25ns of simulation. Between 28 and 35ns, oseltamivir diffuses and approaches the periphery of the 
binding pocket away from the binding funnel, but is prohibited from entering due to electrostatic 
repulsion (45ns). However, between 45 and 50ns, oseltamivir was observed to approach and enter the 
neuraminidase binding pocket through the binding funnel, adopting a stable position within the SA 
binding pocket through hydrogen bonds with Y406, R292, D151, E119, and R118. 
The result has shed light on the important role of the electrostatic surface potentials in 
directing the diffusion of oseltamivir into the SA binding site. From our simulations, it is 
clear that the negatively charged funnel serves as a prominent binding and unbinding 
pathway for oseltamivir in the wild type systems investigated with SMD and followup 
equilibrium simulations in simSMD1 and simFEQ1-10. It turns out also that the binding 
funnel may possibly play a crucial role in drug resistance caused by mutations. The 
conspicuous location of residue 294, which maps directly onto this negatively charged 
pathway, may play a key role in the N294S mutation for disrupting the proper guidance of 
the drug into its binding pocket. Thus, it is possible that the 274 and 294 mutations may 
confer drug resistance by not only disrupting the end-point interactions of oseltamivir but 
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also its entry into the binding pocket by interfering with the binding funnel. While sources 
 
Bioinformatics 180 
of end-point interactions, including hydrogen bonds, hydrophobic packing and solvent 
infiltration, of oseltamivir resistance have been thoroughly studied, little is known about the 
kinetics of the drug binding in mutants at atomic level. The idea that drug resistant mutants 
actually disrupt entry of oseltamivir into the SA active site of neuraminidase through 
disruption of an electrostatic binding funnel is in part supported by experiments which have 
noted reduced drug binding kinetics in H5N1 H274Y and N294S mutants. Even though the 
oseltamivir-resistant mutations were seen located in or adjacent to the funnel, clearly 
additional study is still needed for a full understanding of how the H274Y and N294S 
mutations weaken the binding of the drug. Furthermore, the mutations might not only affect 
the electrostatic gradient but also the geometry of the drug binding and unbinding path. 
Future or followup studies should therefore focus on the specific drug entry/exit pathways 
for oseltamivir-resistant mutant systems, sampling timescales great enough (such as in the 
case of simFEQ5 described above) to capture both the binding. 
5. Challenges and opportunities 
We have presented three important applications of MD simulation in drug design against 
influenza A virus. While MD simulation has been proven as a powerful tool complement to 
experiment in drug discovery processes, the problems in accuracy of drug parameter and 
limitation in time scale of MD simulation definitely affect applications of this tool. The 
challenge in drug force field development is that, unlike uniformed amino acids or 
nucleotides, each drug has its own structure and requires separate parameter. Since force 
field for general macromolecules have been well developed, attention should be shifted to 
development of adequately accurate drug force field (Wang et al., 2004; Zoete et al., 2012). 
Another challenge in MD simulation is limitation of time scale. Several important 
phenomena which are important for drug design application happen in the time scales 
that can’t be done by even the biggest supercomputers in the world. Over the past decade 
several methods were developed to speed up classical MD simulation including SMD, 
accelerated MD (Hamelberg et al., 2009), coarse-grained MD simulation (Izvekov et al., 
2005). Last but not least, the implementations of specialized hardware including CBE, 
GPU, and FPGA architectures are important to broaden application of MD simulation to 
modern drug discovery (Horacio et al., 2012). The recent finding of oseltamivir binding 
pathway using GPU acceleration and SMD (Le et al., 2010) is an example that the 
combined improvement of theoretical algorithm and specialized hardware architecture 
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1. Introduction 
To better understand the basis of the activity of any molecule with biological activity, it is 
important to know how this molecule interacts with its site of action, more specifically its 
conformational properties in solution and orientation for the interaction. Molecular 
recognition in biological systems relies on specific attractive and/or repulsive interactions 
between two partner molecules. This study seeks to identify such interactions between ligands 
and their host molecules, typically proteins, given their three-dimensional (3D) structures. 
Therefore, it is important to know about interaction geometries and approximate affinity 
contributions of attractive interactions. At the same time, it is necessary to be aware of the fact 
that molecular interactions behave in a highly non-additive fashion. The same interaction may 
account for different amounts of free energy in different contexts and any change in molecular 
structure might have multiple effects, so it is only reliable to compare similar structures. In 
fact, the multiple interactions present in a single two-molecule complex are a compromise 
between attractive and repulsive interactions. On the other hand, a molecular complex is not 
characterised by a single structure, as can be seen in crystal structures, but by an ensemble of 
structures. Furthermore, changes in the degree of freedom of both partners during an 
interaction have a large impact on binding free energy [Bissantz et al., 2010]. 
The availability of high-quality molecular graphics tools in the public domain is changing 
the way macromolecular structure is perceived by researchers, while computer modelling 
has emerged as a powerful tool for experimental and theoretical investigations. 
Visualisation of experimental data in a 3D, atomic-scale model can not only help to explain 
unexpected results but often raises new questions, thereby affecting future research. Models 
of sufficient quality can be set in motion in molecular dynamic (MD) simulations to move 
beyond a static picture and provide insight into the dynamics of important biological 
processes. 
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Computational methods have become increasingly important in a number of areas such as 
comparative or homology modelling, functional site location, characterisation of ligand-
binding sites in proteins, docking of small molecules into protein binding sites, protein-
protein docking, and molecular dynamic simulations [see for example Choe & Chang, 2002]. 
Current results yield information that is sometimes beyond experimental possibilities and 
can be used to guide and improve a vast array of experiments.  
To apply computational methods in drug design, it is always necessary to remember that to 
be effective, a designed drug must discriminate successfully between the macromolecular 
target and alternative structures present in the organism. The last few years have witnessed 
the emergence of different computational tools aimed at understanding and modelling this 
process at the molecular level. Although still rudimentary, these methods are shaping a 
coherent approach to help in the design of molecules with high affinity and specificity, both 
in lead discovery and in lead optimisation. Moreover, current information on the 3D 
structure of proteins and their functions provide a possibility to understand the relevant 
molecular interactions between a ligand and a target macromolecule. As a consequence, a 
comprehensive study of drug structure–activity relationships can help identify a 3D 
pharmacophore model as an aid for rational drug design, as a pharmacophore model can be 
defined as ‘an ensemble of steric and electronic features that is necessary to ensure the 
optimal supramolecular interactions with a specific biological target and to trigger (or block) 
its biological response’, and a pharmacophore model can be established either in a ligand-
based manner, by superposing a set of active molecules and extracting common chemical 
features that are essential for their bioactivity, or in a structure-based manner, by probing 
possible interaction points between the macromolecular target and ligands. 
Molecular recognition (MR) is a general term designating non-covalent interactions between 
two or more compounds belonging to host-guest, enzyme-inhibitor and/or drug-receptor 
complexes. A rigorous approach to an MR study should involve the adoption of a 
computational method independent from the chemical intuition of the researcher. Drug 
design purposes prompt another challenging feature of such an ideal computational 
method, the ability to make sufficiently accurate thermodynamic predictions about the 
recognition process. 
2. Molecular modelling methods and their usefulness 
Molecular recognition is a central phenomenon in biology, for example, with enzymes and 
their substrates, receptors and their signal inducing ligands, antibodies and antigens, among 
others. Given two molecules with 3D conformations in atomic detail, it is important to know 
if the molecules bind to each other and, if it is so, what does the formed complex look like 
(“docking”) and how strong is the binding affinity (that can be related to the 
“scoring”functions). 
Molecules are not rigid. The motional energy at room temperature is large enough to let all 
atoms in a molecule move permanently. That means that the absolute positions of atoms in a 
molecule, and of a molecule as a whole, are by no means fixed, and that the relative location 
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of substituents on a single bond may vary with time. Therefore, any compound containing 
one or several single bonds exists at every moment in many different conformers, but 
generally only low energy conformers are found to a large extent [Kund, 1997, as cited in 
Tóth et al., 2005]. 
The biological activity of a drug molecule is supposed to depend on one single unique 
conformation amongst all the low energy conformations, the search for this so-called 
bioactive conformation for compound sets being one of the major tasks in Medicinal 
Chemistry. Searching for all low energy conformations is possible with molecular modelling 
studies, since molecular modelling is concerned with the description of the atomic and 
molecular interactions that govern microscopic and macroscopic behaviours of physical 
systems. These molecular interactions are classified as: (a) bonded (stretching, bending and 
torsion), (b) non-bonded (electrostatic (including interactions with metals), van der Waals 
and π-stacking), and (c) derived, as they result from the previous ones (hydrogen bonds and 
hydrophobic effect). 
Protein-ligand or, in general, molecule-molecule binding free energy differences can a priori 
be computed from first principles using free energy perturbation techniques and a full 
atomic detailed model with explicit solvent molecules using molecular dynamics 
simulations. However, these are computationally demanding. More affordable approaches 
use end-point molecular dynamic simulations and compute free energies accounting for 
solvent effects with continuum methods, such as MM-PBSA (molecular mechanics Poisson-
Boltzman surface area) or MM-GBSA (generalized Born surface area) [Kollman et al., 2000; 
Wang et al., 2005]. One of the first approaches was comparative molecular field analysis 
(CoMFA) [Cramer et al., 1988], which enabled interpretation and understanding of enzyme 
active sites when the crystal structure was absent. However, this type of analysis was not 
possible until in vitro drug-drug interaction studies were widely used (through the 1990s). 
2.1. Molecular mechanics, molecular dynamics and docking 
Molecular mechanics (MM) is often the only feasible means with which to model very large 
and non-symmetrical chemical systems such as proteins and polymers. Molecular 
mechanics is a purely empirical method that neglects explicit treatment of electrons, relying 
instead on the laws of classical physics to predict the chemical properties of molecules . As a 
result, MM calculations cannot deal with problems such as bond breakage or formation, 
where electronic or quantum effects dominate. Furthermore, MM models are wholly 
system-dependent. MM energy predictions tend to be meaningless as absolute quantities, as 
the zero or reference value depends on the number and types of atoms and their 
connectivity, and so they are generally useful only for comparative studies. A force field is 
an empirical approximation for expressing structure-energy relationships in molecules and 
is usually a compromise between speed and accuracy. 
Molecular mechanics have been shown to produce more realistic geometry values for the 
majority of organic molecules, owing to the fact that they are highly parameterised. 
Parameterisation of structures should be performed with care and non-“standard” 
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molecules will need to have new parameters. This is usually done by analogy for bonded 
terms and assigning charges by a procedure consistent with the used force field. 
There are many levels of theory in which computational models of 3D structures can be 
constructed. The overall aim of modelling methods is often to try to relate biological activity 
to structure. An important step towards this goal is to be able to compute the potential 
energy of the molecule as a function of the position of the constituent atoms. Once a method 
for evaluating the molecular potential energy is available, it is natural to search for an 
optimum molecular geometry by minimising the energy of the system. In a biological 
macromolecule, the potential energy surface is a complicated one, in which there are many 
local energy minima as well as a single overall energy minimum. All the energy 
minimisation algorithms commonly used have a marked tendency to locate only a local 
energy minimum that is close to the starting conformation. For a biological macromolecule, 
the number of conformations that have to be searched rises exponentially with the size of 
the molecule; hence, systematic searching is not a practical method for large molecules. 
Molecular dynamics (MD) is a conformation space search procedure in which the atoms of a 
biological macromolecule are given an initial velocity and are then allowed to evolve in time 
according to the laws of Newtonian mechanics [van Gunsteren & Berendsen, 1977]. 
Depending on the simulated temperature of the system, the macromolecule can then 
overcome barriers at the potential energy surface in a way that is not possible with a 
minimisation procedure. One useful combination of molecular dynamics and minimisation 
schemes is a method known as simulated annealing [Kirkpatrick et al, 1983, Černý, 1985]. 
This method uses a molecular dynamics calculation in which the system temperature is 
raised to a high value to allow for a widespread exploration of the available conformational 
space. The system temperature is then gradually decreased as further dynamics are 
performed. Finally, a minimisation phase may be used to select a minimum energy 
molecular conformation. 
One of the most important applications of molecular modelling techniques in structural 
biology is the simulation of the docking of a ligand molecule onto a receptor. These methods 
often search to identify the location of the ligand binding site and the geometry of the ligand 
in the active site, to get the correct ranking when considering a series of related ligands in 
terms of their affinity, or to evaluate the absolute binding free energy as accurately as 
possible. To select a force field and the adequate modelling methodology for a given task, it 
is important to appreciate the range of molecular systems to which it is applicable and the 
types of simulations that can be performed. 
2.2. Most used existing force fields 
AMBER (Assisted Model Building with Energy Refinement) developed by Kollman et al. 
[http://ambermd.org/] was originally parameterised specifically for proteins and nucleic 
acids [Weiner et al., 1984, 1986; Cornell et al., 1995], using 5 bonding and non-bonding terms 
along with a sophisticated electrostatic treatment and with no cross terms included. The 
results obtained with this method can be very good for proteins and nucleic acids, but less 
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so for other systems, although parameters that enable the simulation of other systems have 
been published [for examples see Doshi & Hamelberg, 2009; Zgarbová et al., 2011]. 
CHARMM (Chemistry at HARward Macromolecular Mechanics) developed by Karplus et 
al. [http://www.charmm.org] was originally devised for proteins and nucleic acids [Brooks 
et al., 1983], and is now used for a range of macromolecules, molecular dynamics, solvation, 
crystal packing, vibrational analysis and QM/MM (quantum mechanics/molecular 
mechanics) studies. It uses five valence terms, one of which is electrostatic and is a basis for 
other force fields (e.g., MOIL [Elber et al., 1995]). 
GROMOS (Groningen Molecular Simulation) developed at the University of Groningen and 
the ETH (Eidgenössische Technische Hochschule) of Zurich [http://www.igc.ethz. 
ch/GROMOS/index] is quite popular for predicting the dynamical motion of molecules and 
bulk liquids, also being used for modelling biomolecules. It uses five valence terms, one of 
which is electrostatic [van Gunsteren and Berendsen., 1977]. Its parameters are currently 
being updated [Horta et al., 2011]. 
MM1-4 (Molecular Mechanics) developed by Allinger [1976] are general purpose force fields 
for monofunctional organic molecules. The first version of this method was the MM1 
[Allinger, 1976]. MM2 was parameterised for a lot of functional groups while MM3 [Allinger & 
Durkin, 2000; Allinger & Yan, 1993] is probably one of the most accurate ways of modelling 
hydrocarbons. MM4 is the latest version with several improvements [Allinger et al., 1996]. 
MMFF (Merck Molecular Force Field) developed by Halgren [1996] is also a general purpose 
force field mainly for organic molecules. MMFF94 [Halgren, 1996] was originally designed 
for molecular dynamics simulations, but has also been widely used for geometrical 
optimisation. It uses five valence terms, one of which is electrostatic and another is a cross 
term. MMFF was parameterised based on high level ab initio calculations. MMFF94 contains 
parameters for a wide variety of functional groups that arise in Organic and Medicinal 
Chemistry. 
OPLS (Optimized Potential for Liquid Simulations) developed by Jorgensen at Yale 
[http://zarbi.chem.yale.edu] was designed for modelling bulk liquids [Jorgensen & Tirado-
Rives, 1996] and has been extensively used for modelling the molecular dynamics of 
biomolecules. It uses five valence terms, one of which is an electrostatic term and none of 
them is a cross term. 
TRIPOS (Sybil force field) is a commercial method designed for modelling organics and 
biomolecules. It is often used for CoMFA analysis and uses five valence terms, one of which 
is an electrostatic term. 
CVFF (Consistent Valence Force Field) developed by Dauber-Osguthorpe is a method 
parameterised for small organic (amides and carboxylic acids, among others) crystals and 
gas phase structures [Dauber-Osguthorpe et al., 2004]. It handles peptides, proteins and a 
wide range of organic systems. It was primarily intended for studies of structures and 
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2.3. Popular docking programs 
One of the most important and useful areas of application of molecular modelling is the 
approach of docking a protein onto a second molecule, typically a small ligand. This is of 
interest because it models the possible interactions between the protein and the ligand in the 
formation of a biologically important protein-ligand complex. To perform a computational 
docking, experimental or model 3D structures of both the protein and ligand molecules are 
required together with the charge distribution for each molecule. 
There are several software programs that are available for carrying out docking calculations, 
only some of them will be considered here. The DOCK program suite [Kuntz, 1992] is one of 
the best known. First of all, a set of overlapping spheres are used in the program to 
construct a negative image of a specified site on the protein or another macromolecule, and 
the negative image is then matched against structures of potential ligands. Matches can be 
scored in this program by the quality of the geometric fit, as well as by the molecular 
mechanics interaction energy [Meng et al., 1992] and can lead to protein-binding ligands 
that have micromolecular levels of binding affinity [Kuntz et al., 1994]. It has also been used 
for modelling protein-protein docking [Shoichet & Kuntz, 1996]. 
The program GRID [Goodford, 1985] identifies likely protein binding sites for ligands 
[Reynolds et al., 1989; Cruciani & Goodford, 1994] using a 3D grid around the protein. 
The program AutoDock developed by Morris et al.; [http://www.scripps.edu/pub/olson-
web/doc/autodock/] uses a grid-based scheme for energies of individual atoms, allowing a 
quick computation of the interaction energy of the protein-ligand complex as the interaction 
between the ligand and the grid. 
GLIDE software [Friesner et al., 2004, 2006; Halgren et al., 2004] also uses a grid-based 
scheme to represent the shape and properties of the receptor and then uses a systematic 
search algorithm to produce a set of initial conformations, using a OPLS-AA force field for 
ligand minimisation in the field of the receptor. 
SURFLEX [Jain, 2003, 2007] is a fully automatic flexible molecular docking algorithm that 
presents results evaluated for reliability and accuracy in comparison with crystallographic 
experimental results on 81 protein/ligand pairs of substantial structural diversity. 
In a recent study, comparison of seven popular docking programs [Plewczynski et al., 2011] 
clearly showed that the ligand binding conformation could be identified in most cases by 
using the existing software. Yet, there is still the lack of universal scoring function for all 
types of molecules and protein families. One can always hope that incremental 
improvements in current techniques will gradually lead to major advances in this field.  
3. The solvent and how to model it 
Solvation plays an important role in ligand-protein association and has a strong impact on 
comparisons of binding energies for dissimilar molecules. The binding affinity of a ligand 
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for a receptor (ΔGbind) depends on the interaction free energy of the two molecules relative 
to their free energy in solution: 
 ΔGbind = ΔGinteract – ΔGsolv,L - ΔGsolv,R (1) 
where ΔGinteract is the interaction free energy of the complex, ΔGsolv,L is the free energy of 
desolvating the ligand, and ΔGsolv,R is the free energy of occluding the receptor site from the 
solvent. Various methods have been proposed to evaluate or estimate these terms. The 
problem is difficult because the energy of each component on the right hand side of 
Equation 1 is large while the difference between them is small. 
An accurate way to calculate relative binding energies is with free-energy perturbation 
techniques, although they are usually restricted to calculating the differential binding of 
similar compounds and require extensive computation, making it impractical as an initial 
screen, but quite useful sometimes [Buch et al., 2011; Reddy & Erion, 2007]. Several authors 
have described force fields that consider the bound and solvated states [see for example 
Chen et al., 2008; Moon & Howe, 1991], successfully predicting new ligands and also the 
structures of ligand-receptor complexes [Wilson et al., 1991]. 
When calculating interactions in congeneric series, the cost in electrostatic free energy of 
desolvating both the enzyme binding site and the burial part of the ligand (ΔGdesolv) is 
roughly constant within the series. This is particularly true when the calculation is done 
partitioning the electrostatic free energy contributions into a van der Waals term from the 
molecular mechanics force field, and an electrostatic contribution computed using a 
continuum method [Checa et al., 1997]. For that reason, it has been proposed to  neglect 
ΔGdesolv  in earlier studies. 
The binding energy between ligand and receptor is approximated to the interaction 
enthalpy calculated by means of empirical energy functions that represent van der Waals 
repulsion, dispersion interactions by a Lennard-Jones term, and electrostatic interactions in 
the form of a Coulomb term that uses atom-centred point charges [Ajay & Murcko, 1995]. In 
most cases, these calculations of molecular mechanics are performed on a structure that is 
taken to represent the ensemble average of each complex. Entropy contributions are usually 
ignored although solvation terms are sometimes added to the scoring function by 
calculating changes in buried nonpolar surface area [Viswanadhan et al., 1999] or 
differences in the ease of desolvation of both the ligand and the binding site upon complex 
formation [Checa et al., 1997]. Molecular mechanics-based QSAR studies on ligand-receptor 
complexes can benefit greatly from proper incorporation of solvation effects into a 
COMBINE framework based on residue-based interaction energy decomposition [Pérez et 
al., 1998]. 
The relevance of solvation in modulating the biological activity of drugs is well known 
[Orozco & Luque, 2000]. In the last years, theoretical methods have been developed to 
calculate fragment contributions to the solvation free energy, particularly in the framework 
of quantum mechanical (QM) continuum solvation methods [Klamt et al., 2009]. Thus, 
fractional methods based on GB/SA methods have been developed [Cramer & Truhlar, 
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clearly showed that the ligand binding conformation could be identified in most cases by 
using the existing software. Yet, there is still the lack of universal scoring function for all 
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improvements in current techniques will gradually lead to major advances in this field.  
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When calculating interactions in congeneric series, the cost in electrostatic free energy of 
desolvating both the enzyme binding site and the burial part of the ligand (ΔGdesolv) is 
roughly constant within the series. This is particularly true when the calculation is done 
partitioning the electrostatic free energy contributions into a van der Waals term from the 
molecular mechanics force field, and an electrostatic contribution computed using a 
continuum method [Checa et al., 1997]. For that reason, it has been proposed to  neglect 
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of quantum mechanical (QM) continuum solvation methods [Klamt et al., 2009]. Thus, 
fractional methods based on GB/SA methods have been developed [Cramer & Truhlar, 
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2008], as well as those based on the MST(Miertus-Scrocco-Tomasi) solvation method model 
[Soteras et al., 2004]. 
An explicit solvent model includes individual solvent molecules and calculates the free 
energy of solvation by simulating solute-solvent interactions. It requires an empirical 
interaction potential between the solvent and the solute, and between the solvent molecules, 
usually involving Monte Carlo (MC) calculations and/or molecular dynamics. MC 
calculations can be used to compute free energy differences and radial distribution 
functions, among others, and cannot be used to compute time-dependent properties such as 
diffusion coefficients or viscosity. MD simulations, on the other hand, can be used to 
compute free energies and time-dependent properties, transport properties, correlation 
functions, and others. 
An implicit solvent model treats solvent as a polarisable continuum with a dielectric 
constant, , instead of explicit solvent molecules. The charge distribution of the solute 
polarises the solvent, producing a reaction potential that alters the solute. This interaction is 
represented by a solvent reaction potential introduced into the Hamiltonian. As interactions 
should be self consistently computed, they are also known as self-consistent reaction field 
(SCRF) methods [Onsager, 1936]. These models are significantly easier than explicit solvent 
models, but cannot model specific interactions such as hydrogen bonds. 
Changes in hydration free energy during complex formation are a crucial element of 
binding free energies [Gilson & Zhou, 2007]. With the use of methods to predict binding free 
energies becoming common-place in the field of drug design, there is still a need for 
solvation methods that are both quick and accurate [Mancera, 2007], although much 
research has been carried out on the improvement of existing methods and development of 
new solvation models at many levels of theory [Chambers et al., 1996; Gallicchio et al., 2002; 
Palmer et al., 2011]. 
Explicit solvation models such as free energy perturbation (FEP), thermodynamic 
integration (TI) [Gilson & Zhou, 2007; Khavertskii & Wallquist, 2010] and the faster linear 
interaction energy (LIE) [Aqvist et al., 1994; Carlson & Jorgensen, 1995] offer detail on the 
distinct nature of water around the solute and are transferable across a wide range of data 
sets, although there is a lack of throughput in the field of drug design. 
Implicit solvation models offer a faster alternative to explicit models by replacing the 
individual water molecules with a continuous medium [Baker, 2005; Chen et al., 2008], 
combining the hydration free energy density and group contribution [Jäger & Kast, 2001], 
or, more recently, calculating solvation free energy directly from the molecular structure 
[Delgado & Jaña, 2009]. For small organic molecules, the loss of molecular detail of the 
solvent results in relatively small differences between hydration free energy prediction 
accuracies calculated with explicit solvent models relative to the explicit treatment [Mobley 
et al., 2009; Nicholls et al., 2009]. To cope with some of these pitfalls, the variational implicit 
solvent model (VISM) has been proposed for calculating the solute/water interface where 
established models fail [Dzubiella et al., 2006a, 2006b]. 
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It is sometimes possible to get quite accurate results with very simple models, such as the 
case of the molecular modellisation of phenethylamine carriers conducted in our lab. 
Calculations were carried out using chloride anion to mimic the picrate anion used in 
experimental measurements and with no explicit solvent molecules. The chloroform 
environment was simulated by a constant dielectric factor, as this solvent has a low 
dielectric constant and thus, interactions should not end quickly with the distance 
[Campayo et al., 2005]. When complexation takes place in water as the solvent, the 
environment is simulated by a distance-dependent dielectric factor, as it takes into account 
the fact that the intermolecular electrostatic interactions should vanish with distance faster 
than in the gas phase. This assumption proves to work as it gives theoretical results in good 
agreement with experimental transportation values [Miranda et al., 2004; Reviriego et al., 
2008]. Results for theoretical interactions have been supported by NMR experiments. 
When applied to complex biomolecular systems, this loss of detail may become problematic 
in locations where water does not behave as a continuum medium, for example, the 
individual water molecules occurring in concave pockets at the surfaces of proteins [Li & 
Lazaridis, 2007]. The ELSCA (Energy by Linear Superposition of Corrections 
Approximation) method [Cerutti et al., 2005] has also been proposed for the rapid 
estimation of solvation energies. This procedure calculates the electrostatic and apolar 
solvation energy of bringing two proteins into close proximity or into contact compatible 
with the AMBER ff99 parameter set. The method is most useful in macromolecular docking 
and protein association simulations. 
Solvent treatment is also of considerable interest in MD simulations as the solvent molecules 
(usually water, sometimes co-solvent and counterions/buffer or salt for electrolyte solutions) 
enter pockets and inner cavities of the proteins through their conformational changes. This 
is a very slow process and nearly as difficult to model as protein solving. One solution to 
this problem is using an efficient coupling of molecular dynamics simulation with the 3D 
molecular theory of solvation (3D-RISM-KH), contracting the solvent degrees of freedom 
[Luchko et al., 2010] or using free energy perturbation and OPLS force field together with 
molecular dynamics [Shivakumer et al., 2010]. 
4. Molecule-molecule or ion-molecule interactions in active molecule 
design 
Non-covalent interactions are central to biological structure and function. In considering 
potential interactions of molecules and/or ions and their receptor, the focus has been on 
hydrophobic interactions, hydrogen bonding and ion pairing. Although hydrogen bonds are 
by far the most important interactions in biological recognition processes, the cation-π 
interaction is a general, strong, non-covalent binding force that occurs throughout nature, 
being energetically comparable or stronger than a typical hydrogen bond. 
Cooperativity in multiple weak bonds (hydrogen bond and ion-π interactions among 
others) has been considered and studied at the MP2/6-311++ G(d,p) computational level 
 
Bioinformatics 192 
2008], as well as those based on the MST(Miertus-Scrocco-Tomasi) solvation method model 
[Soteras et al., 2004]. 
An explicit solvent model includes individual solvent molecules and calculates the free 
energy of solvation by simulating solute-solvent interactions. It requires an empirical 
interaction potential between the solvent and the solute, and between the solvent molecules, 
usually involving Monte Carlo (MC) calculations and/or molecular dynamics. MC 
calculations can be used to compute free energy differences and radial distribution 
functions, among others, and cannot be used to compute time-dependent properties such as 
diffusion coefficients or viscosity. MD simulations, on the other hand, can be used to 
compute free energies and time-dependent properties, transport properties, correlation 
functions, and others. 
An implicit solvent model treats solvent as a polarisable continuum with a dielectric 
constant, , instead of explicit solvent molecules. The charge distribution of the solute 
polarises the solvent, producing a reaction potential that alters the solute. This interaction is 
represented by a solvent reaction potential introduced into the Hamiltonian. As interactions 
should be self consistently computed, they are also known as self-consistent reaction field 
(SCRF) methods [Onsager, 1936]. These models are significantly easier than explicit solvent 
models, but cannot model specific interactions such as hydrogen bonds. 
Changes in hydration free energy during complex formation are a crucial element of 
binding free energies [Gilson & Zhou, 2007]. With the use of methods to predict binding free 
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new solvation models at many levels of theory [Chambers et al., 1996; Gallicchio et al., 2002; 
Palmer et al., 2011]. 
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Implicit solvation models offer a faster alternative to explicit models by replacing the 
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combining the hydration free energy density and group contribution [Jäger & Kast, 2001], 
or, more recently, calculating solvation free energy directly from the molecular structure 
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[Alkorta et al., 2010]. Due to the presence of a great number of aromatic rings containing 
heteroatoms in biological systems, this effect might be important and help to understand 
some biological processes where the interplay between both interactions may exist. 
Computer-assisted drug design (CADD) has contributed to the successful discovery of 
numerous novel enzyme inhibitors, having been used to predict the binding affinity of an 
inhibitor designed from a lead compound prior to synthesis [Reddy & Erion, 2005]. A free 
energy simulation technique known as the thermodynamic cycle perturbation (TCP) 
approach [Reddy et al., 2007], used together with calculations of molecular dynamics, offers 
a theoretically precise method to determine the binding free energy differences of related 
inhibitors. 
Many small molecules are transported across cell membranes by large integral membrane 
proteins, which are referred generically as transporters. Selection among competing 
alternatives is always interesting and cation-π interactions are strongly involved in substrate 
recognition by many transporters. Drug transporters are able to carry small molecules or 
ions across membranes, being an important target for pharmaceutical development 
[Zacharias & Dougherty, 2002]. 
The regulation of metal ions plays a major role in enzymes, allowing to catalyse a range of 
biological reactions. Identification and characterisation of the metal ion binding sites and 
their selectivity have received immense attention over the past few decades [Ma & 
Dougherty, 1997]. It is evident from earlier studies that metal ions can bind to aromatic 
groups in a covalent as well as non-covalent fashion. Non-covalent interactions between 
metal ions and an aromatic ring, which are considered strong cation-aromatic interactions, 
are increasingly being recognised as an important binding force relevant to structural 
biology [Meyar et al., 2003; Elguero et al., 2009]. However, in many cases, the cation is the 
side chain protonated nitrogen of a basic amino acid. Reddy et al. have made available a 
web-based cation-aromatic database (CAD) including metal ions and basic amino acids 
[Reddy et al., 2007b]. 
Macrocyclic entities that act as ion receptors and carriers exhibit a large number of 
conformations in crystals and solutions, depending on the nature of their environments and 
of the complexed ion. To ensure the formation of the most favourable cavity for a given ion, 
as well as to enhance the binding and release of the ion during transport at interfaces, 
flexibility in the ligand structure is of utmost importance. 
Complexation studies of ions with macrocycles are well documented in the literature. Some 
representative trends in these studies would include the following: taking into account the 
existence of hydrogen-bonded water molecules [Hill & Feller, 2000; Durand et al., 2000; 
Fantoni, 2003] and sometimes using molecular dynamics and free energy perturbation 
studies [Varnek et al., 1999]. The complexation phenomena have also been studied in cases 
where the ligand can exist as different conformers able to complex the cation [Hashimoto & 
Ikuta, 1999]. 
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One of the most important aspects of ion complexation is ion selectivity, which is considered 
in terms of the more or less favourable binding energies. The binding energy (BE) is defined 
as the difference between the energy of the complex and the energy of the free ligand and 
ion: 
 BE = Ecomplex – (Eion + Eligand) (2) 
Metal ion affinity is enhanced if the host molecule has a unique conformation that is optimal 
for complexation, that is, with all the binding sites positioned to structurally complement 
the metal ion [Lumetta et al., 2002]. 
Density functional theory based on electronic structure calculations is computationally 
affordable. It has very good predictability power for various structural and thermodynamic 
properties of a molecular system, and has therefore been used to model M+-crown ether 
complexes [Ali et al., 2008] and collarenes acting as ionophores and receptors [Choi et al., 
1998]. In both cases, the most stable equilibrium structure for complexes are estimated based 
on PM3 semi-empirical calculations followed by B3LYP calculations using the G-
311++G(d,p) basis set of functions. Currently, the Protein Data Bank (PDB) contains over 
25,000 structures that contain a metal ion. Thus, methodologies to incorporate metal ions 
into the AMBER force field have been developed there [Hoops et al., 1991; Reichert et al., 
2001; Peters et al., 2010].  
Molecular modellisation of Cu(II) and Zn(II) coordination complexes has been studied by 
our research group, among many others. The parameters used by us were checked against a 
known X-ray structure and the data obtained agreed quite well with similar deviations 
published for other theoretical results [Miranda et al., 2005]. The models obtained were 
useful in explaining the differences observed among the complexes obtained in different 
environments. Our cation metal parameters have also been used to help in the data 
elucidation of coordination metal complex structures [Rodríguez-Ciria, 2000; Rodríguez-
Ciria et al., 2002]. 
Coordination and complexation of ions by aromatic moieties have been studied, taking into 
account the different characteristics of the electronic charge distribution on the aromatic 
frame as an addition of coulombic potentials [Albertí et al., 2010]. This type of interaction is 
quite common in biology as signalling in the nervous system is generally mediated by the 
binding of small molecules (neurotransmitters) to the appropriate receptors, which usually 
contain a cationic group at physiological pH.  
An organic ammonium ion never exists as a sole cation; an anion is always associated with 
it. Depending on the polarity and hydrogen donor/acceptor abilities of the solvent, the 
association strength is different [Marcus & Hefter, 2006]. Strongly coordinating counter ions 
such as chloride generally lead to weaker binding constants upon recognition of the 
associated cation, when compared to weakly coordinating counterions such as iodide or 
perchlorate [Gevorkyan et al., 2001]. 
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Molecular modellisation of Cu(II) and Zn(II) coordination complexes has been studied by 
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published for other theoretical results [Miranda et al., 2005]. The models obtained were 
useful in explaining the differences observed among the complexes obtained in different 
environments. Our cation metal parameters have also been used to help in the data 
elucidation of coordination metal complex structures [Rodríguez-Ciria, 2000; Rodríguez-
Ciria et al., 2002]. 
Coordination and complexation of ions by aromatic moieties have been studied, taking into 
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frame as an addition of coulombic potentials [Albertí et al., 2010]. This type of interaction is 
quite common in biology as signalling in the nervous system is generally mediated by the 
binding of small molecules (neurotransmitters) to the appropriate receptors, which usually 
contain a cationic group at physiological pH.  
An organic ammonium ion never exists as a sole cation; an anion is always associated with 
it. Depending on the polarity and hydrogen donor/acceptor abilities of the solvent, the 
association strength is different [Marcus & Hefter, 2006]. Strongly coordinating counter ions 
such as chloride generally lead to weaker binding constants upon recognition of the 
associated cation, when compared to weakly coordinating counterions such as iodide or 
perchlorate [Gevorkyan et al., 2001]. 
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5. Selective formation of complexes 
There are several examples of molecular modelling studies on complexes between cyclic 
receptors and ammonium ions, calixarenes [Choe & Chang, 2002] and crown ethers being 
the most used. As an example, it is noteworthy to mention the theoretical studies on 
calix[4]crown-5 and a series of alkyl ammonium ions [Park et al., 2007], having shown that 
the energy of complex formation depends on the number of amine groups in the alkyl chain 
as well as on the number of methylene groups between the primary and secondary amine 
groups, results that agree with experimental measurements. Although the calculations are 
performed under quite different conditions of vacuum compared with the experimental 
conditions of the phase system of chloroform-water, the binding properties of calixarene-
type compounds towards alkyl ammonium ions have been successfully simulated, 
providing general and useful explanations for the molecular recognition behaviour. 
Complex formation of compounds containing benzene rings with ammonium cations has 
also been theoretically studied using many computational techniques, including ab initio 
calculations [Kim et al., 2000]. It has been shown that two types of NH-aromatic π and CH-
aromatic π interactions, which are important in biological systems, are responsible for 
binding, and that charged hydrogen bonds versus cation-π interaction is the origin of the 
high affinity and selectivity of novel receptors for NH4+ over K+ ions [Oh et al., 2000]. 
Organic molecules complexed with metal cations have also been studied by MM2 molecular 
modelling [Mishra, 2010]. The search for metal ion selectivity is of interest in the field of 
biomimetic models of metalloenzymes and molecular modelling helps in the design of new 
ligands with this purpose [Kaye, 2011]. 
Molecular modelling has been used to suggest possible contributions of carrier effectivity 
and selectivity to complex formation in accordance with experimental results [Chipot et al., 
1996; Ilioudis et al., 2005]. Our research group has evaluated the possible cation-receptor 
interactions involved in the complexes with ammonium and metal cations of selective 
carriers using the Amber force field with appropriate parameters developed by us. The 
complexation energies obtained are in reasonable agreement with experimental values, 
taking into account that complexation/decomplexation processes have a great influence on 
transport rates and are not equally favoured in cyclic and acyclic carriers [Campayo et al., 
2004]. 
Both binding and selectivity in binding can be understood through the combined efforts of 
several non-covalent interactions, such as hydrogen bonding, electrostatic interactions, 
hydrophobic interactions, cation-π interactions, π-π stacking interactions and steric 
complementarity [Späth & König, 2010]. Formation of complexes is also possible in the case 
of neutral ligands. For example, the interactions between cholesterol and cyclodextrins have 
been theoretically studied to investigate their 1:1 and 1:2 complexes [Castagne et al., 2010], 
while the formation of stable complexes between trehalose and benzene compounds have 
been investigated by the general Amber force field (GAFF) and Gaussian 03 for MP2/6G-
31G** calculation of atomic charges [Sakakura et al., 2011]. 
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Docking of a ligand into a receptor may occur via an automated procedure [Subramanian et 
al., 2000] or manually [Filizola et al., 1999]. In both cases, docking is a combination of two 
components: a search strategy and a scoring function [Taylor et al., 2002]. The 
computational method MOLINE (Molecular Interaction Evaluation) was created to study 
complexes in an unbiased fashion [Alcaro et al., 2000]. It is based on a systematic, automatic 
and quasi-flexible docking approach that prevents the influence of the chemist`s intuition on 
generating the configuration. This method has been used with acceptable results in studying 
inclusion complexes [Alcaro et al., 2004]. 
It would be adequate at this point to remember that testing the `drug-receptor 
complexation’ for a receptor model against available experimental data usually involves the 
use of site-directed mutagenesis experiments. This fact provides information on the amino 
acids involved in ligand binding and receptor activation. However, it should be noted that 
the results of mutagenesis studies are not necessarily related to receptor-ligand interactions. 
In fact, mutations can also alter the 3D structure of a receptor and therefore, modify the 
binding profile of a ligand by this mechanism. Besides that, efficient binding to a receptor 
does not guarantee that a ligand will produce a pharmacological action, given that the 
ligand may act as an agonist or antagonist. 
6. Interaction of molecules with DNA 
Anthracycline antibiotics such as doxorubicin and its analogues have been in common use 
as anticancer drugs for around half a century. There has been intense interest in the DNA-
binding sequence specificity of these compounds in recent years, with the hope of 
identifying a compound that can modulate gene expression or exhibit reduced toxicity. 
Cashman and Kellog have studied models of binding for doxorubicin and derivatives 
[Cashman & Kellog, 2004], looking for sequence specificity and the effects of adding 
aromatic or aliphatic ring substituents or additional amino or hydroxyl groups. They 
performed a hydropathic interaction analysis using the HINT program (a Sybyl program 
module, Tripos Inc.) and four double base pair combinations. Interaction of some 
intercalators with two double DNA base pairs have also been studied with the density 
functional based tight binding (DFTB) method [Riahi et al., 2010], despite DFT methods 
being known to be inherently deficient in calculating stacking interactions, and the Amber 
force field and then AM1 to dock the intercalator between DNA base pairs [Miri et al., 2004]. 
Studies on sequence-selectivity of DNA minor groove binding ligands have shown that the 
most reliable results for AT-rich DNA sequences are obtained when MD simulations are 
performed in explicit solvent, when the data are processed using the MM-PB/SA approach, 
and when normal mode analysis is used to estimate configurational entropy changes 
[Shaikh et al., 2004; Wang & Laughton, 2009]. Use of the GB/SE model with a suitable choice 
of parameters adequately reproduces the structural and dynamic characteristics in explicitly 
solvated simulations in approximately a quarter of the computational time, although 
limitations become apparent when the thermodynamic properties are evaluated [Sands & 
Laughton, 2004]. Water molecules taking part in the complexation have been studied using 
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the MMX force field and then PMB for gas phase optimisation, followed by re-optimisation 
in aqueous phase with the PM3 method using the AMSOL package [Silva & Jayasundera, 
2002]. Optimisation geometries with AM1 and the use of implicit solvent have been taken 
into account when considering intercalation versus insertion into the minor or major groove 
[Bendic & Volanschi, 2006]. 
Calculating the curvature radius of molecular DNA structures has been reported [Slickers et 
al., 1998] as a new method for understanding the dependence of binding affinity on ligand 
structure, assuming that strong binders should have a shape complementary to the DNA 
minor groove. A method for predicting sequence selectivity and minor groove binding, 
based on MD simulations on DNA sequences with and without the bound ligand, to obtain 
an approximate free energy of binding has been proposed [Wang & Laughton, 2010]. 
Amber force field, developing the necessary parameters, has also been used together with 
electrostatic potential-derived (ESP) charges and explicit solvent molecules to study 
bisintercalation into DNA. The targeted molecular dynamics (tMD) approach has been 
considered for comparing the relative energetic cost involved in creating the intercalation 
sites and also studying the mechanisms of action [Braña et al., 2004]. It has been found that 
the electrostatic contribution is a critical characteristic of binding selectivity [Marco et al., 
2005]. Reports on duplex and triplex formation of oligonucleotides by stacking aromatic 
moieties in the major groove, using Amber force field and the GB/SA solvation model in 
molecular dynamic simulations, can be found in the literature [Andersen et al., 2011].  
Studies on docking using GOLD [Kiselev et al., 2010] to optimise the starting structures with 
the MMFF94 force field have also been performed. 
Most of the published molecular modelling studies use two double base pairs or more than 
eight double base pairs to represent DNA. In our opinion, molecular modelling of DNA 
intercalation complexes should be done using at least the two base pairs of the intercalation 
site and an additional base pair at the two strand ends to maintain DNA shape and avoid 
distortion leading to inaccurate results. That means four base pairs for monointercalation 
studies and five or six base pairs for bisintercalation ones should be used. Using these DNA 
models, our studies on the mono and bisintercalation of benzo[g]phthalazine derivatives 
strongly suggest the possibility of bisintercalation and the important role played by an N-
methyl group in stabilising the DNA complex of one of the compounds, throwing some 
light over the experimental results obtained [Rodríguez-Ciria et al., 2003]. The possibility of 
bisintercalation for a 1,4-disubstituted piperazine has been studied on duplexes of five and 
six base pairs, obtaining much better results in the case of five base pairs, in accordance with 
the theoretical calculations of binding mode not conforming to the neighbouring exclusion 
principle proposed by different authors [Veal et al., 1990]. 
7. Interaction of small molecules with enzymes 
The potential of molecular simulations to enhance our understanding of drug behaviour and 
resistance relies ultimately on their ability to achieve an accurate ranking of drug binding 
affinities at clinically relevant time scales. Several computational approaches exist to 
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estimate ligand binding affinities and selectivities, with various levels of accuracy and 
computational expense: free energy perturbation (FEP), thermodynamic integration (TI), 
lineal response (LR), and molecular mechanics Poisson-Boltzman surface area (MM/PBSA). 
Identification of conformational preferences and binding site residues, as well as structural 
and energetic characterisation, is possible using MD simulations [Anzini et al., 2011; 
Dastidor et al., 2008; Stoika et al., 2008]. It is also possible to estimate conformational energy 
penalties for adopting the bioactive conformation identified by using a pharmacophore 
model [Frølund et al., 2005]. 
A model based on van der Waals intermolecular contribution from Amber and electrostatic 
interactions derived from the Poisson-Boltzman equation has been used to predict the 
change in the apparent dissociation constant for a series of six enzyme-substrate complexes 
during COMBINE analysis [Kmunicek et al., 2001]. In COMBINE analysis, binding energies 
are calculated for the set of enzyme-substrate complexes using the molecular mechanics 
force field. The total binding energy, ΔU, may be assumed to be the sum of five terms: the 
intermolecular interaction energies between the substrate and each enzyme residue, EinterES, 
the change in the intramolecular energy of the substrate upon binding to the enzyme, ΔES, 
the change in the intramolecular energy of the enzyme upon binding, ΔEE, the desolvation 
energy of the substrate, EdesolvS, and the desolvation energy of the enzyme, EdesolvE. 
 ΔU = EinterES + ΔES + ΔEE + EdesolvS + EdesolvE (3) 
When the substrate is a rather small molecule, there is no evidence for large differences in 
the structure of the enzyme when different substrates are bound and so the second and third 
are neglected. This method identifies the amino acid residues responsible for modulating 
enzyme activity [Kmunicek et al., 2005]. 
Molecular modelling of proteins is sometimes directed towards homology modelling, 
enabling progress in understanding the mechanisms of action despite the lack of detailed 
information on the 3D structure of a protein. Molecular dynamic simulations are usually 
used to test the stability of the complete structure derived from homology modelling 
[Srinivas et al., 2006]. 
Molecular docking examples can be used to compare relative stabilities of the complexes, 
but not calculate binding affinities, since changes in entropy and solvation effects are not 
taken into account [Pastorin et al., 2006; Tschammer et al., 2011]. In any case, docking 
calculations are common studies on novel drugs, Autodock being one of the most used 
docking programs [see for example Venskutonyte et al., 2011]. Docking programs treat 
enzymes and substrates as rigid entities, but  flexible docking is also possible, if several 
different protein conformations extracted from molecular dynamic simulations are used 
[Roumen et al., 2010]. 
In our laboratory, molecular modelling has been tentatively used to study the 
trypanosomicidal activity of some phthalazine derivatives. Results obtained with Amber 
force field implemented in HyperChem 8.0 plus our own necessary parameters, and with 
AutoDock 4.2 using the PDB structure for T. cruzi Fe-SOD enzyme, were in accordance with 
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experimental data, helping to explain the experimental results obtained. However, if there is 
no PDB structure for the desired enzyme and only a model of the active site, as for 
Leishmania Fe-SOD enzyme, results obtained with our calculations do not agree with the 
experimental ones when compared to the T. cruzi ones. This indicates that the interaction 
with the external part of the enzyme plays an important role as it might collaborate in, or 
make access to the active site difficult, since the enzyme shape and conformation plays a 
crucial role in its activity [Sanchez-Moreno et al., 2011; Yunta, unpublished results]. 
8. Conclusion 
Modern molecular modelling techniques are remarkable tools in the search for potentially 
novel active agents by helping to understand and predict the behaviour of molecular 
systems, having assumed an important role in the development and optimisation of leading 
compounds. Moreover, current information on the 3D structure of proteins and their 
functions provide a possibility of understanding the relevant molecular interactions 
between a ligand and a target macromolecule. Although improvements are still needed in 
the techniques used, they have been shown to be invaluable in structure–activity 
relationship research.  
On the basis of the current improved level of understanding of molecular recognition and 
the widespread availability of target structures, it is reasonable to assume that 
computational methods will continue to aid not only the design and interpretation of 
hypothesis-driven experiments in disease research, but also the fast generation of new 
hypotheses. 
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experimental data, helping to explain the experimental results obtained. However, if there is 
no PDB structure for the desired enzyme and only a model of the active site, as for 
Leishmania Fe-SOD enzyme, results obtained with our calculations do not agree with the 
experimental ones when compared to the T. cruzi ones. This indicates that the interaction 
with the external part of the enzyme plays an important role as it might collaborate in, or 
make access to the active site difficult, since the enzyme shape and conformation plays a 
crucial role in its activity [Sanchez-Moreno et al., 2011; Yunta, unpublished results]. 
8. Conclusion 
Modern molecular modelling techniques are remarkable tools in the search for potentially 
novel active agents by helping to understand and predict the behaviour of molecular 
systems, having assumed an important role in the development and optimisation of leading 
compounds. Moreover, current information on the 3D structure of proteins and their 
functions provide a possibility of understanding the relevant molecular interactions 
between a ligand and a target macromolecule. Although improvements are still needed in 
the techniques used, they have been shown to be invaluable in structure–activity 
relationship research.  
On the basis of the current improved level of understanding of molecular recognition and 
the widespread availability of target structures, it is reasonable to assume that 
computational methods will continue to aid not only the design and interpretation of 
hypothesis-driven experiments in disease research, but also the fast generation of new 
hypotheses. 
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1. Introduction 
The prediction of the three-dimensional structure of a protein, starting with the amino acid 
sequence, is still an unsolved issue. However a number of important advancements have 
been made and some methods offer solutions to this problem, specially when the target 
sequence has homologues whose structure has been determined. In any case, it is important 
to evaluate the quality of the prediction, as none of the methods offers assurance of success. 
The ROSETTA-design-HHMer (Rd.HMM) protocol stands out among the current quality 
assessment methods, because it offers evidence of the biological appropriateness of the 
prediction. In addition, Rd.HMM can be used to guide the modeling process towards the 
improvement of the model's quality. This chapter deals with the principles behind this 
protocol and gives practical advice on how to use the Rd.HMM to evaluate the quality of a 
three-dimensional modeled structure of a protein, and how to use the information to 
improve the model. The limitations of the protocol are also discussed. 
2. The folding problem is a NP-hard problem involving a degenerate 
informational code 
As implied by the well-known Levinthal paradox (Levinthal, 1968), a full exploration of the 
entire conformational space theoretically available to a protein is out of the reach of current 
computational techniques. Equally unaccessible to nature is the sequence space available to 
polypeptide chains (Kono & Saven, 2001). Currently, the amount of available protein 
structures (the PDB) represents a fraction of the known protein amino acid sequences, and if 
the available sample is grouped in terms of different folds, the diversity in the PDB is even 
smaller. In addition, protein structure and function can tolerate a significant number of 
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mutations. Both facts suggest an important degree of degeneracy between the information in 
polypeptide sequences and the associated code leading to their native structure (Bowie et 
al., 1990). In other words, the so-called folding code is degenerate. 
However, even if the number of protein structural folds is smaller that the sequence space, 
the folding problem is still unsolved, because exploring the total number of conformations 
available to a protein or its energy landscape are NP-hard problems (Hart & Istrail 1997), 
and because the available methods to calculate the energy of a protein conformation imply a 
large systematic error (Faver et al., 2011). 
The above facts set forth the intractability of solving the problem through an exhaustive 
search. Nevertheless, proteins in nature do reach a native structure in short times, and 
finding a native-like solution to the three-dimensional structure of a protein may not require 
a full examination of the conformational space, or its corresponding energy landscape. In 
fact, recent years have seen important progress in the search for solutions to the protein 
folding problem (Dill et al., 2008).  
3. The problem of quality scoring for 3D models 
In theory, the native three-dimensional structure of a protein must lie at an energy 
minimum, underneath all accessible intermediates with near-native fold. However, an 
accurate calculation of the energy for a protein conformation requires quantum chemical 
calculations. Properties such as electron-electron correlation, charge transfer, polarization, 
and bond break/formation, including proton exchange, involve quantum mechanical effects 
and cannot be correctly described using the equations of classical physics. The relevance of 
quantum mechanics for accurate energy calculations of protein-ligand complexes and 
protein conformations have been recently demonstrated (Raha and Merz, 2005). Numerical 
approximations to the electronic state of a multielectronic system have been developed for a 
variety of system up to date. But only a few simplified solutions, implying low-precision, 
can tackle an electronic macromolecular system, and even these demand a large amount of 
computational resources (He & Merz, 2010). The common simplifications, based on 
molecular mechanics, do carry a systematic error that precludes the accurate finding of the 
true native energy minimum (Faver et al., 2011). 
Many methods have been proposed to model the three-dimensional structure of proteins 
starting from their amino acid sequence. Based on their use of experimental structural 
information, these methods can be classified into comparative modeling or ab initio methods.  
Because rating the success of any method requires an impartial judge to be trustworthy, the 
scientific community implemented the contests for CRITICAL ASSESMENT OF THE 
STRUCTURE OF PROTEINS (CASP) (Kryshtafovych et al., 2009). In such contests, the 
judges are computer algorithms, which compare a 3D-structure solved by an experimental 
method (but yet unpublished) to a 3D-model predicted by a CASP contestant. The 
comparative modeling strategies have had a remarkable degree of success in the prediction 
of 3D-structures of soluble proteins, with the amino acid sequence as starting information. 
On the Assessment of Structural Protein Models with  
ROSETTA-Design and HMMer: Value, Potential and Limitations 217 
Comparative modeling exploits the wealth of experimental structural information 
nowadays available for proteins (Rose et al., 2011), and relies on powerful sequence 
alignment algorithms (Wallace et al., 2005). In CASP contests, comparative modeling 
servers, such as I-TASSER (Roy et al., 2010), ROBETTA (Kim et al., 2004) and SAM-T08 
(Karplus, 2009), have achieved a high success rate in their predictions for protein 3D-
structures of low to intermediate difficulty (as defined by the CASP staff). Yet, one mayor 
limitation in these methods lies in the strategies used to match each amino acid in a target 
sequence to its corresponding best hosting spot in the 3D-structure of the template and, 
again, this is a NP-complete problem (Lathrop, 1994).  
In ab initio methods, the laws of physics and chemistry and/or artificial intelligence are used 
to generate a prediction for a native-like folding solution of a protein with known amino 
acid sequence (Dill et al., 2008). While ab initio methods have been less successful than 
comparative modeling, these are the only choice if no suitable homologous 3D-template is 
available, for a given amino acid sequence (Kryshtafovych et al., 2009). 
The above considerations are all fine when the question is to grade the methods and chose 
the one with highest success rate, but to date, no single method gives the correct answer 
every time. Yet, the final aim of such methods is to produce good native-like protein 3D-
predictions, when experimental X-ray or NMR data are not available. How then is it 
possible to set apart models with wrong fold assignment, from those with a correct fold 
assignment, but with a mistraced sequence to 3D-fold alignment (Luthy et al., 1992)? Is it 
possible to identify cases where the fold assignment and the alignment are adequate, but the 
solution to the atom repacking of replaced amino acids is deficient? These questions lie 
behind the quality assessment of a protein 3D-structure prediction.  
The quality assessment is of particular relevance in cases where a suitable 3D-template 
cannot be found, because the predicted 3D-model cannot be compared back the starting 
template. Again, this problem can be tackled with a number of strategies, and most of them 
have been implemented as computer software programs, and their validity tested at the 
CASP contests (Shi et al., 2009).  
Quality assessment methods for the predicted 3D-structures of proteins can be classified 
according to their underlying principles:  
i. Physics-based methods use the regularities in chemical structures and the laws of 
physics and chemical bonding to find how much a 3D-structure deviates from the 
known canonical values. These methods may come in the form of force-fields and they 
report energies (Hu & Jiang, 2010), or may seek for abnormalities in geometrical and 
chemical features such as bonding lengths, bonding angles, dihedral torsion values, 
charge-charge distances and so on (Rodriguez et al. 1998).  
ii. Statistics-based methods use the known 3D-structures to generate a set of probability 
distributions for a number of features of the experimentally solved structures. These 
distributions can be used as reference to judge the quality of a prediction. When these 
probability distributions are transformed into energies, using the Boltzmann law, the 
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cannot be found, because the predicted 3D-model cannot be compared back the starting 
template. Again, this problem can be tackled with a number of strategies, and most of them 
have been implemented as computer software programs, and their validity tested at the 
CASP contests (Shi et al., 2009).  
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according to their underlying principles:  
i. Physics-based methods use the regularities in chemical structures and the laws of 
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known canonical values. These methods may come in the form of force-fields and they 
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distributions for a number of features of the experimentally solved structures. These 
distributions can be used as reference to judge the quality of a prediction. When these 
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result is designated as a statistical potential. Although statistical potentials started as 
empirical constructs, their theoretical basis have been substantiated recently 
(Hamelryck et al., 2010). These constructs turned out be very useful since any 
experimental quantitative variable can be treated as an energy and used to generate a 
potential landscape for 3D-structures. Amongst these latter methods, ANOLEA (Melo 
& Feytmans, 1998) has a simple conception, and it can be calculated quickly and with a 
modest computer system, even for very large 3D-structures. Despite its simplicity, 
ANOLEA stands as one of the most reliable quality assessment indices (Chodanowski 
et al., 2008). 
iii. Artificial intelligence programs such as neural networks, or support vector machines 
have shown limited success in predicting the 3D-structure of proteins, but their success 
in quality assessment has been acceptable. A number of these programs has appeared 
through the years and, again, these methods depend on experimental data to train or 
setup the program's intelligence (Wallner & Elofsson, 2003). Unfortunately, what 
features has the computer learned to judge is not always clear, and in some specific 
cases, the results may be unexpected. 
iv. Finally, hybrid methods combine different strategies to test a 3D-structure quality. 
Amongst these methods, web metaservers, such as metaMQAP (Pawlowski etal., 2008), 
deserve a note, because they meld the scores from a number of servers into a weighted 
quality index of a 3D-structure.  
While most methods mentioned above may be of value to assess the quality of a predicted 
protein 3D-structure, it is possible for a model to have acceptable geometrical features, 
resemble the fold of a structure in the PDB, and still represent a non-native 3D-conformation 
of the protein under consideration. We have designated this limitation as the 
appropriateness problem of a 3D-structure prediction. After a careful analysis of several 
related methods, in our opinion, only the recently published protocol ROSETTA-design-
HMMer (Rd.HMM) (Martínez-Castilla & Rodríguez-Sotres 2010) offers robust and explicit 
evidence of the biological appropriateness of a protein 3D-structure. 
4. The reverse folding problem 
Due to the degeneracy of the amino acid sequence to three-dimensional fold translation 
code (Bowie et al., 1990), discussed above, proteins can tolerate amino acid changes in 
their sequence, as long as these changes do not fall in positions crucial to their folding 
stability, folding kinetics, macromolecular meaningful interactions, conformational 
transitions, ligand binding, or catalytic function. Therefore, two proteins sharing more 
than 40% sequence identity are likely to participate in the same or very similar cellular 
functions. Based on these considerations, sequence databases may be automatically 
annotated based on sequence homology between the new unannotated entries and 
already annotated ones. 
As an additional consequence of the folding code degeneracy, the prediction of a 3D-fold 
starting with the amino acid sequence, i.e. the folding problem, is a far more complex 
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problem than it is the reverse folding problem, which attempts to predict an amino acid 
sequence compatible with the atomic 3D-coordinates of a protein backbone. One of the first 
approaches to this problem was published by Eisemberg and co-workers (Luthy et al., 1992; 
Wilmanns & Eisenberg, 1995). According to their data, given a set of the atomic 3D-
coordinates from the native 3D-structure of a protein, it is possible to reconstruct the amino 
acid sequence of the corresponding natural protein, with a good level of confidence. 
A second attempt was published by the group of David Baker (Cheng et al., 2005), who 
expanded the search beyond the natural amino acid sequence of the protein, to explore part of 
the sequence space compatible with a given 3D-fold. These authors used the 3D-atomic 
coordinates from a protein backbone to complement the set of amino acid sequences from 
natural homologues, with a set of predicted artificial amino acid sequences. In the alignment 
from this set, they could distinguish the conservation due to structural constraints from the 
functional conservation. Their data indicated a clear tendency of functional sites to have sub-
optimal free energies of stability and their computed sequence profiles diverged from the 
natural sequence profile. This method was offered as a web service to predict functional sites 
(Protinfo MFS, http://protinfo.compbio.washington.edu/mfs/, accesed on may 15, 2012). 
In a later work, Chivian and Baker (Chivian & Baker, 2006) used a sophistication of the 
earlier approach to refine a sequence-to-structure alignment, as part of an homology 
modeling protocol. Their data showed an increase in the alignment's quality of a target 
amino acid sequence to a 3D-template. These authors integrated this alignment method in 
the ROBETTA 3D-structure prediction server (Kim et al., 2004). As mentioned in the 
preceding section, ROBETTA has been repeatedly among the top servers in recent CASP 
contests and, very likely, this alignment method is part of its success. 
In the approaches discussed in this section, the authors applied strategies to account for the 
conformational flexibility of the backbone in their search, widening the range of amino acid 
choices for these segments. Therefore, the higher the backbone flexibility, the lower the 
conservation and the higher the likelihood of such site to be declared as functional. In 
addition, during the estimation a region's flexibility, part of the natural amino acid 
information must be retained, because the instability of any segment is intrinsically linked to 
the properties of the local side chains and their neighbors.  
The alternative to this search is to accept the 3D-coordinates for the X-ray solved structure as 
valid equilibrium conformations, and ignore those segments where the excessive mobility 
prevented the assignment of atom positions. In NMR solved structures, there is usually 
more information on accessible conformations, and the approach may take this into account, 
or use the more populated conformation. In this last case, the conformational flexibility is 
lost, but the computed set of sequences will make a better sampling of the sequence space 
available to this particular equilibrium conformation. 
From this considerations, any attempt to explore the sequence space available to a given fold 
clearly must accept some informational loss, but at this point, the sequence space compatible 
with a completely fixed backbone was in need of a deeper exploration. 
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In the Rd.HMM protocol (Martínez-Castilla & Rodríguez-Sotres 2010), ROSETTA-design 
(Rd) is used to redesign the 3D-structure of a protein by reassigning amino acids to every 
position in the structure, and with no restriction in the choice of amino acids or rotamers. To 
completely suppress the information present in the starting amino acid sequence, a 
preliminary redesign of the protein is made by imposing to the 3D-backbone a fixed new 
random sequence. To reduce any bias possibly introduced by this random sequence, this 
step is performed several times. When scored with the ROSETTA force-field for stability, the 
3D-structures with randomized sequence have very high energies, because the artificial side 
chains will frequently fail to fit into the cavities left by the natural side chains, and 
neighboring contacts are likely to be unfavorable. In other words, these randomized 
sequence 3D-models are in silico constructs, meaningless in terms of chemistry or biology. 
In the second step, Rd is used to redesign each 3D-structure with randomized sequence 
produced before, but this time with complete freedom of amino acid choice, and the 
reconstruction is done many times. Rd can be trusted to find amino acids combinations with 
high stability (Kuhlman et al., 2003; Jiang et al., 2008; Slovic et al., 2004; Butterfoss et al., 
2006; see also next section) and each new redesign will harbor a new theoretically low-
energy sequence of amino acids for the 3D-backbone under consideration, but most likely, a 
non-natural one, because the selection pressure in natural proteins is not limited to stability 
constraints (Cheng et al., 2005). 
In the end, a set of amino acid sequences can be recovered from the corresponding set of 3D-
redesigns, as large as requested, and representing a sample of theoretically possible, but 
naturally inexistent amino acid combinations, optimized only for 3D-fold stability. The 
theoretical stability of the redesigns are expected to exceed natural protein stability (Cheng 
et al., 2005; Butterfoss et al., 2006), but a folding pathway to the 3D-fold may not exist for 
such sequences, because ROSETTA-design has not been imprinted with any information 
related to the folding process. That is to say, no all redesigns are expected to fold correctly in 
experimental tests. 
5. The merits of ROSETTA-design 
ROSETTA-design (Rd) is a program developed by the group of David Baker (Kuhlman et 
al., 2003) with a remarkable success in the design of suitable amino acid sequences for a 
given-fold. The ROSETTA suite includes modules for protein structure refinement, ab initio 
protein folding predictions, antibody design, protein-ligand docking, protein-protein 
docking, and others. However the merits and limitations of those other protocols will not be 
discussed here.  
Rd was created with one application in mind, namely "to find amino acid sequences able to 
fold into a given three-dimensional structure". To this aim, Baker's group developed three 
basic components: a modified force-field with a large penalty for atomic overlap, a rotamer 
database taken from the PDB and refined with quantum chemical calculations, and a Monte-
Carlo search algorithm to replace the amino acid side-chains of the starting structure 
(Kuhlman et al., 2003).  
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The approach followed by Rd has proven very robust because it made possible to design the 
first artificial protein folding into a completely novel topology (Kuhlman et al., 2003). Rd has 
been also used with success to place a novel enzyme active site, of human design, into an 
unrelated protein (Jiang et al., 2008), and to convert a membrane protein into a soluble 
protein (Slovic et al., 2004), among other notable protein engineering applications 
(Butterfoss et al., 2006). 
Monte-Carlo methods can be implemented in algorithms to various aims. Some are 
designed to provide an extensive sampling of a given landscape, but in other cases the 
algorithm is set to find a optimum (usually a minimum) in such landscape. The very well-
known Metropolis algorithm (Metropolis et al., 1953) can be used for both purposes, but it 
has been theoretically proven to converge to the true optimum, if no time limit is set 
(Mengersen & Tweedie, 1966). In practice, Monte-Carlo methods may take too many steps 
and the search has to be stopped when the sampling is considered extensive enough, 
usually, well before the true optimum is determined (Cowles & Carlin, 1996). 
Once again, due to the degeneracy in the folding code (see section 1), low-energy solutions 
for amino acid side chain replacements on a 3D-backbone have many local minima, and 
some may be within the reach of a short to moderate Monte-Carlo random-walk. Rd 
narrows down the list of amino acid rotamers to be tried at each α carbon, uses  a computer-
efficient code for energy calculations, an improved force-field, and has a curated database of 
rotamers, with improved geometries obtained through quantum mechanical calculations. In 
addition, Rd starts with a geometrical analysis of the structure and removes from the search 
amino acid sites where the local environment makes the choices' list too narrow or too 
undefined. The assignment at those sites becomes then trivial. 
Finally, Rd can be fed with a list of amino acid choices for each residue in the 3D-backbone, 
ranging from not allowing changes, to the full set of 20 amino acids and all of their rotamers. 
Rd is, therefore, one of the most flexible programs for protein design (Butterfoss et al., 2006). 
6. Hidden Markov models to deal with the reverse folding problem 
A Markov model (MM) is a model of a stochastic process with the Markov property. The 
model has the Markov property if, along the random succession of states, the future state is 
determined by the present state only, with no influence of the previous states (Eddy, 2004). 
The change from one state to another is called a transition, and each state has an associated 
transition probability. The states are finite or countable, but the succession itself may be 
infinite.  
A MM can be used to describe a number of natural phenomena. For example, in a chemical 
kinetic mechanism, the states are chemical intermediates and transition probabilities are rate 
equations (Shapiro & Zeilberger, 1982). When these states constitute symbol emitters and 
each state has a defined emission probability for each possible symbol, and a concatenation 
of states will broadcast a symbols' sequence, for instance, an amino acid sequence (Eddy et 
al., 1995).  
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A very simple sequence-generating MM may consist of two states (Fig. 1): Let the state S1 be 
an emitter of any of the 20 amino acids abbreviations. Let the amino acid compositions of an 
infinite sequence of symbols produced by S1 equal the composition of natural proteins. With 
a probability of 0.1, state S1 may suffer a transition to a second emitter S2. In turn, S2 is able 
to emit a stop, or to transit back to S1, with 0.9 probability. This two states will go forth and 
back to give an infinite number of sequences of short length, because, given the 
probabilities, sequences longer than a few tenths of amino acids will be very infrequent.  
Since a MM is a stochastic device, it is unsuited to represent only one particular sequence, 
but instead, it can be a powerful tool to represent a subset of the sequence space, notably, 
a sequence alignment. Such MM represents the observed aligned sequences, usually a 
subset of all the possible sequences in the alignment, but the states of the model (each one 
encoding the probabilities of one or more alignment positions) cannot be observed. When 
such is the case, the MM is then said to be hidden (HMM). However, the Viterbi 
algorithm, the forward algorithm, and the Baum–Welch algorithm make it possible to 
compute the most likely parameters of the model's states, out of the observations available 
(Eddy, 2004; Eddy et al., 1995). 
 
Figure 1. A simple Markov model to emit random amino acid sequences of variable length with an 
amino acid composition similar to that in natural proteins. 
Because the HMM represents more sequences than those observed, it can be used to 
produce new sequences, but most importantly, for any available sequence in a database, its 
emission probability by the HMM can be calculated and compared to corresponding 
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emission probability by a very general model, such as the one in figure 1. The ratio of these 
two probabilities can be used as an index or score, the higher the score, the higher the 
likelihood of the sequence being a member of the alignment. From this information, the 
expectancy of such an index value being due to chance can be estimated. Expectancies of 
one or above may indicate a meaningless score. 
HMMer is a suite of programs developed by Sean Eddy (Eddy, 2004, Eddy et al., 1995) to 
create and use HMMs of amino acid and nucleic acid sequence alignments. HMMer has 
executables to estimate the parameters of a HMM from a sequence alignment and calibrate 
the model to allow a good estimation of scores and expectancies. Other executables will test 
a sequence database to extract those sequences with high score and low expectancy, aligning 
the new sequences to the model. Additional executables can create the starting HMM, use it 
to emit sequences with high probability of being members of the model, or update the 
model parameters using the newly discovered additional sequences. 
One critical step in the HMM preparation is the starting alignment fed to HMMer (Eddy, 
2004), because as mentioned in section 1, the optimal alignment of sequence sets is not a 
trivial problem (Lathrop, 1994). When a HMM gives poor results, it is frequently as a 
consequence of a defective alignment.  
Another limitation of a HMM lies on its very definition, because a MM must be memoryless 
(Markov property). In the 3D-structure of proteins those amino acids brought into proximity 
during folding, must be of compatible nature from the sterical and chemical points of view. 
This property is stored in the sequence as sites with correlated variability, also known as 
mutual information. Its relevance has been recognized and exploited (Socolich et al., 2005), 
but HMM are unable to encode such information. 
After the above discussion of HMMer features, we can consider its value in dealing with the 
large a set of amino acid sequences redesigned by the Rd protocol described in the 
preceding section: 
1. Rd.HMM produces many sequences that can be trivially aligned, because every amino 
acid has biunivocal correspondence with a 3D-backbone site.  
2. Using a HMM to represent the redesigned sequences will result in the statistical 
extension of the sample to sequences with a similar frequency profile. This extension is 
however inaccurate, because not all off the sequences possibly emitted by the HMM 
will actually be low-energy solutions to the 3D-backbone redesign (Hamelryck et al., 
2010).  
3. The HMM can be used to search those natural sequences having amino acid 
combinations suitable to the 3D-structure under analysis. The value of HMM in the 
analysis of relationships between biological sequences has been extensively 
documented (Eddy, 2004).  
4. Due to (1), the search made in a database of natural sequences by means of the HMM 
will align each selected sequence in a structurally aware manner (Martínez-Castilla & 
Rodríguez-Sotres 2010). But given (2), such structurally aware alignment is somehow 
inaccurate, the lower the HMMer score, the less reliable this alignment becomes. 
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7. The unexpected sensitivity of Rd-HMMer 
In theory, when a Rd.HMM is used to scan a general sequence database, such as the NCBI-
nr (Jiang et al., 2008), a sequence is selected if it is considerably less likely to be generated at 
random, than to be emitted by the Rd.HMM. But the Rd-step leaves only information 
related to the 3D-fold, which is then fed into the HMM, thus any selected sequence should 
be able to fold into a 3D-structure very similar to the starting one. Sequences selected by 
HMMer should then belong to the same folding family. 
One of the unexpected results of Rd.HMM is the sensitivity of this protocol, for instance, it is 
able to separate those sequences of the TIM-barrel fold that belong to the triose phosphate 
isomerase from those that belong to other TIM-barrels, such as the 
phosphoribosylpyrophosphate isomerase (PRAI) (Martínez-Castilla & Rodríguez-Sotres 2010).  
Apparently, the Rd-step can imprint its artificial sequences with some details related to loop 
and turn shapes, as well as contact between secondary structure elements within the tertiary 
structure adopted by the original polypeptide chain. Then, only when two proteins with 
completely different activity retain an almost identical structure, a single Rd.HMM can score 
their corresponding sequences with a significant score. Such is the case of the novel 
engineered retroaldolases (RA-61, RA-22) and the corresponding templates used to host the 
newly designed amino acid catalyst, a β-1,4-endo-xylanse from Nonomuraea flexuosa and one 
indole-3-glycerol phosphate syntase from Sulfolobus solfataricus (Martínez-Castilla & 
Rodríguez-Sotres 2010; Jiang et al., 2008). This was also the case with the 
imidazoleglycerolphosphate synthase From Thermotoga maritima and the engineered 
imidazoleglycerol_evolvedcerolphosphate synthase (Martínez-Castilla & Rodríguez-Sotres 
2010; Röthlisberger et al., 2008). 
The remarkable sensitivity of the Rd.HMM protocol is reflected also in the change of the 
score reported for the 3D-structure of one protein resolved by NMR, as compared to its X-
ray 3D-structure. An Rd.HMM produced with a X-ray 3D-structure will score its 
corresponding natural sequence with a value close to 0.6 times the length of its amino acid 
sequence. Instead a Rd.HMM from an NMR derived structure will report half of that score 
for its corresponding natural sequence (Martínez-Castilla & Rodríguez-Sotres 2010). 
As an additional test of the Rd.HMM sensitivity, we compared the Rd.HMMs 
corresponding to subunit A from two prokaryotic glycyl-tRNA-synthases, one from Thermus 
thermophilus and another from Thermotoga maritima. These two X-ray resolved structures 
have a very similar core (Fig 2A), but the sequence similarity is below 15%. Despite the 
structural similarity, both proteins have extensive regions where the structure differs 
completely. Accordingly, the 1ATI:A Rd.HMM scored the T. thermophilus sequence (its 
corresponding natural one) with a value of 161.8 (score over sequence length 0.37) and a 
highly significant E-value (3.8 ×10-49), but the T. maritima sequence received a negative score 
of -271.1 (score over sequence length -0.94) lacking statistical significance (E-value 2). In 
contrast, the 1J5W:A Rd.HMM scored the T. thermophilus sequence with a value of -200.0 (-
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0.88) lacking significance (E-value 0.065), and the T maritima sequence (its corresponding 
natural one) received a positive score of 30.3 (0.11) and high statistical significance (E-value 
8.4×10-17). In these cases, the score was obtained lowering the software threshold, because in 
a standard search of the NCBI-nr the 1ATI:A Rd.HMM only identified the T. thermophilus 
glycyl-tRNA amino acid sequence and its homologues. 
 
Figure 2. (A) Comparison of glycyl-tRNA synthetases from Thermus thermophilus  (PDB 1ATI:A, yellow 
tube) and from Thermotoga maritima  (PDB 1J5W:A, green trace). The core α/β region was superimposed 
using TOPOFIT (Ilyin et al., 2004)  (shown as cartoons) and colored according to its sequence similarity 
from blue (identical) to white (dissimilar). The figure was prepared using VMD (Humphrey et al., 1996). 
(B) HMM logo of the profile to profile alignment (Schuster-Böckler & Bateman, 2005) of Rd.HMMs 
from glycyl-tRNA synthetases in (A). (C) The segments in (A) corresponding to the nodes in the 
alignment in (B)  
In the previous example, the dissimilar regions have enough information to allow the 
discrimination between the structures. In addition, since the scores for the non-related 
sequence on each case were negative, the alignment produced by the Rd.HMM of both 
sequences is unreliable. Figure 2B shows the profile to profile comparison of HMM logos 
(Schuster-Böckler & Bateman, 2005) for the Rd.HMM derived from both glycyl-tRNA 
synthetases, which paired a significant subset of both Rd.HMMs. The corresponding 
segments were indeed structurally related (Fig. 2C).  
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Figure 3. (A) TOPOFIT (Ilyin et al., 2004) sequence alignment based on the structural alignment in 
figure 2. Amino acids are aligned if their backbones are less than 3 Å apart. (B) Alignment guided by the 
Rd.HMM derived from 1ATI:A. (C) Alignment guided by the Rd.HMM derived from 1J5W:A. For 
clarity, only the section of the alignment  including aminoacids 166 to 424 of 1ATI:A is shown. 
Figure 3 (A to C) shows the lack of coincidence between the TOPOFIT structural alignment 
(Ilyin et al., 2004), and the two Rd.HMM based alignments for the core regions. A careful 
analysis of the alignments in figure 3 suggests a possible explanation for the notable 
specificity of 1ATI:A and 1J5W:A Rd.HMMs. While repacking the rotamers into the 
theoretical 3D-structures, Rosetta-design identifies sites of low or no variation, with higher 
informational content. Clearly these sites are distributed in a rather different way on the 
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1ATI:A, or 1J5W:A Rd.HMMs (Fig. 3 B and C), and only a fraction of these low-variance 
sites do coincide with structurally equivalent sites (Fig. 3A), making each Rd.HMM different 
enough. 
A similar analysis of the lysozymes from lambda phage (or E. coli), T4 phage, chicken (Gallus 
gallus) and goose (Anser anser anser) led to very similar results. 
A somehow artificial example comes from the Rosetta-designed non-natural proteins Top7 
and M. This example is used to illustrate the interpretation of the Rd.HMM information in 
the next section. 
8. The Rd-HMMer protocol: A practical guide 
This section describes how to generate a Rd.HMM and interpret the results.  
1. Software requirements:  
 Rosetta suite v. 2.3 or above. The examples given here apply to v. 2.3, but the 
porting to v. 3.1 is straightforward. Rd v. 2.1 is considerably faster, but exploration 
of the sequence space is better in Rd. v 3.1. 
 HMMer v. 2 or above. The examples given here were done with v. 3, which is 
considerably faster, therefore recommended.  
 VMD v. 1.8.7 or above. (Humphrey et al., 1996) 
 SwissPDB viewer v. 4, or above (Kaplan &Littlejohn, 2001). 
 Sequence databases. You may download the protein nr, SeqRef or UniProt-Sprot 
databases from the NCBI site (Sayers et al., 2010), or any other fulfilling your needs. 
As an alternative, you may prepare a small database using psi-blast at any server. It 
is recommended to include not only the sequences of proteins related to the 
structure of interest, but also other unrelated sequences, preferably selected at 
random. 
VMD and SwissPDB viewer are not essential but are very useful for PDB file manipulation. 
2. Prepare your PDB file. Rd v. 2.3 requires your PDB file to have non-zero beta factors. 
Residues may be absent, as long as none of the corresponding backbone heavy atoms 
are present. Therefore atoms with types C, CA, N, C and O for a particular residue 
should be all present for each residue, or all absent. For an incomplete residue you may 
open your file with Swiss PDB viewer. This program will rebuild the missing atoms, 
which is recommended for models; but you can use the software to completely remove 
the residue, which is preferable for experimental data. A special case is the oxygen atom 
of the C-terminus (OXT), which is required by Rd. This atom can be rebuilt with 
SwissPDB viewer, but this is not done automatically. An alternative to Swiss PDB 
viewer is VMD using the PFSgen plugin. Although PDB manipulation in VMD requires 
more experience, its scripting language is more powerful. 
If your structural PDB file comes from a modeling exercise, review the geometrical and 
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sterical quality of your model. If required, refine it with molecular mechanics software. A 
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more detailed description of this kind of problems in protein modeling and how to fix them 
can be found elsewhere (Chavelas Adame et al., 2011; Rosales-León et al., 2012). 
3. Build many replicates of your PDB file with a random assignment of amino acid 
sequence. This can be done in two ways:  
a. With VMD. Use the atomselect command to select the backbone atoms of all residues, 
one at a time, and change the residue name to any amino acid selected at random. In the 
C-terminal residue make sure to include the OXT atom in your selection. Then select all 
backbone atoms including the OXT and save the file. A script to do this with VMD can 
be requested to the corresponding author. 
b. With Rd. Prepare several Rosetta input resfile with a tag PICKAA X (replace X for a 
random 1-letter amino acid code) for every position in the PDB file of interest. Then run 
Rd, once for each resfile you made, with the following command: 
rosetta.gcc -s 1QYS.pdb-design -fixbb -chain A -resfile 1QYSaa.res-ndruns 1 -pdbout 1QYSAaa 
Here, we assume 1QYS.pdb to be the starting PDB file, A to be the subunit of interest, 
1QYSaa.res is the resfile, and your result will be named 1QYSAaa_0001.pdb (depending on the 
version, you will also need a paths.txt in your folder, or the path to the rosetta database 
should be indicated in the command line). In Rd v. 3.1, the resfile format and some command 
line options have changed (check Rosetta documentation for details). 
This step can be repeated at will, to create many sequence-randomized PDB files, but in our 
experience, at least 10 are needed for a reliable HMM. 
4. Rebuild each sequence-randomized PDB file with Rd. First you will need a resfile with 
the tag ALLAA (1QYSall.res), and a text file (pdb4rbld.lst) containing the names of all 
the sequence-randomized PDB file created in the previous step, one per line. Then, 
rebuild each input file 29 times using the command: 
rosetta.gcc -design -fixbb -chain A-l pdb4rbld.lst -resfile 1QYSall.res -ndruns 29 -pdbout  
You can generate many rebuilt PDBs per input file, but you need at least 100 sequences in 
the end to produce a representative HMM. In our experience, a better exploration of the 
sequence space results from many sequence-randomized input files and between 10 to 30 
rebuilt PDBs for each input PDB file. 
5. Extract the amino acid sequence for each rebuilt PDB file and save it in a text file 
(1QYSA_a-O.fas), in fasta format. This file represents an alignment, though a sequence 
alignment software is not necessary, due to the reasons commented at the end of section 
5. Then use HMMer to prepare a hidden Markov model of your sequence alignment: 
hmmbuild --informat afa 1QYSA_a-O.hmm 1QYSA_a-O.fas 
If you are using HMMer v. 2.0, you need to calibrate your model with: 
hmmcalibrate 1QYSA_a-O.hmm 
6. Search a sequence database (i.e. NCBI-nr) with: 
hmmsearch -E 100 -Z 10000000 1QYSA_a-O.hmm path2db/nr 
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Here a local copy of the nr is assumed to be in your system in fasta format. The -Z flag will 
scale the E-values to 10 million sequences. This is recommended to make E-values 
comparable, because E-values are linearly dependent on the size of the sequence database 
searched. The default E value is 10, but here it was set to 100 to lower the search threshold.  
 
Figure 4. An HMMer search output result. The search was done using an Rd.HMM from Top7 (PDB id. 
1QYS) and the NCBI-nr as database. (A) heading, (B) scores, (C) domain-parsed scores and alignments. 
The statistics at the end and some information was removed for brevity. The format is as in HMMer 3.0. 
An extract of the results from a typical search is presented in figure 4. The HMMer search 
output will report three sections: (a) Heading, (b) scores for complete sequences, (c) domain 
parsing, alignments and statistics. As it can be seen, according to the information in the 
Rd.HMM from Top7, the Top7 amino acid sequence fits into the Top7 3D-atomic 
coordinates (1QYS). The most relevant sections are the scores and the alignment sections. 
Notice how this X-ray solved 3D-stucture reports an HMM score of 51.2, matching the 
sequence from amino acid 3 to 94, that gives a ratio of 0.56, close to the 0.6 average value for 
X-ray solved structures. The reason behind the relationship is not simple, but it holds for 
most X-ray solved structures (with a few exceptions) (Martínez-Castilla & Rodríguez-Sotres 
2010). The second hit is the C-terminal fragment of Top7 solved by NMR, the score is 39.8 
for a fragment of length 50 (ratio = 0.79). This last score is higher than the score for the 
complete sequence, because as shown in figure 4, the C-terminus has higher proportion of 
local coincidences to the HMM. In the alignment to the full sequence, the contribution of the 
N-terminus lowers the overall score. The alignment for the C-terminal fragment was 
omitted because it is identical to the 1QYS alignment from position 44 to 91 (Fig. 4C). The 
alignment shows a consensus for the hidden Markov model, as a reference, then the 
sequence found aligned separated by an intermediate mask. Uppercase letters indicate 
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Here a local copy of the nr is assumed to be in your system in fasta format. The -Z flag will 
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Figure 4. An HMMer search output result. The search was done using an Rd.HMM from Top7 (PDB id. 
1QYS) and the NCBI-nr as database. (A) heading, (B) scores, (C) domain-parsed scores and alignments. 
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strong conservation, lower case letter conservative changes and plus sign a positive local 
score. The lower line, absent in HMMer 2 is the encoded posterior probability (d=0...9,*; * 
equals 9.5), where the approximate value of posterior probability for each site is given by 
equation (1). 
 0.1  0.025pp d    (1) 
The final hit in the search in figure 4 is the M artificial protein. This protein was designed with 
Rosetta-design using the same Top7 folding. Its sequence is different, but it belongs to the 
same family of Rd proteins. The score is smaller than for Top7 (ratio of 32/(88-7), or 0.395), but 
still above 0.3 and with high statistical significance. Although Rd was used to design these 
proteins, the concordance reveals the robustness of the amino acid assignment made by Rd, 
and gives further support to the structurally aware nature of the Rd.HMM alignments. 
The alignment is very useful to protein modeling, because it reveals the distribution of 
coincident regions between the 3D-atomic coordinates of the backbone and the amino acid 
sequence in the database. The following features are to be taken into account: 
a. Frame shift. If the residue number in the 3D-structure has an offset relative to the amino 
acid numbering in the sequence, either from the beginning, or starting at some 
intermediate site; this is usually a sign of a wrong threading of the model and the 
template during the modeling step. In the example, there is a difference in amino acid 
numbering, but this is not a frame shift, as the first residue solved in the PDB is ASP-3, 
corresponding to node one in the HMM, then the first 3 HMM nodes did not match the 
Top7 sequence and were discarded by HMMer search making the first match to residue 
6, at HMM node 4. 
b. Insertion/deletions. An insertion in the sequence appears as a dot in the HMMer 
consensus, a deletion as dashes in the sequence found. Such changes are expected if the 
sequence is a homologue, and not the natural sequence that corresponds to the 3D-
structures analyzed with Rd.HMM. They may occur also when the PDB file has some 
missing amino acids (this happens frequently, due to experimental limitations of X-ray 
crystalography). If so, you expect this insertions to match the missing amino acids. For in 
silico modeled structures this means a local threading error, or a local defect in the model. 
c. Distribution of conserved sites. The higher the number of conserved sites, the better the 
model. However, some strained conformations have lower energy for glycine, proline 
and asparagine than for every other amino acid and these residues tend to appear as 
strongly conserved (Uppercase letters in the mask line, and in the Rd.HMM consensus). 
If the sequence conservation observed is dominated by these residues, you model may 
be wrong, even if your score has statistical significance. 
9. Guiding the 3D-modeling of proteins with Rd-HMMer 
There are many publications describing different approaches to the solution to the protein 
folding problem (Roy et al., 2010; Kim et al., 2004; Karplus, 2009; Melo & Feytmans, 1998) 
but most of them focus on the theory, or present a technical treatment. Fisher and Sali 
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published a practical guide to the use of the popular modeling software MODELLER (Fiser 
& Sali 2003), where many useful hints are given. Recently, Chavelas-Adame and coworkers 
published a guide with emphasis on the use of open software [45]. The present account will 
not attempt to repeat the work, and only the most important conclusions are given here: 
a. Many servers and software programs are available to aid the comparative modeling of 
proteins (Roy et al., 2010; Kim et al., 2004; Karplus, 2009; Melo & Feytmans, 1998; 
Rosales-León et al., 2012; Fiser & Sali 2003), some options are available for ab initio 
modeling (Kryshtafovych et al., 2009; Kim et al., 2004; Srinivasan et al., 2004; Xu & 
Zhang, 2012), and this list is far form complete. None of them achieves 100% success, 
and even the most successful can fail where other, usually less reliable, may succeed 
(Kryshtafovych et al., 2009; Melo & Feytmans, 1998). 
b. A model is fundamentally wrong when the folding pattern in the model bears little or 
no relationship to the true native fold. Some models may offer a good approximation, 
but have wrong geometrical, sterical and/or chemical features at some locations, i.e. the 
bond lengths, angles, sidechain-sidechain contact distances and orientation may have 
important deviations from the expected values found in known chemical structures. 
This last kind are usually designated as unrefined models. 
c. Unrefined models can be recognized with various energy scoring strategies (Luthy et 
al., 1992; Shi et al., 2009; Hu & Jiang, 2010; Melo & Feytmans, 1998); and can be 
corrected through the use of molecular mechanics software (Rosales-León et al., 2012; 
Fiser & Sali 2003), though this approach has limitations, as mentioned before (Faver et 
al., 2011; Hu & Jiang, 2010; Melo & Feytmans, 19985). 
d. Wrong models instead may frequently be deceitful, because, due to their systematic 
error [5], a molecular mechanics force-field may report a low energy value, as long as 
the chemical and geometrical details are well refined. Rd.HMM offers a solution to this 
problem, because these models will produce an HMM search report with no hits, or will 
score sequences, other than the modeling target (Chavelas Adame et al., 2011; Rosales-
León et al., 2012). 
e. The analysis of the Rd.HMM search report may help in the identification of errors in the 
alignment between the target amino acid sequence and the template selected for 
comparative modeling. If you find a frame-shift or an unexpected insertion/deletion 
pair, you can use the HMM search alignment and realign the target sequence and the 
template. MODELLER is a very good choice for that aim (Fiser & Sali 2003). In addition, 
a wrongly threaded model can be recycled by replacing the consensus sequence with 
the PDB sequence in the model (which is the target sequence), and producing a target to 
target alignment, with the insertions and deletions suggested by HMMer. MODELLER 
can then be used to generate new models. This last procedure is only recommended if 
your HMMer score is positive and has good statistical significance, for otherwise, the 
structural inaccuracy of the Rd.HMMs becomes a serious issue. 
f. Comparative modeling has been extended thanks to methods able to find templates 
with low sequence homology to the target (Wallace et al., 2005; Karplus, 2009). But 
sometimes the selected template is too distant. If the Rd.HMM of the candidate 
structures are obtained, these can be use to score the target sequence. The resulting 
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scores, statistical significance and the alignment may guide your template selection. 
However, if the Rd.HMM of a template candidate gives a negative score, and still you 
decide to use it, do not trust the Rd.HMM alignment without further improvement 
using other tools, as it may be seriously flawed. 
g. Finally, if you use the ROSETTA suite or the ROBETTA server to produce your models, 
these structures are expected to have a ROSETTA-like bias, i.e. their Rd.HMM scores 
will increase and a good model with this bias is expected to have a ratio of HMMer 
score to sequence length close to one. While in models produced with other software a 
Rd.HMM score ratio of 0.3 is acceptable, in a ROSETTA produced model this score is 
low and may reflect important flaws. Look at the alignment carefully, as recommended 
in the previous section. 
 
Figure 5. Comparison of the yeast α-glucosidase model produced included in the publication by 
Brindis et al (Brindis et al., 2011), with the X-ray solved structure of its homologue, the yeast isomaltase 
(Yamamoto et al., 2010). The isomaltase is shown as blue cartoons and the α-glucosidase cartoons are 
colored according to the amino acid rmsd from isomaltase, ranging from very low (blue) to 
intermediate (white) to high (red). 
As an example of the advantages of Rd.HMM, we refer to two cases of recent success. 
Brindis and coworkers (Brindis et al., 2011) analyzed the effects of a natural product on α-
glucosidase. This work reports a model for the budding yeast α-glucosidase used to analyze 
the molecular grounds for the (Z)-3-butylidenephthalide inhibitory action. In the 
preparation of the model, Rd.HMM allowed to detect a threading problem 
(insertion/deletion pair) in one β-strand in the core of the model. While the sheet was slid 
only a few Å from its position, the contact with neighboring strands completely distorted 
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the chemical interaction network affecting the model stability. The correction of this 
problem and the use of molecular dynamics simulations led to a well refined and reliable 
model with a good Rd.HMM score. A few months later (when the paper was in press) the 
3D-structure of a close homologue (isomaltase) was released (Yamamoto et al., 2010). The X-
ray data corroborated the model quality, as the model core backbone has an rmsd of 1.81 Å 
form the experimental data. Figure 5 shows a superposition of both structures colored by 
backbone rmsd form blue (low) to white (medium) to red (high).  
In a second example, the 3D-structure of two isoforms of plant inorganic pyrophophatases 
was obtained using a combined strategy of web servers, MODELLER and molecular 
dynamics simulations. The resulting models provided ground for the lack of quaternary 
structure in plant pyrophosphatases (Rosales-León et al., 2012). Although the sequences of 
several related isoforms were initially sent to the servers, only one isoform was correctly 
modeled, according to Rd.HMM, but the Rd.HMM of the good model gave an alignment for 
the sequence of a second isozyme. This alignment, and the correct model were then used to 
produce the second model. Though this last model was not directly based on experimental 
data, its quality was high, according to Rd.HMM (Rosales-León et al., 2012).  
10. Rd-HMMer limitations 
Since most Rd.HMM limitations have been mentioned. We only summarize them here: 
a. Rd.HMM sensitivity makes it useful for medium to good quality models. Low quality 
models, may still be of use as starting points, but the Rd.HMM data will only indicate the 
low quality and will not allow to discriminate a wrong model from an unrefined one. 
b. The structurally aware nature of the Rd.HMM alignments is to be trusted only for good 
quality models. As the Rd.HMM score drops, the sequence to structure correlation 
becomes weak. 
c. Rd.HMM does not offer much information on how to modify the model to improve its 
appropriateness, other than the presence of insertion/deletions or sequence to structure 
frame-shifts. 
d. A model may be badly refined and get a good Rd.HMM score, as long as Rosetta-design 
is able to process the backbone coordinates and repack the residues. Therefore, the 
Rd.HMM score is insufficient information. Information from other software, such as 
ANOLEA energy (Melo & Feytmans, 1998) or molecular mechanics energy (Hu & Jiang, 
2010) is always required to test a model quality. 
e. Finally, there is no formal proof for the perfect correspondence between a Rd.HMM 
high score and the prediction for the 3D-structure of a protein to be native-like. 
Therefore, from two predictions, of which only one represents the native fold, it might 
be possible to produce a high Rd.HMM score for the target sequence (a false positive). 
However, despite our best efforts we have only found the false negative case, i.e. a good 
prediction (or even a 3D-structure from experimental data) may give a low Rd.HMM 
score. To the best of our knowledge, among the quality assessment methods, this 
feature is unique to the Rd.HMM protocol. 
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11. Conclusions and perspectives 
Although the Rd.HMM protocol is highly sensitive and its alignments become inaccurate 
when the HMM score decreases, it can be used to guide the comparative modeling of 
proteins, as the examples given in section 8 show. Even if the alignment employed is flawed, 
when the model is produced and analyzed with Rd.HMM, the flaw will become evident and 
the model can then be discarded, and additional modeling rounds may be tried.  
An additional advantage of Rd.HMM alignments, as a guide to comparative modeling, 
comes form the fact that Rd.HMM models are independent of the functional constrains 
reflected in the conservation of active and binding sites. Since the Rd. step removes all 
conservation due to ligand binding and functional sites, other than that required to keep the 
structure stable, geometrical differences in the organization of two related, but not identical 
active sites will not affect the modeling process. In contrast, in the classic comparative 
modeling methods, the residue conservation at active and other functional sites is usually an 
important reference to perform the sequence to structure alignment. Then when a model in 
produced with the guidance of Rd.HMM, and a model with good quality and 
appropriateness is obtained, any coincidences in the active site geometry, would not come 
as a consequence of forcing the conserved residues in the target sequence to fall at the 
template's active site, but should be a consequence of meeting the structural requirements of 
the target. 
From the above discussion, Rd.HMM is clearly a valuable tool, but has some limitations. We 
speculate that some of this limitations derive form the inability of HMMs to incorporate 
long range interactions, which can be detected as significant mutual information between 
distant positions in the sequence alignments. Currently we are working on the analysis of 
the mutual information in the Rosetta-designed sequence alignments using the statistical 
coupling analysis strategy (Socolich et al., 2005,Lockless et al., 1999). We hope this powerful 
statistical approach can extend the Rd.HMM and provide a richer tool. 
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11. Conclusions and perspectives 
Although the Rd.HMM protocol is highly sensitive and its alignments become inaccurate 
when the HMM score decreases, it can be used to guide the comparative modeling of 
proteins, as the examples given in section 8 show. Even if the alignment employed is flawed, 
when the model is produced and analyzed with Rd.HMM, the flaw will become evident and 
the model can then be discarded, and additional modeling rounds may be tried.  
An additional advantage of Rd.HMM alignments, as a guide to comparative modeling, 
comes form the fact that Rd.HMM models are independent of the functional constrains 
reflected in the conservation of active and binding sites. Since the Rd. step removes all 
conservation due to ligand binding and functional sites, other than that required to keep the 
structure stable, geometrical differences in the organization of two related, but not identical 
active sites will not affect the modeling process. In contrast, in the classic comparative 
modeling methods, the residue conservation at active and other functional sites is usually an 
important reference to perform the sequence to structure alignment. Then when a model in 
produced with the guidance of Rd.HMM, and a model with good quality and 
appropriateness is obtained, any coincidences in the active site geometry, would not come 
as a consequence of forcing the conserved residues in the target sequence to fall at the 
template's active site, but should be a consequence of meeting the structural requirements of 
the target. 
From the above discussion, Rd.HMM is clearly a valuable tool, but has some limitations. We 
speculate that some of this limitations derive form the inability of HMMs to incorporate 
long range interactions, which can be detected as significant mutual information between 
distant positions in the sequence alignments. Currently we are working on the analysis of 
the mutual information in the Rosetta-designed sequence alignments using the statistical 
coupling analysis strategy (Socolich et al., 2005,Lockless et al., 1999). We hope this powerful 
statistical approach can extend the Rd.HMM and provide a richer tool. 
Author details 
León P. Martínez-Castilla and Rogelio Rodríguez-Sotres 
Facultad de Química, Universidad Nacional Autónoma de México, México 
Acknowledgement 
Funding PAPIIT-DGAPA-UNAM IN210212, CONACyT CB2008-1-101186, PAIP-FQ-UNAM 
4290-09, PAIP-FQ-UNAM 4290-07. 
Abbreviations 
NP-hard problem, as hard to solve as an NP-complete problem; NP-complete problem, no 
algorithm taking a polynomial-time exists for its solution; Rd, ROSETTA-design; MM, 
On the Assessment of Structural Protein Models with  
ROSETTA-Design and HMMer: Value, Potential and Limitations 235 
Markov model; HMM, hidden Markov model; CASP, critical assessment of the structure of 
proteins; PDB, international protein data bank; TIM, triose phosphate isomerase. 
12. References 
Bowie, J., Reidhaar-Olson, J., Lim, W., & Sauer, R.(1990). Deciphering the message in protein 
sequences: tolerance to amino acid substitutions. Science, Vol. 247, No. 4948,  (Mar 1990) 
pp. 1306-1310, ISSN 0036-8075 (print), 1095-9203 (electronic) 
Brindis, F., Rodríguez, R., Bye, R., González-Andrade, M., & Mata, R.(2011). (Z)-3-
butylidenephthalide from Ligusticum porteri , an α-glucosidase inhibitor. J Nat Prod, Vol. 
74, No. 3,  (Sep 2011) pp. 314-20, ISSN 0163-3864 (print) 1520-6025 (electronic) 
Butterfoss, G. L. & Kuhlman, B.(2006). Computer-based design of novel protein structures. 
Annu Rev Biophys Biomol Struct, Vol. 35,  (Jun 2006) pp. 49-65, ISSN 1056-8700 
Chavelas Adame, E. A., Hernández-Domínguez, E. E., Gaytán-Mondrangón, S., Rosales 
León, L., Valencia-Turcotte, L., & Rodríguez-Sotres, R.(2011). A Hitchhiker's Guide to 
the modeling of the three-Dimensional structure of proteins. International Color 
Biotechnology Journal, Vol. 1, No. 1,  (Nov 2011) pp. 26-35, ISSN 2226-0404 (electronic) 
Cheng, G., Qian, B., Samudrala, R., & Baker, D.(2005). Improvement in protein functional 
site prediction by distinguishing structural and functional constraints on protein family 
evolution using computational design. Nucleic Acids Research, Vol. 33, No. 18,  (Sep 
2005) pp. 5861--7, ISSN 1362-4962 (print) 
Chivian, D. & Baker, D.(2006). Homology modeling using parametric alignment ensemble 
generation with consensus and energy-based model selection. Nucleic Acids Research, 
Vol. 34, No. 17,  (Sep 2006) pp. e112, ISSN 1362-4962 
Chodanowski, P., Grosdidier, A., Feytmans, E., & Michielin, O.(2008). Local Alignment 
Refinement Using Structural Assessment. PLoS ONE, Vol. 3, No. 7,  (Jul 2008) pp. e2645, 
ISSN 1932-6203 (electronic) 
Cowles, M. K. & Carlin, B. P.(1996). Markov Chain Monte Carlo Convergence Diagnostics: A 
Comparative Review. Journal of the American Statistical Association, Vol. 91, No. 434,  (Jun 
1996) pp. 883-904, ISSN 0162-1459 (print), 1537-274X (electronic) 
Dill, K. A., Ozkan, S. B., Shell, M. S., & Weikl, T. R.(2008). The protein folding problem. Annu 
Rev Biophys, Vol. 37,  (Jun 2008) pp. 289-316, ISSN ISSN:1936-122X (print) 1936-1238 
(electronic) 1936-122X (linking) 
Eddy, S. R., Mitchison, G., & Durbin, R.(1995). Maximum discrimination hidden Markov 
models of sequence consensus. J Comput Biol, Vol. 2, No. 1,  (Jan 1995) pp. 9--23, ISSN 
1066-5277 (print); 1557-8666 (electronic) 
Eddy, S. R.(2004). What is a hidden Markov model? Nat Biotech, Vol. 22, No. 10,  (Oct 2004) 
pp. 1315--1316, ISSN 1087-0156 
Faver, J. C., Benson, M. L., He, X., Roberts, B. P., Wang, B., Marshall, M. S., Sherrill, C. D., & 
Merz, Jr., K. M.(2011). The Energy Computation Paradox and ab initio Protein Folding. 
PLoS ONE, Vol. 6, No. 4,  (Apr 2011) pp. e18868, ISSN e1932-6203 
Fiser, A. & Sali, A.(2003). Modeller: generation and refinement of homology-based protein 




Hamelryck, T., Borg, M., Paluszewski, M., Paulsen, J., Frellsen, J., Andreetta, C., Boomsma, 
W., Bottaro, S., & Ferkinghoff-Borg, J.(2010). Potentials of Mean Force for Protein 
Structure Prediction Vindicated, Formalized and Generalized. PLoS ONE, Vol. 5, No. 11,  
(Nov 2010) pp. e13714, ISSN e1932-6203 
Hart, W. E. & Istrail, S.(1997). Robust proofs of NP-hardness for protein folding: general 
lattices and energy potentials. J Comput Biol, Vol. 4, No. 1,  (Jan 1997) pp. 1-22, ISSN 
1066-5277 (print); 1557-8666 (electronic) 
He, X. & Merz, K. M.(2010). Divide and Conquer Hartree-Fock Calculations on Proteins. 
Journal of Chemical Theory and Computation, Vol. 6, No. 2,  (Jan 2010) pp. 405-411, ISSN 
1549-9618 (print) 1549-9626 (electronic) 
Hu, Z. & Jiang, J.(2010). Assessment of biomolecular force fields for molecular dynamics 
simulations in a protein crystal. J Comput Chem, Vol. 31, No. 2,  (Jan 2010) pp. 371-80, 
ISSN 1096-987X 
Humphrey, W., Dalke, A., & Schulten, K.(1996). VMD: visual molecular dynamics. J Mol 
Graph, Vol. 14, No. 1,  (Feb 1996) pp. 33-38, ISSN 1093-3263 
Ilyin, V. A., Abyzov, A., & Leslin, C. M.(2004). Structural alignment of proteins by a novel 
TOPOFIT method, as a superimposition of common volumes at a topomax point. 
Protein Science: A Publication of the Protein Society, Vol. 13, No. 7,  (July 2004) pp. 1865-
1874, ISSN 0961-8368 
Jiang, L., Althoff, E. A., Clemente, F. R., Doyle, L., Röthlisberger, D., Zanghellini, A., 
Gallaher, J. L., Betker, J. L., Tanaka, F., Barbas, C. F., Hilvert, D., Houk, K. N., Stoddard, 
B. L., & Baker, D.(2008). De novo computational design of retro-aldol enzymes. Science 
(New York, N.Y.), Vol. 319, No. 5868,  (Mar 2008) pp. 1387-1391, ISSN 0036-8075 (print), 
1095-9203 (electronic) 
Kaplan, W. & Littlejohn, T. G.(2001). Swiss-PDB Viewer (Deep View). Briefings in 
Bioinformatics, Vol. 2, No. 2,  (May 2001) pp. 195-197, ISSN 1477-4054 (print) 1467-5463 
(electronic) 
Karplus, K.(2009). SAM-T08, HMM-based protein structure prediction. Nucleic Acids Res, 
Vol. 37, No. Web Server issue,  (July 2009) pp. W492-7, ISSN 1362-4962 (print) 
Kim, D. E., Chivian, D., & Baker, D.(2004). Protein structure prediction and analysis using 
the Robetta server. Nucleic Acids Res, Vol. 32, No. Web Server issue,  (Jul 2004) pp. 
W526-W531, ISSN 1362-4962 (print) 0305-1048 (electronic) 
Kono, H. & Saven, J. G.(2001). Statistical theory for protein combinatorial libraries. packing 
interactions, backbone flexibility, and the sequence variability of a main-chain structure. 
Journal of Molecular Biology, Vol. 306, No. 3,  (Feb 2001) pp. 607 - 628, ISSN 0022-2836 
Kryshtafovych, A., Krysko, O., Daniluk, P., Dmytriv, Z., & Fidelis, K.(2009). Protein 
structure prediction center in CASP8. Proteins, Vol. 77, No. Suppl 9,  (July 2009) pp. 5-9, 
ISSN 1097-0134 
Kuhlman, B., Dantas, G., Ireton, G. C., Varani, G., Stoddard, B. L., & Baker, D.(2003). Design 
of a novel globular protein fold with atomic-level accuracy. Science, Vol. 302, No. 5649,  
(Nov 2003) pp. 1364--1368, ISSN 0036-8075 (print), 1095-9203 (electronic) 
Lathrop, R. H.(1994). The protein threading problem with sequence amino acid interaction 
preferences is NP-complete. Protein Engineering, Vol. 7, No. 9,  (Sep 1994) pp. 1059-1068, 
ISSN 1741-0134 (print) 1741-0126 (electronic) 
On the Assessment of Structural Protein Models with  
ROSETTA-Design and HMMer: Value, Potential and Limitations 237 
Levinthal, C.(1968). Are there pathways for protein folding? Journal de Chimie Physique et de 
Physicochimie Biologique, Vol. 65, No. 1-4,  (Jan 1968) pp. 44-45, ISSN 0021-7689 
Lockless, S. W. & Ranganathan, R.(1999). Evolutionarily conserved pathways of energetic 
connectivity in protein families. Science, Vol. 286, No. 5438,  (Oct 1999) pp. 295-299, ISSN 
0036-8075 (print), 1095-9203 (electronic) 
Luthy, R., Bowie, J. U., & Eisenberg, D.(1992). Assessment of protein models with three-
dimensional profiles. Nature, Vol. 356, No. 6364,  (Mar 1992) pp. 83--85, ISSN 0028-0836 
(print) 
Martínez-Castilla, L. P. & Rodríguez-Sotres, R.(2010). A score of the ability of a three-
dimensional protein model to retrieve its own sequence as a quantitative measure of its 
quality and appropriateness. PLoS One, Vol. 5, No. 9,  (Sep 2010) pp. e12483, ISSN 
e1932-6203 
Melo, F. & Feytmans, E.(1998). Assessing protein structures with a non-local atomic 
interaction energy. J Mol Biol, Vol. 277, No. 5,  (Apr 1998) pp. 1141-1152, ISSN 0022-2836 
Mengersen, K. L. & Tweedie, R. L.(1966). Rates of convergence of the Hastings and 
Metropolis algorithms. Annals of Statistics, Vol. 24, No. 1,  (Feb 1966) pp. 101-121, ISSN 
0090-5364 
Metropolis, N., Rosenbluth, A. W., Rosenbluth, M. N., Teller, A. H., & Teller, E.(1953). 
Equation of State Calculations by Fast Computing Machines. The Journal of Chemical 
Physics, Vol. 21, No. 6,  (Jun 1953) pp. 1087-1092, ISSN 0021-9606 (print), 1089-7690 
(electronic) 
Pawlowski, M., Gajda, M. J., Matlak, R., & Bujnicki, J. M.(2008). MetaMQAP: a meta-server 
for the quality assessment of protein models. BMC Bioinformatics, Vol. 9, No. Sep,  (Sep 
2008) pp. 403, ISSN 1471-2105 
Raha, K. & Merz, Jr, K. M.(2005). Large-scale validation of a quantum mechanics based 
scoring function: predicting the binding affinity and the binding mode of a diverse set 
of protein-ligand complexes. J Med Chem, Vol. 48, No. 14,  (Jul 2005) pp. 4558-4575, ISSN 
0022-2623 (print) 1520-4804 (electronic) 
Rodriguez, R., Chinea, G., Lopez, N., Pons, T., & Vriend, G.(1998). Homology modeling, 
model and software evaluation: three related resources. Bioinformatics, Vol. 14, No. 6,  
(Jul 1998) pp. 523-528, ISSN 1460-2059 (print) 1367-4803 (electronic) 
Rosales-León, L., Hernández-Domínguez, E. E., Gaytán-Mondragón, S., & Rodríguez-Sotres, 
R.(2012). Metal binding sites in plant soluble inorganic pyrophosphatases. An example 
of the use of ROSETTA design and hidden Markov models to guide the homology 
modeling of proteins. Journal of the Mexican Chemical Society, Vol. 56, No. 1,  (Jan-Mar 
2012) pp. 23-31, ISSN 1665-9686 
Rose, P. W., Beran, B., Bi, C., Bluhm, W. F., Dimitropoulos, D., Goodsell, D. S., Prlic, A., 
Quesada, M., Quinn, G. B., Westbrook, J. D., Young, J., Yukich, B., Zardecki, C., Berman, 
H. M., & Bourne, P. E.(2011). The RCSB Protein Data Bank: redesigned web site and 
web services. Nucleic Acids Res, Vol. 39, No. Database issue,  (Jan 2011) pp. D392-D401, 
ISSN 1362-4962 (print) 0305-1048 (electronic) 
Röthlisberger, D., Khersonsky, O., Wollacott, A. M., Jiang, L., DeChancie, J., Betker, J., 
Gallaher, J. L., Althoff, E. A., Zanghellini, A., Dym, O., Albeck, S., Houk, K. N., Tawfik, 
D. S., & Baker, D.(2008). Kemp elimination catalysts by computational enzyme design. 
 
Bioinformatics 236 
Hamelryck, T., Borg, M., Paluszewski, M., Paulsen, J., Frellsen, J., Andreetta, C., Boomsma, 
W., Bottaro, S., & Ferkinghoff-Borg, J.(2010). Potentials of Mean Force for Protein 
Structure Prediction Vindicated, Formalized and Generalized. PLoS ONE, Vol. 5, No. 11,  
(Nov 2010) pp. e13714, ISSN e1932-6203 
Hart, W. E. & Istrail, S.(1997). Robust proofs of NP-hardness for protein folding: general 
lattices and energy potentials. J Comput Biol, Vol. 4, No. 1,  (Jan 1997) pp. 1-22, ISSN 
1066-5277 (print); 1557-8666 (electronic) 
He, X. & Merz, K. M.(2010). Divide and Conquer Hartree-Fock Calculations on Proteins. 
Journal of Chemical Theory and Computation, Vol. 6, No. 2,  (Jan 2010) pp. 405-411, ISSN 
1549-9618 (print) 1549-9626 (electronic) 
Hu, Z. & Jiang, J.(2010). Assessment of biomolecular force fields for molecular dynamics 
simulations in a protein crystal. J Comput Chem, Vol. 31, No. 2,  (Jan 2010) pp. 371-80, 
ISSN 1096-987X 
Humphrey, W., Dalke, A., & Schulten, K.(1996). VMD: visual molecular dynamics. J Mol 
Graph, Vol. 14, No. 1,  (Feb 1996) pp. 33-38, ISSN 1093-3263 
Ilyin, V. A., Abyzov, A., & Leslin, C. M.(2004). Structural alignment of proteins by a novel 
TOPOFIT method, as a superimposition of common volumes at a topomax point. 
Protein Science: A Publication of the Protein Society, Vol. 13, No. 7,  (July 2004) pp. 1865-
1874, ISSN 0961-8368 
Jiang, L., Althoff, E. A., Clemente, F. R., Doyle, L., Röthlisberger, D., Zanghellini, A., 
Gallaher, J. L., Betker, J. L., Tanaka, F., Barbas, C. F., Hilvert, D., Houk, K. N., Stoddard, 
B. L., & Baker, D.(2008). De novo computational design of retro-aldol enzymes. Science 
(New York, N.Y.), Vol. 319, No. 5868,  (Mar 2008) pp. 1387-1391, ISSN 0036-8075 (print), 
1095-9203 (electronic) 
Kaplan, W. & Littlejohn, T. G.(2001). Swiss-PDB Viewer (Deep View). Briefings in 
Bioinformatics, Vol. 2, No. 2,  (May 2001) pp. 195-197, ISSN 1477-4054 (print) 1467-5463 
(electronic) 
Karplus, K.(2009). SAM-T08, HMM-based protein structure prediction. Nucleic Acids Res, 
Vol. 37, No. Web Server issue,  (July 2009) pp. W492-7, ISSN 1362-4962 (print) 
Kim, D. E., Chivian, D., & Baker, D.(2004). Protein structure prediction and analysis using 
the Robetta server. Nucleic Acids Res, Vol. 32, No. Web Server issue,  (Jul 2004) pp. 
W526-W531, ISSN 1362-4962 (print) 0305-1048 (electronic) 
Kono, H. & Saven, J. G.(2001). Statistical theory for protein combinatorial libraries. packing 
interactions, backbone flexibility, and the sequence variability of a main-chain structure. 
Journal of Molecular Biology, Vol. 306, No. 3,  (Feb 2001) pp. 607 - 628, ISSN 0022-2836 
Kryshtafovych, A., Krysko, O., Daniluk, P., Dmytriv, Z., & Fidelis, K.(2009). Protein 
structure prediction center in CASP8. Proteins, Vol. 77, No. Suppl 9,  (July 2009) pp. 5-9, 
ISSN 1097-0134 
Kuhlman, B., Dantas, G., Ireton, G. C., Varani, G., Stoddard, B. L., & Baker, D.(2003). Design 
of a novel globular protein fold with atomic-level accuracy. Science, Vol. 302, No. 5649,  
(Nov 2003) pp. 1364--1368, ISSN 0036-8075 (print), 1095-9203 (electronic) 
Lathrop, R. H.(1994). The protein threading problem with sequence amino acid interaction 
preferences is NP-complete. Protein Engineering, Vol. 7, No. 9,  (Sep 1994) pp. 1059-1068, 
ISSN 1741-0134 (print) 1741-0126 (electronic) 
On the Assessment of Structural Protein Models with  
ROSETTA-Design and HMMer: Value, Potential and Limitations 237 
Levinthal, C.(1968). Are there pathways for protein folding? Journal de Chimie Physique et de 
Physicochimie Biologique, Vol. 65, No. 1-4,  (Jan 1968) pp. 44-45, ISSN 0021-7689 
Lockless, S. W. & Ranganathan, R.(1999). Evolutionarily conserved pathways of energetic 
connectivity in protein families. Science, Vol. 286, No. 5438,  (Oct 1999) pp. 295-299, ISSN 
0036-8075 (print), 1095-9203 (electronic) 
Luthy, R., Bowie, J. U., & Eisenberg, D.(1992). Assessment of protein models with three-
dimensional profiles. Nature, Vol. 356, No. 6364,  (Mar 1992) pp. 83--85, ISSN 0028-0836 
(print) 
Martínez-Castilla, L. P. & Rodríguez-Sotres, R.(2010). A score of the ability of a three-
dimensional protein model to retrieve its own sequence as a quantitative measure of its 
quality and appropriateness. PLoS One, Vol. 5, No. 9,  (Sep 2010) pp. e12483, ISSN 
e1932-6203 
Melo, F. & Feytmans, E.(1998). Assessing protein structures with a non-local atomic 
interaction energy. J Mol Biol, Vol. 277, No. 5,  (Apr 1998) pp. 1141-1152, ISSN 0022-2836 
Mengersen, K. L. & Tweedie, R. L.(1966). Rates of convergence of the Hastings and 
Metropolis algorithms. Annals of Statistics, Vol. 24, No. 1,  (Feb 1966) pp. 101-121, ISSN 
0090-5364 
Metropolis, N., Rosenbluth, A. W., Rosenbluth, M. N., Teller, A. H., & Teller, E.(1953). 
Equation of State Calculations by Fast Computing Machines. The Journal of Chemical 
Physics, Vol. 21, No. 6,  (Jun 1953) pp. 1087-1092, ISSN 0021-9606 (print), 1089-7690 
(electronic) 
Pawlowski, M., Gajda, M. J., Matlak, R., & Bujnicki, J. M.(2008). MetaMQAP: a meta-server 
for the quality assessment of protein models. BMC Bioinformatics, Vol. 9, No. Sep,  (Sep 
2008) pp. 403, ISSN 1471-2105 
Raha, K. & Merz, Jr, K. M.(2005). Large-scale validation of a quantum mechanics based 
scoring function: predicting the binding affinity and the binding mode of a diverse set 
of protein-ligand complexes. J Med Chem, Vol. 48, No. 14,  (Jul 2005) pp. 4558-4575, ISSN 
0022-2623 (print) 1520-4804 (electronic) 
Rodriguez, R., Chinea, G., Lopez, N., Pons, T., & Vriend, G.(1998). Homology modeling, 
model and software evaluation: three related resources. Bioinformatics, Vol. 14, No. 6,  
(Jul 1998) pp. 523-528, ISSN 1460-2059 (print) 1367-4803 (electronic) 
Rosales-León, L., Hernández-Domínguez, E. E., Gaytán-Mondragón, S., & Rodríguez-Sotres, 
R.(2012). Metal binding sites in plant soluble inorganic pyrophosphatases. An example 
of the use of ROSETTA design and hidden Markov models to guide the homology 
modeling of proteins. Journal of the Mexican Chemical Society, Vol. 56, No. 1,  (Jan-Mar 
2012) pp. 23-31, ISSN 1665-9686 
Rose, P. W., Beran, B., Bi, C., Bluhm, W. F., Dimitropoulos, D., Goodsell, D. S., Prlic, A., 
Quesada, M., Quinn, G. B., Westbrook, J. D., Young, J., Yukich, B., Zardecki, C., Berman, 
H. M., & Bourne, P. E.(2011). The RCSB Protein Data Bank: redesigned web site and 
web services. Nucleic Acids Res, Vol. 39, No. Database issue,  (Jan 2011) pp. D392-D401, 
ISSN 1362-4962 (print) 0305-1048 (electronic) 
Röthlisberger, D., Khersonsky, O., Wollacott, A. M., Jiang, L., DeChancie, J., Betker, J., 
Gallaher, J. L., Althoff, E. A., Zanghellini, A., Dym, O., Albeck, S., Houk, K. N., Tawfik, 
D. S., & Baker, D.(2008). Kemp elimination catalysts by computational enzyme design. 
 
Bioinformatics 238 
Nature, Vol. 453, No. 7192,  (May 2008) pp. 190-195, ISSN 0028-0836 (print) 1476-4687 
(electronic) 
Roy, A., Kucukural, A., & Zhang, Y.(2010). I-TASSER: a unified platform for automated 
protein structure and function prediction. Nat Protoc, Vol. 5, No. 4,  (Mar 2010) pp. 725-
738, ISSN 1754-2189 (print) 1750-2799 (electronic) 
Sayers, E. W., Barrett, T., Benson, D. A., Bolton, E., Bryant, S. H., Canese, K., Chetvernin, V., 
Church, D. M., Dicuccio, M., Federhen, S., Feolo, M., Geer, L. Y., Helmberg, W., 
Kapustin, Y., Landsman, D., Lipman, D. J., Lu, Z., Madden, T. L., Madej, T., Maglott, D. 
R., Marchler-Bauer, A., Miller, V., Mizrachi, I., Ostell, J., Panchenko, A., Pruitt, K. D., 
Schuler, G. D., Sequeira, E., Sherry, S. T., Shumway, M., Sirotkin, K., Slotta, D., 
Souvorov, A., Starchenko, G., Tatusova, T. A., Wagner, L., Wang, Y., John Wilbur, W., 
Yaschenko, E., & Ye, J.(2010). Database resources of the National Center for 
Biotechnology Information. Nucleic Acids Res, Vol. 38, No. suppl 1,  (Jan 2010) pp. D5-16, 
ISSN 1362-4962 (print) 0305-1048 (electronic) 
Schuster-Böckler, B. & Bateman, A.(2005). Visualizing profile‚ profile alignment: pairwise 
HMM logos. Bioinformatics, Vol. 21, No. 12,  (Jun 2005) pp. 2912-2913, ISSN 1367-4803 
(print) 1460-2059 (electronic) 
Shapiro, L. W. & Zeilberger, D.(1982). A Markov chain occurring in enzyme kinetics. Journal 
of Mathematical Biology, Vol. 15, No. 3,  (Nov 1982) pp. 351-357, ISSN 0303-6812 
Shi, S., Pei, J., Sadreyev, R. I., Kinch, L. N., Majumdar, I., Tong, J., Cheng, H., Kim, B.-H., & 
Grishin, N. V.(2009). Analysis of CASP8 targets, predictions and assessment methods. 
Database (Oxford), Vol. 2009,  (Apr 2009) pp. bap003, ISSN 1758-0463 
Slovic, A. M., Kono, H., Lear, J. D., Saven, J. G., & DeGrado, W. F.(2004). Computational 
design of water-soluble analogues of the potassium channel KcsA. Proc Natl Acad Sci U 
S A, Vol. 101, No. 7,  (Feb 2004) pp. 1828-1833, ISSN 1091-6490 
Socolich, M., Lockless, S. W., Russ, W. P., Lee, H., Gardner, K. H., & Ranganathan, R.(2005). 
Evolutionary information for specifying a protein fold. Nature, Vol. 437, No. 7058, (Sep 
2005) pp. 512-8, ISSN 0028-0836 (print) 1476-4687 (electronic) 
Srinivasan, R., Fleming, P. J., & Rose, G. D.(2004). Ab initio protein folding using LINUS. 
Methods Enzymol, Vol. 383,  (Apr 2004) pp. 48-66, ISSN 978-0-12-391860-4 
Wallace, I. M., Blackshields, G., & Higgins, D. G.(2005). Multiple sequence alignments. Curr 
Opin Struct Biol, Vol. 15, No. 3,  (Jun 2005) pp. 261-266, ISSN 0959-440X 
Wallner, B. & Elofsson, A.(2003). Can correct protein models be identified? Protein Sci, Vol. 
12, No. 5,  (May 2003) pp. 1073-1086, ISSN 1469-896X 
Wilmanns, M. & Eisenberg, D.(1995). Inverse protein folding by the residue pair preference 
profile method: estimating the correctness of alignments of structurally compatible 
sequences. Protein Eng, Vol. 8, No. 7, (July 1995) pp. 627-39, ISSN 1741-0134 (print) 1741-
0126 (electronic) 
Xu, D., Zhang, J., Roy, A., & Zhang, Y.(2011). Automated protein structure modeling in CASP9 
by I-TASSER pipeline combined with QUARK-based ab initio folding and FG-MD-based 
structure refinement. Proteins, Vol. 79, No. S10, (Aug 2011) pp. 147-160, ISSN 1097-0134 
Yamamoto, K., Miyake, H., Kusunoki, M., & Osaki, S.(2010). Crystal structures of isomaltase 
from Saccharomyces cerevisiae and in complex with its competitive inhibitor maltose. 











Nature, Vol. 453, No. 7192,  (May 2008) pp. 190-195, ISSN 0028-0836 (print) 1476-4687 
(electronic) 
Roy, A., Kucukural, A., & Zhang, Y.(2010). I-TASSER: a unified platform for automated 
protein structure and function prediction. Nat Protoc, Vol. 5, No. 4,  (Mar 2010) pp. 725-
738, ISSN 1754-2189 (print) 1750-2799 (electronic) 
Sayers, E. W., Barrett, T., Benson, D. A., Bolton, E., Bryant, S. H., Canese, K., Chetvernin, V., 
Church, D. M., Dicuccio, M., Federhen, S., Feolo, M., Geer, L. Y., Helmberg, W., 
Kapustin, Y., Landsman, D., Lipman, D. J., Lu, Z., Madden, T. L., Madej, T., Maglott, D. 
R., Marchler-Bauer, A., Miller, V., Mizrachi, I., Ostell, J., Panchenko, A., Pruitt, K. D., 
Schuler, G. D., Sequeira, E., Sherry, S. T., Shumway, M., Sirotkin, K., Slotta, D., 
Souvorov, A., Starchenko, G., Tatusova, T. A., Wagner, L., Wang, Y., John Wilbur, W., 
Yaschenko, E., & Ye, J.(2010). Database resources of the National Center for 
Biotechnology Information. Nucleic Acids Res, Vol. 38, No. suppl 1,  (Jan 2010) pp. D5-16, 
ISSN 1362-4962 (print) 0305-1048 (electronic) 
Schuster-Böckler, B. & Bateman, A.(2005). Visualizing profile‚ profile alignment: pairwise 
HMM logos. Bioinformatics, Vol. 21, No. 12,  (Jun 2005) pp. 2912-2913, ISSN 1367-4803 
(print) 1460-2059 (electronic) 
Shapiro, L. W. & Zeilberger, D.(1982). A Markov chain occurring in enzyme kinetics. Journal 
of Mathematical Biology, Vol. 15, No. 3,  (Nov 1982) pp. 351-357, ISSN 0303-6812 
Shi, S., Pei, J., Sadreyev, R. I., Kinch, L. N., Majumdar, I., Tong, J., Cheng, H., Kim, B.-H., & 
Grishin, N. V.(2009). Analysis of CASP8 targets, predictions and assessment methods. 
Database (Oxford), Vol. 2009,  (Apr 2009) pp. bap003, ISSN 1758-0463 
Slovic, A. M., Kono, H., Lear, J. D., Saven, J. G., & DeGrado, W. F.(2004). Computational 
design of water-soluble analogues of the potassium channel KcsA. Proc Natl Acad Sci U 
S A, Vol. 101, No. 7,  (Feb 2004) pp. 1828-1833, ISSN 1091-6490 
Socolich, M., Lockless, S. W., Russ, W. P., Lee, H., Gardner, K. H., & Ranganathan, R.(2005). 
Evolutionary information for specifying a protein fold. Nature, Vol. 437, No. 7058, (Sep 
2005) pp. 512-8, ISSN 0028-0836 (print) 1476-4687 (electronic) 
Srinivasan, R., Fleming, P. J., & Rose, G. D.(2004). Ab initio protein folding using LINUS. 
Methods Enzymol, Vol. 383,  (Apr 2004) pp. 48-66, ISSN 978-0-12-391860-4 
Wallace, I. M., Blackshields, G., & Higgins, D. G.(2005). Multiple sequence alignments. Curr 
Opin Struct Biol, Vol. 15, No. 3,  (Jun 2005) pp. 261-266, ISSN 0959-440X 
Wallner, B. & Elofsson, A.(2003). Can correct protein models be identified? Protein Sci, Vol. 
12, No. 5,  (May 2003) pp. 1073-1086, ISSN 1469-896X 
Wilmanns, M. & Eisenberg, D.(1995). Inverse protein folding by the residue pair preference 
profile method: estimating the correctness of alignments of structurally compatible 
sequences. Protein Eng, Vol. 8, No. 7, (July 1995) pp. 627-39, ISSN 1741-0134 (print) 1741-
0126 (electronic) 
Xu, D., Zhang, J., Roy, A., & Zhang, Y.(2011). Automated protein structure modeling in CASP9 
by I-TASSER pipeline combined with QUARK-based ab initio folding and FG-MD-based 
structure refinement. Proteins, Vol. 79, No. S10, (Aug 2011) pp. 147-160, ISSN 1097-0134 
Yamamoto, K., Miyake, H., Kusunoki, M., & Osaki, S.(2010). Crystal structures of isomaltase 
from Saccharomyces cerevisiae and in complex with its competitive inhibitor maltose. 















© 2012 Silva and Echeverrigaray, licensee InTech. This is an open access chapter distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits 
unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 
Bacterial Promoter Features Description and 
Their Application on E. coli in silico  
Prediction and Recognition Approaches 
Scheila de Avila e Silva and Sergio Echeverrigaray 
Additional information is available at the end of the chapter 
http://dx.doi.org/10.5772/48149 
1. Introduction 
The determination of when and how genes are “turned on and off” is a challenge in pos-
genomic era. Differences between two species are closer to gene expression and regulation 
than to gene structures (Howard & Benson, 2002). The first and key step in gene expression 
is promoter recognition by RNA polymerase enzyme (RNAP). The promoter sequences can 
be defined as cis-acting elements located upstream of the transcription start site (TSS) of 
open reading frames (ORF). To make an analogy, genes represent the “computer memory” 
and promoters represent the “computer program” which acts on that memory. The study 
about promoters can assist in providing new models about the constitution of the computer 
program and how it operates (Howard & Benson, 2002). 
The proper regulation of transcription is crucial for a single-cell prokaryote since its 
environment can change dramatically and instantly (Huffmann & Brennan, 2002). In face of 
this, the detailing of the principals and the organization of transcriptional process is helpful 
for understanding the complexity of biological systems involved, for instance, cellular 
responses to environmental changes or in the molecular bases of many diseases caused by 
microbes (Janga & Collado-Vides, 2007). 
While several sequenced genomes have their protein-coding gene repertoire well described, 
the accurate identification and delineation of cis-regulatory elements remain elusive 
(Fauteux et al., 2008). At this moment, the challenges are to analyze the available sequences 
and to locate TSS, promoters and other regulatory sequences (Askary et al., 2009). The 
purpose of this review is to provide a brief survey of promoter sequences characteristics and 
the advances of computer algorithms for their analysis and prediction. This chapter is 
organized in two main sections. The established knowledge about biological features of the 
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promoters will be described in the first section, focusing in their genetic role and sequence 
content constitution. This is an important topic for understanding the intrinsic difficulties in 
the in silico promoter prediction approaches. The second section is devoted to give a 
reasonably concise background of the most used methodologies for E. coli promoter 
prediction and recognition, presenting their applications, as well as their limitations.  
2. The bacterial promoter sequences 
A common feature of the transcriptional regulators is their ability to recognize specific DNA 
patterns in order to modulate gene expression (Jacques et al., 2006). The upstream 
regulatory region of the bacterial coding regions contains the promoter, that is, the DNA 
sequence which determines specific recognition by RNAP (Barrios et al., 1999). The 
following section presents a concerned description about the promoter sequences and their 
role as gene expression regulators. 
2.1. Promoter sequences and gene expression specificity 
In bacteria, RNAP holoenzyme consists of five subunits (2α,β,β’,ω) and an additional sigma 
(σ) subunit factor (Figure 1). A collection of different σ subunits act as key regulators of 
bacterial gene expression. The σ factor led RNAP sequence-specific binding at promoter 
where melting of the DNA double strand occurs (Borukov & Nudler, 2003). The substitution 
of one σ factor by another can initiate the transcription of different groups of genes 
(Schultzaberger et al., 2006). The numbers of σ factors encoded in bacterial genomes is 
highly variable. It is possible that the number of σ factor genes is related to the diversity of 
lifestyles encountered by a bacterium (Janga & Collado-Vides, 2007). 
 
Figure 1. The RNAP enzyme (KEEG-modified1). 
1Available on http://www.genome.jp/kegg/pathway/ko/ko03020.html). 
The σ factors are labeled according to their molecular weight (e.g. σ24, σ28, σ32, σ38, σ54 and 
σ70) and each one has been assigned to a global function role (Table 1). The σ70 is most 
commonly used σ factor in E. coli. It is the responsible for the bulk housekeeping 
transcriptional activity, for this reason it is responsible for the initiation of a large number of 
genes (Potvin & Sanschagrin, 2008; Schultzaberger et al., 2006).  
Regardless of the σ factor, most of the promoters can be dissected into two functional sites, 
known as the -35 and -10 regions upstream of the TSS. Mutations in the consensus 
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sequences of the promoters can affect the level of expression of the gene(s) they control, 
without altering the gene products themselves (Lewin, 2008). The canonical consensus and 
the number interspacing nucleotides recognized by the most important σ are presented on 
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CTGGNA 6pb TTGCA 
Barrios et al., 
1999 




Heat shock  
Response 
GGAACTT   15pb  GTCTAA 
Rhodius et 
al.,2006 
Table 1. E. coli σ factors and their promoter sequences binding sites (LEWIN, 2008).  
A comprehensive study of the promoter content information was carried out by 
Schultzaberger et al. (2006). The authors have used the Claude Shannon’s information 
theory and have built a promoter model by aligning and refining of 559 sequences upstream 
of TSS. The results for the promoter motifs showed, among others, two interesting results: (i) 
the difference of TSS prokaryotic information (0.39+-0.06 bits) in opposite to eukaryotic TSS 
(~3bits) and, (ii) the notorious high degree of conservation of the last nucleotide (T) in the     
-10 region. Another important discussion described in the paper is about the -10 extended 
region. According to Hook-Barnard et al. (2006), some promoters are functional without the 
-35 region and this missing information is compensated by four nucleotides upstream of the 
-10 element. Its consensus sequence is TRTG (according to IUPAC code, the letter R 
represents A or G). About this issue, the authors suggest that in prokaryotes the extended -
10 may be an evolutionary predecessor to the modern bipartite promoter or vice versa. 
However, the second possibility does not explain the origin of bipartite promoter.  
As it has been related so far, the promoter motifs are not strictly conserved within a set of 
promoters recognized by a given σ factor and also differ according to the σ factor which 
recognizes them. The structure of bacterial promoters limits the efficacy of prediction by a 
global analysis approach. A limited analysis of a putative promoter sequence by comparison 
with the σ70 promoter consensus motif can lead to an unacceptable rate of false negatives 
and incorrect assignments (de Avila e Silva et al., 2011). 
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2.2. Structural properties of promoter sequences  
The motifs obtained from promoter sequences compilation are indicative of the existence of 
a nucleotide signal in them. Nonetheless, it also been demonstrated that primary DNA 
sequence is not the only source of information in the genome for the transcription regulatory 
process (Olivares-Zavaleta et al., 2006).  According to many authors (e.g, Kanhere & Bansal, 
2005a; Klaiman et al., 2009; Wang & Benham, 2006), not only regulatory sequences contain 
specific sequence elements that serve as target for interacting proteins, but also present 
different properties, such as: suitable geometrical arrangement of DNA (curvature), 
propensity to adopt a deformed conformation facilitating the protein binding (flexibility) 
and physical properties (e.g., stacking energy, stability, stress-induced duplex 
destabilization). Several studies have reported that eukaryotic and prokaryotic σ70-
dependent promoter sequences have lower stability, higher curvature and lesser flexibility 
than coding sequences (Gabrielian & Bolshoy, 1999; Kanhere & Bansal, 2005a). 
DNA stability is a sequence-dependent property based on the sum of the interactions 
between the dinucleotides of a given sequence. It is possible to calculate the DNA duplex 
stability and to predict the melting behavior if the contribution of each nearest-neighbor 
interaction is known (SantaLucia & Hicks, 2004). A eukaryotic and prokaryotic promoter 
stability analysis was carried out by Kanhere & Bansal (2005a). The authors reported that 
promoters from three bacteria which have different genome composition (A+T composition: 
E. coli 0.49, B. subtilis 0.56 and C. glutamicum 0.46) show low stability peak around the -10 
region. It is also reported that the average stability of upstream region is lower than the 
average stability of downstream region.  
Intrinsic DNA curvature and bendability were shown to be important as physical basis in 
many biological processes, in particular in those which have interaction of DNA with DNA-
binding site proteins, such as transcription initiation and termination, DNA origins of 
replication and nucleosome positioning (Gabrielian & Bolshoy, 1999; Jáuregui et al., 2003; 
Nickerson & Achberger, 1995; Thiyagarajan et al., 2006). Specifically, bending is related with 
twists and short bends of approximately 3 base-pairs, while curvature refers to loops and 
arcs involving around 9 base-pairs (Holloway et al., 2007). DNA curvature in prokaryotes is 
usually present upstream of the promoter but sometimes within the promoter sequence 
(Jáuregui et al., 2003; Kozobay-Avraham et al., 2006). The distribution of curved DNA in 
promoter regions is evolutionarily preserved, since orthologous groups of genes with highly 
curved upstream regions were identified (Kozobay-Avraham et al., 2006). As related by 
Pandey & Krishnamachari (2006), sequences derived from non-coding regions had similar 
overall base composition but different curvature values from promoter regions, indicating 
that the differences in curvature values are not just the consequence of base composition but 
also the organization of bases in sequences. 
Another DNA feature that can distinguish promoter sequences is stress-induced DNA 
duplex destabilization (SIDD). According to Wang & Benham (2006), SIDD is not directly 
related to primary sequence alone, nor equivalent to stability of DNA double helix. In this 
complex process, the differences between the energy cost of strand separation for the 
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specific base pairs involved and the energy benefit from fractional relaxation of the 
superhelical stress provides the energies that govern SIDD. Promoters are strongly 
associated with regions of low SIDD energy. Certain non-coding regions containing 
promoters or terminators are unstable, while transcripted regions remain stably duplexed 
under the stress imposed by negative superhelicity. The change of the level of superhelicity 
on a promoter region can shows a variety of effects on the expression of the genes it encodes 
(Wang & Benham, 2006).  
As related so far, the promoters present organizational properties which, in different scales, 
may play a significant role in the transcription process. Recent studies have reported 
promising results using DNA structural or biophysical properties as predictors of promoter 
regions, either alone or associated with the sequence composition. A concerned description 
of these approaches and their results will be presented in the next section. 
3. In silico promoter prediction  
In silico promoters prediction and recognition is an active research topic in molecular 
biology and a challenge in bioinformatics. The correct classification of a given DNA 
sequence as promoter or non promoter improves genome annotation and allows generating 
hypotheses in the context of the bacterial transcription initiation process and gene function 
(de Avila e Silva et al., 2011; Jacques et al., 2006).  
Experimental methods applied to the identification of promoters by molecular methods can be 
laborious, time-consuming and expensive. Consequently, it is important to develop algorithms 
that can rapidly and accurately evaluate the presence of promoters (Jacques et al., 2006; Li & 
Lin, 2006). A variety of in silico techniques have been used to identify TSS and to characterize σ 
factor-DNA interactions. Despite the wide range of research carried out in promoter 
prediction, these techniques are still not fully developed, particularly for genome scale 
applications. Currently, many programs for promoters and TSS prediction are available. 
However, their results are not completely satisfactory due to their rate of false positive 
predictions (Askary et al., 2008; Li & Lin, 2006). An overview about how to evaluate a 
classification performance of a given approach and the results of some published papers 
especially devoted to improve promoter prediction will be described in the following sections.  
3.1. Performance measures for the evaluation of promoter classification 
programs 
A classification model (or classifier) is a mapping from instances of predicted classes 
(Fawcett, 2006). The promoter prediction problem is a kind of binary classification, as the 
input sequence can be classified in only one class of two non-overlapping classes (Sokolova 
& Lapalme, 2009). The result of a classifier during testing is based on the counting of the 
correct and incorrect classifications from each class (Bradley, 1997). In this way, the four 
possible outcomes of a classification model evaluate this correctness (Bradley, 1997; Fawcett, 
2006; Sokolova & Lapalme, 2009):  
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i. TP: promoter sequences classified as promoter (true positive);  
ii. TN: non-promoter sequences recognized as non-promoters (true negative); 
iii. FP: non-promoter sequences classified as promoter (false positive); 
iv. FN: promoters classified as non-promoter sequences (false negative). 
This information is then normally displayed in a two-by-two confusion matrix (Table 2). A 
confusion matrix is a form of contingency table showing the differences between the true 
and predicted classes for a set of labeled examples (Bradley, 1997).  
 
Data Class Classified as promoter Classified non-promoter 
Promoter True positive (TP) False negative (FN) 
Non-promoter False positive (FP) True negative (TN) 
Table 2. Confusion matrix for classification results 
Although the confusion matrix shows the whole information about the classifier’s 
performance, it is the basis for many common metrics (Bradley, 1997; Fawcett, 2006). The 
often used performance measures are accuracy, sensitivity, specificity, precision and 
receiver operating characteristics ROC graphs. Their formulas are presented in equations 1 
to 4. The accuracy measure gives an overall effectiveness of a classifier. Alternative 
measures are sensitivity (proportion of observed promoter sequences that are predicted as 
such) and specificity (probability of a classifier identifies non-promoter sequences). 
Additionally, the precision is related to the class agreement of identified promoters given by 
the classifier (Sokolova & Lapalme, 2009). A reliable performance of a promoter prediction 
program is the harmonic average of the sensitivity and specificity. A ROC graph is a 
technique for visualizing, organizing and selecting classifiers based on their performance 
(Figure 2). ROC graph allows visualizing and selecting classifiers based on their 
performance. It is presented as two-dimensional graphs in which TP rate is plotted on the Y  
 
Figure 2. An example of ROC curve obtained from NN simulations results of E. coli promoter 
prediction and recognition (de Avila e Silva et al., 2011b) 
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axis and FP rate is plotted on the X axis. A common method associated with the ROC graph 
is to calculate the area under the ROC curve, abbreviated AUC. The AUC of a classifier is 
equivalent to the probability that the classifier will rank a randomly chosen positive instance 
higher than a randomly chosen negative instance. Further information about the ROC curve 
can be found in Fawcett (2006). 
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3.2. Position-weight matrices 
Consensus sequences have been used to predict promoters by simple pattern matching. 
These strategies for promoter identification are usually based on a prior knowledge of some 
characterized sequences (Jacques et al., 2006). The first alignments of E. coli promoters were 
carried out by Hawley & McClure (1983), Galas et al. (1985), Lisser & Margalit (1993). From 
those compilations, the promoter consensual motifs were established. 
A more sophisticated approach based on alignment is the Position-Weight Matrix (PWM). In 
this two-dimensional array, the rows represent one of the nucleotides A, T, C or G and the 
columns represent the analyzed motif. This accepted method yields results by aligning 
examples of referenced sequences, which allow estimating the base preference at each 
position of a matrix (Song et al., 2007). A weight is assigned to each base at each position in 
the promoter sequence and the final score of a candidate sequence decreases according to 
given differences of the reference matrix. Detailed information about the first 
implementations and the mathematical background can be found in Stormo (2000). 
Huerta & Collado-Vides (2003) use a two stage PWM code-named Cover. This approach 
searches for conserved motifs using multiple sequence alignment methods and generates 
weight matrices for σ70-dependent promoter sequences. Aiming to select the best matrices, 
the authors added some criteria, such as the spacers between -10 and -35 hexamers, the 
distance from -10 region and the start codon, the distance from -10 region and the TSS, and 
statistical analysis and the matrix score. Despite the 86% of predictive capacity of this 
approach, the accuracy obtained was 53%. This value indicates that this approach presents a 
high number of false positives. 
Li & Lin (2006) have proposed a variation from PWMs called Position Correlation Scoring 
Matrix (PCSM). This approach considers the position-specific weight matrices at ten specific 
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positions for the promoter. A PCSM for promoter and another for non-promoter training 
sequences sets have been computed. For classifying a new test sequence, the resulted scores 
from promoter and negative PCSM were used. Based on those scores, the sequence was 
identified as promoter only if the score was higher for positive PCSM. The results achieved 
in this paper present sensitivity of 91% and specificity of 81%. In order to predict promoters 
in the whole genome, the PCSM was applied and all the 683 experimentally identified σ70-
dependent promoter sequences were successfully predicted. Besides that, 1567 predictions 
were considered as probable promoters. 
To predict σ28 promoter-dependent sequences of ten gamma-proteobacteria species, Song et 
al. (2007) carried out an alternative approach based on PWM named as Position Specific 
Score Matrix (PSSM). The species chosen were E. coli, Bacillus subtilis, Campylobacter jejuni, 
Helicobacter pylori, Streptomyces coelicolor, Corynebacterium glutamicum, Vibrio cholera, 
Shewanella oneidensis, Xanthomonas oryzae and Xanthomonas campestris. This approach 
involved two steps: (i) a simple pattern-matching with the short E. coli σ28 promoter 
consensus sequence (TAAAG-N14-GCCGATAA) for predicting σ28 promoters upstream of 
mobility and chemotaxis genes in test species; (ii) these predicted promoters were used to 
generate a preliminary PSSM for each species. The total length of DNA analyzed for each 
bacteria was between 4 x 105 bp and  7 x 105 bp. The cut-off values chosen were set to control 
the false positive rate at 1 every 5 x 105 bp of sequence analyzed using random DNA 
sequence of 5 x 107 pb. Although the performance measures were not present by the authors, 
this paper is devoted to predict other promoter sequences than those recognized by σ70 and 
it shows interesting results about the σ28 consensual promoter sequences. 
PWM models are commonly used because they are a simple predictive approach. Moreover, 
they are a convenient way to account for the fact that some positions are more conserved, 
than others (Stormo, 2000). However, in a large number of sequences the consensus can be 
insufficiently conserved, that is, they present insertions, deletions, variable spacing between 
elements or they are difficult to define. In such cases, this approach yield many false 
predictions (Kalate et al., 2003). Another limitation is the assumption that the occurrence of a 
given nucleotide at a position is independent of the occurrence of nucleotides at other 
positions (Stormo, 2000). Additionally, the use of this approach is highly influenced by the 
cut-off value chosen, since low cut-off values encourage a high false positive rate, while high 
cut-off values encourage a high false-negative rate (Song et al., 2007).  
3.3. Machine Learning 
Machine Learning (ML) concerns the development of computer algorithms which allow the 
machine to learn from examples. The classification (or pattern recognition) is an important 
application of ML techniques in bioinformatics due to their capability of capturing hidden 
knowledge from data. This is possible to achieve even if the underlying relationships are 
unknown or hard to describe. Additionally, they can recognize complex patterns in an 
automatic way or distinguish exemplars based on these patterns (Cen et al., 2010; Sivarao et 
al., 2010).  
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ML approaches usually split the data set into training and test groups. They learn from 
examples (training data), and the set of examples, which were not exposed to the classifier in 
the training process, are used to test the classification model. Among all ML techniques, 
Support Vector Machines (SVM) and Artificial Neural Network (ANN) applications have 
produced promising results in the promoter prediction problem. For this reason, the 
purpose of this section is to provide an explanation about the basic ideas of these two ML 
approaches.  
3.3.1. Support vector machines 
SVM has been applied to identify important biological elements including protein, 
promoters and TSS, among others. This technique is used in bioinformatics as not only it can   
represent complex nonlinear functions but it also has flexibility in modeling diverse sources 
of data. This approach, introduced by Vapnik and his collaborators in 1992, is usually 
implemented as binary classifiers and it yields results by two key concepts: the separation of 
the data set into two classes by a hyperplane, and the application of supervised learning 
algorithms denoted as kernel machines (Ben-Hur et al., 2008; Kapetanovic et al., 2004; Polat 
& Günes, 2007). In a simple way (Figure 3), SVM classifies the data by: (i) drawing a straight 
line which separates the positive examples in one side and negative examples in the other 
side and, (ii) computing the similarity of two points with the kernel function (Ben-Hur et al., 
2008). The kernel function is crucial for SVM, since the knowledge captured from the data 
set is obtained if a suitable kernel is defined (Ben-Hur et al., 2008). Further information and 
mathematical background of SVM can be found in Abe (2010), Ben-Hur et al. (2008), and 
Zhang (2010). 
 
Figure 3. Representation of the basic idea of the SVM classification  
Some published paper devoted to promoter prediction using SVM. L. Gordon et al. (2003) 
carried out SVM with alignment kernel in two different data sets: promoters and coding 
regions, and promoters and non-promoter intergenic regions. The average error achieved 
was 16.5% and 18.6%, respectively for the data sets used. This method is preferable in cases 
which present a sufficient number of known promoter regions, but might not know 
anything about their composition (L. Gordon et al., 2003). This tool is available online in 
http://nostradamus.cs.rhul.ac.uk/~leo/sak_demo/. Another SVM carried out by J. J. Gordon 
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positions for the promoter. A PCSM for promoter and another for non-promoter training 
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et al. (2006) made a joint prediction of E. coli TSS and promoter region. Their approach was 
based on an ensemble SVM with a variant of string kernel. This classifier combines a PWM 
and a model based on the distribution of distances from TSS to gene start. They have 
achieved results close to those previously described in the literature (average error rate of 
11.6%). The authors report that their results open up the application of SVM on the 
prediction and recognition of special categories of regulatory motifs. Moreover, the authors 
also claim that this model can be broad to other bacterial species which present similar 
consensus sequences and TSS location.  
By using a combination of feature selection and least square support vector machine (LSSVM), 
Polat and Günes (2007) have proposed an approach named FS_LSSVM based in two steps. 
In the first step, the feature selection process was carried out aiming to reduce the 
dimensionality of E. coli promoter sequences with the use of C4.5 decision tree rules. As a 
result, the data set, which originally presented 57 attributes, was reduced to 4 attributes. 
After this process, the second step made the prediction of promoter sequences with the 
application of the LSSVM algorithm. The success rate (capability of recognizing promoter 
sequences) of this approach was of 100%. In face of this result, the authors claim that 
FS_LSSVM has the highest success rate and can be helpful in the promoter prediction and 
recognition issue. Nonetheless, this approach was carried out in a small data set (53 
promoters and 53 non-promoters sequences) which does not represent the available entire 
set of E. coli σ70-dependent promoter sequences (600 sequences experimental identified, 
approximately). In a small data set, the lack of conservation that characterizes bacterial 
promoter sequences cannot be detected, explaining the high efficiency reported. 
The SVM algorithms present many advantages in their use when compared with other 
methods. First of all, SVM produces a unique solution since it is basically a linear problem. 
Second, SVM is able to deal with very large amounts of dissimilar information. Third, the 
discriminant function is characterized by only a comparatively small subset of the entire 
training data set, thus making the computations noticeably faster (Kapetanovic et al., 2004). 
On the other hand, a problem of SVM is its slow training, as it is trained by solving a 
quadratic programming problem with the number of variables equal to the number of 
training data (Abe, 2010). 
3.3.2. Artificial Neural Networks 
The artificial neural networks (ANN) are powerful computational tools inspired (they are 
not a faithful models of biological neural or cognitive phenomena) on the structure and 
behavior of biological neurons (Hilal et al., 2008; Wu, 1996). As in the human brain, the basic 
unit of ANN is called artificial neuron (Figure 4b), and it can be considered as a processing 
unit which performs a weighted sum of inputs (Hilal et al., 2008). In a simplest form, ANN 
can be viewed as a graphical model consisting of networks with interconnected units. The 
connection from a unit j to unit i usually has a weight denoted by Wij. The weights represent 
information being used by the net to solve a problem (Wu, 1996). 
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Figure 4. In (a) an example of MLP architecture and in (b) an artificial neural representation 
The way by which the neurons are interconnected defines the ANN architecture. There are 
many kinds of architecture, but this review describes only the multilayer perceptron (MLP) 
architecture. The reasons for this choice are the capability of MLP capture and discover 
high-order correlations and/or relationships in input data and its wide applicability on 
promoter prediction (Hilal et al., 2008; Wu, 1996). Three-layer ANN (Figure 4a) is known as 
universal classifier as it is able to classify any labeled data correctly if there are no identical 
data in different classes (Baldi & Brunak, 2001). 
The MLP presents three kinds of layers: input layer, output layer, and hidden layers (Figure 
4a). The input layer contains the neurons which receive the information from external 
sources and passes this information to the hidden layer for network processing. The use of 
hidden neurons makes the learning process harder to visualize, since the search has to be 
conducted in a much larger space of possible functions in order to decide how input 
features should be represented by the hidden neurons. The output layer contains neurons 
that receives processed information and sends output signals out of the system. In all layers 
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there is a bias input which provides a threshold for the activation of neurons (Hilal et al., 
2008). The neurons in a given layer are fully connected by weights with the neurons on the 
adjacent layer. Each layer is comprised of a determined number of neurons. The number of 
input neurons corresponds to the number of input variables into the ANN, and the number 
of output neurons is the same as the number of desired output variables. The number of 
neurons in the hidden layer(s) depends on the application of the network (Hilal et al., 2008). 
MLPs have been applied successfully to solve many problems by training them in a 
supervised way with a highly popular algorithm known as back-propagation (Wu, 1996). 
This algorithm is the most widely used to adjust the connection weights. During the training 
of multilayer neural networks classifiers, the weights are usually corrected so that the sum 
of squares error between the network outputs and the desired output are minimized (Abe, 
2010). 
The first NN promoter prediction, as presented by Demeler and Zhou (1991), had simple 
architecture and the results showed high accuracy and false positive rate. More complex 
architectures were applied by Mahadevan and Ghosh (1994), who used a combination of 
two ANN to identify E. coli promoters of all spacing classes (15 to 21 bases). The first ANN 
was used to predict the consensus motifs, while the second was designed to predict the 
entire sequence containing varying spacer lengths. Since the second NN used the 
information of the entire sequence, there were possible dependencies between the bases in 
various positions. This procedure presents as result a poor prediction (recall). To predict and 
find relevant signals related to TSS, Pedersen and Engelbrecht (1995) devised two ANN 
with different windows on the input data. An interesting result obtained from the sequence 
content information analysis suggests that important regions for promoter recognition 
include more positions on the DNA than usually assumed (-10 and -35 region). In spite of 
the high false positive rate, the interesting idea of both papers was to measure the relative 
information and the dependencies between bases in various positions. A comprehensive 
summary of the first ANNs application on promoter prediction can be obtained from Wu 
(1997). 
Neural Networks Promoter Prediction (NNPP) is - up to now - one of the few online available 
tools (http://www.fruitfly.org/seq_tools/promoter.html). NNPP was originally developed to 
predict core promoter regions in Drosophila melanogaster (Reese, 2001). However, this tool 
was also trained to predict E. coli promoter sequences. NNPP is based on a neural network 
where the prediction for each promoter sequence element is combined in time-delay neural 
networks for a complete promoter site prediction (Reese, 2001). An improved version of 
NNPP was obtained by addition of the distance between the TSS and TLS (Burden et al., 
2005). Despite the improved sensitivity (86%), the NNPP approach gives a large number of 
false positives (precision 54%). 
DNA promoter information, other than nucleotide composition, was used as ANN input 
data by several authors. Rani et al. (2007) propose a global feature extraction scheme which 
extracts an average signal from the entire promoter sequence of 80 bp length. The resulting 
signal was composed by a combination of promoter dinucleotides. After this procedure, 
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MLP training was carried out with the promoter signal as positive examples and four 
different negative data sets: (i) genes, (ii) genes and non-promoter intergenic sequences, (iii) 
60% AT reach random sequences and (iv) 50% AT reach random sequences. The specificity 
values for each data set were 79%, 88%, 98% and 99%, respectively. For the sensitivity, the 
results achieved were 80%, 63%, 93% and 95%. After the ANN results simulations, the 
authors spliced the promoter data in two linearly separable groups: a major data set and a 
minor data set. The first group was composed by sequences which were correctly classified 
by ANN, and the misclassified sequences were grouped in the minor data set. Although it 
was possible to separate the sequences in two groups, both set of promoter sequences 
showed a similar signal in the dinucleotide space. The authors claim that the feature 
extraction and classification methods are generic enough to be applied to the more complex 
problem of eukaryotic promoter recognition. Although highly efficient, this approach is 
limited to the AT-rich sigma sequences like σ70, as showed by the promoter sequence 
description obtained from de Avila e Silva et al. (2011). 
By using an ANN architecture fed by difference in DNA stability values between upstream 
and downstream regions in vicinity of known TSS, Askary et al. (2009) presented an 
approach named N4 devoted to E. coli TSS prediction. In this paper, the ANN input 
sequence slides a 414-nucleotides window with sliding size of one nucleotide. Each window 
was applied in the form of 413 nearest neighbors (or dinucleotides). The results obtained 
show sensitivity and precision of 94%. The initial state of this ANN was the Kanhere and 
Bansal’s algorithm (described in the section 3.4) which was improved by the training 
process. In fact, the authors transpose the idea of the Kanhere and Bansal’s algorithm into 
the ANN architecture. An interesting result presented in this paper, was the analysis of how 
the promoter information was used by N4 to learn. They show that N4 learn from the -10 
and -35 motifs, and the +160 position. A single alteration at the +160 position makes N4 to 
recognize a non-promoter sequence as promoter. This position is downstream of TLS which 
indicates that this approach probably uses the position of ORF for the accurate prediction of 
TSS. 
Rani and Bapi (2007) used n-gram as feature for a neural network classifier for promoter 
prediction in Escherichia coli and Drosophila melanogaster. An n-gram is defined as a selection 
of n contiguous characters from a given character stream. The authors show that the number 
of n-grams which presents the best results for E. coli was n=3 against a negative examples set 
consisting of gene and non-promoter intergenic segments. The performance measures 
presented were: sensitivity of 67.75%, specificity of 86.10% and precision of 80.0%. 
According to the authors, these results reinforces the idea that 3-grams usage a pattern 
which can distinguishing a promoter of other sequences, since higher order n-grams 
features was not powerful enough to discriminate promoter and non-promoter. In addition 
to this result, the authors apply challenge the 3-grams on promoter identification in the 
whole genome. The identification of 19 NCBI annotated promoters was 100% positive and 
encouraging them to propose this methodology as a potential promoter annotation tool. 
An ANN-based approach was used by de Avila e Silva et al. (2011) for promoter prediction 
according to the σ factor which recognizes the sequence. This bioinformatics tool, denoted 
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content information analysis suggests that important regions for promoter recognition 
include more positions on the DNA than usually assumed (-10 and -35 region). In spite of 
the high false positive rate, the interesting idea of both papers was to measure the relative 
information and the dependencies between bases in various positions. A comprehensive 
summary of the first ANNs application on promoter prediction can be obtained from Wu 
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Neural Networks Promoter Prediction (NNPP) is - up to now - one of the few online available 
tools (http://www.fruitfly.org/seq_tools/promoter.html). NNPP was originally developed to 
predict core promoter regions in Drosophila melanogaster (Reese, 2001). However, this tool 
was also trained to predict E. coli promoter sequences. NNPP is based on a neural network 
where the prediction for each promoter sequence element is combined in time-delay neural 
networks for a complete promoter site prediction (Reese, 2001). An improved version of 
NNPP was obtained by addition of the distance between the TSS and TLS (Burden et al., 
2005). Despite the improved sensitivity (86%), the NNPP approach gives a large number of 
false positives (precision 54%). 
DNA promoter information, other than nucleotide composition, was used as ANN input 
data by several authors. Rani et al. (2007) propose a global feature extraction scheme which 
extracts an average signal from the entire promoter sequence of 80 bp length. The resulting 
signal was composed by a combination of promoter dinucleotides. After this procedure, 
Bacterial Promoter Features Description  
and Their Application on E. coli in silico Prediction and Recognition Approaches 253 
MLP training was carried out with the promoter signal as positive examples and four 
different negative data sets: (i) genes, (ii) genes and non-promoter intergenic sequences, (iii) 
60% AT reach random sequences and (iv) 50% AT reach random sequences. The specificity 
values for each data set were 79%, 88%, 98% and 99%, respectively. For the sensitivity, the 
results achieved were 80%, 63%, 93% and 95%. After the ANN results simulations, the 
authors spliced the promoter data in two linearly separable groups: a major data set and a 
minor data set. The first group was composed by sequences which were correctly classified 
by ANN, and the misclassified sequences were grouped in the minor data set. Although it 
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limited to the AT-rich sigma sequences like σ70, as showed by the promoter sequence 
description obtained from de Avila e Silva et al. (2011). 
By using an ANN architecture fed by difference in DNA stability values between upstream 
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approach named N4 devoted to E. coli TSS prediction. In this paper, the ANN input 
sequence slides a 414-nucleotides window with sliding size of one nucleotide. Each window 
was applied in the form of 413 nearest neighbors (or dinucleotides). The results obtained 
show sensitivity and precision of 94%. The initial state of this ANN was the Kanhere and 
Bansal’s algorithm (described in the section 3.4) which was improved by the training 
process. In fact, the authors transpose the idea of the Kanhere and Bansal’s algorithm into 
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the promoter information was used by N4 to learn. They show that N4 learn from the -10 
and -35 motifs, and the +160 position. A single alteration at the +160 position makes N4 to 
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indicates that this approach probably uses the position of ORF for the accurate prediction of 
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Rani and Bapi (2007) used n-gram as feature for a neural network classifier for promoter 
prediction in Escherichia coli and Drosophila melanogaster. An n-gram is defined as a selection 
of n contiguous characters from a given character stream. The authors show that the number 
of n-grams which presents the best results for E. coli was n=3 against a negative examples set 
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According to the authors, these results reinforces the idea that 3-grams usage a pattern 
which can distinguishing a promoter of other sequences, since higher order n-grams 
features was not powerful enough to discriminate promoter and non-promoter. In addition 
to this result, the authors apply challenge the 3-grams on promoter identification in the 
whole genome. The identification of 19 NCBI annotated promoters was 100% positive and 
encouraging them to propose this methodology as a potential promoter annotation tool. 
An ANN-based approach was used by de Avila e Silva et al. (2011) for promoter prediction 
according to the σ factor which recognizes the sequence. This bioinformatics tool, denoted 
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as BacPP, was developed by weighting rules extracted from ANNs trained with promoter 
sequences known to respond to a specific σ factor. The information obtained from the rules 
was weighted to optimize promoter prediction and classification of the sequences according 
to σ factor which recognize them. The accuracy results for E. coli were 86.9%, 92.8%, 91.5%, 
89.3%, 97.0% and 83.6% for σ24, σ28, σ32, σ38, σ54 and σ70 dependent promoter sequences, 
respectively. As related by the authors, the sensitivity and specificity results showed similar 
values, indicating that this tool present a reduction of false positive rate. In contrast to tools 
previously reported in the literature, BacPP is not only able to identify bacterial promoters 
in background genome sequence, but it is also designed to provide pragmatic classification 
according to σ factor. By separating the promoter sequences according their σ factor which 
recognize them, the authors have demonstrated that the current boundaries of prediction 
and classification of promoters can be dissolved. Moreover, when applied to a set of 
promoters from diverse enterobacteria, the accuracy of BacPP was 76%, indicating that this 
tool can be reliably extended beyond the E. coli model.  
In spite of the ANN capability capture imprecise and incomplete patterns, such as 
individual promoter motifs including mismatches (Cotik et al., 2005), this ML approach can 
present some intrinsic difficulties. Many decisions related to the choice of ANN structure 
and parameters are often completely subjective. The final ANN solution may be influenced 
by a number of factors (e.g., starting weights, number of cases, number of training cycles, 
etc.). Besides, the overtraining needs to be avoided, since it results in ANN which 
memorizes the data, instead of to do a generalization of them (Kapetanovic et al., 2004). 
3.4. Other approaches 
The symbolic representation of DNA nucleotides given by the letters A,T,G,C lead to many 
studies which aiming at understanding its structure through distributions, complexities, 
redundancy and statistical regularities (Krishnamachari et al., 2004). All this kind of 
information have a theoretical potential to be a distinguish feature of promoter sequences. 
Some papers are devoted to applied this features either alone or in combination with other 
approaches for improve promoter prediction results. 
Kanhere and Bansal (2005b) developed their own promoter recognition approach based on 
differences of DNA stability between promoter and coding regions. That tool was improved 
by Rangannan e Bansal (2007) and achieves sensitivity of 98% and a just precision of 55%. 
The authors claim that this stability-based approach can be used to annotate entire genome 
sequences for promoter regions. According to the authors, the low precision can be reduced 
if it was combined with other sequence based methods. Additionally, they argue that this 
method can be used to investigate characteristic properties of specific subclasses of 
promoters, as well as other functional elements which no exhibit obvious consensus 
sequences. 
Jacques et al. (2006) describe a novel approach based on matrices representing the genomic 
distribution of hexanucleotides pairs. The principal strategy was based on the observation 
that the promoters are over-represented in intergenic regions relative to the whole genome. 
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This approach was carried out for ten prokaryotic genomes and the analysis of characterized 
promoter sequences generates a sensibility of the matrices generated. These results present 
different sensibility values according to the analyzed bacteria. The lowest value was 29.4% 
for C. glutamicum and the highest value was 90.9% for Bradyrhizobium japonicum. For the 
other genomes (E. coli, B. subtilis, S. coelicolor, H. pylori, C. jejuni, Staphylococcus aureus, 
Mycobacterium tuberculosis and Mycoplasma pneumonia), the sensibility achieved was around 
45%. According to the authors, these results suggest that transcription factor DNA binding 
sites from various bacterial species have a genomic distribution significantly different from 
that of non-regulatory sequences. Besides the lower sensitivity values for some species, this 
paper presents the potential of genomic distribution as indicator of DNA motif function. 
This algorithm took advantage of a yet unexploited concept, can be used in a wide variety of 
organisms, required almost no previous knowledge of promoter sequences to be effective 
and can be combined with other methodologies. Additionally, the authors claim that this 
approach can be designed to predict precise promoter sequences using any annotated 
prokaryotic genome. 
The SIDD values were used by Wang and Benham (2006) for demonstrating that this 
information can be useful when applied to promoter prediction. They define a promoter as 
extending from positions -80 to +20 with respect to the TSS and they define strong SIDD as 
any value below 6 kcal/mole. SIDD values correctly predicted 74.6% of the real promoters 
with a false positive rate of 18%. When the SIDD values were combined with -10 motifs 
scores in a linear classification function, they predict promoter regions with better than 90% 
accuracy. The authors attribute their success to the fact that about 80% of documented 
promoters contain a strong SIDD site. The authors also observed a bimodal distribution of 
SIDD properties, which can reflect the complexity of transcriptional regulation, suggesting 
that SIDD may be needed to initiate transcription from some promoters, but not others. 
4. Conclusions 
A brief survey of currently E. coli promoter information and their recognition and prediction 
approaches was presented. In order to improve the in silico promoter prediction, an 
appreciation of the biological mechanistic of promoter sequences is necessary. In this way, 
the comprehensive analyses of bacterial promoter sequences revealed the fact that the 
sequence dependent properties are important and can be exploited in developing in silico 
tool for promoter prediction. 
The currently available approaches described in this paper make efforts to reduce the 
number of false predictions. Recent bioinformatics applications are increasingly 
appreciating the DNA structural features and incorporating this kind of information for 
detecting promoter tools. Some works shows the advantage of the use of the feature 
selection or extraction process as an important part of pattern recognition, since this 
procedure can decrease the computation cost and increase the performance of the 
classification (Polat and Günes, 2009). One of the goals of promoter recognition is to locate 
promoter regions in the genome sequence. Predicting promoters on a genome-wide scale is 
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as BacPP, was developed by weighting rules extracted from ANNs trained with promoter 
sequences known to respond to a specific σ factor. The information obtained from the rules 
was weighted to optimize promoter prediction and classification of the sequences according 
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values, indicating that this tool present a reduction of false positive rate. In contrast to tools 
previously reported in the literature, BacPP is not only able to identify bacterial promoters 
in background genome sequence, but it is also designed to provide pragmatic classification 
according to σ factor. By separating the promoter sequences according their σ factor which 
recognize them, the authors have demonstrated that the current boundaries of prediction 
and classification of promoters can be dissolved. Moreover, when applied to a set of 
promoters from diverse enterobacteria, the accuracy of BacPP was 76%, indicating that this 
tool can be reliably extended beyond the E. coli model.  
In spite of the ANN capability capture imprecise and incomplete patterns, such as 
individual promoter motifs including mismatches (Cotik et al., 2005), this ML approach can 
present some intrinsic difficulties. Many decisions related to the choice of ANN structure 
and parameters are often completely subjective. The final ANN solution may be influenced 
by a number of factors (e.g., starting weights, number of cases, number of training cycles, 
etc.). Besides, the overtraining needs to be avoided, since it results in ANN which 
memorizes the data, instead of to do a generalization of them (Kapetanovic et al., 2004). 
3.4. Other approaches 
The symbolic representation of DNA nucleotides given by the letters A,T,G,C lead to many 
studies which aiming at understanding its structure through distributions, complexities, 
redundancy and statistical regularities (Krishnamachari et al., 2004). All this kind of 
information have a theoretical potential to be a distinguish feature of promoter sequences. 
Some papers are devoted to applied this features either alone or in combination with other 
approaches for improve promoter prediction results. 
Kanhere and Bansal (2005b) developed their own promoter recognition approach based on 
differences of DNA stability between promoter and coding regions. That tool was improved 
by Rangannan e Bansal (2007) and achieves sensitivity of 98% and a just precision of 55%. 
The authors claim that this stability-based approach can be used to annotate entire genome 
sequences for promoter regions. According to the authors, the low precision can be reduced 
if it was combined with other sequence based methods. Additionally, they argue that this 
method can be used to investigate characteristic properties of specific subclasses of 
promoters, as well as other functional elements which no exhibit obvious consensus 
sequences. 
Jacques et al. (2006) describe a novel approach based on matrices representing the genomic 
distribution of hexanucleotides pairs. The principal strategy was based on the observation 
that the promoters are over-represented in intergenic regions relative to the whole genome. 
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45%. According to the authors, these results suggest that transcription factor DNA binding 
sites from various bacterial species have a genomic distribution significantly different from 
that of non-regulatory sequences. Besides the lower sensitivity values for some species, this 
paper presents the potential of genomic distribution as indicator of DNA motif function. 
This algorithm took advantage of a yet unexploited concept, can be used in a wide variety of 
organisms, required almost no previous knowledge of promoter sequences to be effective 
and can be combined with other methodologies. Additionally, the authors claim that this 
approach can be designed to predict precise promoter sequences using any annotated 
prokaryotic genome. 
The SIDD values were used by Wang and Benham (2006) for demonstrating that this 
information can be useful when applied to promoter prediction. They define a promoter as 
extending from positions -80 to +20 with respect to the TSS and they define strong SIDD as 
any value below 6 kcal/mole. SIDD values correctly predicted 74.6% of the real promoters 
with a false positive rate of 18%. When the SIDD values were combined with -10 motifs 
scores in a linear classification function, they predict promoter regions with better than 90% 
accuracy. The authors attribute their success to the fact that about 80% of documented 
promoters contain a strong SIDD site. The authors also observed a bimodal distribution of 
SIDD properties, which can reflect the complexity of transcriptional regulation, suggesting 
that SIDD may be needed to initiate transcription from some promoters, but not others. 
4. Conclusions 
A brief survey of currently E. coli promoter information and their recognition and prediction 
approaches was presented. In order to improve the in silico promoter prediction, an 
appreciation of the biological mechanistic of promoter sequences is necessary. In this way, 
the comprehensive analyses of bacterial promoter sequences revealed the fact that the 
sequence dependent properties are important and can be exploited in developing in silico 
tool for promoter prediction. 
The currently available approaches described in this paper make efforts to reduce the 
number of false predictions. Recent bioinformatics applications are increasingly 
appreciating the DNA structural features and incorporating this kind of information for 
detecting promoter tools. Some works shows the advantage of the use of the feature 
selection or extraction process as an important part of pattern recognition, since this 
procedure can decrease the computation cost and increase the performance of the 
classification (Polat and Günes, 2009). One of the goals of promoter recognition is to locate 
promoter regions in the genome sequence. Predicting promoters on a genome-wide scale is 
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problematic due to the higher number of false positive predictions caused by the large 
amount of DNA analyzed. It is important for consideration the fact that a given 
classification method is not universally better than other, since each method has a class of 
target functions for which it is best suited (Bradley, 1997). 
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1. Introduction 
Small RNA mediated RNA interference (RNAi) is a widely adopted mechanism towards 
immunity in plants and invertebrates. Two types of small RNAs- small interfering RNA 
(siRNA) and microRNA (miRNA), play key role in RNA interference either through 
cleaving or through translational repression of the target mRNA by guiding RNA induced 
silencing complex (RISC) to its target site. siRNA is a small RNA (19-23 nucleotides) which 
is complementary to part of their target mRNA [1]. siRNAs are very efficient in target gene 
knockdown that makes synthetic siRNA’s perfect choice for use in experiments for silencing 
genes to examine their function. In addition, siRNA have good potential in drug 
development for therapeutic purpose [2]. Exogenous synthetic siRNAs are designed to 
target a part of the coding region in the target mRNA [3]. But, as evident from experiments, 
all siRNAs are not equally efficient in target gene silencing. The potency of siRNAs is largely 
dependent upon the selection of the region it targets. A displacement of 5-6 nucleotide 
position hugely alters the efficiency of siRNA. The reason behind this alteration of efficiency 
is the alteration in local sequence and structural features of the target region. These 
variations in sequence and structural features correlate with target accessibility, RISC 
loading or stimulation of immune response. A lot of study has been done in the field of 
rational siRNA designing to find appropriate parameters that facilitate designing of effective 
siRNAs [4]. Several commercial suppliers and non-profit educational institutes contribute to 
the research for searching appropriate siRNA selection parameters for improving potency of 
designed siRNAs. Progresses have been made in targeting success rate compared to the 
early days- from as low as 0-10% targeting success rate, today siRNAs have reached average 
50% targeting success rate. Still there are many scopes to improve siRNA designing. For 
efficient designing, the siRNA selection parameters must be arranged and weighted in such 
a way that ensures optimal result while selecting the siRNA target site. There are some 
previously suggested guidelines about parameter weight assignment like rational or 
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weighted methods. These guidelines were made in the early days of siRNA selection 
research with small number of data, when experimentally knockdown validated siRNA 
dataset was scarce. But with increasing amount of knockdown validated siRNA datasets, 
new parameter optimization methods must come out to ensure selection of potent siRNAs 
in a bigger scenario. Today, high throughput siRNA screening experiments have become a 
common technique to investigate thousands of gene functions at a time to study some 
specific pathway. These experiments use siRNA libraries targeting transcripts in a genome 
wide range. But the success of these experiments relies on the knockdown success rate of the 
siRNAs in the library. After two decades of research, still many of these large scale 
screening experiments fail because of a large number of non-functional siRNAs present in 
the libraries used in these experiments. So, still there are needs for improvement in the 
siRNA selection algorithm and efficient parameter optimization. 
Another main challenge in computational siRNA designing lies in the specificity issue of 
siRNAs. Exogenous siRNAs often induce off-target effects that arise from near perfect or 
imperfect sequence complementarity with other mRNAs resulting in false positive 
phenotype during RNAi-based study of gene functions. The type of gene regulation 
resulting from imperfect sequence complementarity resembles target regulation by 
endogenous miRNAs- hence this type of off-targeting is called miRNA-like off-targeting. 
Minimization of miRNA-like off-targets involves choosing a siRNA with a seed region 
sequence that has fewer targets in the 3’ UTR of other mRNAs. The siRNA seed region is a 6 
or 7 nucleotide sequence (the 2-8th nucleotide position) from 5’ end of siRNA guide strand 
and finding complementary sequence with this 6 or 7 nucleotide seed in the 3’ UTRs of 
unintended transcripts results in a huge number of potential targets. A majority of these 
predicted targets are not practically relevant, as in practice, a large number of these 
predicted off-targets may not be silenced at all. Like miRNA targets, siRNA targets are also 
dependent on target accessibility and other sequence features around the target site. So, a 
more rational approach is needed when predicting the siRNA off-targets resulting from 
partial sequence complementarity. This chapter focuses on current siRNA designing 
parameters and the approaches towards minimizing the off-target effects as provided by the 
in-silico siRNA designing solutions and then discuss a bit about a customized off-target 
reducing algorithm that will be useful to avoid particular genes from being off-targeted. 
2. Guidelines for selecting potent siRNAs 
As discussed earlier, potency of siRNAs varies greatly with selection of target region. The 
parameters responsible for effectiveness of siRNAs being target accessibility, uniqueness 
of target region, absence of SNP sites etc. Other parameters worth considering while 
selecting the target site is the consideration of alternatively spliced isoforms of the target 
gene [5]. 
A parameter which greatly influences siRNA potency is RISC loading of the intended 
antisense strand [6]. Only one strand of the siRNA duplex enters into RISC and guides the 
complex to the target mRNA for its silencing. So, the choice of strand that enters into RISC 
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complex plays the vital role in the whole silencing process. Generally RISC complex chooses 
the siRNA strand which has weaker 5’ end binding energy. So this thermodynamic property 
should be ensured while selecting siRNAs. Also there are a number of sequence 
compositions that are said to be important for recognition of the intended strand by RISC 
and some parameters for enhancing the stability of siRNA duplex are also worth 
considering while selecting siRNAs. These rules can be divided into three categories 1) 
Selection of target region, 2) Structural and Thermodynamic Consideration and 3) Sequence 
Characteristics. 
2.1. Selection of target region 
Selection of the target region for siRNA should satisfy some constraints to ensure effective 
silencing. Target site should be analyzed for its position within the mRNA, presence of 
polymorphic site or other considerations like homology with other mRNAs or its 
alternatively spliced isoforms. 
2.1.1. Selection of target starting site 
Generally siRNAs are targeted to a part of the coding region of an mRNA. The target site 
should be deep inside the open reading frame (ORF) of the target mRNA for efficient 
silencing. Generally it is advised to start from 50-100 nucleotides downstream of the AUG 
start codon. Besides targeting the coding region, some siRNAs may also be designed to 
target the 3’ un-translated region (UTR) of an mRNA. This type of targeting is especially 
done in case of experiments conducted for restoration of original phenotype. In such cases 
it is advised to start targeting regions at least 15-20 nucleotides downstream of the stop 
codon. 
2.1.2. Consideration for alternative splicing 
In eukaryotic organisms frequent alternative splicing results in diversification of mRNAs. 
To account for the alternative splicing, it is necessary to evaluate a common target region 
where siRNAs can be designed to knockdown a specific mRNA isoform or multiple mRNA 
isoforms from a target gene. 
2.1.3. Absence of homology with other mRNAs 
Cellular mRNAs with 15/16 or more consecutive base match with the siRNA, are likely to be 
silenced and degraded by the siRNA. So target sites with 15 or more consecutive base 
homology with any other mRNA should be avoided. 
2.1.4. Avoiding target sites having polymorphic locus 
Target regions having single nucleotide polymorphic (SNP) sites should be avoided. 
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weighted methods. These guidelines were made in the early days of siRNA selection 
research with small number of data, when experimentally knockdown validated siRNA 
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A parameter which greatly influences siRNA potency is RISC loading of the intended 
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complex to the target mRNA for its silencing. So, the choice of strand that enters into RISC 
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2.2. Structural and thermodynamic consideration 
siRNA potency largely depends upon structural constraints of the target region. Heavily 
structured sites are less likely to be bound by siRNAs as these sites are not accessible by 
siRNAs. The relative binding energy of the 5’ and 3’ ends of the siRNA with the target site 
play a vital role in the choice of strand to be incorporated into RISC complex and thus is one 
of the most important parameter to be considered during siRNA design. 
2.2.1. Presence of Secondary structure 
It has been suggested that presence of local secondary structures (stem loops) in the target 
site restricts its accessibility to RISC and hence reduces the efficiency of the siRNA. So it is 
necessary to filter out those potential inaccessible target sites with strong secondary 
structures. The prediction of local secondary structure can be made by numerous RNA 
secondary structure prediction tools or packages like Mfold [7] or Vienna RNA package [8] - 
that mainly predict minimum free energy secondary structure of a RNA sequence. 
2.2.2. Thermodynamic property for efficient RISC loading 
In a siRNA duplex, antisense strand with relatively low energy in 5’ end is favourable for its 
loading into RISC complex. So, there should be difference in binding energy between the 5’ 
end of the sense and antisense strand. 
2.3. Sequence characteristics 
Years of research for finding appropriate designing parameters identified some sequence 
parameters enriched within efficient siRNAs. These sequence characteristics often contribute 
to efficient RISC loading or siRNA sequence specificity or stability issues.  
2.3.1. Position specific nucleotide composition 
Sequence analysis of effective siRNAs revealed many position specific nucleotide 
compositions for enhancing potency of the siRNA. Some of these preferences are listed 
below in table 1- 
2.3.2. Sequence feature for efficient RISC entry 
siRNA guide strands with low energy at 5’ end are favored for entering the RISC complex. 
So, presence of at least three (A/U)s in the seven nucleotides at the 3' end of the sense strand 
is preferable. 
2.3.3. siRNA duplex stability 
Target sites with low GC content (generally less than 55%) has a greater potential for being 
functional siRNA site, as too high GC content can impede the loading of siRNAs into RISC 
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complex. Also, too low GC content is not favourable because too low GC content can 
destabilize the siRNA duplex and reduce their affinity to target mRNA binding. Analysis of 
effective siRNAs showed G/C content between 35% and 60% is most favorable. 
 
Position specific nucleotides
Presence of A base at position 19 of the sense strand. 
Presence of U base at position 10 of the sense strand. 
Presence of A base at position 3 of the sense strand. 
A base other than G or C at position 19 of the sense strand. 
A base other than G at position 13 of the sense strand. 
Presence of A base at the 2nd nucleotide position of the sense strand. 
Presence of C base at the 4th nucleotide position of the sense strand. 
Absence of C base at the 6th nucleotide position of the sense strand. 
Absence of U base at the 7th nucleotide position of the sense strand. 
Presence of C base at the 9th nucleotide position of the sense strand. 
Presence of A base at the 17th nucleotide position of the sense strand. 
Absence of C base at the 18th nucleotide position of the sense strand. 
No occurrences of four or more identical nucleotides in a row. 
No occurrences of G/C stretch of length 7 or longer. 
Table 1. Position specific nucleotide composition prefered in functional siRNAs 
3. Choice of appropriate parameters 
All the parameters discussed above are not equally important for selection of efficient 
siRNAs. By far, many research groups have conducted studies for evaluation of effective 
parameter sets for siRNA selection. Gong et al. studied 276 known siRNA selection 
parameters on a sufficiently large set of 3277 experimentally validated siRNAs targeting 
1518 genes to identify common parameters that effectively distinguishes functional siRNAs 
from non functional ones [9]. They were able to identify 34 features associated with 
improved siRNA efficacy among which 27 features were associated with greater than 70% 
efficacy. They examined combination of siRNA features to find their cooperative effects on 
potent siRNA selection and used a disjunctive rule merging (DRM) algorithm to generate a 
bunch of non-redundant rules set to efficiently predict functional siRNAs and lower the 
false positive predictions. Table 2 list 17 features set associated with greater than 90% 
efficacy and used for optimal features combination. 
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complex. Also, too low GC content is not favourable because too low GC content can 
destabilize the siRNA duplex and reduce their affinity to target mRNA binding. Analysis of 
effective siRNAs showed G/C content between 35% and 60% is most favorable. 
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All the parameters discussed above are not equally important for selection of efficient 
siRNAs. By far, many research groups have conducted studies for evaluation of effective 
parameter sets for siRNA selection. Gong et al. studied 276 known siRNA selection 
parameters on a sufficiently large set of 3277 experimentally validated siRNAs targeting 
1518 genes to identify common parameters that effectively distinguishes functional siRNAs 
from non functional ones [9]. They were able to identify 34 features associated with 
improved siRNA efficacy among which 27 features were associated with greater than 70% 
efficacy. They examined combination of siRNA features to find their cooperative effects on 
potent siRNA selection and used a disjunctive rule merging (DRM) algorithm to generate a 
bunch of non-redundant rules set to efficiently predict functional siRNAs and lower the 
false positive predictions. Table 2 list 17 features set associated with greater than 90% 




F1 2nd nucleotide = A 
F2 4th nucleotide = C 
F3 6th nucleotide ≠ C 
F4 7th nucleotide ≠ U 
F5 9th nucleotide = C 
F6 17th nucleotide = A 
F7 18th nucleotide ≠ C 
F8 19th nucleotide = (A/U) 
F9 At least three (A/U)s in the seven nucleotides at the 3' end 
F10 No occurrences of four or more identical nucleotides in a row 
F11 No occurrences of G/C stretches of length 7 or longer 
F12 G/C content is between 35 and 60% 
F13 Tm is between 20 and 60°C 
F14 Binding energy of N16–N19 > -9 KCal/Mol 
F15 Binding energy of N16–N19 – binding energy of N1–N4 is between 0 and 1 KCal/Mol 
F16 Local folding potential (mean) ≥ -22.72 KCal/Mol 
F17 Target site is on CDS 
Table 2.  Feature sets predicted to be associated with greater siRNA efficacy as described by Gong 
et al. 
4. Prediction of siRNA potency 
Computational prediction of siRNA potency relies on assessment of appropriate designing 
parameters combined with their optimal weight distribution. Since the early era of siRNA 
designing researches, many studies are made for finding optimal weights for siRNA 
selection parameters. Raynolds et al. proposed a method for rational siRNA designing with 
appropriate parameter weights, by empirical study of 180 experimentally validated efficient 
siRNAs [10]. The designed siRNAs were given a score based on weighted summation of 
these parameters and a score threshold was used to identify efficient siRNAs. Table 3 lists 
the parameters used in the study with their weight distributions. 
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siRNA selection parameter Parameter weight
GC content 30% to 52% Satisfying this criteria earns 1 point 
Occurence of 3 or more A/U base pair at 
position 15-19 of sense strand 
Each A/U base pair in this region earns 1 
point 
Low internal stability at target site (melting 
temperature Tm>-20οc) 
Satisfying this criteria earns 1 point 
Presence of A at position 19 of the sense 
strand 
Satisfying this criteria earns 1 point 
Presence of A at position 3 of the sense 
strand 
Satisfying this criteria earns 1 point 
Presence of U at position 10 of the sense 
strand 
Satisfying this criteria earns 1 point 
Absense of G or C at position 19 of the sense 
strand 
Failure to satisfy this criteria decreases 1 
point 
Absense of G at position 13 of the sense strand Failure to satisfy this criteria decreases 1 point 
Threshold for efficient siRNAs score>=6 
Table 3.  Parameters used in Raynold’s algorithm with their weights 
Since then many siRNA designing algorithm worked on different weight distribution 
schemes for improved prediction of siRNA potency and some even used machine learning 
algorithms. 
4.1. Use of machine learning algorithms for classification of functional siRNAs 
After many years of research about the guidelines for selection of effective siRNAs, we are a 
few steps ahead in the process of improving the targeting success rate. But for better 
targeting success, the siRNA selection parameters provided in various guidelines needs to 
be optimized. Still there is no reliable guideline for optimization of weights of siRNA 
selection parameter. Machine learning algorithms like Support vector machine or artificial 
neural network can serve excellent purpose, when trained with sufficient volume of 
biologically validated siRNA data sets [11]. Some online siRNA designing tools (like 
BioPredsi and Genescript siRNA target finder) use machine learning algorithms for 
classification of effective siRNAs from non-effective ones. 
4.1.1. Use of artificial neural network for siRNA classification 
Artificial neural networks (ANNs), as they aim to mimic the working of biological networks 
through a connectionist approach to computation, provide a powerful method of identifying 
highly complex traits in data sets. ANNs are generally very efficient classifiers in case of 
complex patterns in the given data set as they can adaptively change their weighting 
parameters during the learning process. ANNs have been broadly applied in the biological 
sciences. The prediction quality and generalization capabilities of an ANN of fixed size 
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selection parameters. Raynolds et al. proposed a method for rational siRNA designing with 
appropriate parameter weights, by empirical study of 180 experimentally validated efficient 
siRNAs [10]. The designed siRNAs were given a score based on weighted summation of 
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siRNA selection parameter Parameter weight
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Table 3.  Parameters used in Raynold’s algorithm with their weights 
Since then many siRNA designing algorithm worked on different weight distribution 
schemes for improved prediction of siRNA potency and some even used machine learning 
algorithms. 
4.1. Use of machine learning algorithms for classification of functional siRNAs 
After many years of research about the guidelines for selection of effective siRNAs, we are a 
few steps ahead in the process of improving the targeting success rate. But for better 
targeting success, the siRNA selection parameters provided in various guidelines needs to 
be optimized. Still there is no reliable guideline for optimization of weights of siRNA 
selection parameter. Machine learning algorithms like Support vector machine or artificial 
neural network can serve excellent purpose, when trained with sufficient volume of 
biologically validated siRNA data sets [11]. Some online siRNA designing tools (like 
BioPredsi and Genescript siRNA target finder) use machine learning algorithms for 
classification of effective siRNAs from non-effective ones. 
4.1.1. Use of artificial neural network for siRNA classification 
Artificial neural networks (ANNs), as they aim to mimic the working of biological networks 
through a connectionist approach to computation, provide a powerful method of identifying 
highly complex traits in data sets. ANNs are generally very efficient classifiers in case of 
complex patterns in the given data set as they can adaptively change their weighting 
parameters during the learning process. ANNs have been broadly applied in the biological 
sciences. The prediction quality and generalization capabilities of an ANN of fixed size 
depend on a sufficiently large training set of directly comparable data points. 
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Biopredsi siRNA designing algorithm from Novartis lab used Stuttgart Neural Net 
Simulator to train algorithms on a data set of 2182 randomly selected siRNAs targeted to 34 
mRNA species [11]. It reliably predicted activity of 249 siRNAs of an independent test set 
(Pearson coefficient r = 0.66) and siRNAs targeting endogenous genes at mRNA and protein 
levels. 
4.1.2. Support Vector machine based classification 
Support Vector Machine (SVM) is a non-probabilistic binary linear classifier. Given a set of 
training examples, each marked as belonging to one of two categories, an SVM training 
algorithm builds a model that assigns new examples one of the two categories. An SVM is 
called the maximum margin classifier that optimizes the margin between the example points 
belonging to two classes so that their gap is maximized. 
A newly developed siRNA designing tool enables improved selection of potent siRNAs by 
application of a Support Vector machine based optimization of a set of eight siRNA selection 
parameters. The support vector machine is trained with the feature set of 200 highly efficient 
and 200 poorly efficient siRNA candidates, collected from siRecords, a database of validated 
siRNAs [12]. The support vector machine is trained using a Gaussian kernel and Sequential 
Minimal Optimization (SMO) algorithm [13]. It has been tested with huge number of 
experimentally validated data samples from four different sources and gave sufficiently 
good result. 
5. Experimentally validated siRNA datasets 
The effectiveness of the siRNA designing rules should be tested on biologically validated 
siRNA datasets. On the early days of RNAi research, these biologically validated datasets 
were scarce. But now, with emerging high throughput technologies, large amount of 
validated siRNA data is being generated. Some databases are created by manual curation of 
literature describing validation of siRNA mediated silencing. siRecords [12] is one such 
database where siRNAs are marked with their respective silencing efficacy (low, medium, 
high and very high). MIT siRNA database [14] consists of siRNAs designed by Qiagen with 
validated knockdown efficiency and marked with mRNA knockdown level. 
6. Improving specificity of siRNAs 
The specificity of siRNAs is a big issue in siRNA mediated gene silencing experiments. 
Exogenous siRNAs are reported to have off-target effects arising from either silencing 
unintended targets or toxic effects arising from their recognition by innate immune system [15].  
The recognition of siRNAs by innate immune system can result from interferon response 
triggered by double stranded siRNA duplex or sequence dependent stimulation of toll like 
receptors. Avoiding some sequence motifs and a constraint related to the siRNA duplex 
length can effectively reduce immune response stimulation [16]. 
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siRNAs silence unintended transcripts in mainly two ways: transcripts with near perfect 
complementarity are cleaved while transcripts with imperfect complementarity are 
translationally repressed. mRNAs other than intended targets which exhibit near perfect 
sequence complementarity with the siRNA are likely to be degraded by the siRNA. This 
kind of off-targets can be avoided by choosing targets sites that do not have a large number 
of consecutive base homology with any other mRNA. 
siRNAs down regulate a set of transcripts with 3’ UTR complementarity to the 5’ portion of 
the corresponding siRNA guide strand. These 5’ ends of the guide strand resemble the seed 
region of endogenous microRNA and are responsible for target recognition. Such off-targets 
are regulated by translational repression like miRNA target regulation. This kind of off-
target cannot be fully avoided but can be reduced by computational design.  
6.1. Stimulation of innate immune response 
siRNAs can induce potential unwanted effects by activating innate immune system. 
Exogenous siRNAs are prone to be recognized by Toll-like receptors (TLRs), mainly TLR7, 
TLR8 and TLR9. TLR7 and TLR8 recognize synthetic siRNAs in a sequence dependent 
manner [16]. There seems to be preferential recognition of GU-rich sequences. AU rich 
sequences can also be immune stimulatory. Selecting siRNA sequences lacking GU rich 
regions can provide siRNAs with low immune stimulatory activity. Also presence of the 
motif “GUCCUUCAA” the 4-base motif “UGGC” in the siRNA is known to be immune 
stimulatory [17]. So, this motif should be avoided in the time of designing of siRNAs. The 
length of the siRNA is also an important factor for stimulation of immune response- the 
minimum length of siRNA to be recognized by innate immune system is in the range of 19 
nucleotides. 
6.2. Near perfect complementarity with other mRNAs 
mRNAs other than intended targets which exhibit near perfect sequence complementarity 
with the siRNA are likely to be degraded by the siRNA. This kind of off-targets can be 
avoided by choosing targets sites that do not have many consecutive base homologies with 
any other mRNA. Actually siRNAs can potentially silence transcripts with more than 11 
base complementarity including base matches corresponding its 9th-11th nucleotides. But as 
finding unique 11 base target site is impossible, the siRNA designing algorithms try to find 
unique target sites that do not have 15 or more consecutive base homology with other 
transcripts. 
6.3. miRNA-like off-target effect 
siRNAs down regulate a set of transcripts with 3’ UTR complementarity to the 5’ portion of 
the corresponding siRNA guide strand. These 5’ ends of the guide strand resemble the seed 
region of endogenous miRNA which is responsible for target recognition. Such off-targets 
are regulated by translational repression like miRNA target regulation. That is why this 
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transcripts. 
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kind of off-target effect is called miRNA-like off-target effect [18, 19]. This kind of off-target 
cannot be fully avoided but can be reduced by computational design. Consideration for 
minimization of such off-target effect involves imposing a threshold for number of off-target 
genes. All of the present day online siRNA designing techniques consider only the 
quantitative approach for minimizing miRNA-like off-target effect by restricting the number 
of off-targets [20]. To go beyond mere quantitative approach and look for the functional 
correlation between the on-target and the genes off-targeted by the siRNA will certainly 
prove to be beneficial in minimizing miRNA-like off-target effect. A newly developed 
siRNA designing tool is aimed for such off-target minimization considering functional 
correlation of the off-target and the direct target (explained in section 9). 
7. Prediction of siRNA off-targets 
Prediction of miRNA-like off-targets involves finding the seed complementarity of the siRNA 
with the 3’UTR of a non-target mRNA. But considering only seed region complementarity 
identifies a large number of off-targets that could not be actually targeted. So, a more rational 
approach is needed for prediction of siRNA off-targets that needs understanding the miRNA 
target recognition procedure. Parameters like local AU content near the seed region or 
accessibility of the target site within the 3’UTR of the predicted off-target play roles in siRNA 
off-target detection also [21]. To have a more reliable prediction of off-targets, some siRNA 
designing solutions consider the stability factor of the duplex formed by siRNA guide strand 
seed region and mRNA 3’ UTR target as the off-targets forming duplex with lower stability are 
less likely to be actually silenced by the siRNA [22]. These tools examine thermodynamic 
property of the siRNA seed-mRNA duplex and carefully choose siRNAs with seed sequences 
that are predicted to form less thermodynamically stable duplex with the target mRNA. Some 
siRNA designing solutions consider conservation of such target regions among closely related 
species to determine the candidate mRNAs most likely to be silenced by miRNA-like 
mechanism [23]. Table 4 gives the mechanism adopted by different online siRNA designing 
solutions for minimizing off-targets. 
In a detailed investigation of all possible seed sequence and their frequency of complimenting 
the 3’ UTRs of human mRNAs, it is shown that the seeds can be classified into low, medium 
and high frequency classes according to the number 3’ UTR sites targeted by them [24]. The 
low frequency seeds have targets around 350, while the medium and high frequency seeds 
have targets around 2500 and more than 4800 respectively. So, it is obvious that siRNAs 
having a seed region that falls into the low frequency group will have fewer off-targets. But 
then in many cases, presence of such seed sequences can decrease the potency of the siRNA 
because they often contain stretches of identical nucleotides or other features unfavorable for a 
potent siRNA. So, there is a tradeoff between potency and specificity of a siRNA which have to 
be dealt with in their computational designing. Seed complement frequency (SCF) is the 
frequency of the complement of the hexamer/heptamer seed region within 3’ UTR of an 
mRNA [24]. It is a major parameter which greatly enhances specificity of siRNA off-target 
prediction, but at the cost of decreasing sensitivity. Some microRNA target site features as 
uncovered by combining computational and experimental approaches, also apply to the 
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siRNA off-target prediction problem. A study reported potential silencing of transcripts 
having consecutive 11 or more bases complementarity with miRNA or siRNAs including 
siRNA bases 9-12. These transcripts are more likely to be cleaved by the siRNA. Some other 
off-target prediction parameters include secondary structure analysis for target accessibility 
prediction and A/U base richness near target site [25]. For reliable off-target prediction, an 
optimized combination of all the above mentioned parameters is needed. 
 
siRNA designing tool Approaches towards minimization of  miRNA-like off-target effects 
BIOPREDsi 
[http://www.biopredsi.org/]. 
siRNA seed region match in combination with 10 
or more bases of additional homology to 
unintended target genes is used for pediction of 
off-targets. siRNAs predicted to have a large 
number of off-targets are rejected. 
siRNA Target Finder 
[https://www.genscript.com/ssl-
bin/app/rnai]. 
Depending on their proprietary off-target 
prediction database, a threshold of seed match for 
a specific species is applied which is computed by 
a probability model which has general biological 
significance. siRNAs predicted to have a large 
number of off-targets are rejected. 
siDESIGN Center 
[http://www.dharmacon.com/sidesign].
Chooses siRNAs that has a seed sequence with 
lower seed compliment frequency. 
siDirect [http://sidirect2.rnai.jp]. 
siDirect selects siRNAs with lower melting 
temperature (Tm value) at the seed region, which 
contains 7 nucleotides at positions 2-8 from 5′ end 
of the guide strand as the capability of siRNA to 
induce this seed-dependent off-target effect is 
highly correlated with the thermodynamic stability 
of the duplex formed between the seed region of 
the siRNA guide strand and its target mRNA. 
siDRM [http://sidrm.biolead.org/] 
For each candidate siRNA, siDRM checks and 
reports if its seed region (position 2–8) has full 
homology to the 3’ UTR region of another 
transcript, and this homology region is followed by 
four consecutive mismatches. siRNAs predicted to 
have a large number of off-targets are rejected. 
Whitehead WI siRNA Selection 
Program 
[http://jura.wi.mit.edu/bioc/siRNAext/]. 
Predicts off-targets based on the seed region 
complementarity as well as conservation of the 
target site among related species (human, mouse, 
rat, dog and chicken). siRNAs predicted to have a 
large number of off-targets are rejected. 
Table 4. Off-target minimization techniques of different siRNA designing tools. 
 
Bioinformatics 270 
kind of off-target effect is called miRNA-like off-target effect [18, 19]. This kind of off-target 
cannot be fully avoided but can be reduced by computational design. Consideration for 
minimization of such off-target effect involves imposing a threshold for number of off-target 
genes. All of the present day online siRNA designing techniques consider only the 
quantitative approach for minimizing miRNA-like off-target effect by restricting the number 
of off-targets [20]. To go beyond mere quantitative approach and look for the functional 
correlation between the on-target and the genes off-targeted by the siRNA will certainly 
prove to be beneficial in minimizing miRNA-like off-target effect. A newly developed 
siRNA designing tool is aimed for such off-target minimization considering functional 
correlation of the off-target and the direct target (explained in section 9). 
7. Prediction of siRNA off-targets 
Prediction of miRNA-like off-targets involves finding the seed complementarity of the siRNA 
with the 3’UTR of a non-target mRNA. But considering only seed region complementarity 
identifies a large number of off-targets that could not be actually targeted. So, a more rational 
approach is needed for prediction of siRNA off-targets that needs understanding the miRNA 
target recognition procedure. Parameters like local AU content near the seed region or 
accessibility of the target site within the 3’UTR of the predicted off-target play roles in siRNA 
off-target detection also [21]. To have a more reliable prediction of off-targets, some siRNA 
designing solutions consider the stability factor of the duplex formed by siRNA guide strand 
seed region and mRNA 3’ UTR target as the off-targets forming duplex with lower stability are 
less likely to be actually silenced by the siRNA [22]. These tools examine thermodynamic 
property of the siRNA seed-mRNA duplex and carefully choose siRNAs with seed sequences 
that are predicted to form less thermodynamically stable duplex with the target mRNA. Some 
siRNA designing solutions consider conservation of such target regions among closely related 
species to determine the candidate mRNAs most likely to be silenced by miRNA-like 
mechanism [23]. Table 4 gives the mechanism adopted by different online siRNA designing 
solutions for minimizing off-targets. 
In a detailed investigation of all possible seed sequence and their frequency of complimenting 
the 3’ UTRs of human mRNAs, it is shown that the seeds can be classified into low, medium 
and high frequency classes according to the number 3’ UTR sites targeted by them [24]. The 
low frequency seeds have targets around 350, while the medium and high frequency seeds 
have targets around 2500 and more than 4800 respectively. So, it is obvious that siRNAs 
having a seed region that falls into the low frequency group will have fewer off-targets. But 
then in many cases, presence of such seed sequences can decrease the potency of the siRNA 
because they often contain stretches of identical nucleotides or other features unfavorable for a 
potent siRNA. So, there is a tradeoff between potency and specificity of a siRNA which have to 
be dealt with in their computational designing. Seed complement frequency (SCF) is the 
frequency of the complement of the hexamer/heptamer seed region within 3’ UTR of an 
mRNA [24]. It is a major parameter which greatly enhances specificity of siRNA off-target 
prediction, but at the cost of decreasing sensitivity. Some microRNA target site features as 
uncovered by combining computational and experimental approaches, also apply to the 
 
Computational Approaches for Designing Efficient and Specific siRNAs 271 
siRNA off-target prediction problem. A study reported potential silencing of transcripts 
having consecutive 11 or more bases complementarity with miRNA or siRNAs including 
siRNA bases 9-12. These transcripts are more likely to be cleaved by the siRNA. Some other 
off-target prediction parameters include secondary structure analysis for target accessibility 
prediction and A/U base richness near target site [25]. For reliable off-target prediction, an 
optimized combination of all the above mentioned parameters is needed. 
 
siRNA designing tool Approaches towards minimization of  miRNA-like off-target effects 
BIOPREDsi 
[http://www.biopredsi.org/]. 
siRNA seed region match in combination with 10 
or more bases of additional homology to 
unintended target genes is used for pediction of 
off-targets. siRNAs predicted to have a large 
number of off-targets are rejected. 
siRNA Target Finder 
[https://www.genscript.com/ssl-
bin/app/rnai]. 
Depending on their proprietary off-target 
prediction database, a threshold of seed match for 
a specific species is applied which is computed by 
a probability model which has general biological 
significance. siRNAs predicted to have a large 
number of off-targets are rejected. 
siDESIGN Center 
[http://www.dharmacon.com/sidesign].
Chooses siRNAs that has a seed sequence with 
lower seed compliment frequency. 
siDirect [http://sidirect2.rnai.jp]. 
siDirect selects siRNAs with lower melting 
temperature (Tm value) at the seed region, which 
contains 7 nucleotides at positions 2-8 from 5′ end 
of the guide strand as the capability of siRNA to 
induce this seed-dependent off-target effect is 
highly correlated with the thermodynamic stability 
of the duplex formed between the seed region of 
the siRNA guide strand and its target mRNA. 
siDRM [http://sidrm.biolead.org/] 
For each candidate siRNA, siDRM checks and 
reports if its seed region (position 2–8) has full 
homology to the 3’ UTR region of another 
transcript, and this homology region is followed by 
four consecutive mismatches. siRNAs predicted to 
have a large number of off-targets are rejected. 
Whitehead WI siRNA Selection 
Program 
[http://jura.wi.mit.edu/bioc/siRNAext/]. 
Predicts off-targets based on the seed region 
complementarity as well as conservation of the 
target site among related species (human, mouse, 
rat, dog and chicken). siRNAs predicted to have a 
large number of off-targets are rejected. 
Table 4. Off-target minimization techniques of different siRNA designing tools. 
 
Bioinformatics 272 
8. Discussion about selected siRNA designing tools 
Several siRNA sequence selection algorithms have been developed in the past decade that 
relies on intrinsic sequence, stability and target accessibility features of functional siRNAs. 
Different siRNA selection algorithms follow different set of rules derived from some well-
known siRNA design parameters as discussed above. In general, these algorithms rely on 
features like- low GC content, absence of siRNA self-alignment, absence of internal repeat, 
thermodynamic conditions favouring efficient RISC entry, absence of homology to other 
mRNAs and some position specific nucleotide compositions. Few of them also consider 
silencing of alternatively spliced isoforms of the given gene. Different algorithms use 
different techniques for combination of parameters and their weight distribution- ranging 
from empirical observation to sophisticated machine learning. In spite of a large number of 
online siRNA design solutions, few of them consider miRNA-like off-targeting potential of 
synthetic siRNAs. Consideration for minimization of such off-target effect involves 
imposing a threshold for number of off-target genes. Table 5 lists some of the online siRNA 
designing solutions with their designing parameters. 
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Table 5. A comparison of siRNA designing parameters in different siRNA designing tools 
9. Importance of functional off-target filtering 
Considering only quantity of the off-targets and not the functions of individual off-targets can 
lead to inefficient handling of the miRNA-like off-target issue. Often in siRNA screening 
experiments, it has been reported that the desired output is affected because of silencing of 
unintended off-targets those sometimes are themselves member of the upstream pathway 
components of the direct target gene [26]. In such cases it can be useful to avoid specifically 
some off-targets that can cause more harmful or undesirable effects. It should be considered 
that during silencing process siRNA should not silence any mRNA from the same pathway the 
target mRNA is part of. In case of investigation of a gene function, if any gene from the same 
pathway is silenced rather than target gene then it will be difficult to investigate the actual 
phenotype of silencing the gene under investigation. For e.g. in a siRNA screening experiment 
designed for novel members of the transforming growth factor (TGF)-b pathway in a human 
keratinocyte cell line, dominant off-target effect was observed due to unintended silencing of 
two known upstream pathway components, the TGF-b receptors 1 and 2 (TGFBR1 and 
TGFBR2). Such off-target silencing activity poses threats of confusing and misleading results. 
Also the siRNAs suggested by the online siRNA selection tools often are predicted to have off-
targets that belong to the same pathway or somehow related to the direct target.  
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Das et al reported designing of a siRNA designing tool using a simple approach towards 
minimizing miRNA-like off-target effect through user feedback. Here, the user can actually 
choose from the list of potential off-target genes, the off-targets he/she wants to filter out, by 
considering the effect of silencing of those off-target genes. This tool statistically evaluates 
present day siRNA design rules such as- low GC content, absence of long stretches of identical 
nucleotides, thermodynamic conditions favouring efficient RISC entry, absence of homology 
to other mRNAs, absence of immune stimulatory motifs in the RISC entering strand of the 
siRNA duplex and some position specific nucleotide compositions, in a database of validated 
siRNAs [12] used in experiments to examine the threshold parameters. A support vector 
machine, trained with the optimal features set, is used for classifying potential and effective 
siRNAs. Moreover, with other parameters, it predicts the potential miRNA-like off-target 
genes for each candidate siRNA, sets a threshold for the number of off-targets to minimize 
miRNA-like off-target effect and presents the list of predicted off-target genes. A feedback 
mechanism allows the user to choose specific genes that needs to be filtered out from the list of 
predicted off-target genes recursively until his/her needs are met. This technique gives a more 
rational approach towards handling the miRNA-like off- target issue. 
 
Figure 1. An example of off-target filtering by user feedback 
10. Conclusion 
As many guidelines are available for selection of efficient siRNAs and they promise to 
improve efficacy in silencing, much progress has been made in designing siRNAs with 
improved targeting success rate. Now the main challenge in in-silico siRNA design is 
reducing the unintended effects arising from inadvertent targets. While the off-targets with 
near perfect sequence complementarity with the given siRNA is taken care of much 
efficiently by targeting against a unique region of the target mRNA, which can be found by 
homology searching with other mRNAs of the organism, miRNA-like off-targets remain to 
be addressed with efficiency. The few online siRNA designing solutions those consider for 
reducing such off-targets rely on reducing the number of off-targets. Even then a 
compromise has to be made between potency and specificity as siRNA sequences that could 
give higher specificity often comes with lower potency. Now approaching this specificity 
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issue arising from miRNA-like off-targets of a siRNA from a different point of view, like the 
functional off-target filtering discussed in previous section, may prove to be beneficial and 
may emerge as a new paradigm for designing efficient siRNAs with customized specificity. 
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1. Introduction 
MicroRNAs (miRNAs) participate in several biological processes, including development, 
differentiation, apoptosis, and proliferation (1, 2) through imperfect pairing with target 
messenger RNAs (mRNAs) of protein-coding genes and transcriptional or post-
transcriptional regulation of their expression (3, 4). Approaches to miRNA detection, such as 
parallel sequencing technologies may replace conventional sequencing (5). The GS 454 
technology can produce a similar number of longer (100–150-nucleotides (nt)) sequence 
reads in a single analysis run, with the advantage that this method can derive the complete 
sequence of the mature miRNA. Moreover, recent studies on miRNA profiling performed 
with cloning techniques suggest that sequencing methods are suitable for the detection of 
novel miRNAs, modifications, and precise compositions, and that cloning frequencies 
calculated by clone count analysis strongly correlate with the concentrations measured by 
Northern blotting, and are reproducible. The achievement of comprehensive profiling of 
miRNA in human diseases requires exhaustive qualitative and quantitative analyses. Here 
we show the techniques and the some of the results of the miRNA transcriptomes in the 
liver using sequencing. This serves as a critical step in clarifying the functional significance 
of specific miRNAs as they relate to liver diseases. 
2. Techiniques of MicroRNA cloning and bioinformatics for MiRNAome 
2.1. MicroRNA cloning 
The method for microRNA cloning and sequencing that we moderated from the original 
ones are shown in Fig1. We cloned small RNA by a modification of the published miRNA 
cloning protocol of Lagos-Quintana et al. (6). In brief, total RNA samples were extracted 
using ISOGEN (Nippon Gene, Tokyo, Japan), separated in a denaturing polyacrylamide gel, 
and the 18–24 nt fraction was recovered. Next, 5′- and 3′-adapters were ligated to the RNAs 
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oligonucleotide (5’/5 Phos/rCrUrGrUAGGCACCATCAATdi-deoxyC-3 ’) and the 5’ linker 
oligonucleotide (5’-ATCGTrArGrGrCrArCrCrUrGrArArA-3’)] and RT-PCR was carried out. 
 
Figure 1. Overview of the miRNA cloning. See paper body for details. 
Amplification of the cDNA fragments was obtained by two consecutive rounds of PCR. 
Specific restriction enzyme digestion of the adaptors allowed for concatemerization of the 
cDNA into larger fragments. These fragments were then cloned into a vector to create a 
cDNA library. Concatemerization increases the length of informative sequences obtainable 
from each clone. we concatenated more than 20 cDNAs into a single fragment using a BanI 
restriction enzyme (New England Biolabs, Ipswich, MA, USA), a DNA ligation kit ver. 2.1 
(Takara Bio, Shiga, Japan), and a Geneclean III kit (Qbiogene, Irvine, CA, USA) prior to TA 
cloning. The concatenated products were then inserted into plasmids and sequenced (Fig1).  
The sequences were compared to human DNA to determine the genomic origin of the small 
RNA. It was important to avoid contamination from other samples and molecular-weight 
makers during electrophoresis. Such contaminants considerably diminished the accuracy 
and efficiency of miRNA cloning. We avoided contamination by performing the cloning 
procedure separately for each sample, by using a special gel with a small plastic rod that 
divided the sample and marker lanes, and by using separate vats for each gel for ethidium 
bromide staining. We made small RNA libraries by excising a portion of a polyacrylamide 
gel containing species 18–24 nt in length to avoid contaminating our purified RNAs with 
piRNAs (7).  
2.2. Bioinformatics analysis of the sequence data 
We performed a homology search for all cloned small RNAs and a secondary structural 
analysis for all novel miRNA candidates.  
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2.2.1. Comparing the cloned sequences with those of known RNAs 
The vector sequence, the 5'and 3' linkers, and their coupled sequences 
(CTGTAGGCACCTGAAA) were removed. Those extracted sequences composed of 16–30 nt 
were defined as valid small RNAs and were subjected to followings. The small RNA 
sequences were analyzed for homology with known RNAs, including miRNA, piwi-
interacting (pi) RNA, rRNA, tRNA, small nuclear (sn) RNA, small nucleolar (sno) RNA, and 
mRNA, and human genomic DNA sequences. The databases used were: miRNA (mature- 
and pre-), Sanger Database.; piRNA, the NCBI Entrez Nucleotide database; rRNA, the 
European ribosomal RNA database; tRNA, the Genomic tRNA database; sn/snoRNA, 
RNAdb and NONCODE; mRNA, NCBI Reference Sequence; and human genomic 
sequences, the UCSC Genome Bioinformatics Site. In our searches, we defined the cloned 
sequencing results that had higher than 90% homology as valid if they met our criteria for 
sequence error, erroneous PCR amplification, and 3′- and 5′-end variations. Clones with 
100% homology with human genomic DNA but did not match known RNAs when 
compared to the above databases were termed novel miRNA candidates and were subjected 
to further analysis. The result is shown in table1. 
 
Reads (%) HCC ANL Sum 
Total 314,359 268,708 583,067 
miRNA 256,64 (81.6) 208,038 (77.4) 464,687 (79.7) 
piRNA 2,983 (0.9) 1,440 (0.5) 4,423 (0.8) 
rRNA 5,474 (1.7) 10,161 (3.8) 15,635 (2.7) 
tRNA 1,703 (0.5) 621 (0.2) 2,324 (0.4) 
snRNA 700 (0.2) 343 (0.1) 1,043 (0.2) 
snoRNA 654 (0.2) 747 (0.3) 1,401 (0.2) 
mRNA 6,053 (1.9) 7,279 (2.7) 13,332 (2.3) 
Genome 2,799 (0.9) 3,149 (1.2) 5,948 (1.0) 
Others 15,588 (5.0) 34,686 (12.9) 71,174 (12.2) 
Table 1. Annotation of the sequenced small RNAs 
2.2.2. Secondary structure analysis of Novel microRNAs 
The two-dimensional precursor miRNA (pre-miRNA) configurations of our novel miRNA 
candidates were predicted according to the method described previously (8) with some 
modifications. Briefly, 196-nt of genomic sequence was added to the candidate sequences 
(88-nt at each end). Each candidate sequence was divided into 110-nt windows and 
subjected to two-dimensional analysis along its entire length, using the RNAfold software 
(Vienna RNA Secondary Structure Package (9)). The configurations that had the lowest free 
energy and that had a high conservation (described below) and met the following criteria 
were termed novel miRNAs: (a) contained a stem-loop configuration; (b) cloned mature 
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miRNA sequence portion consisted of more than 16-nt in its double-stranded region; (c) the 
loop contained fewer than 20-nt; (d) the internal loop contained fewer than 10-nt; and (e) the 
bulge contained fewer than 5-nt. Furthermore, novel sequences with overlapping positions 
in the genome were grouped together. Novel antisense miRNAs are defined with above 
criteria (a)-(e) but without conservation score if they are coded in same chromosomal region.  
2.2.3. Determination of hairpin conservation of Novel MicroRNAs 
We classified all the candidate miRNAs using the PhastCon database at the University of 
California at Santa Cruz.(10, 11) This database has scores for each nucleotide in the human 
genome relative to its degree of conservation when compared to nucleotides in the 
armadillo, bush baby, cat, chicken, chimpanzee, cow, dog, elephant, frog, fugu, guinea pig, 
hedgehog, horse, lizard, medaka, mouse, opossum, platypus, rabbit, rat, rhesus monkey, 
shrew, stickleback, tenrec, tetraodon, tree shrew, and zebrafish. The algorithm is based on a 
phylogenetic hidden Markov model that uses best-in-genome pairwise alignment for each 
species (based on BLASTZ), followed by multiple alignment of the twenty eight genomes. A 
hairpin was defined as conserved if the average PhastCon conservation score over the 28 
species for any 15-nt sequence in the hairpin stem was at least 0.8 .(12)  
3. Other techniques for MicroRNAome 
3.1. Real-time PCR analysis of known miRNAs 
Real-time PCR was performed on an ABI7300 (Applied Biosystems, Foster City, CA, USA) 
using various mirVana qRTPCR primer sets (Ambion, Austin, TX, USA) and a SYBR 
ExScript RT-PCR kit (Takara Bio), or with TaqMan miRNAs assays (Applied Biosystems), a 
High capacity cDNA archive kit (Applied Biosystems), and Absolute QPCR ROX mix 
(Abgene, Rochester, NY, USA), according to the manufacturers’ instructions. As an 
endogenous control, 5SrRNA or U6 snRNA was used.  
3.2. Ago2-immunoprecipitation and PCR analysis of novel miRNAs 
After bioinformatic analysis of the sequence data, we further validated novel miRNAs by 
using a combination of Ago2-immunoprecipitation (13) followed by PCR-based miRNA 
detection (14). Briefly, 50 ml Dynabeads protein G slurry (Invitrogen) was immobilized with 
20 mg human P4 anti-mouse Ago2 monoclonal antibody (clone 2D4, Wako Pure Chemical 
Industries, Osaka, Japan). One hundred fifty micrograms of human tissue P4 were 
homogenized in 1.5 ml of a cell lysis solution (provided in miRNAs isolation kit, Wako) 
using a Polytron PT1200C homogenizer (Kinematica AG, Lucerne, Switzerland) for 10 s at 4 
8C, and then 1.5 ml of the cell lysis solution was added into the homogenized solution. 
Following incubation for 15 min on ice, lysate was centrifuged at 20 000 g for 20 min at 4 8C 
and filtered through a 0.8 mmSupor Acrodisc syringe filter (Pall Corporation, Ann Arbor, 
MI, USA). One milliliter of the filtered lysate was incubated with 25 ml of the anti-Ago2-
Dynabead protein G for incubation for 60 min at 4 8C. After immunoprecipitation, Ago2-
 
Novel microRNA Cloning Using Bioinformatics 281 
associated RNAs were isolated from the immunoprecipitate according to the manufacture’s 
protocol (Wako). We confirmed that the immunoprecipitate contained human P5 Ago2 
protein of w100 kDa in size by western blot (data not shown). Non-immune human IgG 
(Sigma) was used as a control for Ago2-immunoprecipitation. Preparation of the cDNA 
library using the Ago2-associated RNAs and semi-quantitative PCR analysis of the above-
mentioned novel miRNA candidates were performed, as reported previously (14). A small 
RNA-specific primer and a universal reverse primer RTQ-UNIr (14), were used for 
amplification of each of the small RNAs. The PCR products were analyzed on a 12% 
polyacrylamide gel. The primers for the human GAPDH were used for negative control. 
3.3. PCR analysis of novel miRNAs (Alternative method of 3.2) 
After bioinformatic analysis of the sequence data, we further validated novel miRNAs by 
PCRbased miRNA detection (14). Briefly, small RNAs were isolated using the mirVana™ 
miRNA isolation kit (Ambion). Small RNA samples were polyadenylated with Poly(A) 
Tailing Kit (Ambion) and were purified with Acid-Phenol:Chloroform and with filter 
cartridge provided in the mirVana Probe & Marker Kit (Ambion). To generate a small RNA 
cDNA library, tailed RNA were reverse transcripted using RTQ primer(14) and the samples 
were purified using the QIAquick 
spin PCR purification kit (QIAGEN). A small RNA-specific primer and a universal reverse 
primer RTQ-UNIr (14), were used for amplification of each of the small RNAs. The PCR 
products were analyzed on a 12% polyacrylamide gel. The primers for the human GAPDH 
were used for negative control. 
3.4. Real-time PCR-based miRNA expression profiling 
Total miRNA (350 ng) was reverse-transcribed using Megaplex RT Primers (Applied 
Biosystems). The resulting cDNAs were pre-amplified using Megaplex PreAmp Primers 
(Applied Biosystems) and the pre-amplified products applied to a TaqMan Human 
MicroRNA Array Panel (A and B, v2.0).  
3.5. siRNA, Pre-miR and anti-miR transfections 
Cultured cells were transfected with precursor hsa-miR-200c and hsa-miR-141 (ID: 
PM11714; PM10860); Anti-miR™ 200c and 141 inhibitors (ID: MH11714; MH10860) 
(Ambion, Austin, TX) for 8 hours in serum free medium. Serum supplemented medium was 
added and gene and protein expression measured at the indicated time points. 
4. Study designs 
Sequencing using 454 sequencing and conventional cloning from 22 pair of HCC and 
adjacent normal liver (ANL) and 3 HCC cell lines identified reliable reads of more than 
300000 miRNAs from HCC and more than 270000 from ANL for registered human miRNAs. 
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associated RNAs were isolated from the immunoprecipitate according to the manufacture’s 
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5. Detected novel microRNAs using cloning 
Eleven novel opposite miRNAs (defined as miRNAs cloned from the other arm of 
precursors from which known miRNAs have been cloned) were identified from the 
annotated miRNAs (Figure 2A).Based on above criteria, a scan of all the novel miRNA 





A: Chromosomal locations of our cloned mature miRNAs which correspond to previously identified pre-miRNAs. The 
bar graphs indicate the location of mature miRNAs (both our cloned miRNAs and previously identified miRNAs) 
based on known pre-miRNA sequences. Many of our cloned sequences were found in these regions. Arrowheads 
indicate novel “opposite” miRNAs cloned in our experiments. These sequences represent mature miRNAs which 
originate on the opposite DNA strand of the known precursor miRNA.  
B: The 222 novel mature miRNAs identified in our study were checked for species conservation using the PhastCon 
database and their corresponding hairpin conservation scores charted in this figure.  
Figure 2. Qualitative analysis of miRNAs in the human liver. 
 











AB372573 TGCAATGGTTGTCCTGAGA + 1 30294032 30294114 0.00 -28.6 
AB372574 GTGGGGGAGAGGCTGTCA + 1 150066781 150066870 0.00 -50.7 
AB372575 TTGCACAACTCTCACATTC + 1 152498870 152498979 0.39 -38.2 
AB372576 CCCCTCACTTCTCCGTCATATC + 1 153367241 153367332 0.05 -28.8 
AB372577 CCCCAGATTCCACACC + 1 154326362 154326427 0.85 -28.9 
Table 2. Summary of the novel miRNAs 
Summary of predicted novel miRNAs. The predicted novel miRNAs with their PhastCon scores are 
listed. And the most frequent cloned sequences, genome locations, clone counts, and conservation 
scores calculated with PhastCon are listed. The stem-loop is a 110-nt sequence derived by 
computational prediction. The precursor structures are listed in Table 3. 
 
 
Table 3. Samples of the Secondary structures of predicted novel miRNAs. The predicted novel miRNAs 
with their particular ID numbers are listed. The mature miRNAs are depicted in blue in the drawing of 
the precursor.  
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We cloned 210 novel microRNA candidates. Samples of the novel microRNAs that were 
detected from our study and its bioinformatics data are tabulated in Table 2 and 3. And 
those novel miRNAs have been deposited with DDBJ under consecutive accession codes 
from AB372573 to AB372814. 
6. Future direction 
We have been demonstrated the usefulness and accuracy of sequencing in genetic 
research of the liver. One of the main problems with applying sequencing to the miRNA 
transcription research is that sequencing is a time-consuming procedure. And an 
important consideration for the discovery of miRNA by sequencing is the difficultly in 
identifying miRNAs that are expressed at low levels, at highly specific stages or in rare 
cell types. Moreover, a serious problem is that some miRNAs are difficult to profile 
precisely due to their physical properties or post-transcriptional modifications, such as 
RNA editing. In principle, these limitations can be overcome by extensive sequencing of 
small RNA libraries from a broad range of samples. For differential display, the 
sequencing-based method has the theoretical advantage in that it has the capability to 
discover and detect novel miRNAs. Based on our sequence variability results, especially 
with regard to RNA modifications, the accuracy of the sequence-based method is 
expected to be superior to that of the hybridization-based method. For the prediction of 
novel miRNAs, methods that rely on phylogenetic 1 genes. To overcome this problem, we 
made use of a computational approach for structural conservation criteria using the 
thermodynamic stability and intrinsic structural features of miRNAs. In clinics, 
pathologists often meet difficult situations in which they cannot clearly tell whether the 
tissue specimens they are observing are malignant or benign. Thus, in our opinion, using 
some miRNAs as a tumor marker would help clinicians to clearly determine whether that 
tissue is cancerous. miRNA sequences followed by bioinformatics have greater power 
than individual miRNAs or other clinic-pathological variables for the detection of high 
risk patients’ groups with poor prognoses. There is currently little data available as to 
how we can use each miRNA to predict high risk groups; however, additional future 
miRNA work and data accumulation will elucidate such criteria. And further 
investigation is warranted to clarify the mechanism of aberrant expression of miRNAs in 
cancer and its participation in carcinogenesis. Nevertheless, these findings show that 
sequence-based miRNA profiling has potential for the confirmation of precise miRNA 
dynamics in a specific disease. In addition, it will increase our understanding of the 
mechanisms and factors involved in human liver cancer. 
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1. Introduction
Recent technologies and tools generated excessive data in bioinformatics domain. For
example, microarrays measure expression levels of ten thousands of genes simultaneously
in a single chip. Measurements involve relative expression values of each gene through an
image processing task.
Biological data requires both low and high level analysis to reveal significant information
that will shed light into biological facts such as disease prediction, annotation of a gene
function and guide new experiments. In that sense, researchers are seeking for the effect of
a treatment or time course change befalling. For example, they may design a microarray
experiment treating a biological organism with a chemical substance and observe gene
expression values comparing with expression value before treatment. This treatment or
change make researchers focus on groups of genes, other biological molecules that have
significant relationships with each other under similar conditions. For instance, gene class
labels are usually unknown, since there is a little information available about the data.
Hence, data analysis using an unsupervised learning technique is required. Clustering
is an unsupervised learning technique used in diverse domains including bioinformatics.
Clustering assigns objects into the same cluster, based on a cluster definition. A cluster
definition or criterion is the similarity between the objects. The idea is that one needs to find
the most important cliques among many from the data. Therefore, clustering is widely used
to obtain biologically meaningful partitions. However, there is no best clustering approach for
the problem on hand and clustering algorithms are biased towards certain criteria. In other
words, a particular clustering approach has its own objective and assumptions about the data.
Diversity of clustering algorithms can benefit from merging partitions generated individually.
Ensemble clustering provides a framework to merge individual partitions from different
clustering algorithms. Ensemble clustering may generate more accurate clusters than
individual clustering approaches. Here, an ensemble clustering framework is implemented
as described in [10] to aggregate results from K-means, hiearchical clustering and C-means
algorithms. We employ C-means instead of spectral clustering in [10]. We also use different
©2012 Pirim and Şeker, licensee InTech. This is an open access chapter distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits
unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Chapter 13
©2012 Pirim and ¸Seker, licensee InTech. This is a p per distributed under the te ms of the Cr a iv  Co m ns
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
 
Bioinformatics 286 
NONCODE, http://www.bioinfo.org.cn/NONCODE/; NCBI Reference Sequence, 
ftp://ftp.ncbi.nih.gov/refseq/; UCSC Genome Bioinformatics Site, http://genome.ucsc.edu; 
OncoDb HCC, http://oncodb.hcc.ibms.sinica.edu.tw/index.ht 
Chapter 0
Ensemble Clustering for Biological Datasets
Harun Pirim and Şadi Evren Şeker
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data sets. Two different biological datasets are used for each algorithm. A comparison of
the results is presented. In order to evaluate the performance of the ensemble clustering
approach, one internal and one external cluster validation indices are used. Silhouette (S)
[31] is the internal validation index and C-rand [23] is the external one. The chapter reviews
some clustering algorithms, ensemble clustering methods, includes implementation, and
conclusion sections.
2. Clustering algorithms
Clustering biological data is very important for identification of co-expressed genes, which
facilitates functional annotation and the elucidation of biological pathways. Accurate
predictions can serve as a guide for targeting further experiments and generating additional
hypotheses. Furthermore, accurate predictions can facilitate identification of disease markers
and targets for drug design [4]; clustering can also be used to determine whether certain
patterns exist near viral integration sites[16].
Current algorithms used in gene clustering have some drawbacks. For example, K-means
algorithm is sensitive to noise that is inherent in gene expression data. In addition, the solution
(i.e. the final clustering) that the K-means algorithm finds may not be a global optimum since
it relies on randomly chosen initial objects. However, K-means-based methods are prevalent
in the literature such as [12, 17, 33]. K-means works upon randomly chosen centroid points
that represent the clusters. The objects are assigned to the closest clusters based on distance
calculation regarding centroid points. For example, the dataset illustrated in Figure 1 is
assigned two centroids.
(a) Data to be clustered (b) Random centroid points
Figure 1. The dataset and two centroid points
The distance between any object from the dataset to both of the centroid points are calculated
and the objects are assigned to the closest cluster represented by the closest centroid point as
seen in Figure 2. Then new centroid points of clusters are calculated and objects are assigned
to the closest clusters regarding the distance to new centroid points. Recalculation of centroid
points and assignment of objects to new clusters goes on till centroids points remain the same
as in Figure 3.
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Another method, Self-organizing Map (SOM), is one of the machine-learning techniques
widely used in gene clustering. A recent study is [14]. SOM requires a grid structured input
that makes it ineffective.
Figure 2. Initial clusters
(a) Initial clusters (b) Final clusters
Figure 3. Iteration of K-means
Hierarchical clustering (HC) algorithms are also widely used and area of two types:
agglomerative and divisive. In agglomerative approach objects are all in different clusters
and they are merged till they are all in the same cluster as seen in Figure 4. Two
important drawbacks of the HC algorithms are that they are not robust and they have high
computational complexity. HC algorithms are "greedy" which often means that the final
solution is suboptimal due to locally optimal choices being made in initial steps, which turn
out to be poor choices with respect to the global solution. A recent study is [26].
Graph-theoretical clustering techniques exist in which the genomic data are represented
by nodes and edges of a graph. Network methods have been applied to identify and
characterize various biological interactions [13]. Identification of clusters using networks is
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Figure 4. Agglomerative approach
often intractable, that is finding an optimal partition of a graph is an NP-hard problem [1].
NP-hard is a class of problems that are at least as hard as NP-complete problems. NP-complete
is a class of problems that are in NP and reducible to an NP-complete problem in polynomial
time. Some examples of graph theory-based clustering approaches are: [30] and [24].
Model-based clustering approaches are the ones using probability distributions to predict the
distribution of gene expression data. However, gene expression data does not have a unique
distribution. Some examples are given in [19] and [34].
Sub-space clustering (biclustering) methods, which employ the reasoning that one gene may
belong to multiple pathways or no pathways are also used in the literature as in [28]. There are
also optimization-based algorithms as in [15], spectral algorithms as in [25], fuzzy algorithms
as in [32], meta-heuristics as in [18] used for clustering genomic data.
3. Ensemble clustering
Combining diverse partitions from different clustering algorithms may result in high quality
and robust clusters, since ensemble approaches such as bagging and boosting used in
classification problems have proven to be effective [22]. The fact that the objects have various
features makes it difficult to find an optimal clustering of similar objects. In other words,
objects may be classified based on different features such as size, color, and age. In that sense,
ensemble clustering is a promising heuristic combining results based on different features.
Figure 5 represents a clustering ensemble framework. CAs are clustering algorithms, Ps are
partitions generated by them, N is number of clustering algorithms and partitions FC is the
consensus function and CP is the consensus partition.
Ensemble clustering requires the following tasks [2]:
1. selection of base clustering algorithms
2. definition of a consensus function
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Figure 5. Ensemble clustering framework
3. merging of individual partitions by the chosen consensus function
[2] apply an ensemble approach for clustering scale-free graphs. They use metrics based on the
neighborhood which uses the adjacency list of each node and considers the nodes as having
several common neighbors, the clustering coefficient, and the shortest path betweenness
of nodes in the network. The scale-free graph used in the study is from a budding yeast
PPI network that contained 15147 interactions between 4741 proteins. It is reported that
ensemble clustering can provide improvements in cluster quality for scale-free graphs based
upon the preliminary results. [3] propose an ensemble clustering framework to extract
functional modules that are relevant biologically in protein-protein interaction (PPI) networks.
Their method attempts to handle the noisy false positive interactions and specific topological
interactions present in the network. The method uses graph clustering algorithms, repeated
bisections, direct k-way partitioning, and multilevel k-way partitioning, to obtain the base
partitions. The method utilizes two topological distance matrices. One of the distance
matrices is based on the clustering coefficient [36], and the other distance matrix is generated
using the betweenness measure [29]. The proposed study demonstrates a soft ensemble
method such that proteins are allowed to be assigned to more than one cluster. Empirical
evaluation of the different ensemble methods in the study shows the superior performance of
the proposed ensemble framework.
Fuzzy clustering algorithms are widely used with well-understood properties and benefits in
various applications. Nevertheless, there has been very little analysis of using fuzzy clustering
algorithms in regards to generating the base partitions in cluster ensembles. [35] compares
hard and fuzzy C-means [7] algorithms in the well-known evidence-accumulation framework
of cluster ensembles. In the study, it is observed that the fuzzy C-means approach requires
much fewer base partitions for the cluster ensemble to converge, and is more tolerant of
outliers in the data.
[5] propose a fuzzy ensemble clustering approach to address the issue of unclear boundaries
between the clusters from the biological and biomedical gene expression data analysis. The
approach takes into account their inherent fuzziness. The goal of the study is improving the
accuracy and robustness of clustering results. After applying random projections to obtain
lower dimensional gene expression data, the method applies the fuzzy K-means algorithm on
the low dimensional data to generate multiple fuzzy base clusters. Then, the fuzzy clusters
are combined using a similarity matrix where the elements of the matrix are generated by the
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fuzzy t-norms algorithm, and finally, the fuzzy K-means algorithm is applied to the rows of
the similarity matrix to obtain the consensus clustering. It is demonstrated that the proposed
ensemble approach is competitive with the other ensemble methods.
High throughput data may be generated by microarray experiments. If the dataset is very
large, it is possible to generate an ensemble of clustering solutions, or partition the data so
that clustering may be performed on tractable-sized disjoint subsets [20]. The data can then
be distributed at different sites, for which a distributed clustering solution with a final merging
of partitions is a natural fit. [20] introduce two new approaches to combining partitions
represented by sets of cluster centers. It is stated that these approaches provide a final
partition of data that is comparable to the best existing approaches and that the approaches
can be 100,000 times faster while using much less memory. The new algorithms are compared
with the best existing cluster ensemble approaches that cluster all of the data at once, and
a clustering algorithm designed for very large datasets. Fuzzy and hard K-means based
clustering algorithms are used for the comparison. It is demonstrated that the centroid-based
ensemble merging algorithms presented in the study generated partitions which are as good
as the best label vector method, or the method of clustering all the data at once. The proposed
algorithms are also more efficient in terms of speed.
[11] propose evidence accumulation clustering based on dual rooted prim tree cuts (EAC-DC).
The proposed algorithm computes the co-association matrix based on a forward algorithm
that repeatedly adds edges to Prim’s minimum spanning tree (MST) to identify clusters until
a satisfying criterion is met. A consensus cluster is then generated from the co-association
matrix using spectral partitioning. Here, a MST is a fully connected sub-graph with no cycles
and a dual-rooted tree is obtained by finding the union of two sub-trees. They test their
approach using the Iris dataset [8], the Wisconsin breast cancer dataset [27] (both obtained
from [9]) and synthetic datasets, and presented a comparison of their results with other
existing ensemble clustering methods.
[22] use a cluster ensemble in gene expression analysis. In the proposed ensemble framework,
the partitions generated by each individual clustering algorithm are converted into a distance
matrix. The distance matrices are then combined to construct a weighted graph. A graph
partitioning approach is then used to generate the final set of clusters. It is reported that the
ensemble approach yields better results than the best individual approach on both synthetic
and yeast gene expression datasets.
[10] merge multiple partitions using evidence accumulation. Each partition generated by a
clustering algorithm is used as a new piece of knowledge, to help uncover the relationships
between objects. For this chapter, we adopt their ensemble approach. The core idea
behind the ensemble approach here is constructing the co-association matrix by employing
a voting mechanism for the partitions generated using individual clustering algorithms. A
co-association matrix C is constructed based upon the formulation below, where nij is the





After constructing the co-association matrix, [10] use single linkage hierarchical clustering to
obtain the new cluster tree (dendrogram) and then use a cut-off value corresponding to the
maximum life time (difference between merge points where branching starts) on the tree.
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They also employ the same ensemble framework using K-means partitions with different
parameters. They test their algorithms on ten different datasets, comparing the results with
other ensemble clustering methods. They report that their ensemble approach can identify
the clusters with arbitrary shapes and sizes, and perform better than the other combination
methods.
4. Implementation
We employ the ensemble approach described in [10]. Different set of base clustering
algorithms are chosen and implemented on protein and lymphoma datasets.
Protein dataset consists of 698 objects (corresponding to protein folds) with 125 attributes.
The protein dataset contains 698 proteins from 125 samples. The real clusters correspond to
the four classes of protein−folds: α, β, α/β and α+β protein classes. DLBCL−B is 2−channel
custom cDNA microarray dataset. This is a B cell lymphoma dataset with predefined three
subtypes [21].
The ensemble clustering algorithm uses an array of vectors data structure for each of the file,
in order to use the dynamic memory allocation and starts with initializing the file content in
the vectors. The algorithm also processes the vectors and generates two temporary matrices
with the dimension of maximum vector length. The ensemble clustering algorithm steps are
as follows:
Algorithm 1 Ensemble Clustering Algorithm
Require: partitions
Ensure: distance matrix
for i = 0 to max(V[n]) do
for j = 0 to max(V[n]) do
for k = 0 to n do
if V[k].elementAt(i) = V[k].elementAt(j)) then
C[i][j] = C[i][j] + 1/n
end if




Here, n is the number of files, V[n] are the vectors holding the content of each file. max(V[n])
is the length of the longest vector, C[i][j] is the co-association matrix and D[i][j] is the distance
matrix. The algorithm iterates through the two dimensional matrix via i and j loop variables
inside a nested loop at lines 1 and 2 and for each member of the matrix, all the vectors are
processed inside the loop via k loop variable at line 3. The condition of equality for the
selected vector with the selected loop variables i and j, causes an increase on the co-association
matrix elements at lines 4 and 5. Finally the distance matrix is calculated at line 7. After
obtaining the distance matrix, hierarchial clustering with complete linkage is used to generate
the dengrogram. The dendrogram is cut at a certain level to obtain consensus partition.
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Ensemble approach is coded as a java application which is available upon request.
The software allows addition of many partitions to generate the distance matrix of the
corresponding ensemble. Files including the partitions can be added by clicking on the "Add
File" button as seen in Figure 6. Distance matrix of the ensemble is generated by "Calculate"
button.
Figure 6. File input interface
The output is displayed on a separate screen as demonstrated on Figure 7. The output with
csv format can be written into a file by clicking on the "Output CSV" button.
Figure 7. Example clusters
Considering two different partitions of a dataset with six objects which are (1, 1, 2, 1, 3, 3) and
(2, 2, 2, 1, 3, 3), the algorithm’s output is the distance matrix:
⎛
⎜⎜⎜⎜⎜⎜⎝
0 0 0.5 0.5 1 1
0 0 0.5 0.5 1 1
0.5 0.5 0 1 1 1
0.5 0.5 1 0 1 1
1 1 1 1 0 0
1 1 1 1 0 0
⎞
⎟⎟⎟⎟⎟⎟⎠
The distance matrix is used in hierarchical clustering with complete linkage and the following
dendrogram is generated. The dendrogram is cut at a level to give three clusters. The
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corresponding partition is (1, 1, 1, 2, 3, 3) which is the same as second partition (2, 2, 2, 1,
3, 3).
Figure 8. Example clusters
We employ hierarchical clustering, K-means and C-means to obtain base partitions. K-means
and hierarchical clustering algorithm are implemented using R base package, C-means is
implemented using R e1071 package. Silhouette and C-rand indices are utilized to evaluate
the performance of individual and ensemble algorithms. Silhouette and C-rand values are
calculated using R clusterSim and flexclust packages respectively. Silhouette is an internal
measure of compactness and separation of clusters [6]. The silhouette index values are
between -1 and 1 representing worst and best values. C-rand is an external measure of
agreement between two partitions. C-rand has maximum value of 1 and it can take negative
values. The silhouette and C-rand values found by the base and ensemble algorithms are
given in Table 1. Ensemble approach improves clustering result both for the protein and
DLBCL-B datasets. Ensemble approach finds better C-rand value, 0.157 than values by
K-means and C-means, 0.127 for the protein dataset. Ensemble approach also finds the best
C-rand value, 0.135 compared to values generated by individual clustering algorithms, 0.021,
0.063, 0.098. However, the ensemble approach makes S values worse in most cases.
Dataset Method Num. of clusters S value C value
Protein
HC 4 0.344 0.199
K-means 4 0.379 0.127
C-means 4 0.379 0.127
Ensemble 4 0.078 0.157
DLBCL-B
HC 3 -0.034 0.021
K-means 3 -0.015 0.063
C-means 2 -0.005 0.098
Ensemble 3 -0.017 0.135
Table 1. Index values for base and ensemble algorithms
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5. Conclusion
Clustering groups of objects such that similar ones are placed in the same cluster, and in
its application to biological datasets are very important in that it can help identification
of natural groups of biological entities that might give insight about biomarkers. In this
chapter, we review some clustering algorithms applied to biological data. Ensemble clustering
approaches for biological data are also reviewed. Implementation of K-means, C-means and
HC algorithms and merging of the algorithms using an ensemble frame work are presented
using two different datasets. The datasets are protein and DLBCL-B. Two different cluster
validation indices, adjusted rand and silhouette, are used for comparing the partitions from
individual algorithms and ensemble clustering. Investigating Table 1, we conclude that
merging individual partitions improves C-rand values meaning that ensemble approach finds
partitions similar to the real partitions. Ensemble approach is coded as a Java application and
available upon request.
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using two different datasets. The datasets are protein and DLBCL-B. Two different cluster
validation indices, adjusted rand and silhouette, are used for comparing the partitions from
individual algorithms and ensemble clustering. Investigating Table 1, we conclude that
merging individual partitions improves C-rand values meaning that ensemble approach finds
partitions similar to the real partitions. Ensemble approach is coded as a Java application and
available upon request.
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[1] Arora, S., Rao, S. & Vazirani, U. [2009]. Expander flows, geometric embeddings and
graph partitioning, Journal of the ACM 56(2): 1–37.
URL: http://doi.acm.org/10.1145/1502793.1502794
[2] Asur, S., Parthasarathy, S. & Ucar, D. [2006]. An Ensemble Approach for Clustering
Scale-Free Graphs, KDD-2006 Workshop on Link Analysis, 12th ACM SIGKDD International
Conference on Knowledge Discovery and Data Mining.
[3] Asur, S., Ucar, D. & Parthasarathy, S. [2007]. An ensemble framework for clustering
protein&#8211;protein interaction networks, Bioinformatics 23(13): 29–40.
URL: http://dx.doi.org/10.1093/bioinformatics/btm212
[4] Asyali, M. H., Colak, D., Demirkaya, O. & Inan, M. S. [2006]. Gene expression profile
classification: A review, Current Bioinformatics pp. 55–73.
URL: http://dx.doi.org/10.2174/157489306775330615
[5] Avogadri, R. & Valentini, G. [2009]. Fuzzy ensemble clustering based on
random projections for dna microarray data analysis, Artificial Intelligence in Medicine
45(2-3): 173–183. URL: http://dx.doi.org/10.1016/j.artmed.2008.07.014
[6] Bandyopadhyay, S., Mukhopadhyay, A. & Maulik, U. [2007]. An improved algorithm for
clustering gene expression data, Bioinformatics 23(21): 2859–2865.
296 Bioinformatics Ensemble Clustering for Biological Datasets 11
[7] Bezdek, J. C. [1981]. Pattern Recognition with Fuzzy Objective Function Algorithms, Kluwer
Academic Publishers, Norwell, MA, USA.
[8] Fisher, R. A. [1936]. The use of multiple measurements in taxonomic problems, Annals
Eugen. 7: 179–188.
[9] Frank, A. & Asuncion, A. [2010]. UCI machine learning repository.
URL: http://archive.ics.uci.edu/ml
[10] Fred, A. L. N. & Jain, A. K. [2005]. Combining multiple clusterings using evidence
accumulation, IEEE Transaction on Pattern Analysis and Machine Intelligence 27: 835–850.
[11] Galluccio, L., Michel, J.J., O., Comon, P., Hero, A. O. & Kliger, M. [2009]. Combining
multiple partitions created with a graph-based construction for data clustering,
Proceedings of IEEE International Workshop on Machine Learning for Signal Processing,
Grenoble, France, pp. –.
[12] Geraci, F., Leoncini, M., Montangero, M., Pellegrini, M. & Renda, M. E. [2009]. K-boost: a
scalable algorithm for high-quality clustering of microarray gene expression data, Journal
of Computational Biology 16(6): 859–873.
[13] Ghazalpour, A., Doss, S., Zhang, B., Wang, S., Plaisier, C., Castellanos, R., Brozell, A.,
Schadt, E. E., Drake, T. A., Lusis, A. J. & Horvath, S. [2006]. Integrating genetic and
network analysis to characterize genes related to mouse weight, PLoS Genetics 2(8).
URL: http://dx.plos.org/10.1371
[14] Ghouila, A., Yahia, S. B., Malouche, D., Jmel, H., Laouini, D., Guerfali, F. Z. & Abdelhak,
S. [2009]. Application of multi-som clustering approach to macrophage gene expression
analysis, Infection, Genetics and Evolution 9(3): 328–336.
[15] Glover, F. W. & Kochenberger, G. [2006]. New optimization models for data mining,
International Journal of Information Technology and Decision Making 5(4): 605–609.
[16] Gumus, E., Kursun, O., Sertbas, A. & Ustek, D. [2012]. Application of
canonical correlation analysis for identifying viral integration preferences, Bioinformatics
28(5): 651–655.
[17] Gungor, Z. & Unler, A. [2008]. K-harmonic means data clustering with tabu-search
method, Applied Mathematical Modelling 32(6): 1115–1125.
[18] He, Y. & Hui, S. C. [2009]. Exploring ant-based algorithms for gene expression data
analysis, Artificial Intelligence in Medicine 47(2): 105–119.
[19] Heath, J. W., Fu, M. C. & Jank, W. [2009]. New global optimization algorithms for
model-based clustering, Computational Statistics and Data Analysis 53(12): 3999–4017.
[20] Hore, P., Hall, L. O. & Goldgof, D. B. [2009]. A scalable framework for cluster ensembles,
Pattern Recognition 42(5): 676–688.
URL: http://dx.doi.org/10.1016/j.patcog.2008.09.027
[21] Hoshida, Y., Brunet, J. P., Tamayo, P., Golub, T. R. & Mesirov, J. P. [2007]. Subclass
mapping: Identifying common subtypes in independent disease data sets, PLoS ONE
2(11): 1195.
URL: http://dx.plos.org/10.1371
[22] Hu, X. & Yoo, I. [2004]. Cluster ensemble and its applications in gene expression analysis,
Proc. 2nd conference on Asia-Pacific bioinformatics (APBC’04), Australian Computer Society,
Inc., Darlinghurst, Australia, Australia, pp. 297–302.
[23] Hubert, L. & Arabie, P. [1985]. Comparing partitions, Journal of Classification 2: 193–218.
10.1007/BF01908075. URL: http://dx.doi.org/10.1007/BF01908075
[24] Huttenhower, C., Flamholz, A. I., Landis, J. N., Sahi, S., Myers, C. L., Olszewski, K. L.,
Hibbs, M. A., Siemers, N. O., Troyanskaya, O. G. & Coller, H. A. [2007]. Nearest neighbor
297Ensemble Clustering for Biological Datasets
12 Will-be-set-by-IN-TECH
networks: clustering expression data based on gene neighborhoods, BMC Bioinformatics
8(250): 1–13.
[25] Kim, J. & Choi, S. [2006]. Semidefinite spectral clustering, Pattern Recognition
39: 2025–2035.
[26] Langfelder, P., Zhang, B. & Horvath, S. [2008]. Defining clusters from a hierarchical
cluster tree: the dynamic tree cut package for r, Bioinformatics Applications Note
24(5): 719–720.
[27] Mangasarian, O. L. & Wolberg, W. H. [1990]. Cancer diagnosis via linear programming,
23(5): 1–18.
[28] Mitra, S., Das, R., Banka, H. & Mukhopadhyay, S. [2009]. Gene interaction - an
evolutionary biclustering approach, Information Fusion 10: 242–249.
[29] Newman, M. E. J. & Girvan, M. [2004]. Finding and evaluating community structure in
networks, Physical Review E 69(026113): 1–15.
[30] Phan, V., George, E. O., Tran, Q. T. & Goodwin, S. [2009]. Analyzing microarray data
with transitive directed acyclic graphs, Journal of Bioinformatics and Computational Biology
7(1): 135–156.
[31] Rousseeuw, P. [1987]. Silhouettes: A graphical aid to the interpretation and validation of
cluster analysis, Journal of Computational and Applied Mathematics 20(1): 53–65.
URL: http://dx.doi.org/10.1016/0377-0427(87)90125-7
[32] Saha, S. & Bandyopadhyay, S. [2009]. A new point symmetry based fuzzy
genetic clustering technique for automatic evolution of clusters, Information Sciences
179(19): 3230–3246.
[33] Tseng, G. C. [2007]. Penalized and weighted k-means for clustering with scattered
objects and prior information in high-throughput biological data, Bioinformatics
23(17): 2247–2255.
[34] Wang, S. & Zhu, J. [2008]. Variable selection for model-based high-dimensional clustering
and its application to microarray data, Biometrics 64(2): 440–448.
[35] Wang, T. [2009]. Comparing hard and fuzzy c-means for evidence-accumulation
clustering, Proceedings of the 18th international conference on Fuzzy Systems, FUZZ-IEEE’09,
IEEE Press, Piscataway, NJ, USA, pp. 468–473.
URL: http://dl.acm.org/citation.cfm?id=1717561.1717643
[36] Watts, D. J. & Strogatz, S. H. [1998]. Collective dynamics of ’small-world’ networks,
Nature 393(6684): 440–442.
URL: http://dx.doi.org/10.1038/30918





© 2012 Wang et al., licensee InTech. This is an open access chapter distributed under the terms of the 
Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits 
unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 
Research on Pattern Matching with  
Wildcards and Length Constraints:  
Methods and Completeness 
Haiping Wang, Taining Xiang and Xuegang Hu 
Additional information is available at the end of the chapter 
http://dx.doi.org/10.5772/48574 
1. Introduction 
The practical importance of the string matching problem should be obvious to everyone. For 
typical word-processing applications, immense amounts of work have been done on this 
subject. However, with the developments in bioinformatics (Cole et al., 2005), information 
retrieval (Califf et al., 2003), pattern mining (Xie et al., 2010; Ji et al., 2007; He et al., 2007), etc, 
sequential Pattern Matching with Wildcards and Length constraints (PMWL) has attracted 
more and more attention. It is not difficult to think up realistic cases where PMWL plays an 
important role. In Dan Gusfield’s book (Gusfield, 1997), they give an example about 
transcription factor to illustrate the concept of wildcard. A transcription factor is a protein that 
binds to specific locations in DNA and regulates the transcription of the DNA into RNA. In 
this way, production of the protein that the DNA codes for is regulated. Many transcription 
factors are found and can be separated into families characterized by specific substrings 
containing wildcards. They use Zinc Finger, a common transcription factor as an example. It 
has the following signature: 
CYS¢¢CYS¢¢¢¢¢¢¢¢¢¢¢¢¢HIS¢¢HIS 
Where CYS is the amino acid cysteine and HIS is the amino acid histidine. They also give a 
conclusion that if the number of wildcards is bounded by a fixed constant, the problem can 
be solved in linear time.  
Another respective example is about promoter. In bioinformatics, promoter will help 
researchers to quickly locate the starting position of the intron from hundreds of millions of 
the sequence of ACGT. Among these promoters, TATA box is a common one (Manber & 
Baeza-Yates, 1991). It has very loose sequence specificity, so many TATA sequences are not 
© 2012 Wang et al., licensee InTech. This is a p per distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
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TATA box. As a result, indirect positioning by pairs of sites is needed. The commonly used one 
is CAATCT sequence. The DNA sequence TATA is a common promoter that often occurs after 
the sequence CAATCT within 30-50 wildcards. Therefore, matching patterns with wildcards 
becomes especially crucial in exploring valuable information from DNA sequences. 
There are many applications that involve pattern matching with wildcards and various 
researches have provided many solutions to different forms of this problem. Fischer and 
Paterson were the first to generalized pattern matching with wildcards (Fischer & Paterson, 
1974): given a pattern P and a text T, either of which may contain wildcards, denoted by ¢, 
the goal is to locate all P’s occurrences in T. ¢ can match any letter in a given alphabet, such 
as a¢¢c¢t. Unlike previous work, Chen, et al. proposed a PMWL problem integrating two 
problems(Chen et al., 2006): one is complex local constraints which means the user can 
specify a different range of wildcards between each two consecutive letters of P, for 
example, a¢[0,3]c¢[1,3]t. Another one is global length constraints. The user can constrain the 
length of each matching substring of T in which P occurs. Therefore, flexible constraints of 
wildcards conduct flexible jump of the matching positions. The definition of PMWL 
problem is an extension of Fischer and Paterson’s definition and the introduction of complex 
local constraints increase the flexibility. On one hand, this definition of pattern is more 
suitable for areas such as bioinformatics; on the other hand, the size of the matching 
candidate positions is in the exponential increment which greatly increases the complexity 
of the problem solving. 
 
Figure 1. The flexibility and complexity of PMWL problem 
From a view of practical point, they also proposed two issues: with and without the one-off 
condition (Chen et al., 2006; Min et al., 2009). In their problem definition, users have more 
flexibility to search on sequences and the one-off condition has both theoretical and practical 
significance. One-off condition means that every letter in T can be used once at most. In 
practical applications, with and without the one-off condition has practical meaning in specific 
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areas. For example, in sequential pattern analysis in data mining, P can be treated as a 
candidate shopping pattern, the user is interested in how frequently P occurs in one document, 
it makes sense to count each occurrence for once, what is more, the one-off condition also 
makes the problem solving possible. However, under the one-off condition, how to allocate 
limited text resource to each matching occurrences, in order to obtaining the maximum 
number of occurrences, belongs to optimization problem. In the allocation of resources, the 
matching of different letters in the pattern possess a strong correlation, which conducts the 
selection of matching positions in the combination of explosive growth. Since it is difficult to 
develop a complete matching strategy in this problem, almost existed algorithms for PMWL 
are using greedy matching strategies, which is the root reason why matching algorithm is not 
complete. This article will focus on SAIL algorithm (Chen et al., 2006) which is a representative 
algorithm for PMWL problem and will also describe RSAIL (Wang et al., 2010), SBO (Wu et al., 
2011), BPBM (Guo et al., 2011) algorithm which are all designed to solve PMWL problem in 
different conditions. The each of above algorithms has its own characteristics in the data 
structures and matching strategies, which will be analyzed in this paper. 
What is more, since the theoretic and practical importance of the definition of PMWL, we 
need to research the nature of this problem. To our best knowledge, there are still no efficient 
methods on this problem, because as for completeness of the problem, we still do not know 
whether it could be solved in polynomial time. In this article, we will research the 
completeness of PMWL under certain condition. In the traditional matching problem, 
description of pattern and text information is the key to the algorithm design, however, 
flexibility and complexity of the PMWL problem all depends on the pattern features, so this 
article will focus on pattern information, especially the pattern features including the size of 
alphabet, the length of pattern, the gap of wildcards in the pattern, etc. We will also investigate 
the relationship between pattern features and completeness, and use the approximate ratio 
judgment. Further more, since the definition itself is produced in realistic background, we 
need to consider the situation in real biological background and improve the solution of the 
problem. Based on the above, we choose this topic as a research object in this book.  
This capture is organized as follows: In section 2 we will give the development, definition 
and application of PMWL problem; Section 3 will show the representative algorithms, we 
will introduce their structure, strategy, complexity and completeness; Section 4 will analyze 
the PMWL problem completeness based on pattern features. We will give our conclusions in 
section 5. 
2. Pattern matching with wildcards and length constraints 
The sequential pattern matching problem is to given a Text T and a pattern P as input, and 
output all the occurrences of P in T. After Fischer and Paterson’s work, there are a variety of 
non-standard definitions of the pattern matching problem: the approximate matching (He et 
al., 2007), the swapped matching (Amir et al., 2000), the Parameterized matching (Amir et 
al., 2009), etc. They all belong to Non-standard Stringology problem (Muthukrishnan, 1994). 
Many of them are still open problems. 
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2.1. The development of PMWL problem 
After years of development, these Non-standard Stringology problems always focus on a 
problem: that is, how to conduct the traditional pattern matching definition to be more 
flexible to adapt the development of application. The don’t cares problem always focus on 
how to combine the wildcards and the pattern. After Fischer and Paterson’s work, Cole et al. 
considered a slightly different problem (Cole et al., 2004), where instead of fixing the 
number of ¢s between two consecutive letters in P and T, they fixed the total number of ¢s in 
P. The disadvantage of these problem definitions is that the number of ¢s is a constant but 
not a range. This limits flexibilities for the user’s queries. To alleviate the problem of a fixed 
number of ¢s, Kucherov et al. (Kucherov et al., 1995) proposed a solution to allow an 
unbounded number of ¢s between two consecutive letters in a given pattern. Given a set of 
such patterns, their objective is to find whether any of these patterns matches some 
substring of the text that does not contain any ¢.Obviously, allowing an unbounded number 
of ¢s still does not offer the users enough flexibilities to control their queries. Manber et al. 
(Manber & Baeza-Yates, 1991) proposed an algorithm for string matching with a sequence of 
wildcards. They considered the following problem: given two pattern strings P and Q, each 
of which consists of letters, and an integer g, all occurrences of the form P¢0−gQ in the text are 
returned. The number of ¢s between P and Q is in the range of [0, g], and the text does not 
contain any ¢. This problem was so-called exact string matching with variable-length don’t 
cares. Chen et al. sum up all these definitions into three conditions (Chen et al., 2006): firstly, 
there is a wildcard between two consecutive letters in P, for example A¢[0,1]T¢[0,2]G¢[1,3]C; 
secondly, every letter in T can only be used once for matching; thirdly, there is a global 
constraint to limit the matching occurrence length. We call the problem satisfying above 
definition PMWL problem, which has been used in approximate matching, pattern mining, 
information retrieval, etc. 
2.2. The potential applications of the PMWL problem 
1. Text Indexing: There is a large amount of hypertext information on the Internet. How to 
effectively obtain information that meet users’ needs is becoming more and more 
urgent. Text indexing is a method to solve this problem. How to determine the position 
of user-specified pattern (may contain wildcards) is a challenge task. 
2. Data stream is becoming more and more crucial in many new database applications 
such as data warehouse and sensor network. Mining dependence or association in large 
amounts of data flow has practical value and during which the sequential pattern 
matching with wildcards is the first and the most important step. In addition, in data 
mining, sequential pattern mining also search frequent patterns as in transaction 
sequence, a typical instance is the similar consuming pattern of many consumers, for 
example, buying a desktop, a laser printer, a digital camera and an LCD screen monitor 
in turn, between each of them exists a certain time interval. Mining such typical user 
mode, which is obviously a pattern matching with wildcards, will has a great influence 
on the market. 
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3. Network Security: Pattern matching methods in network security and intrusion 
detection need high performance. A complete IDS (Intrusion Detection System) based 
on Snort rules needs to optimize hundreds of rules and many of them need to do 
pattern matching efficiently for the entire data partition of a package. Efficient pattern 
matching and mining with wildcards constraints give the system administrator a more 
flexible and accurate solution to locate the suspicious users. 
2.3. Problem statement for PMWL 
Definition 1 Let   be an alphabet, T = t0t1…tn-1 ∈ *  is called a text of   where n = |T| is the 
length of T. A pattern is a tuple P = (p, g) where p = p0p1…pm-1 is a sequence of characters, 
which belong to the alphabet  , and g = g0g1…gm-2 is a sequence of wildcards. And m = |P| is 
the length of P. The interval of wildcards between pi and pi+1 is denoted by gi = g(Ni, Mi) 
where 0 ≤ i ≤ m - 1, called the local constraints. Ni and Mi is the upper and lower limit of 
wildcard. Such as P = a¢[1,3]g, where 1, 3 is respectively the lower and upper limit of local 
constraints. ¢[1,3] means the wildcards between a and g is referring to a string which length 
is 1~3. Given interval [minLen, maxLen], set globalLength = t[am-1] - t[a0] +1, if globalLength 
∈[minLen, maxLen], then it is called global constraint (Chen et al., 2006). 
Definition 2 Given a pattern P = (p, g), p = p0p1…pm-1, gi = g(Ni, Mi). The max {Mi - Ni} where 0 
≤ i ≤ m - 1 is called the gap of local constraints, named Gap for short. For example, P = 
a¢[0,2]g¢[1,4]g, then gap = max{2 - 0, 4 - 1} = 3. 
PMWL problem can be defined by the above definition: 
Definition 3 PMWL problem (Pattern Matching with Wildcards and Length constraints) 
Pattern Matching with Wildcards and Length constraints meets the following conditions: 
1. ¢s can occur between each two consecutive letters in pattern and are independent to 
each other; 
2. ¢s between two consecutive letters can match a string which length is limited by local 
constraints, and the total length of pattern is limited by global constraint; 
3. One-off condition is taken into consideration that every letter in T can only be used once 
for matching pj (0 ≤ j ≤ m - 1) and as soon as there exists one occurrence of P in T when T 
is being scanned from left to right it will be returned. 
Definition 4 Given a text T and a pattern P, if there is a sequence of matching positions A = 
(a1, a2, …, am-1), where t[ai] = p[i] for every 0 1i m   , we say A is a matching occurrence of 
P. A set of occurrences A1, A2, ..., At constitute an occurrence set U where t is the number of 
occurrences, and also named matching number in our paper. 
Definition 5 Let t be the matching number of A, if there is no occurrence set A’ with the 
matching number t’, and t’ > t, then A is called a complete occurrence set. If there is another 
occurrence set U, with the matching number tu = t, the U is equivalent to A. Specially, if A is 
complete, and so is U. So the complete occurrence set is not always unique. 
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3. Algorithms for PMWL  
The results of traditional matching algorithm are complete, so the focus of research is to 
improve the matching efficiency. As a kind of searching problem, the key to solving 
matching problem is how to use and extract information getting from text and pattern. 
KMP, BM algorithm uses automata to describe the pattern characteristics, and deposit 
information obtained from scanning during matching process into automata. Algorithm 
visits the automata, when the jump distance needs to be calculated, thus to avoid obtaining 
the pattern information repeatedly and to ensure the jump in matching process does not 
affect the final result. The basic idea the suffix tree is to use the tree structure to describe the 
text information, and to avoid scanning the same text repeatedly when matching a set of 
patterns. We believe that data structure and search strategy are crucial for traditional 
algorithms to access to information of text and pattern. Reasonable data structure is better to 
explore the potential of the computer, such as bit parallel technology, and can also be a more 
reasonable representation of the sequence information, such as automata. In addition, there 
exist the sliding window, indexes and other data structures. Reasonable matching strategy 
makes better use of sequence information. These strategies can approximately be divided 
into prefix searching, suffix searching and factor searching (Navarro & Raffinot, 2001). 
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Table 1. Analysis of the traditional pattern matching algorithms 
 
Research on Pattern Matching with Wildcards and Length Constraints: Methods and Completeness 305 
As different extension of traditional matching problem, PMWL problem, approximate 
matching, and swap matching all belong to the Non-standard Stringology problem. Problems 
in this field mostly belong to the optimization problem, and most of them have not yet been 
completely solved, such as PMWL and approximate matching problems with wildcards etc. 
What PMWL and traditional matching problem have in common are: 
1. From the view of algorithm itself, the data structures and matching strategies are as the 
key of algorithm design.  
2. From the view of describing the object, how to effectively describe the patterns and text 
information is the key to solve the problem. 
What PMWL and traditional matching problem have in difference are: 
1. For PMWL, there is no complete solving yet, so algorithm evaluation criteria include 
both time efficiency and solution quality; but traditional matching algorithm is only 
concerned with matching time. 
2. The flexibility and complexity of the PMWL problem definition are reflected in the 
pattern, therefore, compared with traditional matching, PMWL pay more attention to 
the description of the pattern information. Pattern characteristics are extremely 
associated with the solution of PMWL problem. 
Next, we will give the representative algorithms for solving PMWL problem, and detailed 
description of their design ideas from the perspective of data structure and matching 
strategy. 
3.1. The SAIL Algorithm 
Description of SAIL Algorithm (Chen et al., 2006): 
Input: A text T = t0t1…tn-1, a pattern P = p0p1…pm-1, local constraints gi = g(Ni, Mi), global 
constraints [minLen, maxLen].  
Output: Occurrences of P in T satisfying the constraints. 
The Steps of the algorithm:  
1. Location: ① Search position i where t[i] = p[m-1], and locate position k where t[k] = p[0] 
by considering the global constraint. ② Cut out a substring in T from t[k] to t[i] named 
T’. ③ Build the table with the row and column according to T’ and P. 
2. Forward: Scan the table forward, and mark all the positions satisfying the local and 
global constraints. They are the potential matching positions. 
3. Backward: Scan the table backward, and select the left-most position in the marked cells 
every row that compose an occurrence. Then mark them used. 
Generally, SAIL starts from the beginning of T to search position i where t[i] = p[m-1]. After 
that, SAIL conducts two phases, the Forward phase and the Backward phase. In the Forward 
phase, SAIL determines whether there is a potential matching occurrence by using a search 
table. Afterwards, if a potential matching occurrence can be determined, Backward phase is 
triggered out to output an optimal occurrence by using the left-most strategy.  
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A running example for SAIL: 
In this subsection, we show how SAIL works with a running example where P, T and 
constraints are given as follows. 
 0 1 2 3 4 5 6 7 8 9 
T t t a a g g c c c c 
P a¢[0,1]g¢[0,1]c¢[0,1]c, minLen = 6, maxLen = 7 
Table 2. A running example for SAIL 
Step 1. Scan the P[m-1], that is the letter ‘c’, in T from left to right. The first matching 
position is 6, and then SAIL enters the Location phase. Use the global constraint [6, 7] to 
locate P[0]’s position, that is the letter ‘a’. We get the scanning range is [6-6, 7-6]. 
However there are no matching in [0, 1]. Then SAIL move on. 
Step 2. The second matching position is 7, and we can locate P[0] in position 2. Then we 
get the substring “aaggcc” from T. In this way global constraint is satisfied. 
Step 3. Build a 4×6 table. The row stand for character in P, and the column is the substring. 
Then set the position pos[3][5], pos[0][0] and pos[0][1] to 1. 
Step 4. Enter Forward and set all the positions to 1 in the table, which satisfy the local 
constraints. 
 
Positions in Text 






Table 3. The constructed search table pos[j][i-start] when P[m-1] is 7 
Step 5. Enter Backward and select the left-most one from the marked positions in each row, 
and they are highlighted. In this way, we will get an occurrence {2, 4, 6, 7} and mark the 
four positions used. 
Step 6. Go on to execute Location and get the third matching position is 8, then we can 
build the table below. Notice the positions of 6, 7 have been used. Under the one-off 
condition, all used positions (marked as * in Table) of T are never considered for further 
matching again. If the one-off condition is not considered, SAIL will get another two 
occurrences {2, 4, 6, 8} and {3, 5, 7, 9}. Then the Forward phase returns false, and SAIL go 
back to Location. 
Step 7. In position 9, the Forward also returns false. Finally, SAIL output only one 
occurrence {2, 4, 6, 7}. 
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Table 4. The constructed search table pos[j][i-start] when P[m-1] is 8 
The time complexity and completeness analysis: 
O(SAIL) = O(n + klmg) where n is the length of T, k is the frequency of P’s last letter 
occurring in T, l is the user-specified maximum length for each matching substring, m is the 
length of P, and g is the maximum gap of wildcards in P.  
Two important issues, Online searching and Optimization, are taken into consideration to 
design SAIL. As for optimization, under the one-off condition, SAIL determines which 
occurrence is an optimal one if multiple occurrences end at a P[m-1]’s position by applying 
the left-most strategy. As a heuristic algorithm, SAIL utilizes a kind of greedy strategy to 
select a set of occurrences; consequently, SAIL may obtain locally optimal solution which 
lead to losing occurrences in offline searching. 
Form the above example, we can know that a complete occurrence set for text T is {{2, 4, 6, 
8}, {3, 5, 7, 9}}, but SAIL’s output is {{2, 4, 6, 7}}. 
We believe that the SAIL’s data structure is based on the sliding window, the Location also 
uses the left-most strategy, so it is possible to lose occurrences, for instance: 
 
Figure 2. A sliding window in SAIL 
Obviously, in the above example, SAIL loses occurrences in offline condition because of the 
selection of character c’s matching position. For further observation, it is not difficult to find 
that character c appears in the pattern twice. If pattern is a¢[0,1]g¢[0,1]c, SAIL will get a 
complete occurrence set, that is, {{2, 4, 6},{3, 5, 7}}. Further experiments show that, the 
recurring appearances of pattern characters influence the quality of matching occurrences 
obtained by the algorithm. In next part, we will analyze the completeness of PMWL based 
on pattern features.  
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3.2. The RSAIL Algorithm 
Description of RSAIL Algorithm (Wang et al., 2010): 
Definition 6 Given a pattern P, if there are letters p[i] = p[j] where 0 ≤ i ≤ m-1,0 ≤ j ≤ m-1, P is 
called a pattern with Recurring characters, and R pattern in short, such as 
a¢[0,1]c¢[0,1]c¢[0,1]t. 
Definition 7 Given a pattern P, if all the letters in P are different, P is called a pattern with 
No-Recurring characters and NR Pattern for brevity, such as a¢[0,1]c¢[0,1]g¢[0,1]t. 
Definition 8 Given a pattern P, if there is a position i such that p[i] = p[i+1] =……= p[m-1] 
where 1 ≤ i < m-1, P is called a pattern with recurring tail characters and RT pattern in short. 
Such as a¢[0,1]c¢[0,1]c. As we can see, the RT pattern is a special form of the R pattern. 
From the above discussion, in the research of Chen et al., since they only concern about 
the on-line situation, their proof of SAIL’s completeness is incomplete, which is only 
suitable for the on-line situation. What is more, it ignores the interaction between different 
occurrences. 
We find that SAIL satisfies the completeness under a certain restriction, i.e. the pattern with 
no-recurring character (NR pattern), such as a¢[0, 1]t¢[0, 1]g¢[0, 1]c¢[0, 1]. The concept of 
NR pattern has practical significance, for example, in text mining, where the text is a 
sequence of words, the NR pattern reflects the semantic relation between words. 
We utilize the symmetry to scan the text and the pattern. Then convert an RT pattern into an 
R pattern.  
1. According to the characteristic of P, if it is not an RT pattern, we directly call SAIL; 
otherwise go to (2); 
2. Reverse T and P, respectively get T’, P’; 
3. Call SAIL, and obtain the occurrences of P’ in T’; 
4. Obtain the occurrences of P in T by coordinate transformation of the obtained solution. 
Obviously, since the time of the identification of pattern’s characteristics is linear, O (RSAIL) 
= O (SAIL). 
Experiments and Analysis: 
We will give a set of experiments to illustrate two problems: 
1. Analysis of the complete extent of the SAIL algorithm; 
2. The comparison of the complete extent of RSAIL and SAIL algorithm; 
Considering there is no algorithm can obtain the completeness occurrences of PMWL 
problem in polynomial time, we have developed a text generator (Xie et al., 2010) to 
generate experimental text, by which way we can know the completeness occurrences in 
order to analyze the complete extent of algorithm. In addition, the patterns used in these 
experiments are all RT patterns. 
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 Experiment1 Experiment 2 Experiment 3 Experiment 4 
Size of alphabet ∑ 4 4 4 7 
Length of pattern m 3 4 5 5 
gap 0~30 0~30 0~30 0~30 
Table 5. The parameters in the experiments. 
The experimental results and analysis: 
 
Figure 3. The approximate ratio experimental results of RSAIL and SAIL 
From the above images, SAIL itself is already a near-complete algorithm, in the above 
graphs, the average approximation ratio of SAIL is higher than 0.94;For the RT patterns, 
the completeness of RSAIL is better than SAIL in different  , m and gap. Thus, not only a 
revised algorithm is obtained, the SAIL’s deficiency on handling RT patterns is also 
proved from another aspect. 
3.3. The BPBM Algorithm 
Description of BPBM Algorithm (Guo et al., 2011): 
Like the SAIL algorithm, the BPBM algorithm also focuses on pattern matching in online 
sequential text with both flexible gap constraints by user’s specification and the one-off 
condition. BPBM is based on bit-parallel technology to simulate the matching process and 
adopt two nondeterministic finite state automatons (NFAs). One is a search mechanism to 
identify all pattern P’s suffix, and another one is a security window transition mechanism 
which accelerates the scanning process by dropping useless sequences in text.  
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3.2. The RSAIL Algorithm 
Description of RSAIL Algorithm (Wang et al., 2010): 
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1. According to the characteristic of P, if it is not an RT pattern, we directly call SAIL; 
otherwise go to (2); 
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Experiments and Analysis: 
We will give a set of experiments to illustrate two problems: 
1. Analysis of the complete extent of the SAIL algorithm; 
2. The comparison of the complete extent of RSAIL and SAIL algorithm; 
Considering there is no algorithm can obtain the completeness occurrences of PMWL 
problem in polynomial time, we have developed a text generator (Xie et al., 2010) to 
generate experimental text, by which way we can know the completeness occurrences in 
order to analyze the complete extent of algorithm. In addition, the patterns used in these 
experiments are all RT patterns. 
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From the above images, SAIL itself is already a near-complete algorithm, in the above 
graphs, the average approximation ratio of SAIL is higher than 0.94;For the RT patterns, 
the completeness of RSAIL is better than SAIL in different  , m and gap. Thus, not only a 
revised algorithm is obtained, the SAIL’s deficiency on handling RT patterns is also 
proved from another aspect. 
3.3. The BPBM Algorithm 
Description of BPBM Algorithm (Guo et al., 2011): 
Like the SAIL algorithm, the BPBM algorithm also focuses on pattern matching in online 
sequential text with both flexible gap constraints by user’s specification and the one-off 
condition. BPBM is based on bit-parallel technology to simulate the matching process and 
adopt two nondeterministic finite state automatons (NFAs). One is a search mechanism to 
identify all pattern P’s suffix, and another one is a security window transition mechanism 
which accelerates the scanning process by dropping useless sequences in text.  
 
Bioinformatics 310 
BPBM has following characteristics: 
1. BPBM also uses the left-most strategy to obtain the maximal occurrence of pattern in 
text, and return all these matching position sequences. This algorithm combines bit-
parallel technology with nondeterministic finite state automatons. It also simplifies the 
calculation of shift distance of the security window transition, which gets good results. 
BPBM inherits the advantage of BM algorithm to skip some of characters in text, which 
conducts the algorithm with a sub linear average time complexity. Therefore, the time 
complexity of BPBM is lower compared to SAIL. 
2. Compared with Gaps-Shift-And algorithm and Gaps-BNDM algorithm, since they are 
all based on bit-parallel technology, their time performances are equal, however, 
because BPBM improves the formula of ε-transition in matching process, BPBM is fit for 
all patterns. In addition, BPBM returns a concrete set of matching position sequence, 
which makes it more applicable.  
3. Compared with SAIL, SAIL applies two-dimensional table as data structure, but BPBM 
is base on bit-parallel technology. Since the difference in data structure, BPBM has a 
better time performance. The similarity between these two algorithms is they all utilize 
the left-most strategy, therefore, they are all heuristic algorithm with greedy strategy. In 
addition, the matching occurrences of these two algorithms are same and both 
incomplete. 
3.4. The SBO Algorithm 
Description of BPBM Algorithm (Wu et al., 2011): 
Wu et al. propose a new nonlinear structure called Nettree to deal with pattern matching 
with flexible constraints of wildcards. A Nettree is a kind of directed acyclic graph (DAG) 
with edge labels. They apply a heuristic algorithm to select better occurrence (SBO). In this 
algorithm, they use two strategies: Strategy of Greedy-Search Parent, SGSP and Strategy of 
right-most Parent, SRMP to two occurrences of the same leaf, and select the better one as 
occurrence. The core idea of SGSP is finding an approximately optimal parent (AOP) of 
current node in each step; while the core idea of SRMP is finding the right-most parent node 
of current node in each step.  
In off-line conditions, owing to its heuristic strategy, SBO can obtain more occurrences than 
SAIL and BPBM in most cases, but it is still incompleteness. However, the time complexity 
of SBO algorithm is O(gap*n*(n+m2)) which is nonlinear of length of text. Further more, 
experiments show that, in general, SBO indeed consumes more time than SAIL. In SBO, the 
improvement of solution’s quality is relying on using heuristic strategies repeatedly, and 
this also consumes a lot of time. Therefore, we need consider the balance between 
completeness and time efficiency of algorithm. What is more, SAIL originally is not 
designed for off-line condition, as an on-line algorithm, it only has current information, so 
when applying it to off-line matching it will definitely be imperfect. But SBO uses global 
information to search occurrences, it also uses heuristic strategies to search on solution 
space. With the improvement of occurrences’ quality, there are two problems: more 
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information need more place to store, so the space complexity of SBO is O(gap*m*n), the next 
one is more information means more calculations thus consuming more time. 
3.5. Other algorithms 
In many literatures, similar problems are defined and various algorithms are put out to 
solve certain problems. Morgante, et al. (Morgante, et al., 2004) described a structured 
model, which can be considered as ‘compound patterns’ made of a list of simple motifs and 
a list of intervals that specify at what distances adjacent motifs should occur. They gave a 
detailed description of the biological background of the problem definition. For example, 
many retrotransposons belonging to the Ty1-copia group contain a match of 
MT¢[115,136]MTNTAYGG¢[121,151]GTNGAYGAY, which consists of three patterns and 
two intervals. As the paper pointed out, structured motifs are called classes of Characters 
and Bounded Gaps (CBG) expressions in Navarro and Raffinot, but use of these expressions 
is quite different: the underlying motivation for CBG expressions is searching in database 
like PROSITE and a sequence of this kind is usually not very long, while structured motifs 
can be very long since gaps may span many letters. As we can see, the concept of CBG and 
structured motifs are all have practical meaning. Because of the different application 
background, they design different algorithms to solve their problems. From the application 
point, this paper also considered a problem of q-approximation match which means just 
finding partial motifs in the sequence. In this paper, they proposed a two-step procedure 
which is used in many algorithms for PMWL: firstly, finding the occurrences of all the 
component patterns; secondly, combining the occurrences that satisfy the distance 
constraints into a structured motif. For step two, they gave a detailed algorithm to build a 
directed acyclic graph according to the positions of the component patterns and interval 
constraints. Then they discussed how to output all the occurrences in detail. In (Rahman et 
al., 2006), the definition of their problem likes SAIL, but they don’t consider global 
constraints and the one-off searching. In addition, just like paper (Chen et al., 2006), the local 
constraints exist between two substrings, while in SAIL, exist between any two consecutive 
letters. Certainly, a single character is a substring, but in this paper, all these substrings are 
used to build an AC automaton. It is not efficient to build a Trie structure over a set of single 
letters. This paper also used a two-step procedure: firstly using AC automaton to get 
occurrences of each sub-patterns in orders and combine them. They built an implicit graph, 
in which vertices are partitioned into several sets in order according to the corresponding 
sub-pattern and edges between two consecutive sets means two positions in these two 
consecutive sets fit corresponding local constraints. To output all P in T, we have to 
enumerate all possible paths in the implicit directed graph which length is the number of 
sub-patterns in the pattern. Morgante, et al. (Morgante, et al., 2004) applied a revised depth 
first searching algorithm. Philip Bille et al. (Bille et al., 2010) defined a concept named 
variable length gap (VLG) which is a pattern formed by a sequence of strings and variable 
length gaps. Obviously, this definition is almost the same with above works. Unlike 
Rahman’s work, although this paper also applies AC automaton, it maintains a sorted list 
containing the ranges defined by previously reported relevant occurrences, and naturally it 
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BPBM has following characteristics: 
1. BPBM also uses the left-most strategy to obtain the maximal occurrence of pattern in 
text, and return all these matching position sequences. This algorithm combines bit-
parallel technology with nondeterministic finite state automatons. It also simplifies the 
calculation of shift distance of the security window transition, which gets good results. 
BPBM inherits the advantage of BM algorithm to skip some of characters in text, which 
conducts the algorithm with a sub linear average time complexity. Therefore, the time 
complexity of BPBM is lower compared to SAIL. 
2. Compared with Gaps-Shift-And algorithm and Gaps-BNDM algorithm, since they are 
all based on bit-parallel technology, their time performances are equal, however, 
because BPBM improves the formula of ε-transition in matching process, BPBM is fit for 
all patterns. In addition, BPBM returns a concrete set of matching position sequence, 
which makes it more applicable.  
3. Compared with SAIL, SAIL applies two-dimensional table as data structure, but BPBM 
is base on bit-parallel technology. Since the difference in data structure, BPBM has a 
better time performance. The similarity between these two algorithms is they all utilize 
the left-most strategy, therefore, they are all heuristic algorithm with greedy strategy. In 
addition, the matching occurrences of these two algorithms are same and both 
incomplete. 
3.4. The SBO Algorithm 
Description of BPBM Algorithm (Wu et al., 2011): 
Wu et al. propose a new nonlinear structure called Nettree to deal with pattern matching 
with flexible constraints of wildcards. A Nettree is a kind of directed acyclic graph (DAG) 
with edge labels. They apply a heuristic algorithm to select better occurrence (SBO). In this 
algorithm, they use two strategies: Strategy of Greedy-Search Parent, SGSP and Strategy of 
right-most Parent, SRMP to two occurrences of the same leaf, and select the better one as 
occurrence. The core idea of SGSP is finding an approximately optimal parent (AOP) of 
current node in each step; while the core idea of SRMP is finding the right-most parent node 
of current node in each step.  
In off-line conditions, owing to its heuristic strategy, SBO can obtain more occurrences than 
SAIL and BPBM in most cases, but it is still incompleteness. However, the time complexity 
of SBO algorithm is O(gap*n*(n+m2)) which is nonlinear of length of text. Further more, 
experiments show that, in general, SBO indeed consumes more time than SAIL. In SBO, the 
improvement of solution’s quality is relying on using heuristic strategies repeatedly, and 
this also consumes a lot of time. Therefore, we need consider the balance between 
completeness and time efficiency of algorithm. What is more, SAIL originally is not 
designed for off-line condition, as an on-line algorithm, it only has current information, so 
when applying it to off-line matching it will definitely be imperfect. But SBO uses global 
information to search occurrences, it also uses heuristic strategies to search on solution 
space. With the improvement of occurrences’ quality, there are two problems: more 
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information need more place to store, so the space complexity of SBO is O(gap*m*n), the next 
one is more information means more calculations thus consuming more time. 
3.5. Other algorithms 
In many literatures, similar problems are defined and various algorithms are put out to 
solve certain problems. Morgante, et al. (Morgante, et al., 2004) described a structured 
model, which can be considered as ‘compound patterns’ made of a list of simple motifs and 
a list of intervals that specify at what distances adjacent motifs should occur. They gave a 
detailed description of the biological background of the problem definition. For example, 
many retrotransposons belonging to the Ty1-copia group contain a match of 
MT¢[115,136]MTNTAYGG¢[121,151]GTNGAYGAY, which consists of three patterns and 
two intervals. As the paper pointed out, structured motifs are called classes of Characters 
and Bounded Gaps (CBG) expressions in Navarro and Raffinot, but use of these expressions 
is quite different: the underlying motivation for CBG expressions is searching in database 
like PROSITE and a sequence of this kind is usually not very long, while structured motifs 
can be very long since gaps may span many letters. As we can see, the concept of CBG and 
structured motifs are all have practical meaning. Because of the different application 
background, they design different algorithms to solve their problems. From the application 
point, this paper also considered a problem of q-approximation match which means just 
finding partial motifs in the sequence. In this paper, they proposed a two-step procedure 
which is used in many algorithms for PMWL: firstly, finding the occurrences of all the 
component patterns; secondly, combining the occurrences that satisfy the distance 
constraints into a structured motif. For step two, they gave a detailed algorithm to build a 
directed acyclic graph according to the positions of the component patterns and interval 
constraints. Then they discussed how to output all the occurrences in detail. In (Rahman et 
al., 2006), the definition of their problem likes SAIL, but they don’t consider global 
constraints and the one-off searching. In addition, just like paper (Chen et al., 2006), the local 
constraints exist between two substrings, while in SAIL, exist between any two consecutive 
letters. Certainly, a single character is a substring, but in this paper, all these substrings are 
used to build an AC automaton. It is not efficient to build a Trie structure over a set of single 
letters. This paper also used a two-step procedure: firstly using AC automaton to get 
occurrences of each sub-patterns in orders and combine them. They built an implicit graph, 
in which vertices are partitioned into several sets in order according to the corresponding 
sub-pattern and edges between two consecutive sets means two positions in these two 
consecutive sets fit corresponding local constraints. To output all P in T, we have to 
enumerate all possible paths in the implicit directed graph which length is the number of 
sub-patterns in the pattern. Morgante, et al. (Morgante, et al., 2004) applied a revised depth 
first searching algorithm. Philip Bille et al. (Bille et al., 2010) defined a concept named 
variable length gap (VLG) which is a pattern formed by a sequence of strings and variable 
length gaps. Obviously, this definition is almost the same with above works. Unlike 
Rahman’s work, although this paper also applies AC automaton, it maintains a sorted list 
containing the ranges defined by previously reported relevant occurrences, and naturally it 
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uses the left-most strategy to count an occurrence as soon as it appears. Haapasalo et al. 
(Haapasalo et al., 2011) extended the usual dictionary matching problem to the case in 
which patterns may include single wildcards, or wildcard strings of variable length with 
fixed or unlimited upper bound. And their algorithm is designed for on-line matching: the 
text is scanned only once, and the matches for all patterns are reported at the point of 
occurrence. Firstly, they constructed an AC PMA (pattern matching automaton) with output 
tuples identifying the keywords of the patterns to be matched. The idea in their algorithm is 
that they recognize keywords by the PMA and check whether or not a newly found 
keyword forms a continuation of a pattern prefix found thus far. 
3.6. Discussion 
Because of the complexity of the PMWL problem definition, we believe that the matching 
occurrence of PMWL problem is with high degrees of freedom. In traditional matching 
problem with fixed-length wildcard, the positions of each match in the same set of the 
matching occurrence are relatively fixed to each other. Therefore, to determine the position 
of any one character, a set of matching occurrences have been identified. We believe that 
matching of each character in above problem has a strong correlation. For instance, in 
pattern a¢g¢¢c, p[2] – p[1] = 1, p[3] – p[2] = 2. However, for pattern in PWML, matching 
positions of adjacent characters are bounded by local constraints, which means matching of 
each character has a weak correlation, and to determine the positions of all characters, a set 
of matching occurrences could have been identified, that is, freedom degree of matching 
increases. This is an important factor leads to  the complexity of the PMWL problem, which 
greatly increases the difficulties of searching process in matching algorithms. In order to get 
a complete solution, a lot of backtracking operation are required, making it difficult to be 
completed in polynomial time, therefore, almost all PMWL algorithms use greedy strategies 
in matching process. This is destined to incomplete results. However, on the other hand, 
although the above algorithms are not complete, we find that when length of pattern is 
shorter than 6, the approximation ratio of these algorithms are more than 0.9. Consequently, 
the next work can be considered form two aspects: 1, based on SAIL algorithm etc, 
improving the time efficiency, like BPBM; 2, designing algorithm for PMWL under certain 
conditions, such as RSAIL’s work for RT pattern. We believe that the pattern features, data 
structures and matching strategies will continue to be the center for PMWL algorithm 
design. 
 











Data structure Sliding window Sliding window Bit-parallel  Nettree 
Time consumption All polynomial time and SBO > RSAIL = SAIL > BPBM 
Completeness All incompleteness, in general SBO > RSAIL > SAIL = BPBM 
Table 6. The strategy, structure, time consumption and completeness of PMWL methods 
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4. Analysis of PMWL based on pattern features 
In the traditional matching problems, how to search pattern in text much faster as well as 
the correlation between pattern and text are paid more attention. But the characteristics of 
the pattern itself are paid little direct attention, because traditional matching problems can 
always have complete occurrences. The main characteristic of PMWL is with flexible 
wildcards, which leads to a large number of candidate matching positions. And the conflict 
between these occurrences will cause the final output incompleteness. However, our 
research shows that the direct cause which impacts PMWL incompleteness is not wildcards; 
it is the pattern characteristics directly conduct PMWL incompleteness. This is much 
different from traditional matching problems. 
4.1. The impact of the alphabet, the length of pattern and the gap on 
completeness 
In the traditional pattern matching research, the length of pattern and the size of alphabet 
are key elements influencing time complexity when analyzing traditional matching 
problems. Taking into account PMWL problem definition, upper and lower limits of the 
length constraints probably affect problem solving. Especially, instead of upper and lower 
limits themselves, the distance between the upper and lower limits, that is gap, are taken 
into consideration. Therefore, the parameters related to the algorithm completeness may be 
the size of alphabet, the length of pattern and distance between the upper and lower limits, 
denoted as Σ, m, and gap respectively. In this article, the approximate degree of 
completeness of the algorithm will be measured by approximation ratio ε. Consequently, we 
try to build following model: 
 ε = F (Σ, m, gap) (1) 
Taking into account that the size of Σ is determined in a specific area, for example, in 
bioinformatics, DNA sequences can be defined on Σ = {a, c, g, t}, the above formula can be 
simplified as ε = F (m, gap). In experiment project, input text is a biology DNA sequence, so 
Σ = {a, c, g, t}. Then the remaining parameter values are as follows: gap ∈ [1, 30], m ∈ [3, 9], 
consequently, there are 30*7 = 210 groups of experiments. The aim is to find approximation 
ratio ε. 
Firstly, pattern P is generated randomly by pattern generator according to Σ, m, and gap. For 
example, when m = 5, Σ = {a, c, g, t}, gap = 2, a¢[0,2]c¢[0,2]c¢[0,2]t¢[0,2]g is a qualified pattern. 
For simplicity, in generated patterns, each two consecutive characters have the same length 
constraints i.e. gap. Then, what needs to be done is calculating approximate ratio ε for each 
pattern. Since ε = N(UALG) / N(Uopt), we need to know N(Uopt). However, it is not desirable to 
directly solve this from a text T, since there is no any known algorithm to obtain the 
completeness solution. If we use a simple brute-force, the exponential time will be need. 
Therefore, we have developed a text generator, which can generate text T according to P and 
N(UALG). In addition, SAIL algorithm is currently regarded as the most representative 
algorithm for PMWL problem, since SAIL firstly adopts the left-most strategy which is 
 
Bioinformatics 312 
uses the left-most strategy to count an occurrence as soon as it appears. Haapasalo et al. 
(Haapasalo et al., 2011) extended the usual dictionary matching problem to the case in 
which patterns may include single wildcards, or wildcard strings of variable length with 
fixed or unlimited upper bound. And their algorithm is designed for on-line matching: the 
text is scanned only once, and the matches for all patterns are reported at the point of 
occurrence. Firstly, they constructed an AC PMA (pattern matching automaton) with output 
tuples identifying the keywords of the patterns to be matched. The idea in their algorithm is 
that they recognize keywords by the PMA and check whether or not a newly found 
keyword forms a continuation of a pattern prefix found thus far. 
3.6. Discussion 
Because of the complexity of the PMWL problem definition, we believe that the matching 
occurrence of PMWL problem is with high degrees of freedom. In traditional matching 
problem with fixed-length wildcard, the positions of each match in the same set of the 
matching occurrence are relatively fixed to each other. Therefore, to determine the position 
of any one character, a set of matching occurrences have been identified. We believe that 
matching of each character in above problem has a strong correlation. For instance, in 
pattern a¢g¢¢c, p[2] – p[1] = 1, p[3] – p[2] = 2. However, for pattern in PWML, matching 
positions of adjacent characters are bounded by local constraints, which means matching of 
each character has a weak correlation, and to determine the positions of all characters, a set 
of matching occurrences could have been identified, that is, freedom degree of matching 
increases. This is an important factor leads to  the complexity of the PMWL problem, which 
greatly increases the difficulties of searching process in matching algorithms. In order to get 
a complete solution, a lot of backtracking operation are required, making it difficult to be 
completed in polynomial time, therefore, almost all PMWL algorithms use greedy strategies 
in matching process. This is destined to incomplete results. However, on the other hand, 
although the above algorithms are not complete, we find that when length of pattern is 
shorter than 6, the approximation ratio of these algorithms are more than 0.9. Consequently, 
the next work can be considered form two aspects: 1, based on SAIL algorithm etc, 
improving the time efficiency, like BPBM; 2, designing algorithm for PMWL under certain 
conditions, such as RSAIL’s work for RT pattern. We believe that the pattern features, data 
structures and matching strategies will continue to be the center for PMWL algorithm 
design. 
 











Data structure Sliding window Sliding window Bit-parallel  Nettree 
Time consumption All polynomial time and SBO > RSAIL = SAIL > BPBM 
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4. Analysis of PMWL based on pattern features 
In the traditional matching problems, how to search pattern in text much faster as well as 
the correlation between pattern and text are paid more attention. But the characteristics of 
the pattern itself are paid little direct attention, because traditional matching problems can 
always have complete occurrences. The main characteristic of PMWL is with flexible 
wildcards, which leads to a large number of candidate matching positions. And the conflict 
between these occurrences will cause the final output incompleteness. However, our 
research shows that the direct cause which impacts PMWL incompleteness is not wildcards; 
it is the pattern characteristics directly conduct PMWL incompleteness. This is much 
different from traditional matching problems. 
4.1. The impact of the alphabet, the length of pattern and the gap on 
completeness 
In the traditional pattern matching research, the length of pattern and the size of alphabet 
are key elements influencing time complexity when analyzing traditional matching 
problems. Taking into account PMWL problem definition, upper and lower limits of the 
length constraints probably affect problem solving. Especially, instead of upper and lower 
limits themselves, the distance between the upper and lower limits, that is gap, are taken 
into consideration. Therefore, the parameters related to the algorithm completeness may be 
the size of alphabet, the length of pattern and distance between the upper and lower limits, 
denoted as Σ, m, and gap respectively. In this article, the approximate degree of 
completeness of the algorithm will be measured by approximation ratio ε. Consequently, we 
try to build following model: 
 ε = F (Σ, m, gap) (1) 
Taking into account that the size of Σ is determined in a specific area, for example, in 
bioinformatics, DNA sequences can be defined on Σ = {a, c, g, t}, the above formula can be 
simplified as ε = F (m, gap). In experiment project, input text is a biology DNA sequence, so 
Σ = {a, c, g, t}. Then the remaining parameter values are as follows: gap ∈ [1, 30], m ∈ [3, 9], 
consequently, there are 30*7 = 210 groups of experiments. The aim is to find approximation 
ratio ε. 
Firstly, pattern P is generated randomly by pattern generator according to Σ, m, and gap. For 
example, when m = 5, Σ = {a, c, g, t}, gap = 2, a¢[0,2]c¢[0,2]c¢[0,2]t¢[0,2]g is a qualified pattern. 
For simplicity, in generated patterns, each two consecutive characters have the same length 
constraints i.e. gap. Then, what needs to be done is calculating approximate ratio ε for each 
pattern. Since ε = N(UALG) / N(Uopt), we need to know N(Uopt). However, it is not desirable to 
directly solve this from a text T, since there is no any known algorithm to obtain the 
completeness solution. If we use a simple brute-force, the exponential time will be need. 
Therefore, we have developed a text generator, which can generate text T according to P and 
N(UALG). In addition, SAIL algorithm is currently regarded as the most representative 
algorithm for PMWL problem, since SAIL firstly adopts the left-most strategy which is 
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applied in different situations and technologies such as BPBM(Guo et al., 2011) algorithm 
and the mining algorithm MAIL(Xie et al., 2010). Based on the above analysis, we have SAIL 
as a research object, that is, N(UALG) = N(USAIL).  
In summary, the concrete steps of the experiment are as follows: 
1. For given Σ, m and gap, 100 patterns pi are generated randomly, where i = 1, 2,.., 100; 
2. For pattern pi, given N(Uopt) = 100, text length n = 2000, generate text Ti; 
3. For Ti, call SAIL algorithm to get N(USAIL); 
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 Experiment1 Experiment 2 
∑ 4 7 
m 3~9 3~9 
gap 1~29 1~29 
Table 7. Parameters in experiments for ε = F (gap) 
The experimental results： 
 
Figure 4. Curves of ε = F (gap) in experiment 1 
By the figure 4, as m increases, ε is gradually decreasing. As the gap increases, the trend of ε 
is decreasing first and then increases, especially when gap = 1 and ε = 1, since the left-most 
strategy can obtain a complete occurrence set. With the increase of gap, ε begin to decline 
because when the gap is becoming greater, the probability of matching occurrences overlap 
is becoming greater and the algorithm is becoming more easily to lose occurrences; when 
gap is sufficient, although matching occurrences are still overlap, greater gap reserve enough 
space for matching, making the remaining occurrences which have not yet been still have 
enough resources. Moreover, it is worth noting that the minimum of these curves can be 
reached when gap is about 7, and have nothing to do with the pattern length.  
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Figure 5. Curves of ε = F (gap) in experiment 2 
In figure 5, the trend of curves is the same as in figure 4. The difference between them is 
curves in figure 5 reach the minimum when gap is about 9~11. It can be found that the impact 
of Σ, m, and gap on the curves is that the change of gap determines the trend of the curve, m 
affects the magnitude of this change, and Σ makes the curve do translational move.  
 






























































































































Table 8. Parameters in mathematic model 
 
Bioinformatics 314 
applied in different situations and technologies such as BPBM(Guo et al., 2011) algorithm 
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2. For pattern pi, given N(Uopt) = 100, text length n = 2000, generate text Ti; 
3. For Ti, call SAIL algorithm to get N(USAIL); 
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After a series of experiments, we speculate that ε = A*gap4+ B*gap3+ C*gap2+ D*gap +E, where 
A, B, C, D and E are parameters and for different m there are different parameters. We try to 
use this model to illustrate the relation between gap and approximation ratio ε. 
Use this parameter table, some of illustrations for m = 3, 4……14 are listed below, where 
horizontal axis is the gap, vertical axis is the ε. 
 
Figure 6. Model fitting 
We believe this model can be used to predict the completeness of solutions given a certain 
pattern. For example, given m = 10, Σ = {a, c, g, t}, gap = 5, this model shows the prediction of 
approximation ratio ε of SAIL algorithm is about 0.878. Therefore, this model can be used in 
pattern mining showed as below. 
PMWL pattern mining evaluation mechanism 
Input: Given T, Σ, m, gap, support sup 
Output: pattern P 
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As we know, mining algorithm strategy is to learn from the strategy of matching algorithm, 
so PMWL pattern mining problem is naturally based on PMWL matching problem. For 
example, in mining algorithm MAIL (Xie et al., 2010), although a graph structure is utilized 
which conducts it different from SAIL; it is still based on the left-most strategy. As a result, 
they have the same degree of completeness. Therefore, our model can propose an evaluation 
mechanism for mining. 
4.2. The impact of pattern rep on completeness 
In next part, we will put forward another important concept, named rep, and analyze its 
impact on completeness. We first give an example to illustrate the reason why this concept is 
needed. Given m = 4, Σ = {a, c, g, t}, gap = 2, the corresponding patterns maybe P1 = 
a¢[0,2]c¢[0,2]g¢[0,2]t or P2 = a¢[0,2]c¢[0,2]c¢[0,2]t. They have the same Σ, m and gap. 
However, when applying SAIL or BPBM, the completeness of solutions is not the same, 
since for P1 algorithms can obtain complete solutions while for P2 can not. 




 0 1 2 3 4 5 6 
T b c b b b c c 
P b¢[1,2] b¢[1,2]c  
Table 9. Example 1 for rep concept 
A complete occurrence set of this example is {{0, 3, 5}, {2, 4, 6}}, the number of matching 
occurrences is 2. It is not difficult to find that, in SAIL algorithm, for position 5, the selection 
of position 2 as p[1]’s occurrence by the left-most strategy will consume the position for the 
next matching occurrence. We can guess that, the recurring 'b' character in this pattern affect 
the quality of matching occurrences. 
 
 
 0 1 2 3 4 5 
T a a c c c c 
P a¢[0,1] c¢[0,1]c 
 
Table 10. Example 1 for rep concept 
In this example, A complete occurrence set is {{0, 2, 4}, {1, 3, 5}}, the number of matching 
occurrences is 2. If we use SAIL algorithm and first obtain {0, 2, 3}, then we will only get this 
occurrence and lose {0, 2, 4}, {1, 3, 5}. Obviously, the recurring 'b' character in this pattern 
affects the completeness. 
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From above examples, the matching of recurring character in the pattern may determine the 
completeness of the algorithm. As a result, we consider this repeatability as an element to 
influence the completeness. 
In order to quantify the repeatability, the concept of repeatability, rep, is proposed in this 
paper. 
Definition 9 Given a pattern P = p0p1…pm-1, let fij = (pi, pj) be all binary combinations of 




















   , where 0 ≤ i, j ≤ m-1, and i ≠ j. then rep is the 
repeatability of characters in pattern. It shows the number of pairs of the same characters in 
pattern. 
Definition 10 Given occurrences A and S, if a[i] = s[k] where 0 ≤ i ≤ m-1, 0 ≤ k ≤ m-1, we say A 
conflicts with S. For example, T = aacccc, P = a¢[0,1]c¢[0,1]c, {0,2,3} conflicts with {0,2,4} and 
{1,3,5}. And “c” is the conflict letter.  
For simplicity, global length constraint is deliberately ignored in our proof, and it does not 
affect the conclusion. 
LEMMA 1 Given two occurrences A, S, if A and S come from the same occurrence set, then 
a[i] ≠ s[k] where 0 ≤ i ≤ m-1, 0 ≤ k ≤ m-1.  
Proof: Assume a[i] = s[k], then A conflicts with S, so they can not belong to the same set. The 
contradiction is achieved. Lemma 1 is proved.  
LEMMA 2 Given two occurrences A and S where S∈USAIL. If there is a conflict between A 
and S, and let a[t] and s[i] be the conflict positions. According to the definition 10, under the 
one-off condition, A should be discarded. Moreover, if i = t, then s[i] = a[i]; if i ≠ t, s[i] < a[i] 
where 0 ≤ i ≤ m-1. For instance, S = {0, 2, 3}, A = {1, 2, 4}, for s[1] = a[1], the conflict position is 
1, and the other positions satisfy s[0] < a[0], s[2] < a[2]. 
Proof: Assume s[i] > a[i], then a[i] is in the left of s[i] in T. In accordance with the left-most 
strategy of SAIL, the left-most one prior to others is selected, which is a[i]. Due to the issue, 
S∈USAIL, so s[i] should be selected. The contradiction is achieved. Thus, s[i] ≤ a[i]. If i = t, s[i] = 
a[t] = a[i], and if i ≠ t, s[i] = a[t] ≠ a[i]. It is obvious to concluded that s[i] < a[i]. 
LEMMA 3 Given a text T, a pattern P and an occurrence S. Let USAIL be the occurrence set of 
SAIL. If S ∉ USAIL, S conflicts with at least one occurrence in USAIL. 
Proof: Assume S does not conflict with any occurrence in USAIL. Then it indicates that the 
reason why SAIL lose S can only be the length constraint. According to the definition 4, all 
the occurrences satisfy the length constraint. The contradiction is achieved. So the lemma is 
proved. 
LEMMA 4 Let USAIL be the occurrence set of SAIL, and Uopt be the optimal one. Let NSAIL 
(Nopt) be the matching number in USAIL (Uopt).  
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(1) If USAIL is the completeness set, NSAIL = Nopt is satisfied. 
(2) Otherwise, NSAIL < Nopt is obtained and there is a conflict between USAIL and Uopt. 
(3) If the condition holds Nopt = 1, NSAIL = Nopt is obtained. 
(4) If there is no conflict, NSAIL = Nopt is achieved. 
Proof: It is obvious to conclude (1) is obviously true. According to the definition 5, if NSAIL < 
Nopt, there is an occurrence S satisfying S∈Uopt and S ∉ USAIL. Due to LEMMA 3, S conflicts 
with at least one occurrence in USAIL. That is Uopt is conflict with USAIL. So (2) is proved. With 
regard to (3), let S be the unique occurrence of Uopt. Assume NSAIL < Nopt, then NSAIL = 0. That is 
SAIL has no occurrence. In accordance with LEMMA 3, S conflicts with at least one 
occurrence of SAIL. But USAIL is empty, so there is no conflict. Thus the contradiction is 
achieved. And (3) is proved. With regard to (4), it is obvious NSAIL ≤ Nopt. We assume NSAIL < 
Nopt, then there is an occurrence S satisfying S∈Uopt and S ∉ USAIL. Due to LEMMA 3, S 
conflicts with at least one occurrence in USAIL. That is Uopt and USAIL have a conflict. The 
contradiction is achieved. So (4) is proved. 
LEMMA 5 Given two occurrence sets U1,U2, if U1 conflict with U2, there are two sub-sets 
u1,u2 with a conflict where u1U1, u2U2. 
Proof: Assume there is no sub-sets with a conflict. All the matching positions of U1 and U2 
have no conflict. According to definition 10, U1 and U2 have no conflict and satisfy the one-off 
condition. The contradiction is achieved. Lemma 5 is proved. 
LEMMA 6 Given two occurrence sets U1, U2, U2 is Uopt. If there is a conflict between U1 and 
U2, and N(U1) < N(U2), there are two subsets u1,u2 where u1U1, u2U2, u1 is conflict with u2 
and N(u1) < N(u2). 
Proof: In accordance with LEMMA 5, there are subsets u1,u2 where u1U1,u2U2 with 
conflict. Let U1 = u11∪u12∪ ……∪u1n, U2 = u21∪u22∪ ……∪u2m, and u1i, u2j are arbitrary 
subsets where u1iU1, u2jU2, 1 ≤ i ≤ n, 1 ≤ j ≤ m. We discuss in three conditions: ①u1i, u2j 
have no conflict and do not satisfy N(u1i) < N(u2j), then U1,U2 have no conflict and N(U1) = 
N(U2), the contradiction is achieved. ② u1i, u2j have a conflict and do not satisfy N(u1i) < 
N(u2j), then U1,U2 have no conflict, the contradiction is achieved. ③ u1i, u2j have no conflict 
and satisfy N(u1i) < N(u2j), then N(U1) = N(U2), the contradiction is achieved. So u1i, u2j have a 
conflict and satisfy N(u1i) < N(u2j). Lemma 6 is proved. 
THEOREM 1 Given a text T, a pattern P, if SAIL is incomplete, P must be R pattern. 
Proof: Let USAIL be the occurrence set of SAIL, Uopt is the completeness set, NSAIL is the 
matching number of SAIL, and Nopt is the complete matching number. Consider the SAIL is 
incompleteness, according to LEMMA 4, NSAIL < Nopt, and USAIL conflicts with Uopt. Due to 
LEMMA 6, we get two subsets u1, u2 with conflict, which are satisfying N(u1) < N(u2) where 
u1USAIL, u2Uopt. Without loss of generality, let N(u1) = 1, N(u2) = 2. Set u1 = {S}, u2 = {A, B}, 
that is S∈USAIL, A∈Uopt, B∈Uopt. Let: 
T = t[0], t[1]… t[i]… t[n-1], t[i] is stand for the ith letter in T where i = 0,1,2……n-1 
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THEOREM 1 Given a text T, a pattern P, if SAIL is incomplete, P must be R pattern. 
Proof: Let USAIL be the occurrence set of SAIL, Uopt is the completeness set, NSAIL is the 
matching number of SAIL, and Nopt is the complete matching number. Consider the SAIL is 
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T = t[0], t[1]… t[i]… t[n-1], t[i] is stand for the ith letter in T where i = 0,1,2……n-1 
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P = p[0], p[1]… p[i]… p[m-1], p[i] is stand for the ith letter in P where i = 0,1,2……m-1 
A = a[0], a[1]… a[u]… a[m-1], a[i] is stand for the ith character maching position of 
occurrence A where i = 0,1,2…m-1 
B = b[0], b[1]… b[w]… b[m-1], another occurrece. 
S = s[0], s[1]… s[i]… s[k]… s[m-1], another occurrece. 
Let a[u], b[w] be the positions in A, B, which conflict with s[i], s[k] in S separately. We assume 
other positions in A and B do not conflict with the occurrences in USAIL. ∴ a[u] = s[i], b[w] = 
s[k] ∴t[a[u]] = t[s[i]], t[b[w]] = t[s[k]] ∵According to the definition 4, t[a[u]] = p[u], t[s[i]] = 
p[i], t[ b[w] ] = p[w], t[s[k]] = p[k] ∴ p[u] = p[i], p[w] = p[k] 
It would be discussed in the following two cases: 
① u ≠ i or w ≠ k 
② u = i and w = k 
For ①, when if u ≠ i, ∵p[u] = p[i] ∴There are two of the same letters from different positions 
in P. ∴According to definition 6, P is an R pattern. For the case of w ≠ k, similarly, it can be 
proved.  
Then we will prove the other condition is impossible, and conclude P is R pattern. 
For ②, we obtain a[u] = s[i] = s[u], b[w] = s[k] = s[w]. There is u ≠ w. ∵ Assume u = w, then u = 
i = w = k ∴a[u] = s[i] = s[k] = b[w]. Consider A, B belong to the same occurrence set, which 
contradicts with LEMMA 1 ∴ u ≠ w. Without loss of generality, let u < w, according to 
LEMMA 2 ∵ SAIL adopts the left-most strategy, and S∈USAIL,A,B ∉ USAIL ∴ s[u] < b[u], s[w] < 
a[w] ∵ a[u] = s[u], b[w] = s[w] 
 ∴ a[u] < b[u], b[w] < a[w]  (1) 
And∵ u < w, we can obtain b[u] < b[w] 
A = …a[u]…………..a[w]… 
B = ……..b[u]…b[w]……… 
The occurrence {b0, b1,…, bu,…,aw,…, am-1} can be considerd as {{b0, b1,…,bu}, {bu,…,aw}, {aw,…, 
am-1}}. 
According to the definition 4, {a0, a1,…,au,…,aw,…,am-1} and {b0, b1,…,bu,…,bw,…,bm-1} satisfy the 
local constraints. So {aw,…, am-1} and {b0, b1,…,bu} satisfy the local constraints. 
Due to {bu,…,aw}, we can get { bu, bu+1…, aw-1, aw }. 
From the equation (1), a[u] < b[u], b[w] < a[w], and according to the definition 4: 
 b[i] < b[i+1], a[i] < a[i+1] where u ≤ i ≤ w-1 (2) 
There is a t satisfying: 
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 b[t+1] < a[t+1] and a[t] < b[t] where u ≤ t ≤ w-1  (3) 
A = …a[u]……a[t]……………a[t+1]……..a[w]… 
B = ……..b[u] ……b[t]……b[t+1]……b[w]……… 
Assume there is no t satisfying the condition, consider b[t] ≠ a[t] where u ≤ t ≤ w.Then due to 
any t there is a[t+1] < b[t+1] or a[t] > b[t] where u ≤ t ≤ w-1.Consider a[u] < b[u], there is a[u+1] 
< b[u+1].Due to a[u+k] < b[u+k], we can obtain a[u+k+1] < b[u+k+1] where 0 ≤ k ≤ w-u-1.Then 
we can induce a[i] < b[i] where u ≤ i ≤ w.It contradicts b[w] < a[w], so the assume is incorrect 
Due to equation (2) and (3), a[t] < b[t] < b[t+1] < a[t+1] where u ≤ t ≤ w-1. 
 b[t+1] - b[t] < a[t+1] - b[t] < a[t+1] - a[t]  (4) 
That is a[t] and b[t-1] satisfy the local constraints. In this way, { bu, bu+1…, aw-1, aw }can be 
considered as {{ bu, bu+1…,bt-1},{bt, at+1},{ at+2 …, aw-1, aw }}. In accordance with definition 4, { bu, 
bu+1…,bt-1},{ at+2 …, aw-1, aw } satisfy the local constraints. ∴{ bu, bu+1…, aw-1, aw } satisfy the local 
constraints. ∴From the above analysis, {b0, b1,…,bu,…,aw,…, am-1} satisfy the local constraints. 
However, according to the theorem, the other positions in A,B do not conflict with USAIL 
except for a[u], b[w]. That is, {b0, b1,…,bu,,aw,…,am-1} satisfies the one-off condition. ∴{b0, 
b1,…,bu, aw,…, am-1} is another occurrence, and does not conflict with any occurrences in USAIL. 
But USAIL does not include this occurrence. It contradicts with LEMMA 3. Thus, condition ② 
is impossible. And from the analysis of ①, under the condition of the theorem, P must be R 
pattern. The theorem 1 is proved. 
THEOREM 2 Given a text T, a pattern P, if P is NR pattern, then SAIL is complete. 
Proof: It is the inverse negation of THEOREM 1. Apparently, THEOREM 2 is true. 
THEOREM 3 Given a text T, a pattern P, if P is R pattern, then SAIL is incomplete. 
Proof: It can be concluded from the analysis and example in section 2. 
THEOREM 4 If the pattern fulfills gap = 0, SAIL is complete. 
Proof: If gap = 0, the wildcard is a constant. For example a¢[1,1]c¢[2,2]c is converted into 
a¢c¢¢c. There won’t be any conflict or exist seizing between occurrences. SAIL will perform 
complete.  
Experiment design1: ∑= 4, m = {5,7,9}, gap = [0,3], rep = {0,1,2,3,4,6,7,10,11,15, 21,28,35}. In 
each set of experiments, 20 patterns are randomly generated; the final result is the average. 
Analysis of experimental results: with increment of rep, the curve of approximation ratio 
gradually decreases, followed by a slight increase. The reason for decline is that rep lead to 
more nested occurrences, resulting in a greater degree of the possibility of losing 
occurrences; the reason for the increscent is that larger rep can cause more extreme pattern. 
For instance, when ∑ = 4, m = 7, rep = 21, patterns like P1 = 
                                                                 
1 When ∑ and m are determined, rep can only be some certain values, because rep has correlation with ∑ and m 
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P = p[0], p[1]… p[i]… p[m-1], p[i] is stand for the ith letter in P where i = 0,1,2……m-1 
A = a[0], a[1]… a[u]… a[m-1], a[i] is stand for the ith character maching position of 
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proved.  
Then we will prove the other condition is impossible, and conclude P is R pattern. 
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 ∴ a[u] < b[u], b[w] < a[w]  (1) 
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B = ……..b[u]…b[w]……… 
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From the equation (1), a[u] < b[u], b[w] < a[w], and according to the definition 4: 
 b[i] < b[i+1], a[i] < a[i+1] where u ≤ i ≤ w-1 (2) 
There is a t satisfying: 
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a¢[0,3]a¢[0,3]a¢[0,3]a¢[0,3]a¢[0,3]a¢[0,3]a which is difficult to find a special text containing 
nested occurrences of such pattern, will be produced. For P1, the text like “aaaaaaaaaaaaaa” 
contains nested occurrences of this pattern. Obviously, this extreme text is very rare. 
Therefore, under the premise of nested occurrences are not easily to be formed, the 
approximation ratio will be increased slightly. 
 
Figure 7. The relation between rep and approximation ratio ε 
Next we will analyze the relationship between the repeatability rep and alphabet size ∑, 
pattern length m. Original problem: a pattern which length is m, and alphabet size is ∑, what 
is the expectation of repeatability E(rep)?  
This description is equivalent to the model of ‘taking ball from the bag’ in the combination 
mathematics:  
There is a bag of balls, and |Σ| kinds of colors, taking m balls from the bag with 




3 4 5 6 …… m 
3 3/3 6/3 10/3 15/3 …… 2 / 3mC  
4 3/4 6/4 10/4 15/4 …… 2 / 4mC  
5 3/5 6/5 10/5 15/5 …… 2 / 5mC  
6 3/6 6/6 10/6 15/6 …… 2 / 6mC  
…… …… …… …… …… …… …… 
Σ 3/| |  6/| |  10/| |  15/| |  …… 2 /| |mC   
Table 11. The relationship between ∑, m and rep 
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As an extension of traditional matching problem, the PMWL problem has aroused more 
and more attention because of its unique flexibility and complexity. Based on problem 
definition and drawing on research idea in traditional matching problem, this article 
introduces SAIL, RSAIL, SBO and BPBM which are representative algorithms for PMWL 
in three important respects: the data structures, the matching strategies and the 
characteristics of pattern. The article also analyzes the pros and cons of the above 
algorithms from the point of quality of the solution and time complexity, and gives 
experimental matching results by using real DNA data. Among them, the SAIL algorithm 
is the first to propose the method of solving PMWL problem, it uses the sliding window 
structure and the representative left-most matching strategy. This paper finds that in short 
patterns, the approximation ratio of SAIL is higher than 0.9, while in longer patterns, the 
occurrences obtained by SAIL are of poor quality; the quality of occurrences obtained by 
SBO is best, but its time consumption has a non-linear relationship with the length of text; 
BPBM utilizes bit parallel technology to improve the efficiency of matching greatly, but 
also is impact by the machine word; for pattern with repeated letters in tail, RSAIL uses 
symmetry to improve the quality of occurrences under certain conditions, thus providing 
a solving idea to PMWL problem, but in longer patterns and wilder gaps, the efficiency is 
not obvious. 
Afterwards, this article focus on relationship between approximation ratio ε and alphabet 
size ∑, pattern length m, wildcards span gap and repeatability rep. Firstly, this article 
proposes the model ε = F (Σ, m, gap), describing the functional relationship between pattern 
characteristics and approximation ratio approximately; secondly, this article proves 
PMWL’s completeness under the conditions of rep = 0; finally, the relationship between the 








In future work, the formal description of the PMWL problem will be considered, in order to 
explain the complexity of the problem better, thus helping algorithm design and analysis for 
problem complexity. 
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